data_1xjs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xjs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 tp . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.351 0.12 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.584 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 19.2 t70 -56.23 -57.12 13.57 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.681 -174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -70.2 -25.36 63.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.001 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.9 tp -70.03 -54.48 12.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.324 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 4.3 p90 -72.28 -24.2 61.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 13.6 tpp180 -56.99 -49.62 75.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.03 -36.86 80.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.555 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 10' ' ' LEU . 84.2 t -60.25 -45.5 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.61 -31.42 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.7 mtt -68.38 -40.65 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 0.0 110.906 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.89 -34.49 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.587 ' HE1' ' HB2' ' A' ' 24' ' ' ASN . 40.9 t-80 -71.33 -21.3 62.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.535 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -85.97 -31.19 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 0.0 110.934 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -67.37 -21.36 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.084 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.35 80.16 72.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.198 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.65 71.55 3.95 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.275 2.65 . . . . 0.0 113.034 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -134.45 125.53 27.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.005 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.587 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 57.7 t30 -167.2 152.41 7.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 1.086 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 55.8 tttm 72.64 94.33 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.334 1.021 . . . . 0.0 110.818 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.07 162.97 31.66 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -136.94 119.47 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.39 0.595 . . . . 0.0 110.435 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' O ' ' HB ' ' A' ' 48' ' ' THR . 2.4 tt -115.41 101.16 8.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.23 108.82 19.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.04 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -152.98 -72.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.376 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.88 -71.89 0.73 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 49' ' ' MET . 41.8 pt -108.25 127.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.3 0.572 . . . . 0.0 111.896 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 48' ' ' THR . 87.3 t -126.44 104.9 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.96 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.05 114.33 29.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.627 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' A' ' 46' ' ' ARG . 4.2 p30 -113.93 154.06 28.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.045 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.485 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 14.9 tpt -140.83 123.39 16.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.71 152.04 26.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.1 -177.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.698 ' HB2' HD12 ' A' ' 131' ' ' LEU . 41.7 t-20 -122.05 83.08 44.27 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.8 -6.71 11.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.236 2.624 . . . . 0.0 113.152 -171.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.5 m -86.11 -43.18 13.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.441 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 49.8 t -99.82 -24.93 14.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.67 0.04 36.78 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.654 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 41' ' ' CYS . 2.8 m-20 -70.52 145.83 50.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.418 ' HG3' ' ND2' ' A' ' 37' ' ' ASN . 20.3 ttm-85 -154.09 114.24 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 64.6 mt -122.4 110.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.494 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.727 ' HB2' ' HB3' ' A' ' 62' ' ' GLU . 32.3 mtp180 -94.42 109.45 21.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.728 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.801 HD22 ' HE1' ' A' ' 49' ' ' MET . 52.3 tp -99.55 104.4 16.2 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.502 0.668 . . . . 0.0 109.331 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.682 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 3.2 p -115.75 103.56 10.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.034 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.801 ' HE1' HD22 ' A' ' 47' ' ' LEU . 60.7 mtt -107.77 163.45 13.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.072 0.463 . . . . 0.0 110.939 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 87.7 tttt -130.01 100.46 5.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.572 174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.33 105.25 17.22 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -109.72 72.54 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 -172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.05 -101.17 0.25 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.366 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.66 20.48 2.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.116 0.96 . . . . 0.0 108.601 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.6 pp -127.37 -162.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.588 -174.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 80' ' ' ILE . 57.6 t -123.76 117.74 52.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.387 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 50.6 mm-40 -86.11 -48.99 8.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.9 174.76 12.74 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.052 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -162.04 131.46 4.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.528 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -121.76 118.99 30.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -106.41 99.45 9.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.839 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.086 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 31.5 tt0 -81.27 79.43 7.91 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -104.18 114.69 4.81 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.637 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 10.1 tp10 -121.01 150.76 40.65 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.44 -132.5 4.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.626 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.58 -175.66 2.92 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.902 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 m -61.48 -40.82 95.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.478 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -79.61 -42.93 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -171.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.681 ' N ' HD13 ' A' ' 68' ' ' ILE . 2.7 p -65.51 -52.35 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.922 0.391 . . . . 0.0 112.048 -170.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -22.38 64.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.016 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -85.28 -48.61 8.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.341 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.4 p -59.22 -46.77 87.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 110.848 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.97 83.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.0 m -61.29 -34.25 74.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.432 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.19 -43.72 27.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 0.0 109.835 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.431 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 95.0 mmm -73.75 -32.08 63.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.527 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.8 p -74.6 -19.97 60.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.994 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -72.04 -38.37 69.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 83' ' ' LYS . . . -71.29 -34.11 70.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.728 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.464 HG23 HG13 ' A' ' 56' ' ' VAL . 14.6 mm -71.99 -41.07 68.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -57.29 -19.0 19.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.322 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.53 25.6 10.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 79' ' ' ALA . 13.2 mptt -127.55 -168.6 1.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.501 . . . . 0.0 110.784 -173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -120.15 -165.98 1.25 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.2 mm -87.27 -38.42 12.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.881 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.36 -49.79 76.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.256 0.551 . . . . 0.0 109.987 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 p -67.55 -32.59 73.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.252 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.72 -43.6 68.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.6 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 79.9 mt -65.79 -36.16 82.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.718 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 t -68.11 -45.48 73.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.292 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 51.1 ttm -58.11 -35.18 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.03 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 7.6 p -87.69 -30.26 20.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.481 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.717 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 83.2 tttt -61.83 -48.2 81.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 tt -71.67 -32.32 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.047 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 91' ' ' MET . 31.7 t80 -57.22 -44.99 84.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.176 0.512 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -77.99 -33.97 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.899 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.286 -177.411 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 113' ' ' ILE . 83.9 mt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -50.05 -57.72 9.63 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.231 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.38 -35.01 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.675 HD12 HD23 ' A' ' 110' ' ' LEU . 59.0 mt -59.78 -39.51 80.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.519 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 40.0 mt-10 -77.61 -23.35 49.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.006 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -43.17 25.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.306 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.7 tp -65.03 -37.4 87.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.286 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 1.8 pt20 -73.37 -23.49 60.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.7 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 -47.98 76.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.189 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.834 HG23 ' HB1' ' A' ' 129' ' ' ALA . 19.3 m -81.99 -18.58 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.868 0.366 . . . . 0.0 111.28 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 t -52.15 -12.64 0.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -117.92 -25.08 6.87 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.689 -0.632 . . . . 0.0 111.043 -163.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -74.58 129.6 83.47 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.49 -29.96 19.89 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.995 2.463 . . . . 0.0 113.022 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.53 -15.32 28.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.658 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 8.5 mmt180 -113.65 -4.98 13.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.633 -172.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.93 -32.05 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.482 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HG3' HD22 ' A' ' 38' ' ' ASN . 13.3 pttt -81.14 -19.03 44.38 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.625 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.452 ' HB3' HD11 ' A' ' 68' ' ' ILE . 56.9 m -85.61 -28.12 25.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.834 ' HB1' HG23 ' A' ' 119' ' ' VAL . . . -75.23 -50.36 16.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.245 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.9 p -64.92 -26.34 68.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.099 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 38' ' ' ASN . 9.9 tt -54.18 -64.67 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 24.9 m -63.94 -34.12 77.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.045 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -66.42 -58.02 6.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.493 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.92 -32.93 74.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.703 0.287 . . . . 0.0 111.377 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 76' ' ' MET . 14.2 tp -79.06 -38.42 36.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' CD ' ' HD3' ' A' ' 142' ' ' LYS . 74.0 mt-10 -70.26 -21.91 62.92 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.731 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -86.98 -22.48 25.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.347 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.64 -60.19 8.57 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.814 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.48 11.49 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.747 -0.267 . . . . 0.0 110.975 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.86 -175.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.031 0.832 . . . . 0.0 109.955 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 59.5 pttt -145.33 166.7 24.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.302 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.717 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 52.4 mt-10 60.15 -104.89 0.2 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.938 0.774 . . . . 0.0 110.201 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.405 ' CD ' ' HZ3' ' A' ' 93' ' ' LYS . 1.6 mp0 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.436 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 47.7 tp . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.62 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.8 m-20 -59.92 -45.26 93.13 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.34 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -59.81 -45.88 90.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.138 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 14' ' ' VAL . 80.8 mt -70.4 -60.72 2.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.955 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.62 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.9 p90 -63.73 -36.09 82.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 12' ' ' ARG . 12.8 ttp180 -74.65 -28.63 60.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.29 -42.16 46.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.4 t -63.4 -46.47 95.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.207 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.6 tt -67.27 -32.75 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.76 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -68.77 -47.31 66.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.86 -48.24 79.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.04 -17.9 61.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.15 -42.49 80.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.592 0.71 . . . . 0.0 109.285 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 1.8 tmmt? -71.15 -27.04 63.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.723 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.96 85.57 28.61 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 121.035 0.445 . . . . 0.0 111.867 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.52 167.78 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.402 2.735 . . . . 0.0 112.88 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -162.99 25.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.83 36.93 1.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.586 -165.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -141.75 108.87 5.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 111.381 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.624 ' HA3' ' HD2' ' A' ' 60' ' ' LYS . . . 167.4 144.83 4.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.136 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.82 111.16 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.0 109.864 171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.627 ' O ' ' HB ' ' A' ' 48' ' ' THR . 47.2 tp -109.53 85.24 2.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.69 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.06 80.07 3.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -141.94 -73.35 0.32 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.635 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 49' ' ' MET . 14.5 m -95.26 -85.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 48' ' ' THR . 78.2 mt -93.35 130.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.051 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.01 95.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' A' ' 47' ' ' LEU . 3.6 p -131.21 108.08 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 111.224 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 5.0 t70 -95.34 145.05 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.959 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.442 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 9.7 tpt -144.17 115.22 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.443 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 4.9 p30 -120.27 158.04 27.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.564 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.547 ' HB2' HD11 ' A' ' 131' ' ' LEU . 10.8 t-20 -135.06 105.88 10.4 Favored Pre-proline 0 CA--C 1.52 -0.184 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.87 -16.94 57.86 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.919 2.413 . . . . 0.0 112.795 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -61.6 -38.91 89.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.411 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 6.4 p -131.0 -14.13 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.76 42.5 4.43 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.557 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' A' ' 131' ' ' LEU . 5.3 m-20 -87.07 145.96 26.26 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 30.0 mtm180 -143.18 113.74 7.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 131' ' ' LEU . 64.7 mt -121.52 93.94 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 42.1 ttm105 -89.12 99.22 12.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.882 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 61' ' ' PHE . 62.5 mt -88.1 106.63 18.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 123.843 0.715 . . . . 0.0 109.466 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 p -115.77 96.16 5.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.337 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.616 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 42.1 mtp -104.38 156.13 18.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.202 -167.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -120.81 87.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.52 0.676 . . . . 0.0 109.47 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.625 HD22 HG13 ' A' ' 32' ' ' ILE . 2.4 pt? -87.38 105.06 17.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.698 173.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.93 67.14 0.74 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.721 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.35 -101.5 0.25 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -139.01 18.2 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.605 HD13 ' O ' ' A' ' 55' ' ' ILE . 2.8 pp -120.26 150.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.65 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.3 112.5 39.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.12 -45.78 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -109.09 147.71 31.98 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.728 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -151.65 118.63 5.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 47.8 mmtm -111.7 111.23 22.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.799 ' HB3' HD21 ' A' ' 47' ' ' LEU . 7.8 p90 -127.01 105.22 8.45 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.318 0.58 . . . . 0.0 110.884 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.89 82.56 2.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 170.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -103.61 109.25 3.39 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.533 -172.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 7.4 pt-20 -127.74 159.58 34.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.47 -131.44 4.2 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.064 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.8 p -102.37 169.1 8.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -52.29 -48.16 65.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.73 0.644 . . . . 0.0 112.452 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.95 HD13 ' HG ' ' A' ' 69' ' ' SER . 2.4 pp -69.6 -36.23 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -171.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.95 ' HG ' HD13 ' A' ' 68' ' ' ILE . 1.9 m -72.11 -43.83 64.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 109.802 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.2 ttt -70.84 -23.93 62.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.584 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.461 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -88.69 -61.04 1.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.76 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -67.19 -50.47 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.842 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.57 94.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 110.328 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.684 ' HG ' ' HE2' ' A' ' 61' ' ' PHE . 35.4 t -69.41 -31.96 70.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.542 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.5 tpt -73.24 -41.4 63.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.163 0.506 . . . . 0.0 109.827 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.514 ' HE3' HD23 ' A' ' 136' ' ' LEU . 88.3 mtp -62.86 -30.86 71.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.879 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.41 HG23 ' CE1' ' A' ' 61' ' ' PHE . 50.8 m -72.91 -22.31 60.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.894 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.53 -33.44 71.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.418 0.627 . . . . 0.0 109.317 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.47 25.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.292 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.17 -32.02 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.089 -174.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.06 -17.11 63.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.308 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.22 27.79 7.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.935 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -134.12 -155.53 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 111.633 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.18 156.7 48.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -170.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 85' ' ' ILE . 2.3 mp -61.49 -42.87 95.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -41.48 73.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.177 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.0 m -79.23 -33.9 43.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.94 88.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.362 . . . . 0.0 110.779 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 144' ' ' GLU . 7.6 mp -64.74 -31.36 72.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.526 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.9 m -72.76 -33.92 66.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.129 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.0 ttm -67.81 -34.73 77.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.794 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 p -82.09 -30.02 31.46 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.98 -42.1 97.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.5 tt -78.95 -25.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.054 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.64 -40.71 97.86 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.3 m -65.6 -31.99 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.875 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.712 -178.27 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 110' ' ' LEU . 2.6 mm? . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.25 0.072 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.58 36.22 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.733 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.72 -38.94 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.067 0.46 . . . . 0.0 111.119 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.62 -34.9 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.936 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.548 ' HA ' ' OE1' ' A' ' 117' ' ' GLN . 40.6 tt0 -62.68 -30.83 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.0 110.239 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.71 -9.97 59.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.4 -44.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.496 0.665 . . . . 0.0 109.773 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.548 ' OE1' ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -77.95 -19.04 55.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.881 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.09 -50.37 63.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.314 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 129' ' ' ALA . 23.1 m -71.87 -19.16 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.232 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.572 ' O ' HG22 ' A' ' 126' ' ' ILE . 58.7 m -55.92 -12.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.769 0.827 . . . . 0.0 112.947 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.29 -8.44 7.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 111.274 -163.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.837 ' HB2' ' HG2' ' A' ' 125' ' ' ARG . 34.3 m-85 -84.5 131.59 49.59 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.68 -18.98 6.88 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.163 2.576 . . . . 0.0 112.943 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.48 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -104.87 -8.53 18.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.837 ' HG2' ' HB2' ' A' ' 122' ' ' PHE . 6.8 mmm-85 -123.55 9.85 9.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.008 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 122' ' ' PHE . 26.3 pt -74.22 -28.65 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.024 0.916 . . . . 0.0 108.889 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -85.2 -25.09 27.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.806 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 26.4 t -86.32 -28.84 23.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.367 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -75.79 -46.34 31.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 p -61.49 -30.15 70.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.9 tt -50.29 -63.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.417 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 m -67.73 -45.21 75.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.509 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.62 -52.18 64.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.829 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 137' ' ' GLU . 37.4 ttmt -74.15 -19.42 60.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.28 91.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.392 . . . . 0.0 110.282 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.514 HD23 ' HE3' ' A' ' 76' ' ' MET . 4.7 mp -81.91 -39.6 23.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.719 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 8.4 mm-40 -64.2 -20.35 65.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.211 0.529 . . . . 0.0 110.863 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.24 -34.98 10.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.2 -55.78 19.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.892 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.43 6.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 122.704 -0.292 . . . . 0.0 111.316 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 74.43 178.21 0.22 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.224 0.953 . . . . 0.0 110.642 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.719 ' HD3' ' HB3' ' A' ' 137' ' ' GLU . 19.1 pttm -143.76 141.33 30.39 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 65.89 -67.64 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.107 0.963 . . . . 0.0 111.551 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.7 ' HA ' HD23 ' A' ' 89' ' ' LEU . 42.5 tt0 . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.208 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' A' ' 115' ' ' ALA . 67.7 tp . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.741 0.305 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.27 -46.76 76.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.22 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -59.02 -33.69 71.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.346 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 14' ' ' VAL . 92.4 mt -75.38 -50.27 16.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' O ' HG13 ' A' ' 15' ' ' ILE . 4.5 m-85 -55.18 -42.44 73.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.858 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -51.42 -45.52 62.6 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.703 0.627 . . . . 0.0 109.911 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -73.43 -42.72 61.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.554 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 ' HE3' ' A' ' 75' ' ' MET . 83.7 t -58.76 -48.54 85.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 111.421 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.9 pp -73.99 -21.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.626 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 78.0 mmm -73.53 -43.31 60.28 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.194 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.81 -39.13 93.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.112 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -76.33 -19.24 58.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -72.05 -39.43 69.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.197 0.522 . . . . 0.0 109.753 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -72.25 -19.97 61.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.759 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -119.44 81.29 22.91 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.19 20.49 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.842 2.361 . . . . 0.0 112.847 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 2.1 mpt_? -93.47 95.21 9.13 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.839 HD22 ' HB2' ' A' ' 70' ' ' MET . 36.6 t30 -118.38 24.38 10.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.0 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.793 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 51.2 mttp -137.59 114.33 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.861 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.563 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -157.34 133.22 3.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.49 105.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.862 0.839 . . . . 0.0 111.699 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 50' ' ' LYS . 3.5 tt -115.8 79.22 1.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.726 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HA ' HG23 ' A' ' 33' ' ' VAL . 4.3 t30 -82.53 8.71 11.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.853 -171.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -94.02 3.65 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.872 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -144.56 -104.31 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.364 -0.21 . . . . 0.0 110.579 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.579 HG23 ' HE3' ' A' ' 49' ' ' MET . 63.6 mt -83.87 128.32 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.273 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 29' ' ' ASN . 24.8 t -128.49 101.23 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.439 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.983 HG23 ' HA2' ' A' ' 139' ' ' GLY . 59.6 t -116.98 120.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -126.05 145.68 50.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.81 0.338 . . . . 0.0 110.163 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.435 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 25.5 mmt -138.37 126.47 22.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.93 135.87 43.81 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.158 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.508 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.6 t-20 -132.91 97.92 16.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 40' ' ' THR . 48.1 Cg_exo -16.81 -79.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 1 C-N-CA 125.886 4.391 . . . . 0.0 115.669 -162.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.41 ' H ' ' HB2' ' A' ' 39' ' ' PRO . 12.1 p -117.0 17.87 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.933 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.1 15.02 4.69 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.766 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.17 54.95 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.86 -71.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.123 1.369 . . . . 0.0 113.307 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 44' ' ' ARG . 10.4 ptt180 -159.84 119.24 2.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.516 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.642 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 5.7 tt -104.33 106.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.38 171.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 62' ' ' GLU . 51.4 mtm180 -96.68 102.72 14.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.973 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.0 104.75 14.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 1.9 p -117.18 121.74 42.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.93 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.579 ' HE3' HG23 ' A' ' 32' ' ' ILE . 56.7 mtm -124.17 136.69 54.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.396 -169.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HB2' HD11 ' A' ' 28' ' ' LEU . 7.1 tmtt? -109.49 87.47 2.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.3 pt? -77.82 115.0 17.23 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.25 66.33 0.67 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.156 0.503 . . . . 0.0 110.128 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.38 -103.07 0.29 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.58 4.67 5.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.1 pp -110.21 -164.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.627 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG22 HG11 ' A' ' 140' ' ' VAL . 25.7 t -126.48 104.2 12.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.635 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 40.9 tt0 -81.7 -71.37 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.956 -171.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' MET . 34.3 t0 -109.68 104.14 13.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.502 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' CB ' ' HG2' ' A' ' 49' ' ' MET . . . -102.44 113.59 27.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.166 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 12.7 mtpp -112.04 131.85 55.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 74' ' ' SER . 2.7 p90 -123.05 102.87 8.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.275 0.56 . . . . 0.0 111.434 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.793 ' HG3' ' HG2' ' A' ' 25' ' ' LYS . 23.9 tt0 -104.84 94.57 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.603 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -111.29 130.11 9.56 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.824 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.19 131.9 56.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.766 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 161.31 -132.25 2.81 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.465 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 70' ' ' MET . 3.5 p -99.65 155.71 17.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 4.3 m -55.63 -36.27 66.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.925 0.765 . . . . 0.0 112.321 -168.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -81.83 -35.75 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.638 ' N ' HD13 ' A' ' 68' ' ' ILE . 35.2 p -73.73 -39.58 64.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.018 0.437 . . . . 0.0 110.693 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.839 ' HB2' HD22 ' A' ' 24' ' ' ASN . 26.1 ptt? -82.07 -8.21 59.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.6 -57.82 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.502 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -64.02 -53.64 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.585 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.76 82.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.317 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.535 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 20.1 m -63.16 -34.11 76.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.54 ' HE3' HG23 ' A' ' 14' ' ' VAL . 56.0 ttp -69.21 -47.43 64.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.07 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.5 69.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.7 m -66.18 -25.36 66.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.144 0.497 . . . . 0.0 110.654 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 74' ' ' SER . 79.1 mt-30 -73.47 -34.54 65.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -69.0 -33.87 74.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.674 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.3 mm -72.32 -30.45 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.63 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.01 -17.29 37.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.506 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.32 31.17 5.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.623 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 66.5 mttm -133.23 -174.89 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.692 -0.299 . . . . 0.0 110.934 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.729 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.7 -175.91 2.99 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -175.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' O ' HD21 ' A' ' 89' ' ' LEU . 1.7 mp -86.01 -46.79 16.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.978 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -59.19 -40.22 85.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.1 p -73.4 -33.46 65.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.999 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.97 90.89 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.418 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 142' ' ' LYS . 4.5 mm? -64.76 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.95 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.0 m -85.03 -29.94 24.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' THR . 92.6 mmm -69.07 -26.31 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.593 176.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.615 ' HG ' ' HG2' ' A' ' 142' ' ' LYS . 2.2 p -85.41 -31.35 22.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -58.28 -47.33 83.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 mt -57.83 -42.67 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.715 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -55.83 -48.14 75.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.831 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.6 p -70.16 -35.96 74.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.948 179.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.752 0.311 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.26 -24.79 69.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.488 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.08 -28.94 43.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.771 0.32 . . . . 0.0 111.332 -175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.06 -35.57 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.224 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.92 -34.74 75.16 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.199 0.524 . . . . 0.0 109.928 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' A' ' 7' ' ' LEU . . . -70.37 -20.65 62.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.872 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.28 -34.41 15.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 109.757 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -61.5 -31.12 71.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.013 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.23 -41.68 98.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.751 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.777 HG13 ' HD3' ' A' ' 125' ' ' ARG . 34.5 m -85.91 -20.44 8.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 111.404 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . 33.0 t -54.04 -15.14 1.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -130.36 -23.37 2.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.841 0.746 . . . . 0.0 112.78 -162.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 68.5 m-85 -70.96 135.63 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.29 -25.07 45.33 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.737 2.292 . . . . 0.0 111.844 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.46 -3.7 39.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.402 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.777 ' HD3' HG13 ' A' ' 119' ' ' VAL . 99.6 mtt180 -123.16 0.82 9.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.605 -0.684 . . . . 0.0 110.327 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 tt -72.43 -31.59 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.528 0.68 . . . . 0.0 109.78 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -79.96 -19.49 47.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.033 175.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.5 t -85.32 -19.54 31.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 120' ' ' SER . . . -75.27 -46.56 32.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.41 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.6 m -58.39 -37.79 76.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.589 HD23 ' HB2' ' A' ' 69' ' ' SER . 6.8 tt -52.95 -70.92 0.08 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.442 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -58.39 3.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.53 0.681 . . . . 0.0 111.087 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.06 -49.83 66.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.205 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 37.3 tttp -83.51 -21.07 32.89 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.184 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.57 -30.11 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.392 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -86.63 -40.83 14.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 1.095 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 2.9 tm-20 -63.68 -47.6 80.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.883 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.912 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -92.87 -11.27 33.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.982 -171.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.983 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -59.22 -54.77 35.14 Favored Glycine 0 C--O 1.23 -0.143 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.095 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.469 HG11 HG22 ' A' ' 56' ' ' VAL . 18.1 m -114.52 21.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 142' ' ' LYS . . . 68.15 155.82 0.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.417 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 1.095 ' HE2' ' HA ' ' A' ' 137' ' ' GLU . 8.9 mtmm -173.33 151.58 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 31.6 tt0 66.73 117.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.744 0.652 . . . . 0.0 110.123 -172.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 m-20 -49.12 -45.78 44.04 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.839 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.3 m -62.36 -43.69 98.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.174 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mm? -76.46 -56.92 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.116 -171.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 9.8 p90 -68.73 -37.49 79.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.797 -169.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -68.59 -37.2 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.91 -46.06 72.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.179 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 10' ' ' LEU . 78.7 t -62.69 -46.48 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.789 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.0 -44.4 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.061 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.1 ttt -61.81 -49.03 77.96 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.72 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.946 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -74.59 -16.99 60.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.395 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -76.73 -32.31 57.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 0.0 109.796 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -76.82 -21.46 55.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -117.95 71.23 8.01 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.85 38.5 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.529 2.819 . . . . 0.0 114.929 -161.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.01 92.52 4.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.932 0.396 . . . . 0.0 110.565 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.51 15.37 8.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.701 . . . . 0.0 109.27 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -118.85 85.22 2.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.56 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.43 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -119.2 122.97 5.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.09 100.04 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.0 111.708 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 48' ' ' THR . 20.4 tp -108.07 175.52 5.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.488 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.2 p-10 -156.93 97.65 1.7 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -141.73 -90.85 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.702 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -108.39 -65.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.821 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.694 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 65.4 mt -87.83 121.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.04 90.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.47 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.68 112.27 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.532 0.682 . . . . 0.0 111.231 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -109.19 123.87 49.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.566 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.553 ' O ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.23 118.59 24.55 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.66 132.4 56.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.417 0.627 . . . . 0.0 112.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.573 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 19.7 t-20 -106.02 105.88 55.03 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.8 Cg_exo -65.58 40.31 0.13 Allowed 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.809 3.673 . . . . 0.0 115.364 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.6 t -178.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.697 0.284 . . . . 0.0 110.742 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 t -133.91 18.94 3.81 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -168.77 42.16 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -33.2 -54.21 0.39 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -146.97 136.47 22.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.902 1.228 . . . . 0.0 112.268 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 36' ' ' MET . 8.1 tt -130.66 94.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 10.4 ttm180 -88.0 115.99 25.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.996 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.65 106.33 9.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.1 p -117.72 112.36 20.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.193 0.521 . . . . 0.0 110.978 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.694 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 81.1 mtp -103.97 162.46 13.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.24 -173.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -130.77 104.58 7.25 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -108.62 94.82 5.26 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.829 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.06 63.52 4.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.525 1.155 . . . . 0.0 109.911 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.74 -100.97 0.25 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.571 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 8.4 m-20 -143.15 30.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.829 -0.685 . . . . 0.0 109.291 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.7 pp -137.1 156.46 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.36 102.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.39 -46.13 16.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -153.59 169.72 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.684 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -158.37 129.81 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.061 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' CG ' ' HB2' ' A' ' 28' ' ' LEU . 67.9 mmtt -112.59 129.54 56.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 27.7 p90 -128.03 128.79 45.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.075 0.464 . . . . 0.0 111.804 -174.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.31 108.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.39 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.09 138.31 14.41 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.455 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -132.41 104.2 6.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.13 -130.3 1.29 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.218 -172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 158.45 19.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -52.14 -38.31 57.13 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.611 0.569 . . . . 0.0 111.882 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.672 HD11 ' N ' ' A' ' 69' ' ' SER . 2.3 pp -72.11 -44.0 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.672 ' N ' HD11 ' A' ' 68' ' ' ILE . 7.4 p -70.9 -38.33 73.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.04 -38.22 82.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.089 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.408 ' HB3' HG11 ' A' ' 14' ' ' VAL . . . -85.49 -45.65 11.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.066 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -55.32 -45.53 76.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.351 . . . . 0.0 110.352 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -56.67 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 40.5 p -58.04 -40.76 81.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.781 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.7 ttt -73.37 -41.81 62.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.146 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.913 ' HE2' HD23 ' A' ' 136' ' ' LEU . 94.8 mtp -73.42 -31.93 64.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.749 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -73.44 -20.36 60.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 74' ' ' SER . 85.3 mt-30 -81.03 -41.33 22.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.51 95.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.067 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.43 -20.91 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.851 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -66.01 -21.86 66.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.56 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.72 29.56 10.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.911 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -135.16 -172.63 3.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.337 0.568 . . . . 0.0 110.626 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.721 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.3 p-10 -112.36 -172.0 1.96 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.2 mm -85.93 -35.2 9.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.1 -39.58 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.694 0.283 . . . . 0.0 110.66 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.38 -23.68 61.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.286 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.982 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 86.8 mt -66.39 -34.14 77.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.653 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.564 ' O ' HG12 ' A' ' 94' ' ' ILE . 4.5 p -78.07 -35.36 49.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 19.0 ttt -60.34 -37.89 82.07 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.081 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 28.2 p -84.71 -27.72 26.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 109.867 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.975 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 17.8 tptp -57.77 -53.29 59.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.719 ' HA ' ' HB2' ' A' ' 97' ' ' ASP . 17.5 pt -75.58 -22.85 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 91' ' ' MET . 34.3 t80 -69.72 -26.79 64.51 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.8 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -85.27 -26.61 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.344 0.593 . . . . 0.0 109.966 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 94' ' ' ILE . 2.0 m-20 . . . . . 0 C--O 1.22 -0.498 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.601 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.807 0.336 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -70.24 -32.15 68.83 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.868 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -45.96 91.73 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.905 0.482 . . . . 0.0 110.292 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.1 -37.73 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.625 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mm-40 -61.34 -36.0 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.48 68.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -91.35 -21.07 21.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.856 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -50.96 -35.25 32.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.19 46.1 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.851 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 125' ' ' ARG . 29.6 m -86.27 -18.32 8.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 65.9 m -52.96 -18.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -169.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.846 ' HZ1' ' HB2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -157.37 5.04 0.14 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.931 -165.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.742 ' HD2' ' HD2' ' A' ' 125' ' ' ARG . 17.0 m-85 -85.7 132.61 43.82 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 172.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.89 -16.1 11.1 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.91 2.407 . . . . 0.0 112.335 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.83 -11.59 17.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.342 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.742 ' HD2' ' HD2' ' A' ' 122' ' ' PHE . 94.8 mtt180 -123.74 1.33 8.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.682 -0.636 . . . . 0.0 110.271 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -79.73 -24.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.537 -168.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -76.3 -19.56 58.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.386 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 95.5 m -85.88 -24.52 26.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.796 172.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -71.9 -48.03 48.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.708 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -60.98 -30.06 70.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.831 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 9.9 tt -60.02 -66.79 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 t -71.02 -42.26 69.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.407 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -67.95 -55.33 13.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.661 0.267 . . . . 0.0 110.833 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.57 -25.38 63.96 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.123 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.11 93.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.298 . . . . 0.0 110.771 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.913 HD23 ' HE2' ' A' ' 76' ' ' MET . 2.3 tp -76.1 -43.79 41.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.84 -19.79 65.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.957 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -85.07 -14.62 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.461 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.56 -68.3 1.69 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.196 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 85' ' ' ILE . 35.6 m -103.47 5.58 10.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 122.843 -0.21 . . . . 0.0 111.158 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 72.96 162.25 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.223 0.952 . . . . 0.0 110.351 -173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 14.5 pttp -121.1 148.36 44.3 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.314 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.975 ' HG2' ' HA ' ' A' ' 93' ' ' LYS . 41.4 mt-10 65.39 -161.27 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.884 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.404 0.621 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.554 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 30.2 t70 -71.46 -43.48 66.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.436 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -69.56 -26.83 64.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.587 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.441 ' O ' HG21 ' A' ' 14' ' ' VAL . 92.0 mt -71.75 -30.48 65.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.218 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 8' ' ' ASP . 15.3 m-85 -59.23 -49.63 77.12 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.893 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 1.8 mpt_? -59.1 -33.79 71.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.725 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -71.4 -49.98 36.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 71' ' ' ALA . 59.5 t -75.25 -39.86 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.806 -173.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.7 -27.96 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.294 -0.254 . . . . 0.0 110.648 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.4 ttt -66.87 -39.19 87.46 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.27 -43.23 74.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.775 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.1 -27.62 69.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.758 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -71.61 -39.71 70.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.518 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -63.71 -32.04 73.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.193 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 23' ' ' ARG . 70.7 m-20 -83.88 166.96 30.94 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.852 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.48 16.92 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.021 2.481 . . . . 0.0 113.445 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 21' ' ' ASN . 51.5 mtt180 59.33 -159.67 0.29 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.865 0.466 . . . . 0.0 111.062 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -103.27 80.09 1.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.88 0.372 . . . . 0.0 111.391 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -145.67 94.22 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.799 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.683 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.23 133.73 2.98 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.778 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.58 104.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 0.0 110.428 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.541 ' O ' ' HB ' ' A' ' 48' ' ' THR . 1.1 tt -111.02 88.88 2.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.03 98.94 8.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 21.2 t70 -143.71 -73.45 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.943 0.401 . . . . 0.0 111.145 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -124.67 -62.37 1.25 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.667 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 37.0 mt -92.35 118.74 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.054 0.454 . . . . 0.0 110.846 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 48' ' ' THR . 48.4 t -136.85 97.01 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.541 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.868 HG12 ' HA ' ' A' ' 135' ' ' ALA . 24.1 t -104.19 130.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.104 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -132.92 118.6 19.1 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -128.74 116.02 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.047 0.451 . . . . 0.0 109.823 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -114.06 140.58 48.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.055 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 34.5 t30 -139.97 105.61 6.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.4 Cg_endo -42.15 113.35 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.984 3.123 . . . . 0.0 113.867 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.8 m 78.93 -22.68 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.663 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 t -121.87 -18.33 7.07 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.296 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -143.68 48.78 0.73 Allowed Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -29.71 -67.26 0.08 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 125.567 1.392 . . . . 0.0 113.392 -164.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.52 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 41.4 ptt85 -167.76 138.69 2.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.23 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.799 ' HB ' ' HE2' ' A' ' 70' ' ' MET . 10.1 tt -132.3 115.22 25.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.237 0.541 . . . . 0.0 109.932 173.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 29.6 ttp180 -106.21 105.99 16.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.845 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.998 HD23 ' HE1' ' A' ' 49' ' ' MET . 10.0 tt -106.85 107.75 18.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 14.5 p -113.27 133.21 55.22 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.718 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.998 ' HE1' HD23 ' A' ' 47' ' ' LEU . 68.2 mtt -126.67 158.06 37.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.488 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 28.4 tttm -130.23 95.74 3.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 176.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -88.18 97.43 11.0 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.39 63.26 1.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.0 -104.3 0.31 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.55 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.31 30.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.802 0.334 . . . . 0.0 110.21 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -137.63 157.71 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.82 88.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 11.7 tp10 -75.87 -56.95 4.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.244 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -131.81 153.13 50.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.757 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -156.01 131.08 9.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.606 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.683 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.5 mttp -140.6 136.13 32.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.2 p90 -132.18 106.52 8.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.822 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.82 114.33 26.05 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -151.03 150.91 22.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.173 -1.489 . . . . 0.0 114.563 -173.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.61 142.72 39.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.05 2.46 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.869 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.8 m -94.06 159.1 15.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -56.82 -39.45 74.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.838 0.711 . . . . 0.0 111.027 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.798 HD11 ' HG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -72.99 -32.63 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.798 ' HG ' HD11 ' A' ' 68' ' ' ILE . 1.5 m -68.25 -54.82 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.752 0.786 . . . . 0.0 110.289 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.799 ' HE2' ' HB ' ' A' ' 45' ' ' ILE . 18.5 mmt -78.4 -5.11 51.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.594 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -86.9 -50.48 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 p -72.9 -47.45 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.275 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.13 81.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.294 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 p -68.25 -30.89 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -47.05 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.484 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 96.3 mmm -61.95 -35.88 79.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 m -71.83 -24.1 61.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.042 0.449 . . . . 0.0 111.057 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -46.68 57.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.88 65.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -74.88 -27.66 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.298 0.571 . . . . 0.0 110.329 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.23 36.32 3.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.659 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.71 174.01 11.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -120.39 -162.53 0.95 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.87 -37.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.81 -46.24 88.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.526 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 p -81.28 -19.18 43.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.753 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.6 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 -46.38 87.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 m -67.57 -28.58 67.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.146 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 44.9 ttp -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.149 0.499 . . . . 0.0 110.106 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.695 ' HB2' ' HB3' ' A' ' 141' ' ' ALA . 48.0 t -85.65 -28.03 25.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.267 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.814 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 3.5 tmtp? -60.25 -49.62 76.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 tt -76.24 -25.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.443 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.441 ' CB ' ' HA ' ' A' ' 92' ' ' SER . 76.4 t80 -57.99 -44.24 87.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.075 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -82.1 -34.97 29.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 110.638 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.073 -174.008 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.226 -0.142 0 CA-C-O 120.408 0.147 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.71 -42.84 97.02 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.299 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.17 -44.25 80.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.191 0.52 . . . . 0.0 110.216 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.7 mm -64.86 -32.5 58.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.41 -36.89 81.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.17 0.51 . . . . 0.0 110.314 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.78 -12.66 61.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.728 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.07 -6.33 17.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.807 0.813 . . . . 0.0 109.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.967 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.47 98.83 Favored Glycine 0 C--N 1.329 0.179 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.15 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 129' ' ' ALA . 27.6 m -69.59 -19.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 29.3 t -59.03 -13.7 7.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 -18.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.378 -165.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -61.95 126.89 88.32 Favored Pre-proline 0 CA--C 1.518 -0.279 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -18.89 9.37 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.829 2.352 . . . . 0.0 112.919 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.428 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -101.13 -10.46 20.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.658 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 5.9 mpt_? -128.27 -1.75 5.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.359 -0.838 . . . . 0.0 110.052 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 120' ' ' SER . 8.0 tt -60.92 -36.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.344 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.567 ' HA ' ' HB ' ' A' ' 130' ' ' THR . 82.2 mttt -85.9 -21.01 28.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.525 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . 82.7 m -71.57 -32.45 68.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.69 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -80.04 -39.7 29.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.525 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 127' ' ' LYS . 51.9 m -59.32 -43.97 92.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.855 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.628 HD12 ' HB3' ' A' ' 69' ' ' SER . 4.4 pp -63.82 -36.02 82.54 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.492 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.435 ' N ' HD11 ' A' ' 131' ' ' LEU . 14.4 m -72.65 -52.64 14.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.907 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 -49.75 64.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.454 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.18 -26.9 65.98 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.373 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.868 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -69.23 -32.66 72.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 0.0 110.596 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 tp -85.48 -39.22 17.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.854 ' HA ' ' HB1' ' A' ' 141' ' ' ALA . 30.3 tt0 -64.95 -44.42 89.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.413 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -69.45 -13.21 62.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.815 -172.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.61 -65.17 1.74 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.441 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 m -144.77 17.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HB1' ' HA ' ' A' ' 137' ' ' GLU . . . -122.17 122.2 38.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.949 -0.469 . . . . 0.0 111.944 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -159.93 30.01 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.944 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.814 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 27.6 tt0 64.55 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.588 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.778 ' HG2' ' HG2' ' A' ' 143' ' ' GLU . 9.5 pt-20 . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.22 -52.15 54.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.12 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -76.01 -26.56 56.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.607 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 14' ' ' VAL . 28.7 mt -74.2 -54.2 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.603 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -67.62 -29.54 68.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.95 -34.27 77.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -76.11 -37.89 57.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.114 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 10' ' ' LEU . 76.6 t -60.45 -48.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 13.4 tt -70.26 -28.51 35.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.027 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 51.3 ttp -79.13 -32.12 44.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.351 . . . . 0.0 110.771 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.652 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 t70 -67.92 -32.81 73.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 110.025 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -85.34 -19.42 31.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.32 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 27.1 t80 -70.28 -23.32 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.703 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 90.8 mttt -59.74 -31.98 70.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.266 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -129.08 80.47 72.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.699 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.71 100.79 1.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.83 2.353 . . . . 0.0 111.759 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -132.27 22.13 4.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.153 0.501 . . . . 0.0 110.035 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.61 76.65 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -164.52 106.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.506 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.689 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -175.74 140.36 5.12 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.207 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.52 95.27 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.738 0.78 . . . . 0.0 109.662 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.05 132.94 46.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.534 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -117.16 100.46 7.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -164.34 -57.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.319 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.687 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 39.6 t -115.63 -77.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.56 -177.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.524 HD11 HD23 ' A' ' 51' ' ' LEU . 62.9 mt -111.08 129.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.781 0.324 . . . . 0.0 110.481 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.664 ' HA ' HG23 ' A' ' 48' ' ' THR . 40.7 t -131.08 98.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.912 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.589 HG21 ' HA2' ' A' ' 139' ' ' GLY . 58.7 t -121.96 122.89 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.888 0.375 . . . . 0.0 110.852 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -122.72 148.29 45.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.437 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -113.49 117.63 32.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.174 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -117.43 86.62 22.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -34.27 122.74 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 124.603 3.536 . . . . 0.0 114.981 -167.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 m 77.32 -7.57 1.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.398 171.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.7 t -130.86 -46.67 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.823 -0.548 . . . . 0.0 111.855 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.57 58.81 0.66 Allowed Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -52.87 -61.01 2.57 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.11 -1.045 . . . . 0.0 113.661 -163.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.631 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 46.1 mtm-85 -142.6 97.44 3.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.874 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.743 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 9.4 tt -95.48 92.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.238 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 78.4 mtt180 -93.87 97.72 10.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.269 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 77' ' ' THR . 66.2 tp -99.91 100.83 11.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.317 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 33' ' ' VAL . 22.3 p -115.52 117.23 29.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.369 -174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.557 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.2 mpp? -114.2 162.07 17.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.036 -171.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 7.5 tmtm? -129.88 100.85 5.62 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 32' ' ' ILE . 3.9 pp -100.36 121.12 40.99 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.16 66.33 0.69 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.713 0.768 . . . . 0.0 109.476 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.91 -109.49 0.52 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.53 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -134.9 32.34 3.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 55' ' ' ILE . 2.0 pp -131.83 129.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.896 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.9 t -81.09 84.57 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.571 ' HB2' HD12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -80.03 -64.18 1.24 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.787 -172.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 38.7 t70 -94.18 147.18 23.42 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.219 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.73 122.24 9.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.968 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 22.3 mmtp -122.7 110.44 15.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.4 p90 -122.05 93.32 3.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.338 0.589 . . . . 0.0 111.859 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.689 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 39.3 tt0 -98.72 98.86 9.93 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -115.97 103.82 1.22 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.769 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.09 95.86 10.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.13 -131.34 1.32 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.131 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.24 177.62 4.82 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.265 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -46.9 -54.82 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.77 HD13 ' HB3' ' A' ' 128' ' ' CYS . 0.1 OUTLIER -70.77 -24.52 25.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.143 -172.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.457 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.6 m -67.89 -47.66 68.2 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.1 mtt -73.55 -21.83 60.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.763 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 68' ' ' ILE . . . -86.66 -60.58 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.385 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.8 m -74.79 -37.96 62.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.799 -169.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.76 67.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.53 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -66.86 -24.21 66.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 52.7 tpp -73.06 -53.14 11.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.11 -33.72 76.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.777 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 39.7 m -72.19 -19.52 61.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -69.07 -43.26 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.45 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.615 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.777 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.4 mm -67.59 -38.15 80.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.154 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 64.5 tttp -60.86 -18.33 55.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.514 0.673 . . . . 0.0 110.352 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.3 26.38 7.8 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.953 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -128.92 -176.37 3.84 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.68 -177.97 3.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.68 -49.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.158 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.31 -32.67 70.27 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.481 0.658 . . . . 0.0 110.057 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -76.79 -24.47 52.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.981 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 91' ' ' MET . . . -74.53 -41.18 61.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.37 -42.23 99.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.594 0.712 . . . . 0.0 109.675 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -68.76 -24.95 64.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.145 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.456 ' HA ' HG23 ' A' ' 94' ' ' ILE . 52.4 ttm -66.44 -28.52 68.67 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.119 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.727 ' OG ' ' HB2' ' A' ' 141' ' ' ALA . 13.4 m -82.3 -39.82 22.37 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 8.5 tmtm? -55.41 -42.46 74.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 11.9 tt -82.92 -25.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 91' ' ' MET . 54.9 t80 -58.04 -46.65 84.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.482 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 p -78.89 -37.54 39.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.33 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 12.9 t70 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.904 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 113' ' ' ILE . 36.7 mt . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.998 0.428 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.67 -62.59 3.55 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.059 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.74 -34.49 78.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.874 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 110' ' ' LEU . 59.5 mt -58.17 -41.03 79.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.389 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.56 -41.35 85.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' HG21 ' A' ' 119' ' ' VAL . . . -71.72 -47.6 52.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.022 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -57.29 -42.47 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.014 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -57.21 -44.99 84.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.881 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.47 -44.61 96.45 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.874 HG12 ' HB3' ' A' ' 125' ' ' ARG . 41.3 t -61.97 -34.73 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.614 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . 67.0 m -61.05 -14.18 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -172.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -125.32 -27.45 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.114 -161.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -65.64 126.78 92.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.36 -16.59 13.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.545 2.163 . . . . 0.0 112.29 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.05 -17.9 23.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.347 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.874 ' HB3' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -126.87 5.22 6.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -176.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 120' ' ' SER . 9.7 tt -72.64 -30.06 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.953 0.882 . . . . 0.0 109.31 -170.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.481 ' HG3' HG22 ' A' ' 126' ' ' ILE . 66.2 mttm -85.43 -18.63 33.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.941 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.77 ' HB3' HD13 ' A' ' 68' ' ' ILE . 66.8 m -81.44 -33.22 32.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.343 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 120' ' ' SER . . . -77.7 -48.51 16.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.848 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 133' ' ' TRP . 18.8 p -61.71 -28.7 69.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.6 tt -54.9 -53.59 53.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.455 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.6 m -75.56 -37.0 60.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.256 0.551 . . . . 0.0 110.754 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 22.5 t90 -62.11 -52.29 64.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 79.0 mttt -72.17 -19.8 61.69 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.346 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.53 80.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.671 HD11 HG13 ' A' ' 80' ' ' ILE . 3.0 mm? -88.87 -50.33 6.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.76 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 4.4 tp10 -63.1 -28.38 70.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.309 -172.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 63.5 tttm -106.56 -18.75 13.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.808 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.589 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -75.8 -64.77 2.17 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.724 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.06 -17.48 6.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.0 110.857 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.727 ' HB2' ' OG ' ' A' ' 92' ' ' SER . . . -97.68 -172.41 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 10.1 tmtt? 176.76 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.305 0.378 . . . . 0.0 111.212 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 1.2 tt0 157.09 -166.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -163.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 118.22 0.464 . . . . 0.0 112.235 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 57.9 tp . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 -47.53 75.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -72.32 -36.03 68.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' HG22 ' A' ' 14' ' ' VAL . 10.3 tt -69.77 -53.35 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 7' ' ' LEU . 2.1 p90 -71.5 -32.54 68.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.955 -0.111 . . . . 0.0 111.153 -171.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -67.82 -30.43 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.294 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -78.5 -38.31 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.449 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 10' ' ' LEU . 60.0 t -62.58 -47.49 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.702 0.287 . . . . 0.0 110.791 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.3 mm -63.37 -36.2 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.63 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.02 -52.57 62.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 14.2 t70 -69.55 -26.94 64.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.635 ' HA ' ' ND2' ' A' ' 21' ' ' ASN . 26.0 t-80 -73.1 -19.33 61.17 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -82.44 -22.68 35.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.742 0.782 . . . . 0.0 109.206 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 30.8 ttpt -72.53 -19.33 61.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.32 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.64 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 p30 -132.74 175.17 3.91 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.621 -175.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' A' ' 21' ' ' ASN . 68.1 Cg_exo -41.58 136.6 2.89 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.265 2.643 . . . . 0.0 114.348 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -108.9 -174.09 2.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.784 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.583 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 4.5 m-20 -82.03 90.45 6.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.852 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 17.0 ptpt -163.13 19.91 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.131 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -97.78 123.23 7.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.201 -173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.23 97.11 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.931 ' HB2' ' HD3' ' A' ' 60' ' ' LYS . 53.9 tp -92.78 90.86 7.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.108 0.48 . . . . 0.0 109.93 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' C ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -78.33 51.16 0.99 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.954 -175.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.61 -87.1 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.864 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 t -92.68 -80.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.429 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.753 HD12 HD22 ' A' ' 51' ' ' LEU . 64.6 mt -88.81 130.41 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.011 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.07 92.47 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 110.171 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.718 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.8 t -109.54 119.27 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -124.86 144.12 50.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.708 0.29 . . . . 0.0 110.835 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.532 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 14.5 tpt -151.34 155.1 38.0 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.11 139.19 30.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.1 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -134.14 97.73 14.76 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -25.15 -64.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 125.24 3.96 . . . . 0.0 115.506 -167.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -109.67 6.17 23.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 128' ' ' CYS . 46.7 t -131.96 4.01 4.11 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.886 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 131' ' ' LEU . . . 167.72 57.88 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -38.4 -40.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.792 1.237 . . . . 0.0 113.611 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -149.02 140.33 23.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 6.1 tt -146.45 96.98 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.736 0.779 . . . . 0.0 109.421 166.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -104.42 105.96 16.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.93 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 ' HE2' ' A' ' 49' ' ' MET . 62.8 tp -102.23 104.47 15.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.808 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 28' ' ' LEU . 1.8 p -117.73 108.81 15.84 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.965 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.691 ' HE2' HD22 ' A' ' 47' ' ' LEU . 65.1 mtt -110.5 163.1 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.919 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HB2' HD23 ' A' ' 28' ' ' LEU . 28.0 ttpp -130.12 91.12 3.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.753 HD22 HD12 ' A' ' 32' ' ' ILE . 1.7 pp -95.99 112.88 24.49 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.11 68.61 0.71 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.594 0.711 . . . . 0.0 109.948 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.51 -105.61 0.35 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.177 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.86 15.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.579 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.574 HD12 ' HG3' ' A' ' 57' ' ' GLU . 1.3 pp -125.84 -166.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.999 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 80' ' ' ILE . 36.5 t -126.73 106.85 16.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.477 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 55' ' ' ILE . 72.8 mt-10 -85.95 -53.88 4.83 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.22 0.534 . . . . 0.0 109.685 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -130.11 163.35 26.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.797 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -165.61 132.28 2.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.5 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.931 ' HD3' ' HB2' ' A' ' 28' ' ' LEU . 2.0 mptp? -128.31 144.15 51.1 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -127.86 110.04 12.19 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.058 -175.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -103.57 97.82 7.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 171.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.583 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -138.54 121.15 2.1 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.162 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.08 155.24 28.51 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.5 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 153.96 -131.95 3.4 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.362 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 9.0 p -104.26 162.5 13.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -44.22 -48.95 9.39 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.279 0.987 . . . . 0.0 112.537 -171.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.693 HD11 ' HG ' ' A' ' 69' ' ' SER . 2.6 pp -75.38 -24.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.693 ' HG ' HD11 ' A' ' 68' ' ' ILE . 4.9 m -75.11 -40.02 60.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.703 0.763 . . . . 0.0 109.307 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.9 ttp -70.77 -25.95 63.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.767 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.51 -56.23 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.175 -174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.7 p -66.41 -44.91 81.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.52 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.56 -55.25 35.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.982 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -65.14 -37.48 87.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.9 tpt -70.02 -43.93 70.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 109.975 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.8 mmm -67.7 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.7 m -69.58 -20.23 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.766 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -75.56 -39.17 58.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.02 -31.54 72.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.147 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 56' ' ' VAL . 18.3 mm -75.67 -33.54 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.667 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -55.55 -20.29 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.47 41.66 1.64 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.992 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 87' ' ' THR . 2.6 tptp -133.66 -156.91 0.77 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.268 0.556 . . . . 0.0 111.515 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -140.66 147.81 39.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -170.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.46 -34.47 61.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.226 0.536 . . . . 0.0 109.714 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -57.86 -46.7 84.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.009 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 83' ' ' LYS . 2.1 m -76.63 -20.81 56.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.134 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' ' HG2' ' A' ' 91' ' ' MET . . . -69.9 -49.94 47.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.329 0.585 . . . . 0.0 110.96 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 142' ' ' LYS . 10.1 mp -65.38 -28.63 69.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.181 0.515 . . . . 0.0 109.623 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -77.67 -20.48 53.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.239 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.722 ' HA ' HG21 ' A' ' 94' ' ' ILE . 9.2 ptt? -77.63 -22.24 51.04 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.585 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 8.2 t -86.11 -29.58 23.22 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.96 -50.8 69.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.185 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.722 HG21 ' HA ' ' A' ' 91' ' ' MET . 10.4 tt -69.82 -28.43 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.103 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' MET . 81.2 t80 -54.63 -45.11 73.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.872 0.368 . . . . 0.0 110.528 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.8 p -85.26 -34.1 22.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 21.1 t70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.615 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.801 0.334 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.61 82.96 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.736 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.87 -32.53 65.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.178 0.513 . . . . 0.0 110.364 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 58.8 mt -69.32 -27.6 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.88 -21.44 66.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.33 59.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.08 -32.0 64.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.35 0.595 . . . . 0.0 110.112 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 117' ' ' GLN . 5.0 tt0 -53.76 -35.16 60.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.904 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.23 53.79 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.631 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 68' ' ' ILE . 28.9 m -85.74 -17.95 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -175.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.1 t -46.44 -17.34 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -164.04 26.63 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.177 0.899 . . . . 0.0 110.271 -164.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.16 140.65 22.92 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.28 -41.75 4.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.45 2.767 . . . . 0.0 113.501 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.4 9.52 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.417 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 98.5 mtt180 -125.13 4.16 7.9 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.053 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.8 tt -83.55 -29.87 7.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.485 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.816 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.536 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 33.5 t -85.99 -19.63 30.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.453 175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -79.44 -45.01 20.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.868 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 p -66.02 -30.65 71.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.303 0.573 . . . . 0.0 109.801 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.558 HD12 ' HA3' ' A' ' 42' ' ' GLY . 8.0 tt -56.64 -67.34 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.764 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 m -70.88 -56.01 7.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.588 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -72.94 -51.59 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.966 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 130' ' ' THR . 48.3 tttm -75.69 -22.76 56.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.664 -168.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.31 -27.0 35.21 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.485 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -79.29 -48.31 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 109.945 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.575 ' HG2' ' HG2' ' A' ' 142' ' ' LYS . 34.7 tt0 -65.96 -27.69 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -88.02 -15.01 37.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.093 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.718 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -57.83 -43.47 94.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.786 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.12 11.57 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.64 172.46 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.844 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.575 ' HG2' ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -150.64 -172.37 4.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.201 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER -66.35 -164.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.048 0.452 . . . . 0.0 111.373 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 . . . . . 0 C--N 1.322 -0.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.614 178.76 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.543 0.211 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.778 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.4 t70 -59.13 -47.37 85.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.493 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -73.26 -23.69 60.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 14' ' ' VAL . 60.6 tp -70.52 -53.68 15.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 8.8 p90 -75.03 -19.72 59.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.355 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 12' ' ' ARG . 38.9 ttp180 -66.98 -35.84 80.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -73.26 -38.31 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.716 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 10' ' ' LEU . 93.9 t -60.64 -50.13 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.548 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 11' ' ' TYR . 32.6 mm -57.95 -52.35 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.825 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.4 ttm -60.23 -54.69 42.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.896 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.4 -37.66 74.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.113 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -77.46 -18.77 56.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.609 0.242 . . . . 0.0 110.802 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.09 -31.88 70.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -73.35 -22.82 60.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.496 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.85 170.19 12.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.321 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.99 126.36 21.41 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.86 1.706 . . . . 0.0 110.792 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -57.71 -74.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.442 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 4.3 p30 -177.53 114.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.84 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -148.98 111.42 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.887 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.48 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . 153.48 142.27 3.43 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.737 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.09 104.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 48' ' ' THR . 3.4 tt -103.12 87.66 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.122 0.487 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.86 100.38 5.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.21 -71.31 0.18 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.468 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.0 -70.7 0.78 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.679 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.512 HG21 ' HE3' ' A' ' 49' ' ' MET . 35.9 mt -87.31 116.86 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.001 0.429 . . . . 0.0 109.894 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' HA ' HG21 ' A' ' 48' ' ' THR . 45.7 t -131.86 91.16 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.627 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 135' ' ' ALA . 41.6 t -114.19 105.71 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 0.0 110.654 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -105.52 123.16 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.848 ' HA ' ' HE1' ' A' ' 36' ' ' MET . 2.0 tpt -124.98 159.06 32.13 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.72 139.31 15.97 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.96 -172.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.851 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 42.3 t-20 -136.72 94.39 13.2 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.2 Cg_exo -65.69 48.78 0.22 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.758 3.639 . . . . 0.0 114.975 -163.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.6 m -159.72 -45.94 0.05 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.407 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 127' ' ' LYS . 10.4 t -133.54 7.35 3.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.245 0.545 . . . . 0.0 111.078 -171.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.28 0.45 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.473 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 31.2 t70 -38.9 -67.01 0.23 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.473 ' HG3' ' OD2' ' A' ' 43' ' ' ASP . 67.2 mtt180 -135.88 140.25 43.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.668 -0.645 . . . . 0.0 112.024 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.622 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 7.9 tt -139.92 108.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 164.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 25.6 mmm-85 -93.03 107.67 19.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.5 tp -122.64 106.21 10.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.331 0.586 . . . . 0.0 109.782 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 33' ' ' VAL . 1.6 p -125.56 115.6 20.44 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.454 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.512 ' HE3' HG21 ' A' ' 32' ' ' ILE . 72.9 mtm -114.33 147.3 39.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.395 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 4.9 tmtt? -106.57 86.16 2.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.33 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.12 83.1 5.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.487 0.66 . . . . 0.0 109.408 171.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -86.9 63.15 7.8 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.07 -100.02 0.22 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.362 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' C ' HD11 ' A' ' 85' ' ' ILE . 4.5 p-10 -150.43 33.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.403 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -136.98 148.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.736 HG13 HG23 ' A' ' 80' ' ' ILE . 45.7 t -85.46 89.23 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 171.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -80.93 -65.03 1.06 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.338 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t0 -119.1 163.87 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.6 130.92 8.64 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.393 . . . . 0.0 110.394 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 12.4 mptt -114.19 131.88 56.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 16.3 p90 -140.53 135.93 32.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.218 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 31.0 tt0 -148.73 119.95 7.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.72 134.23 9.52 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -124.38 120.41 32.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.15 -129.86 2.17 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.772 -170.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.61 166.77 13.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.961 0.41 . . . . 0.0 110.689 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.643 ' HA ' ' HE1' ' A' ' 70' ' ' MET . 2.9 m -59.76 -41.17 90.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.592 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.61 HD11 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -75.15 -35.18 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.61 ' N ' HD11 ' A' ' 68' ' ' ILE . 9.7 p -71.97 -38.73 69.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.643 ' HE1' ' HA ' ' A' ' 67' ' ' SER . 25.7 ptt? -77.42 -17.91 57.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.737 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.89 -55.3 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -60.31 -49.7 76.56 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.905 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.32 -43.16 43.29 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -71.62 -30.35 65.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.572 0.225 . . . . 0.0 111.56 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.6 mmm -77.41 -41.54 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.765 ' HE3' HD22 ' A' ' 136' ' ' LEU . 69.3 mtp -58.12 -37.0 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.61 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.461 HG22 ' CD1' ' A' ' 61' ' ' PHE . 97.1 m -64.95 -33.26 75.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.192 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -76.99 -40.78 45.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.4 87.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.921 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.736 HG23 HG13 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -76.86 -28.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.152 -177.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.75 -19.48 65.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.125 0.488 . . . . 0.0 110.835 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.15 31.18 9.03 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.975 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.05 166.88 22.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -116.3 -162.37 0.84 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.487 ' O ' HD13 ' A' ' 89' ' ' LEU . 1.6 mp -85.62 -46.23 17.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -61.8 -37.76 85.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.086 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -83.01 -23.78 33.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.78 -43.67 24.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 110.741 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 144' ' ' GLU . 9.8 mp -64.56 -39.17 93.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.448 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 94' ' ' ILE . 10.7 p -72.44 -35.62 68.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.171 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.6 tpp -61.25 -32.15 71.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 29.6 t -84.66 -31.08 24.36 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.21 -47.29 83.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 90' ' ' SER . 37.7 pt -74.92 -23.95 17.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.47 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 90.5 t80 -64.04 -42.08 97.19 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 109.819 172.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -80.14 -30.63 39.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.792 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.308 -177.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.425 0.155 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.65 45.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.268 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 0.0 110.247 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.404 HG23 ' HE1' ' A' ' 95' ' ' PHE . 55.7 mt -80.58 -19.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.705 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.19 -30.41 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.061 0.457 . . . . 0.0 110.251 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.4 -21.68 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.649 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD11 ' HE2' ' A' ' 76' ' ' MET . 96.6 mt -90.22 -38.63 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.724 0.774 . . . . 0.0 109.639 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -29.57 67.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.798 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.38 -52.95 19.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 125' ' ' ARG . 13.8 p -73.28 -19.52 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.57 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 91.8 p -55.83 -15.36 3.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -116.89 34.88 4.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 0.0 110.59 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.543 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 71.8 m-85 -131.63 177.3 2.31 Favored Pre-proline 0 C--O 1.219 -0.519 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.437 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 122' ' ' PHE . 57.3 Cg_endo -73.9 -2.83 12.81 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.448 1.432 . . . . 0.0 110.363 165.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.52 -18.83 17.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.516 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.57 ' HB3' ' HA ' ' A' ' 120' ' ' SER . 1.9 ppt_? -55.79 -59.56 4.69 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 119.441 -0.314 . . . . 0.0 111.433 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.509 ' H ' ' HD2' ' A' ' 125' ' ' ARG . 9.0 tt -47.68 -32.42 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.151 0.5 . . . . 0.0 110.573 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.851 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 50.3 mttp -81.93 -58.48 2.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.649 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.4 m -86.72 -21.43 26.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.065 0.46 . . . . 0.0 111.273 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.06 -32.63 21.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.599 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 5.0 t -62.94 -35.65 80.82 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.502 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 69' ' ' SER . 9.4 tt -61.13 -67.73 0.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.984 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.9 m -65.76 -54.68 23.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.291 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.43 ' NE1' ' HG3' ' A' ' 137' ' ' GLU . 84.1 t90 -71.91 -48.73 43.42 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -171.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 130' ' ' THR . 23.0 tptm -68.97 -25.4 64.51 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.148 -172.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.499 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -78.41 -36.36 45.84 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.948 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.765 HD22 ' HE3' ' A' ' 76' ' ' MET . 2.9 tp -80.51 -47.18 14.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 0.0 110.015 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' NE1' ' A' ' 133' ' ' TRP . 22.2 mm-40 -75.49 -19.74 59.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.443 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.87 -18.89 28.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.741 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.38 -54.29 27.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.291 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.424 ' O ' HD12 ' A' ' 89' ' ' LEU . 26.1 m -93.04 -1.19 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.58 94.28 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.283 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -50.58 144.79 7.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.83 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 92' ' ' SER . 30.9 tt0 70.11 -75.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.319 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.507 ' HA ' HD22 ' A' ' 89' ' ' LEU . 34.4 tt0 . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.876 HD12 ' HA3' ' A' ' 118' ' ' GLY . 93.8 mt . . . . . 0 CA--C 1.514 -0.434 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.7 t70 -54.21 -45.23 72.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.62 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -74.35 -40.76 61.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.636 0.731 . . . . 0.0 109.937 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.508 ' O ' HG22 ' A' ' 14' ' ' VAL . 94.9 mt -68.95 -56.51 7.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.385 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.548 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 1.2 p90 -67.53 -27.11 66.7 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 -60.86 -41.61 96.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.665 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -77.59 -41.51 38.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.267 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 81.7 t -61.6 -46.62 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.173 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 tp -71.38 -30.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.616 0.246 . . . . 0.0 110.613 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.3 tpt -70.16 -47.14 62.91 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.44 -38.4 89.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.198 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -68.8 -27.69 66.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.956 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -74.71 -20.57 59.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 0.0 110.02 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -79.54 -21.44 45.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.093 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.47 ' HB3' ' CD ' ' A' ' 22' ' ' PRO . 41.0 m-80 -107.23 177.76 1.24 Allowed Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 21' ' ' ASN . 23.8 Cg_exo -66.02 175.29 4.84 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -79.96 -142.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.328 0.585 . . . . 0.0 110.289 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -120.03 83.62 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.509 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -144.2 109.49 5.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.523 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -168.53 125.71 1.31 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.801 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.97 103.19 8.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.464 0.65 . . . . 0.0 110.493 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.752 ' O ' ' HB ' ' A' ' 48' ' ' THR . 4.2 tt -125.35 83.73 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.78 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.64 99.34 6.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.487 0.66 . . . . 0.0 110.04 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -127.62 -75.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.43 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -101.32 -56.88 2.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 49' ' ' MET . 46.3 pt -122.79 139.2 50.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.228 0.537 . . . . 0.0 110.743 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 48' ' ' THR . 2.3 p -136.27 108.46 7.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.675 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG21 ' CA ' ' A' ' 139' ' ' GLY . 24.4 t -109.5 142.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.901 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -135.04 135.84 41.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.356 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.505 ' O ' HG23 ' A' ' 45' ' ' ILE . 14.5 tpt -152.56 147.82 26.64 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.39 161.16 27.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 127' ' ' LYS . 11.8 m120 -106.75 129.68 24.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 165.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.584 ' O ' ' HB ' ' A' ' 40' ' ' THR . 59.7 Cg_endo -70.46 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.913 2.409 . . . . 0.0 114.199 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 39' ' ' PRO . 14.8 t 158.22 -10.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.792 0.837 . . . . 0.0 111.064 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.63 19.34 4.27 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.071 0.462 . . . . 0.0 111.179 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.21 48.61 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.15 -31.3 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.636 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 4.0 ptm180 -159.15 137.97 11.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.679 1.127 . . . . 0.0 112.374 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 36' ' ' MET . 11.0 tt -133.48 95.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 162.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 38.4 ttm-85 -95.89 107.71 20.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.927 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.754 HD21 ' HE1' ' A' ' 49' ' ' MET . 61.8 tp -104.54 103.69 13.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.801 ' HG1' ' HB2' ' A' ' 60' ' ' LYS . 18.1 p -114.58 106.14 13.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.843 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.754 ' HE1' HD21 ' A' ' 47' ' ' LEU . 61.7 mtt -105.19 167.23 9.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.219 0.533 . . . . 0.0 111.097 -175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -126.94 86.81 2.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.254 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -95.35 82.02 3.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.843 0.83 . . . . 0.0 109.414 174.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.31 68.79 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.841 0.829 . . . . 0.0 109.273 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.1 -99.9 0.22 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.776 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -145.38 21.25 1.53 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.442 0.639 . . . . 0.0 109.395 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 55' ' ' ILE . 1.9 pp -133.87 151.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.808 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.03 89.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 168.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' HD12 ' A' ' 55' ' ' ILE . 13.1 tp10 -75.38 -57.54 3.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 110.04 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -125.01 160.44 28.98 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.263 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -156.83 119.24 3.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.801 ' HB2' ' HG1' ' A' ' 48' ' ' THR . 45.9 mmtm -112.75 138.13 50.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -129.06 100.25 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 38.8 tt0 -90.77 99.81 12.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -126.28 115.51 2.31 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.77 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -127.39 126.63 42.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 169.78 -130.76 2.1 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.634 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.45 162.53 13.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.612 0.244 . . . . 0.0 110.466 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -57.8 -37.86 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -73.72 -35.38 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.635 ' N ' HD13 ' A' ' 68' ' ' ILE . 24.8 p -79.13 -33.58 44.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.328 0.585 . . . . 0.0 110.131 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 90.4 mtp -74.26 -15.68 60.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.405 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.23 -51.56 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.003 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 p -59.23 -44.88 92.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.4 -62.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.532 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -55.74 -42.77 75.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.358 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.8 tpt -68.97 -51.27 41.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.57 ' HB3' HD23 ' A' ' 136' ' ' LEU . 92.4 mtp -72.29 -37.93 68.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.241 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 90.9 m -62.73 -29.26 70.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 111.264 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -86.03 -37.61 18.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.804 0.335 . . . . 0.0 110.327 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.94 89.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 0.0 110.064 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.66 -22.02 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.462 0.648 . . . . 0.0 109.4 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' THR . 81.4 tttt -64.63 -21.74 66.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.629 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.62 40.04 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.942 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 80' ' ' ILE . 98.4 mttt -133.95 -172.79 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.03 -168.96 1.51 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -80.69 -45.69 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.471 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.14 -39.92 91.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.168 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -62.74 -36.03 81.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.842 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.34 60.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.461 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 45.3 mt -61.05 -42.44 98.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.198 0.523 . . . . 0.0 109.667 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 t -63.96 -36.1 82.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.319 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.417 ' HA ' HG21 ' A' ' 94' ' ' ILE . 27.9 ttt -68.25 -28.31 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 0.0 110.843 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 31.0 t -86.22 -35.06 20.26 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.87 -49.84 73.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.821 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 13.3 tt -72.87 -22.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -59.23 -45.08 92.09 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.54 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.6 p -85.95 -28.45 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.082 0.468 . . . . 0.0 111.379 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 33.6 t70 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.58 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 111.587 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.88 -27.06 73.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.691 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.85 -48.0 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.62 -31.32 52.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.365 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 8.0 mm-40 -66.08 -28.15 68.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.651 0.263 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.0 71.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 110.593 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.19 -15.16 24.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.822 0.344 . . . . 0.0 110.5 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 4.2 tp-100 -49.02 -43.85 40.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.653 -173.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.876 ' HA3' HD12 ' A' ' 7' ' ' LEU . . . -78.74 -33.83 36.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.553 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 68' ' ' ILE . 29.0 m -87.55 -17.79 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 26.6 t -50.71 -18.89 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -165.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -169.34 27.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.439 1.018 . . . . 0.0 111.15 -167.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -93.46 138.42 23.0 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.96 -34.91 6.74 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.191 2.594 . . . . 0.0 113.303 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.05 5.96 20.58 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 119' ' ' VAL . 84.2 mtt180 -121.72 -9.03 8.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.423 -0.798 . . . . 0.0 110.374 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.559 HG22 ' HD2' ' A' ' 127' ' ' LYS . 15.5 tt -77.42 -29.35 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.567 -167.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.559 ' HD2' HG22 ' A' ' 126' ' ' ILE . 14.0 mptt -74.74 -22.88 58.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 67.7 m -85.89 -22.54 27.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.158 0.504 . . . . 0.0 110.017 174.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 120' ' ' SER . . . -72.73 -47.73 44.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.533 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.6 p -65.42 -30.74 71.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.062 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HA ' ' CG ' ' A' ' 36' ' ' MET . 6.5 tt -49.8 -53.65 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -71.52 -51.01 25.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -67.59 -41.61 83.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.948 0.404 . . . . 0.0 111.643 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 71.8 mmtt -73.5 -17.61 61.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.35 -44.64 11.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.174 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 76' ' ' MET . 3.0 tp -84.19 -63.27 1.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.02 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.41 -30.89 60.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.054 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.702 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 49.3 tttm -85.17 -4.32 59.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.355 0.598 . . . . 0.0 109.621 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.434 ' CA ' HG21 ' A' ' 34' ' ' VAL . . . -73.6 -50.57 11.28 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.452 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.497 HG22 ' H ' ' A' ' 141' ' ' ALA . 9.8 m -76.0 -57.04 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.202 . . . . 0.0 110.501 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 89' ' ' LEU . . . 169.59 152.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.704 0.802 . . . . 0.0 109.054 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -96.19 127.93 42.65 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.152 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.442 ' H ' ' HB3' ' A' ' 92' ' ' SER . 35.5 tt0 67.5 -76.13 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 111.608 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.606 HD13 ' HA3' ' A' ' 118' ' ' GLY . 94.0 mt . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.03 -46.99 61.76 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.466 0.479 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.89 -24.92 52.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.1 tm? -78.32 -58.69 3.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.445 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -76.57 -21.77 55.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.1 ttp180 -69.15 -35.74 76.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -69.12 -41.04 77.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.667 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 10' ' ' LEU . 94.7 t -69.05 -48.59 68.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 67' ' ' SER . 13.9 tt -66.29 -29.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.965 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -61.94 -49.02 77.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 110.051 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.55 -34.77 65.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -74.27 -19.31 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -77.23 -32.8 56.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -31.65 62.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.762 175.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -129.76 84.62 60.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.267 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.69 140.33 2.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.946 2.431 . . . . 0.0 111.886 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.423 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 16.4 ttm180 -145.44 17.2 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.412 0.625 . . . . 0.0 110.654 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 14.9 m120 -84.08 83.79 7.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.56 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 tptm -165.64 24.81 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 111.181 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.1 6.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.874 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.26 104.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 48' ' ' THR . 60.9 tp -105.71 95.93 6.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.985 0.422 . . . . 0.0 111.825 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -84.18 91.27 7.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' CG ' ' HG2' ' A' ' 50' ' ' LYS . 13.4 t70 -127.58 -69.7 0.73 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.583 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -127.04 -51.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.059 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 71.4 mt -106.84 129.42 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.044 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.802 HG13 HG23 ' A' ' 48' ' ' THR . 3.1 m -142.2 82.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.508 0.67 . . . . 0.0 110.928 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG13 ' HA ' ' A' ' 135' ' ' ALA . 49.1 t -98.81 134.69 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.272 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -128.34 147.01 50.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -153.1 151.2 29.91 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -152.04 145.32 24.7 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 111.898 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' CG ' ' HB3' ' A' ' 41' ' ' CYS . 47.0 t-20 -124.23 111.77 28.36 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -21.56 -64.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 125.688 4.259 . . . . 0.0 115.679 -169.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 m -126.6 23.65 6.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.551 0.691 . . . . 0.0 110.904 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.516 ' HB3' ' CG ' ' A' ' 38' ' ' ASN . 38.3 t -129.43 -36.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.687 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' N ' ' HB3' ' A' ' 38' ' ' ASN . . . -140.88 62.16 0.54 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -34.82 -53.3 0.55 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.399 1.08 . . . . 0.0 113.666 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -156.7 141.75 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.357 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.44 105.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.448 0.642 . . . . 0.0 110.053 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.713 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 18.8 mmt180 -93.34 110.89 22.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.787 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.2 tp -104.57 94.94 5.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.802 HG23 HG13 ' A' ' 33' ' ' VAL . 10.9 p -115.66 111.2 20.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.584 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 65.5 mtt -109.34 161.34 15.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.913 0.387 . . . . 0.0 111.452 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.818 ' HE3' ' HB2' ' A' ' 52' ' ' ASP . 8.7 tmtm? -126.06 100.46 6.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pp -100.35 108.16 20.12 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.614 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.818 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 35.6 t70 -100.06 65.77 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.764 0.792 . . . . 0.0 109.263 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.36 -101.45 0.27 Allowed Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.838 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.631 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 7.7 m-20 -142.63 28.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.711 -0.745 . . . . 0.0 109.811 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 55' ' ' ILE . 1.9 pp -132.5 151.71 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.206 0.527 . . . . 0.0 110.193 -170.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -86.56 96.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.958 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.48 -69.98 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -112.46 159.02 19.17 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.21 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -157.58 132.76 8.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.636 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -123.96 120.36 32.27 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.713 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -115.96 81.13 1.55 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.415 0.626 . . . . 0.0 111.436 -176.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.95 117.31 24.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.548 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.39 161.06 29.97 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.259 -1.448 . . . . 0.0 113.586 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.03 164.39 27.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.55 -130.46 3.33 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.255 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 34.0 m -81.25 159.35 24.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.903 0.382 . . . . 0.0 110.797 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.553 ' HB2' HD11 ' A' ' 15' ' ' ILE . 5.7 p -61.82 -32.94 73.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.975 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -90.57 -24.49 5.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.694 -176.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.483 ' N ' HD11 ' A' ' 68' ' ' ILE . 31.2 p -76.68 -40.15 49.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.072 0.463 . . . . 0.0 110.913 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.5 ptp -72.03 -17.22 62.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.304 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.54 -46.72 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.119 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 76' ' ' MET . 13.7 p -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.59 -51.94 43.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.26 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -70.57 -27.24 63.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.445 ' HE2' ' HA ' ' A' ' 112' ' ' ASP . 27.5 ttt -79.04 -49.18 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.083 0.468 . . . . 0.0 110.288 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.67 ' SD ' ' HB2' ' A' ' 112' ' ' ASP . 90.2 mmm -63.65 -39.84 95.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.192 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.548 HG23 ' HE2' ' A' ' 49' ' ' MET . 31.5 m -75.12 -21.21 59.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.44 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.88 -41.26 78.59 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.23 -26.9 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.298 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.443 ' CD1' HG21 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -72.38 -31.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.667 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.95 -24.58 67.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.579 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -85.68 19.7 23.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.814 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 1.6 mptm? -133.69 -179.25 5.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 109.984 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 5.6 p-10 -116.36 -171.37 1.99 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.34 -40.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.491 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -64.23 -40.97 97.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 109.688 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.555 ' O ' ' HG3' ' A' ' 91' ' ' MET . 23.2 m -74.86 -32.02 61.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.001 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.758 ' HA ' ' HE1' ' A' ' 91' ' ' MET . . . -61.28 -48.65 80.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.847 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 141' ' ' ALA . 72.2 mt -59.14 -39.75 83.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.577 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 m -70.51 -19.89 62.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.232 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.758 ' HE1' ' HA ' ' A' ' 88' ' ' ALA . 67.1 mtm -79.32 -19.38 50.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.723 ' HB2' ' HB3' ' A' ' 141' ' ' ALA . 23.6 t -85.46 -32.62 22.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -58.62 -43.13 89.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.245 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.696 HG12 ' HA ' ' A' ' 91' ' ' MET . 40.5 pt -82.87 -23.94 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.105 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 91' ' ' MET . 37.7 t80 -58.11 -46.97 84.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.131 0.491 . . . . 0.0 110.172 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 p -79.85 -27.85 40.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 22.0 t70 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 113' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.4 0.619 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -57.35 -19.74 34.13 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.67 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 1.2 p-10 -65.27 -48.57 72.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.57 0.348 . . . . 0.0 111.506 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 110' ' ' LEU . 10.6 tt -71.87 -19.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.453 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 70.2 mm-40 -57.51 -31.03 65.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.594 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.22 59.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.148 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.75 -39.22 18.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 114' ' ' GLU . 12.0 pt20 -62.1 -19.88 63.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -75.67 -51.19 7.35 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.596 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 129' ' ' ALA . 23.2 m -78.51 -17.04 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.447 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 75.3 m -43.52 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -147.34 6.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.365 0.984 . . . . 0.0 112.584 -163.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.797 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 36.3 m-85 -81.38 142.5 50.52 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.96 -37.16 12.01 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.218 2.612 . . . . 0.0 113.384 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.93 -1.27 15.52 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 95.5 mtt180 -114.34 -3.29 13.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 -174.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 120' ' ' SER . 11.9 tt -70.58 -31.0 44.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.727 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.524 ' HA ' ' OG1' ' A' ' 130' ' ' THR . 97.2 mttt -81.88 -22.08 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 55.9 m -69.54 -34.84 74.82 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.832 ' HB3' HG21 ' A' ' 119' ' ' VAL . . . -78.77 -46.53 18.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.275 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 127' ' ' LYS . 22.8 p -62.6 -33.96 76.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.711 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 128' ' ' CYS . 4.3 pp -67.68 -41.61 83.4 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.281 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.441 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 m -71.73 -48.29 48.04 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.616 0.722 . . . . 0.0 110.481 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -63.34 -55.35 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.801 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.812 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 68.7 mmtt -72.6 -19.34 61.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -61.3 -45.26 95.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 110.063 173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 76' ' ' MET . 6.5 mp -86.52 -34.16 20.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.223 0.535 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.812 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 8.3 tp10 -63.96 -20.84 66.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.681 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -109.67 -41.56 4.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.941 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.14 -50.91 60.77 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.203 -0.522 . . . . 0.0 114.138 -172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 80' ' ' ILE . 15.5 m -125.27 -8.05 6.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.38 . . . . 0.0 111.753 -172.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 92' ' ' SER . . . -128.15 162.63 26.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.028 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.459 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 2.4 ttpm? 179.68 54.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.69 0.619 . . . . 0.0 109.88 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.417 ' H ' ' CB ' ' A' ' 92' ' ' SER . 36.8 mt-10 60.51 -99.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.004 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.922 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -96.0 -58.23 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.625 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -127.77 128.47 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.68 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -153.1 129.06 10.29 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 9' ' ' THR . . . -83.85 20.11 1.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.505 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.22 -52.84 62.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.844 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.01 -39.88 2.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.198 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.584 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 19.2 t70 -56.23 -57.12 13.57 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.681 -174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 5' ' ' ALA . 29.3 m -70.2 -25.36 63.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.001 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.9 tp -70.03 -54.48 12.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.324 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 4.3 p90 -72.28 -24.2 61.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 13.6 tpp180 -56.99 -49.62 75.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.03 -36.86 80.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.555 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 10' ' ' LEU . 84.2 t -60.25 -45.5 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.61 -31.42 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.7 mtt -68.38 -40.65 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 0.0 110.906 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.89 -34.49 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.587 ' HE1' ' HB2' ' A' ' 24' ' ' ASN . 40.9 t-80 -71.33 -21.3 62.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.535 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -85.97 -31.19 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 0.0 110.934 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -67.37 -21.36 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.084 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.35 80.16 72.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.198 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.65 71.55 3.95 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.275 2.65 . . . . 0.0 113.034 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -134.45 125.53 27.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.005 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.587 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 57.7 t30 -167.2 152.41 7.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 1.086 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 55.8 tttm 72.64 94.33 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.334 1.021 . . . . 0.0 110.818 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.07 162.97 31.66 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -136.94 119.47 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.39 0.595 . . . . 0.0 110.435 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' O ' ' HB ' ' A' ' 48' ' ' THR . 2.4 tt -115.41 101.16 8.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.23 108.82 19.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.04 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -152.98 -72.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.376 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.88 -71.89 0.73 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 49' ' ' MET . 41.8 pt -108.25 127.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.3 0.572 . . . . 0.0 111.896 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 48' ' ' THR . 87.3 t -126.44 104.9 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.96 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.05 114.33 29.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.627 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' A' ' 46' ' ' ARG . 4.2 p30 -113.93 154.06 28.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.045 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.485 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 14.9 tpt -140.83 123.39 16.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.71 152.04 26.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.1 -177.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.698 ' HB2' HD12 ' A' ' 131' ' ' LEU . 41.7 t-20 -122.05 83.08 44.27 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.8 -6.71 11.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.236 2.624 . . . . 0.0 113.152 -171.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.5 m -86.11 -43.18 13.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.441 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 49.8 t -99.82 -24.93 14.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.67 0.04 36.78 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.654 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 41' ' ' CYS . 2.8 m-20 -70.52 145.83 50.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.418 ' HG3' ' ND2' ' A' ' 37' ' ' ASN . 20.3 ttm-85 -154.09 114.24 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 64.6 mt -122.4 110.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.494 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.727 ' HB2' ' HB3' ' A' ' 62' ' ' GLU . 32.3 mtp180 -94.42 109.45 21.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.728 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.801 HD22 ' HE1' ' A' ' 49' ' ' MET . 52.3 tp -99.55 104.4 16.2 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.502 0.668 . . . . 0.0 109.331 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.682 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 3.2 p -115.75 103.56 10.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.034 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.801 ' HE1' HD22 ' A' ' 47' ' ' LEU . 60.7 mtt -107.77 163.45 13.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.072 0.463 . . . . 0.0 110.939 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 87.7 tttt -130.01 100.46 5.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.572 174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.33 105.25 17.22 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -109.72 72.54 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 -172.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.05 -101.17 0.25 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.366 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.66 20.48 2.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.116 0.96 . . . . 0.0 108.601 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.6 pp -127.37 -162.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.588 -174.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 80' ' ' ILE . 57.6 t -123.76 117.74 52.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.387 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 50.6 mm-40 -86.11 -48.99 8.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.9 174.76 12.74 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.052 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -162.04 131.46 4.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.528 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -121.76 118.99 30.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -106.41 99.45 9.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.839 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.086 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 31.5 tt0 -81.27 79.43 7.91 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -104.18 114.69 4.81 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.637 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 10.1 tp10 -121.01 150.76 40.65 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.44 -132.5 4.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.626 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.58 -175.66 2.92 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.902 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 m -61.48 -40.82 95.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.478 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -79.61 -42.93 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -171.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.681 ' N ' HD13 ' A' ' 68' ' ' ILE . 2.7 p -65.51 -52.35 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.922 0.391 . . . . 0.0 112.048 -170.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -22.38 64.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.016 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -85.28 -48.61 8.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.341 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.4 p -59.22 -46.77 87.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 110.848 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.97 83.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.0 m -61.29 -34.25 74.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.432 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.19 -43.72 27.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 0.0 109.835 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.431 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 95.0 mmm -73.75 -32.08 63.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.527 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.8 p -74.6 -19.97 60.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.994 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -72.04 -38.37 69.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 83' ' ' LYS . . . -71.29 -34.11 70.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.728 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.464 HG23 HG13 ' A' ' 56' ' ' VAL . 14.6 mm -71.99 -41.07 68.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -57.29 -19.0 19.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.322 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.53 25.6 10.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 79' ' ' ALA . 13.2 mptt -127.55 -168.6 1.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.501 . . . . 0.0 110.784 -173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -120.15 -165.98 1.25 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.2 mm -87.27 -38.42 12.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.881 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.36 -49.79 76.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.256 0.551 . . . . 0.0 109.987 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 p -67.55 -32.59 73.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.252 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.72 -43.6 68.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.6 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 79.9 mt -65.79 -36.16 82.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.718 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 t -68.11 -45.48 73.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.292 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 51.1 ttm -58.11 -35.18 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.03 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 7.6 p -87.69 -30.26 20.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.481 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.717 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 83.2 tttt -61.83 -48.2 81.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 98' ' ' MET . 12.6 tt -71.67 -32.32 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.047 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 91' ' ' MET . 31.7 t80 -57.22 -44.99 84.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.176 0.512 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -77.99 -33.97 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.899 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.24 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.286 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 88.0 mtp -53.82 -32.88 54.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.442 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.6 ttp -76.66 -18.93 58.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.21 -38.95 9.91 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' HG2' ' A' ' 102' ' ' LYS . . . -70.39 -67.8 1.81 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.712 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 101' ' ' GLY . 17.8 mmtm 169.94 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.815 0.846 . . . . 0.0 110.156 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -166.2 109.5 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.331 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.463 ' HE2' ' HA3' ' A' ' 101' ' ' GLY . 24.3 p90 -173.67 142.05 0.9 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.664 ' HB2' HD22 ' A' ' 110' ' ' LEU . 27.6 t70 -133.9 133.46 41.5 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.89 -26.57 62.32 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.483 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 16.1 m -107.78 -12.0 15.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 107' ' ' SER . 2.1 mp 71.75 4.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.445 1.117 . . . . 0.0 109.712 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.81 80.32 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.834 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 113' ' ' ILE . 83.9 mt -109.58 22.47 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.728 -173.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -50.05 -57.72 9.63 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.231 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.38 -35.01 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.675 HD12 HD23 ' A' ' 110' ' ' LEU . 59.0 mt -59.78 -39.51 80.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.519 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 40.0 mt-10 -77.61 -23.35 49.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.006 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -43.17 25.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.306 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.7 tp -65.03 -37.4 87.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.286 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 1.8 pt20 -73.37 -23.49 60.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.7 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 -47.98 76.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.189 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.834 HG23 ' HB1' ' A' ' 129' ' ' ALA . 19.3 m -81.99 -18.58 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.868 0.366 . . . . 0.0 111.28 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 t -52.15 -12.64 0.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -117.92 -25.08 6.87 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.689 -0.632 . . . . 0.0 111.043 -163.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -74.58 129.6 83.47 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.49 -29.96 19.89 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.995 2.463 . . . . 0.0 113.022 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.53 -15.32 28.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.658 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 8.5 mmt180 -113.65 -4.98 13.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.633 -172.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.93 -32.05 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.482 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.664 ' HG3' HD22 ' A' ' 38' ' ' ASN . 13.3 pttt -81.14 -19.03 44.38 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.625 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.452 ' HB3' HD11 ' A' ' 68' ' ' ILE . 56.9 m -85.61 -28.12 25.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.834 ' HB1' HG23 ' A' ' 119' ' ' VAL . . . -75.23 -50.36 16.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.245 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.9 p -64.92 -26.34 68.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.099 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 38' ' ' ASN . 9.9 tt -54.18 -64.67 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 24.9 m -63.94 -34.12 77.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.045 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -66.42 -58.02 6.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.493 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.92 -32.93 74.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.703 0.287 . . . . 0.0 111.377 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.431 ' CD2' ' HB3' ' A' ' 76' ' ' MET . 14.2 tp -79.06 -38.42 36.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' CD ' ' HD3' ' A' ' 142' ' ' LYS . 74.0 mt-10 -70.26 -21.91 62.92 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.731 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -86.98 -22.48 25.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.347 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.64 -60.19 8.57 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.814 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.48 11.49 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.747 -0.267 . . . . 0.0 110.975 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.86 -175.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.031 0.832 . . . . 0.0 109.955 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 59.5 pttt -145.33 166.7 24.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.302 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.717 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 52.4 mt-10 60.15 -104.89 0.2 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.938 0.774 . . . . 0.0 110.201 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.405 ' CD ' ' HZ3' ' A' ' 93' ' ' LYS . 1.6 mp0 -138.74 19.55 2.68 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.9 -52.7 0.24 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.941 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.32 -75.74 1.74 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.035 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.235 0.308 0 C-N-CA 122.747 0.419 . . . . 0.0 111.051 178.661 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -75.53 104.29 6.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 0.0 110.544 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.23 147.92 31.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.845 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -82.93 90.48 6.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.292 0.568 . . . . 0.0 111.344 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.721 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . . . -102.47 92.83 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 8' ' ' ASP . 25.8 t-20 -49.93 93.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.241 0.963 . . . . 0.0 112.165 -171.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.436 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 47.7 tp 76.61 -15.49 0.72 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.022 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . 4.8 m-20 -59.92 -45.26 93.13 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.34 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -59.81 -45.88 90.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.138 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 14' ' ' VAL . 80.8 mt -70.4 -60.72 2.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.955 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.62 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.9 p90 -63.73 -36.09 82.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 12' ' ' ARG . 12.8 ttp180 -74.65 -28.63 60.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.29 -42.16 46.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.4 t -63.4 -46.47 95.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.207 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.6 tt -67.27 -32.75 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.76 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -68.77 -47.31 66.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.86 -48.24 79.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.04 -17.9 61.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.15 -42.49 80.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.592 0.71 . . . . 0.0 109.285 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 1.8 tmmt? -71.15 -27.04 63.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.723 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.96 85.57 28.61 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 121.035 0.445 . . . . 0.0 111.867 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.52 167.78 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.402 2.735 . . . . 0.0 112.88 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -162.99 25.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.83 36.93 1.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.586 -165.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -141.75 108.87 5.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 111.381 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.624 ' HA3' ' HD2' ' A' ' 60' ' ' LYS . . . 167.4 144.83 4.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.136 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.82 111.16 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.0 109.864 171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.627 ' O ' ' HB ' ' A' ' 48' ' ' THR . 47.2 tp -109.53 85.24 2.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.69 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.06 80.07 3.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -141.94 -73.35 0.32 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.635 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 49' ' ' MET . 14.5 m -95.26 -85.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 48' ' ' THR . 78.2 mt -93.35 130.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.051 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.01 95.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' A' ' 47' ' ' LEU . 3.6 p -131.21 108.08 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 111.224 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 5.0 t70 -95.34 145.05 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.959 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.442 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 9.7 tpt -144.17 115.22 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.443 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 4.9 p30 -120.27 158.04 27.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.564 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.547 ' HB2' HD11 ' A' ' 131' ' ' LEU . 10.8 t-20 -135.06 105.88 10.4 Favored Pre-proline 0 CA--C 1.52 -0.184 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.87 -16.94 57.86 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.919 2.413 . . . . 0.0 112.795 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -61.6 -38.91 89.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.0 -14.13 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.76 42.5 4.43 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.557 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' A' ' 131' ' ' LEU . 5.3 m-20 -87.07 145.96 26.26 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 30.0 mtm180 -143.18 113.74 7.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 131' ' ' LEU . 64.7 mt -121.52 93.94 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 42.1 ttm105 -89.12 99.22 12.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.882 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 61' ' ' PHE . 62.5 mt -88.1 106.63 18.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 123.843 0.715 . . . . 0.0 109.466 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 p -115.77 96.16 5.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.337 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.616 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 42.1 mtp -104.38 156.13 18.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.202 -167.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -120.81 87.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.52 0.676 . . . . 0.0 109.47 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.625 HD22 HG13 ' A' ' 32' ' ' ILE . 2.4 pt? -87.38 105.06 17.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.698 173.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.93 67.14 0.74 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.721 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.35 -101.5 0.25 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -139.01 18.2 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.605 HD13 ' O ' ' A' ' 55' ' ' ILE . 2.8 pp -120.26 150.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.65 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.3 112.5 39.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.12 -45.78 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -109.09 147.71 31.98 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.728 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -151.65 118.63 5.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.624 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 47.8 mmtm -111.7 111.23 22.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.799 ' HB3' HD21 ' A' ' 47' ' ' LEU . 7.8 p90 -127.01 105.22 8.45 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.318 0.58 . . . . 0.0 110.884 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.89 82.56 2.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 170.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -103.61 109.25 3.39 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.533 -172.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 7.4 pt-20 -127.74 159.58 34.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.47 -131.44 4.2 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.064 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.8 p -102.37 169.1 8.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -52.29 -48.16 65.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.73 0.644 . . . . 0.0 112.452 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.95 HD13 ' HG ' ' A' ' 69' ' ' SER . 2.4 pp -69.6 -36.23 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -171.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.95 ' HG ' HD13 ' A' ' 68' ' ' ILE . 1.9 m -72.11 -43.83 64.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 109.802 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.2 ttt -70.84 -23.93 62.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.584 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.461 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -88.69 -61.04 1.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.76 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -67.19 -50.47 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.842 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.57 94.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 110.328 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.684 ' HG ' ' HE2' ' A' ' 61' ' ' PHE . 35.4 t -69.41 -31.96 70.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.542 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.5 tpt -73.24 -41.4 63.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.163 0.506 . . . . 0.0 109.827 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.514 ' HE3' HD23 ' A' ' 136' ' ' LEU . 88.3 mtp -62.86 -30.86 71.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.879 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.41 HG23 ' CE1' ' A' ' 61' ' ' PHE . 50.8 m -72.91 -22.31 60.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.894 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.53 -33.44 71.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.418 0.627 . . . . 0.0 109.317 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.47 25.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.292 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.17 -32.02 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.089 -174.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.06 -17.11 63.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.308 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.22 27.79 7.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.935 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -134.12 -155.53 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 111.633 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.18 156.7 48.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -170.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 85' ' ' ILE . 2.3 mp -61.49 -42.87 95.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -41.48 73.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.177 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.0 m -79.23 -33.9 43.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.94 88.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.362 . . . . 0.0 110.779 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 144' ' ' GLU . 7.6 mp -64.74 -31.36 72.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.526 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.9 m -72.76 -33.92 66.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.129 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.0 ttm -67.81 -34.73 77.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.794 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 p -82.09 -30.02 31.46 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.98 -42.1 97.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.732 HD13 ' H ' ' A' ' 106' ' ' ASP . 14.5 tt -78.95 -25.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.054 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.64 -40.71 97.86 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.3 m -65.6 -31.99 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.875 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.89 -25.8 40.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.712 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.628 ' HG3' ' H ' ' A' ' 104' ' ' TYR . 43.0 ttm -49.06 -39.67 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.028 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -77.0 -26.62 54.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.798 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.731 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.52 -37.05 11.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.745 -172.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.8 -64.39 2.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.915 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -163.26 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.54 0.686 . . . . 0.0 110.567 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.68 ' HG2' ' HG ' ' A' ' 110' ' ' LEU . 36.8 tt0 177.71 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.628 ' H ' ' HG3' ' A' ' 98' ' ' MET . 11.7 p90 -165.17 140.04 5.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.5 106.63 8.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.878 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.732 ' H ' HD13 ' A' ' 94' ' ' ILE . 16.4 t70 58.1 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.817 0.847 . . . . 0.0 113.061 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.8 m -91.39 3.4 55.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 mp 59.03 58.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.968 0.89 . . . . 0.0 110.062 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -133.17 124.59 27.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.68 ' HG ' ' HG2' ' A' ' 103' ' ' GLU . 2.6 mm? -114.94 14.78 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.118 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.58 36.22 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.733 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.72 -38.94 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.067 0.46 . . . . 0.0 111.119 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.581 HD11 ' HE3' ' A' ' 98' ' ' MET . 64.6 mt -73.62 -34.9 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.936 -174.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.548 ' HA ' ' OE1' ' A' ' 117' ' ' GLN . 40.6 tt0 -62.68 -30.83 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.0 110.239 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.71 -9.97 59.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.4 -44.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.496 0.665 . . . . 0.0 109.773 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.548 ' OE1' ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -77.95 -19.04 55.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.881 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.09 -50.37 63.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.314 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 129' ' ' ALA . 23.1 m -71.87 -19.16 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.232 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.572 ' O ' HG22 ' A' ' 126' ' ' ILE . 58.7 m -55.92 -12.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.769 0.827 . . . . 0.0 112.947 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.29 -8.44 7.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 111.274 -163.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.837 ' HB2' ' HG2' ' A' ' 125' ' ' ARG . 34.3 m-85 -84.5 131.59 49.59 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.68 -18.98 6.88 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.163 2.576 . . . . 0.0 112.943 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -104.87 -8.53 18.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.837 ' HG2' ' HB2' ' A' ' 122' ' ' PHE . 6.8 mmm-85 -123.55 9.85 9.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.008 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 122' ' ' PHE . 26.3 pt -74.22 -28.65 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.024 0.916 . . . . 0.0 108.889 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -85.2 -25.09 27.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.806 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 26.4 t -86.32 -28.84 23.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.367 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -75.79 -46.34 31.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 p -61.49 -30.15 70.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.9 tt -50.29 -63.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.417 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 m -67.73 -45.21 75.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.509 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.62 -52.18 64.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.829 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 137' ' ' GLU . 37.4 ttmt -74.15 -19.42 60.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.28 91.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.392 . . . . 0.0 110.282 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.514 HD23 ' HE3' ' A' ' 76' ' ' MET . 4.7 mp -81.91 -39.6 23.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.719 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 8.4 mm-40 -64.2 -20.35 65.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.211 0.529 . . . . 0.0 110.863 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.24 -34.98 10.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.2 -55.78 19.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.892 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.43 6.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 122.704 -0.292 . . . . 0.0 111.316 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 74.43 178.21 0.22 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.224 0.953 . . . . 0.0 110.642 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.719 ' HD3' ' HB3' ' A' ' 137' ' ' GLU . 19.1 pttm -143.76 141.33 30.39 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 65.89 -67.64 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.107 0.963 . . . . 0.0 111.551 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.7 ' HA ' HD23 ' A' ' 89' ' ' LEU . 42.5 tt0 -164.56 -44.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.208 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.36 -136.59 8.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.326 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.58 -5.41 12.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.967 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.554 0.216 . . . . 0.0 110.577 179.454 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HB3' ' H ' ' A' ' 2' ' ' SER . 65.6 mtt . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 1' ' ' MET . 47.9 m -72.83 83.53 1.2 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.379 0.609 . . . . 0.0 111.467 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -146.25 86.71 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 -44.09 3.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.651 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.73 138.24 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -148.01 -79.7 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.917 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' A' ' 115' ' ' ALA . 67.7 tp -141.43 -43.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.741 0.305 . . . . 0.0 110.284 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.27 -46.76 76.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.22 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -59.02 -33.69 71.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.346 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' O ' HG22 ' A' ' 14' ' ' VAL . 92.4 mt -75.38 -50.27 16.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' O ' HG13 ' A' ' 15' ' ' ILE . 4.5 m-85 -55.18 -42.44 73.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.858 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -51.42 -45.52 62.6 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.703 0.627 . . . . 0.0 109.911 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -73.43 -42.72 61.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.554 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.54 HG23 ' HE3' ' A' ' 75' ' ' MET . 83.7 t -58.76 -48.54 85.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 111.421 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.9 pp -73.99 -21.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.626 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 78.0 mmm -73.53 -43.31 60.28 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.194 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.81 -39.13 93.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.112 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -76.33 -19.24 58.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -72.05 -39.43 69.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.197 0.522 . . . . 0.0 109.753 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -72.25 -19.97 61.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.759 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -119.44 81.29 22.91 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.19 20.49 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.842 2.361 . . . . 0.0 112.847 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 2.1 mpt_? -93.47 95.21 9.13 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.839 HD22 ' HB2' ' A' ' 70' ' ' MET . 36.6 t30 -118.38 24.38 10.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.0 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.793 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 51.2 mttp -137.59 114.33 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.861 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.563 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -157.34 133.22 3.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.49 105.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.862 0.839 . . . . 0.0 111.699 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 50' ' ' LYS . 3.5 tt -115.8 79.22 1.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.726 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.436 ' HA ' HG23 ' A' ' 33' ' ' VAL . 4.3 t30 -82.53 8.71 11.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.853 -171.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -94.02 3.65 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.872 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -144.56 -104.31 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.364 -0.21 . . . . 0.0 110.579 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.579 HG23 ' HE3' ' A' ' 49' ' ' MET . 63.6 mt -83.87 128.32 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.273 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 29' ' ' ASN . 24.8 t -128.49 101.23 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.439 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.983 HG23 ' HA2' ' A' ' 139' ' ' GLY . 59.6 t -116.98 120.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -126.05 145.68 50.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.81 0.338 . . . . 0.0 110.163 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.435 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 25.5 mmt -138.37 126.47 22.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.93 135.87 43.81 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.158 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.508 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.6 t-20 -132.91 97.92 16.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 40' ' ' THR . 48.1 Cg_exo -16.81 -79.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 1 C-N-CA 125.886 4.391 . . . . 0.0 115.669 -162.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.41 ' H ' ' HB2' ' A' ' 39' ' ' PRO . 12.1 p -117.0 17.87 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.933 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.1 15.02 4.69 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.766 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.17 54.95 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.86 -71.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.123 1.369 . . . . 0.0 113.307 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 44' ' ' ARG . 10.4 ptt180 -159.84 119.24 2.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.516 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.642 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 5.7 tt -104.33 106.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.38 171.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 62' ' ' GLU . 51.4 mtm180 -96.68 102.72 14.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.973 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.0 104.75 14.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 1.9 p -117.18 121.74 42.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.93 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.579 ' HE3' HG23 ' A' ' 32' ' ' ILE . 56.7 mtm -124.17 136.69 54.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.396 -169.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HB2' HD11 ' A' ' 28' ' ' LEU . 7.1 tmtt? -109.49 87.47 2.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.3 pt? -77.82 115.0 17.23 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.25 66.33 0.67 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.156 0.503 . . . . 0.0 110.128 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.38 -103.07 0.29 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.58 4.67 5.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.1 pp -110.21 -164.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.627 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG22 HG11 ' A' ' 140' ' ' VAL . 25.7 t -126.48 104.2 12.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.635 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 40.9 tt0 -81.7 -71.37 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.956 -171.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' MET . 34.3 t0 -109.68 104.14 13.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.502 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' CB ' ' HG2' ' A' ' 49' ' ' MET . . . -102.44 113.59 27.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.166 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 12.7 mtpp -112.04 131.85 55.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 74' ' ' SER . 2.7 p90 -123.05 102.87 8.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.275 0.56 . . . . 0.0 111.434 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.793 ' HG3' ' HG2' ' A' ' 25' ' ' LYS . 23.9 tt0 -104.84 94.57 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.603 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -111.29 130.11 9.56 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.824 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.19 131.9 56.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.766 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 161.31 -132.25 2.81 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.465 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 70' ' ' MET . 3.5 p -99.65 155.71 17.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 70' ' ' MET . 4.3 m -55.63 -36.27 66.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.925 0.765 . . . . 0.0 112.321 -168.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -81.83 -35.75 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.638 ' N ' HD13 ' A' ' 68' ' ' ILE . 35.2 p -73.73 -39.58 64.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.018 0.437 . . . . 0.0 110.693 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.839 ' HB2' HD22 ' A' ' 24' ' ' ASN . 26.1 ptt? -82.07 -8.21 59.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.6 -57.82 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.502 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -64.02 -53.64 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.585 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.76 82.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.317 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.535 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 20.1 m -63.16 -34.11 76.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.54 ' HE3' HG23 ' A' ' 14' ' ' VAL . 56.0 ttp -69.21 -47.43 64.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.07 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.5 69.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.7 m -66.18 -25.36 66.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.144 0.497 . . . . 0.0 110.654 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 74' ' ' SER . 79.1 mt-30 -73.47 -34.54 65.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -69.0 -33.87 74.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.674 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.3 mm -72.32 -30.45 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.63 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.01 -17.29 37.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.506 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.32 31.17 5.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.623 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 66.5 mttm -133.23 -174.89 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.692 -0.299 . . . . 0.0 110.934 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.729 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.7 -175.91 2.99 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -175.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' O ' HD21 ' A' ' 89' ' ' LEU . 1.7 mp -86.01 -46.79 16.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.978 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -59.19 -40.22 85.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.1 p -73.4 -33.46 65.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.999 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.97 90.89 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.418 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 142' ' ' LYS . 4.5 mm? -64.76 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.95 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.0 m -85.03 -29.94 24.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' THR . 92.6 mmm -69.07 -26.31 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.593 176.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.615 ' HG ' ' HG2' ' A' ' 142' ' ' LYS . 2.2 p -85.41 -31.35 22.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -58.28 -47.33 83.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 mt -57.83 -42.67 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.715 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -55.83 -48.14 75.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.831 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.469 ' HA ' ' HE3' ' A' ' 99' ' ' MET . 4.6 p -70.16 -35.96 74.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.401 ' CB ' ' HH ' ' A' ' 104' ' ' TYR . 29.9 m-20 -72.9 -27.95 62.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.948 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 19.4 ttt -69.8 -51.71 31.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.202 0.525 . . . . 0.0 110.948 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.664 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 26.6 ptt? -82.33 -5.85 58.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.569 -171.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.664 ' HG3' ' HG3' ' A' ' 99' ' ' MET . 18.7 mt-30 -132.57 13.06 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.958 0.409 . . . . 0.0 110.286 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.33 -80.32 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.752 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 98' ' ' MET . 52.5 tttp -152.76 155.13 36.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.926 -167.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.39 113.76 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.338 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HH ' ' CB ' ' A' ' 97' ' ' ASP . 22.4 p90 -173.43 141.89 0.93 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.108 0.48 . . . . 0.0 110.11 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.604 ' HB2' HD13 ' A' ' 110' ' ' LEU . 39.0 t0 -135.36 130.04 34.33 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.77 -24.04 67.61 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.07 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.0 m -98.89 -19.54 17.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.489 ' O ' HG21 ' A' ' 108' ' ' ILE . 25.3 mm 60.11 33.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.644 0.735 . . . . 0.0 110.466 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -141.31 82.51 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 105' ' ' ASP . 94.9 mt -121.82 16.62 11.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.26 -24.79 69.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.488 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.08 -28.94 43.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.771 0.32 . . . . 0.0 111.332 -175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.06 -35.57 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.224 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.92 -34.74 75.16 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.199 0.524 . . . . 0.0 109.928 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.528 ' HA ' HD13 ' A' ' 7' ' ' LEU . . . -70.37 -20.65 62.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.872 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.28 -34.41 15.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 109.757 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -61.5 -31.12 71.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.013 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.23 -41.68 98.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.751 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.777 HG13 ' HD3' ' A' ' 125' ' ' ARG . 34.5 m -85.91 -20.44 8.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 111.404 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . 33.0 t -54.04 -15.14 1.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -130.36 -23.37 2.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.841 0.746 . . . . 0.0 112.78 -162.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 68.5 m-85 -70.96 135.63 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.29 -25.07 45.33 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.737 2.292 . . . . 0.0 111.844 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.46 -3.7 39.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.402 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.777 ' HD3' HG13 ' A' ' 119' ' ' VAL . 99.6 mtt180 -123.16 0.82 9.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.605 -0.684 . . . . 0.0 110.327 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 tt -72.43 -31.59 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.528 0.68 . . . . 0.0 109.78 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -79.96 -19.49 47.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.033 175.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.5 t -85.32 -19.54 31.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 120' ' ' SER . . . -75.27 -46.56 32.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.41 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.6 m -58.39 -37.79 76.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.589 HD23 ' HB2' ' A' ' 69' ' ' SER . 6.8 tt -52.95 -70.92 0.08 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.442 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -58.39 3.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.53 0.681 . . . . 0.0 111.087 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -66.06 -49.83 66.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.205 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.665 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 37.3 tttp -83.51 -21.07 32.89 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.184 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.57 -30.11 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.392 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -86.63 -40.83 14.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 1.095 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 2.9 tm-20 -63.68 -47.6 80.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.883 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.912 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -92.87 -11.27 33.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.982 -171.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.983 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -59.22 -54.77 35.14 Favored Glycine 0 C--O 1.23 -0.143 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.095 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.469 HG11 HG22 ' A' ' 56' ' ' VAL . 18.1 m -114.52 21.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 142' ' ' LYS . . . 68.15 155.82 0.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.417 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 1.095 ' HE2' ' HA ' ' A' ' 137' ' ' GLU . 8.9 mtmm -173.33 151.58 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 31.6 tt0 66.73 117.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.744 0.652 . . . . 0.0 110.123 -172.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.07 -88.3 0.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.48 33.68 47.8 Favored Glycine 0 CA--C 1.521 0.461 0 O-C-N 123.474 0.484 . . . . 0.0 113.685 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.35 46.28 21.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.936 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 N--CA 1.467 0.425 0 C-N-CA 123.422 0.689 . . . . 0.0 111.835 -179.274 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 121.213 0.53 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -150.25 40.11 0.77 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.686 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -64.08 -4.79 3.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.916 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -64.22 -31.04 72.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 8' ' ' ASP . . . -97.68 111.18 23.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -59.14 -76.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.723 0.639 . . . . 0.0 112.292 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.48 -21.49 15.33 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.74 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 5.1 m-20 -49.12 -45.78 44.04 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.839 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.3 m -62.36 -43.69 98.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.174 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mm? -76.46 -56.92 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.116 -171.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 9.8 p90 -68.73 -37.49 79.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.797 -169.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -68.59 -37.2 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.91 -46.06 72.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.179 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 10' ' ' LEU . 78.7 t -62.69 -46.48 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.789 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.0 -44.4 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.061 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.1 ttt -61.81 -49.03 77.96 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.72 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.946 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -74.59 -16.99 60.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.395 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -76.73 -32.31 57.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 0.0 109.796 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -76.82 -21.46 55.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -117.95 71.23 8.01 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.85 38.5 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.529 2.819 . . . . 0.0 114.929 -161.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.01 92.52 4.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.932 0.396 . . . . 0.0 110.565 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.51 15.37 8.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.701 . . . . 0.0 109.27 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -118.85 85.22 2.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.56 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.43 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -119.2 122.97 5.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.09 100.04 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.0 111.708 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 48' ' ' THR . 20.4 tp -108.07 175.52 5.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.488 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.2 p-10 -156.93 97.65 1.7 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -141.73 -90.85 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.702 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -108.39 -65.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.821 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.694 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 65.4 mt -87.83 121.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.7 t -136.04 90.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.47 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.68 112.27 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.532 0.682 . . . . 0.0 111.231 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -109.19 123.87 49.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.566 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.553 ' O ' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.23 118.59 24.55 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.66 132.4 56.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.417 0.627 . . . . 0.0 112.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.573 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 19.7 t-20 -106.02 105.88 55.03 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.8 Cg_exo -65.58 40.31 0.13 Allowed 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.809 3.673 . . . . 0.0 115.364 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.6 t -178.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.697 0.284 . . . . 0.0 110.742 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 t -133.91 18.94 3.81 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -168.77 42.16 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -33.2 -54.21 0.39 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -146.97 136.47 22.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.902 1.228 . . . . 0.0 112.268 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 36' ' ' MET . 8.1 tt -130.66 94.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 10.4 ttm180 -88.0 115.99 25.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.996 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.65 106.33 9.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.1 p -117.72 112.36 20.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.193 0.521 . . . . 0.0 110.978 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.694 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 81.1 mtp -103.97 162.46 13.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.24 -173.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -130.77 104.58 7.25 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -108.62 94.82 5.26 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.829 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.06 63.52 4.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.525 1.155 . . . . 0.0 109.911 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.74 -100.97 0.25 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.571 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 8.4 m-20 -143.15 30.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.829 -0.685 . . . . 0.0 109.291 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.7 pp -137.1 156.46 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.36 102.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.39 -46.13 16.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -153.59 169.72 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.684 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -158.37 129.81 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.061 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' CG ' ' HB2' ' A' ' 28' ' ' LEU . 67.9 mmtt -112.59 129.54 56.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 27.7 p90 -128.03 128.79 45.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.075 0.464 . . . . 0.0 111.804 -174.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.31 108.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.39 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.09 138.31 14.41 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.455 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -132.41 104.2 6.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.13 -130.3 1.29 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.218 -172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 158.45 19.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -52.14 -38.31 57.13 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.611 0.569 . . . . 0.0 111.882 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.672 HD11 ' N ' ' A' ' 69' ' ' SER . 2.3 pp -72.11 -44.0 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.672 ' N ' HD11 ' A' ' 68' ' ' ILE . 7.4 p -70.9 -38.33 73.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.04 -38.22 82.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.089 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.408 ' HB3' HG11 ' A' ' 14' ' ' VAL . . . -85.49 -45.65 11.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.066 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -55.32 -45.53 76.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.351 . . . . 0.0 110.352 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -56.67 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 40.5 p -58.04 -40.76 81.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.781 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.7 ttt -73.37 -41.81 62.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.146 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.913 ' HE2' HD23 ' A' ' 136' ' ' LEU . 94.8 mtp -73.42 -31.93 64.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.749 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -73.44 -20.36 60.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 74' ' ' SER . 85.3 mt-30 -81.03 -41.33 22.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.51 95.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.067 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.43 -20.91 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.851 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -66.01 -21.86 66.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.56 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.72 29.56 10.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.911 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -135.16 -172.63 3.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.337 0.568 . . . . 0.0 110.626 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.721 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.3 p-10 -112.36 -172.0 1.96 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.2 mm -85.93 -35.2 9.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.1 -39.58 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.694 0.283 . . . . 0.0 110.66 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.38 -23.68 61.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.286 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.982 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 86.8 mt -66.39 -34.14 77.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.653 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.564 ' O ' HG12 ' A' ' 94' ' ' ILE . 4.5 p -78.07 -35.36 49.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.437 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 19.0 ttt -60.34 -37.89 82.07 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.081 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 28.2 p -84.71 -27.72 26.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 109.867 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.975 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 17.8 tptp -57.77 -53.29 59.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.719 ' HA ' ' HB2' ' A' ' 97' ' ' ASP . 17.5 pt -75.58 -22.85 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' HG3' ' A' ' 98' ' ' MET . 34.3 t80 -69.72 -26.79 64.51 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.8 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -85.27 -26.61 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.344 0.593 . . . . 0.0 109.966 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 94' ' ' ILE . 2.0 m-20 -83.89 -18.17 38.33 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.601 -177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -52.26 -18.88 1.73 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -73.99 -58.69 3.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.492 0.187 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -104.1 -43.57 5.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.755 0.312 . . . . 0.0 111.203 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.44 -37.17 85.4 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.7 tttt 70.37 28.53 3.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.277 0.631 . . . . 0.0 110.394 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -102.55 152.37 21.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.643 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.607 ' C ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.89 165.69 27.01 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.497 ' O ' HD13 ' A' ' 108' ' ' ILE . 28.1 t70 -75.46 79.16 2.5 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.845 0.355 . . . . 0.0 110.055 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.426 ' HB3' HD13 ' A' ' 108' ' ' ILE . 17.6 t0 73.81 27.42 1.7 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.406 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.566 ' HA ' ' CD1' ' A' ' 104' ' ' TYR . 8.2 t 65.06 47.24 2.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.216 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -103.29 -46.18 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.26 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' OD2' ' HE2' ' A' ' 91' ' ' MET . 1.6 m-20 -68.34 96.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.882 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -148.48 -55.31 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.308 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -70.24 -32.15 68.83 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.868 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -45.96 91.73 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.905 0.482 . . . . 0.0 110.292 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.1 -37.73 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.625 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mm-40 -61.34 -36.0 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.48 68.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -91.35 -21.07 21.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.856 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -50.96 -35.25 32.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.19 46.1 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.851 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 125' ' ' ARG . 29.6 m -86.27 -18.32 8.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.4 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 65.9 m -52.96 -18.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -169.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.846 ' HZ1' ' HB2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -157.37 5.04 0.14 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.931 -165.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.742 ' HD2' ' HD2' ' A' ' 125' ' ' ARG . 17.0 m-85 -85.7 132.61 43.82 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 172.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.89 -16.1 11.1 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.91 2.407 . . . . 0.0 112.335 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.83 -11.59 17.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.342 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.742 ' HD2' ' HD2' ' A' ' 122' ' ' PHE . 94.8 mtt180 -123.74 1.33 8.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.682 -0.636 . . . . 0.0 110.271 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -79.73 -24.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.537 -168.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -76.3 -19.56 58.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.386 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 95.5 m -85.88 -24.52 26.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.796 172.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -71.9 -48.03 48.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.708 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -60.98 -30.06 70.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.831 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 9.9 tt -60.02 -66.79 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 t -71.02 -42.26 69.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.407 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -67.95 -55.33 13.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.661 0.267 . . . . 0.0 110.833 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.57 -25.38 63.96 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.123 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.11 93.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.298 . . . . 0.0 110.771 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.913 HD23 ' HE2' ' A' ' 76' ' ' MET . 2.3 tp -76.1 -43.79 41.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.84 -19.79 65.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.957 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -85.07 -14.62 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.461 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.56 -68.3 1.69 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.196 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.421 ' HB ' HG22 ' A' ' 85' ' ' ILE . 35.6 m -103.47 5.58 10.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 122.843 -0.21 . . . . 0.0 111.158 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 72.96 162.25 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.223 0.952 . . . . 0.0 110.351 -173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 14.5 pttp -121.1 148.36 44.3 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.314 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.975 ' HG2' ' HA ' ' A' ' 93' ' ' LYS . 41.4 mt-10 65.39 -161.27 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.884 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.65 87.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.39 126.98 8.24 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.545 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.21 169.29 51.4 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.156 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 120.615 0.245 . . . . 0.0 110.756 -177.351 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.928 0.394 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -81.88 82.61 7.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -149.04 -34.53 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.928 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.64 101.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.054 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.04 54.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.928 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 8' ' ' ASP . 12.8 t-20 -158.57 -114.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp 72.67 -18.32 0.35 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.727 0.811 . . . . 0.0 110.523 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.554 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 30.2 t70 -71.46 -43.48 66.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.436 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -69.56 -26.83 64.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.587 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 ' O ' HG21 ' A' ' 14' ' ' VAL . 92.0 mt -71.75 -30.48 65.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.218 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 8' ' ' ASP . 15.3 m-85 -59.23 -49.63 77.12 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.893 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 1.8 mpt_? -59.1 -33.79 71.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.725 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -71.4 -49.98 36.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 71' ' ' ALA . 59.5 t -75.25 -39.86 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.806 -173.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.2 tt -71.7 -27.96 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.294 -0.254 . . . . 0.0 110.648 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.4 ttt -66.87 -39.19 87.46 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.27 -43.23 74.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.775 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.1 -27.62 69.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.758 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -71.61 -39.71 70.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.518 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -63.71 -32.04 73.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.193 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 23' ' ' ARG . 70.7 m-20 -83.88 166.96 30.94 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.852 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.48 16.92 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.021 2.481 . . . . 0.0 113.445 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 21' ' ' ASN . 51.5 mtt180 59.33 -159.67 0.29 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.865 0.466 . . . . 0.0 111.062 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -103.27 80.09 1.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.88 0.372 . . . . 0.0 111.391 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -145.67 94.22 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.799 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.683 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.23 133.73 2.98 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.778 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.58 104.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 0.0 110.428 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.541 ' O ' ' HB ' ' A' ' 48' ' ' THR . 1.1 tt -111.02 88.88 2.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.03 98.94 8.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 21.2 t70 -143.71 -73.45 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.943 0.401 . . . . 0.0 111.145 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -124.67 -62.37 1.25 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.667 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 37.0 mt -92.35 118.74 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.054 0.454 . . . . 0.0 110.846 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 48' ' ' THR . 48.4 t -136.85 97.01 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.541 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.868 HG12 ' HA ' ' A' ' 135' ' ' ALA . 24.1 t -104.19 130.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.104 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -132.92 118.6 19.1 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -128.74 116.02 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.047 0.451 . . . . 0.0 109.823 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -114.06 140.58 48.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.055 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 34.5 t30 -139.97 105.61 6.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.4 Cg_endo -42.15 113.35 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.984 3.123 . . . . 0.0 113.867 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.8 m 78.93 -22.68 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.663 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 t -121.87 -18.33 7.07 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.296 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -143.68 48.78 0.73 Allowed Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -29.71 -67.26 0.08 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 125.567 1.392 . . . . 0.0 113.392 -164.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.52 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 41.4 ptt85 -167.76 138.69 2.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.23 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.799 ' HB ' ' HE2' ' A' ' 70' ' ' MET . 10.1 tt -132.3 115.22 25.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.237 0.541 . . . . 0.0 109.932 173.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 29.6 ttp180 -106.21 105.99 16.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.845 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.998 HD23 ' HE1' ' A' ' 49' ' ' MET . 10.0 tt -106.85 107.75 18.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 14.5 p -113.27 133.21 55.22 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.718 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.998 ' HE1' HD23 ' A' ' 47' ' ' LEU . 68.2 mtt -126.67 158.06 37.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.488 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 28.4 tttm -130.23 95.74 3.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 176.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -88.18 97.43 11.0 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.39 63.26 1.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.0 -104.3 0.31 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.55 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.31 30.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.802 0.334 . . . . 0.0 110.21 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.42 HD11 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -137.63 157.71 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.82 88.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 11.7 tp10 -75.87 -56.95 4.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.244 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -131.81 153.13 50.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.757 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -156.01 131.08 9.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.606 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.683 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.5 mttp -140.6 136.13 32.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.2 p90 -132.18 106.52 8.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.822 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.82 114.33 26.05 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -151.03 150.91 22.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.173 -1.489 . . . . 0.0 114.563 -173.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.61 142.72 39.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.05 2.46 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.869 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.8 m -94.06 159.1 15.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -56.82 -39.45 74.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.838 0.711 . . . . 0.0 111.027 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.798 HD11 ' HG ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -72.99 -32.63 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.798 ' HG ' HD11 ' A' ' 68' ' ' ILE . 1.5 m -68.25 -54.82 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.752 0.786 . . . . 0.0 110.289 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.799 ' HE2' ' HB ' ' A' ' 45' ' ' ILE . 18.5 mmt -78.4 -5.11 51.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.594 -177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -86.9 -50.48 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 p -72.9 -47.45 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.275 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.13 81.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.294 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 p -68.25 -30.89 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -47.05 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.484 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 96.3 mmm -61.95 -35.88 79.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 m -71.83 -24.1 61.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.042 0.449 . . . . 0.0 111.057 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -46.68 57.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.88 65.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -74.88 -27.66 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.298 0.571 . . . . 0.0 110.329 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.23 36.32 3.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.659 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.71 174.01 11.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -120.39 -162.53 0.95 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.87 -37.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.81 -46.24 88.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.526 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 p -81.28 -19.18 43.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.753 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.6 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 -46.38 87.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 m -67.57 -28.58 67.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.146 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 44.9 ttp -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.149 0.499 . . . . 0.0 110.106 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.695 ' HB2' ' HB3' ' A' ' 141' ' ' ALA . 48.0 t -85.65 -28.03 25.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.267 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.814 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 3.5 tmtp? -60.25 -49.62 76.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 tt -76.24 -25.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.443 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.441 ' CB ' ' HA ' ' A' ' 92' ' ' SER . 76.4 t80 -57.99 -44.24 87.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.075 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -82.1 -34.97 29.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 110.638 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -30.95 67.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.073 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.46 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -58.33 -37.24 74.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 tpt -79.81 -25.88 40.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.687 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -84.21 -38.67 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.868 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.73 -55.22 6.07 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.423 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 102' ' ' LYS . 34.7 ttpt -177.89 -82.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.918 0.389 . . . . 0.0 111.172 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -176.36 97.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.246 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 98' ' ' MET . 9.5 p90 -164.67 122.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.179 0.514 . . . . 0.0 111.577 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 107' ' ' SER . 25.4 t70 -125.44 82.28 2.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.871 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.73 -82.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.19 0.931 . . . . 0.0 112.418 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' ASP . 10.9 p -83.22 -2.28 55.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.735 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' ILE . 24.6 mm 70.8 33.62 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.973 0.892 . . . . 0.0 110.076 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.13 4.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.585 172.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.28 0.22 57.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.042 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.71 -42.84 97.02 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.299 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.17 -44.25 80.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.191 0.52 . . . . 0.0 110.216 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.7 mm -64.86 -32.5 58.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.41 -36.89 81.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.17 0.51 . . . . 0.0 110.314 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.78 -12.66 61.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.728 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.07 -6.33 17.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.807 0.813 . . . . 0.0 109.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.967 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.47 98.83 Favored Glycine 0 C--N 1.329 0.179 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.15 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 129' ' ' ALA . 27.6 m -69.59 -19.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 29.3 t -59.03 -13.7 7.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 -18.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.378 -165.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -61.95 126.89 88.32 Favored Pre-proline 0 CA--C 1.518 -0.279 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -18.89 9.37 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.829 2.352 . . . . 0.0 112.919 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -101.13 -10.46 20.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.658 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 5.9 mpt_? -128.27 -1.75 5.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.359 -0.838 . . . . 0.0 110.052 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 120' ' ' SER . 8.0 tt -60.92 -36.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.344 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.567 ' HA ' ' HB ' ' A' ' 130' ' ' THR . 82.2 mttt -85.9 -21.01 28.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.525 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . 82.7 m -71.57 -32.45 68.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.69 ' HB3' HG22 ' A' ' 119' ' ' VAL . . . -80.04 -39.7 29.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.525 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 127' ' ' LYS . 51.9 m -59.32 -43.97 92.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.855 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.628 HD12 ' HB3' ' A' ' 69' ' ' SER . 4.4 pp -63.82 -36.02 82.54 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.492 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.435 ' N ' HD11 ' A' ' 131' ' ' LEU . 14.4 m -72.65 -52.64 14.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.907 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 -49.75 64.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.454 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.18 -26.9 65.98 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.373 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.868 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -69.23 -32.66 72.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 0.0 110.596 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 tp -85.48 -39.22 17.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.854 ' HA ' ' HB1' ' A' ' 141' ' ' ALA . 30.3 tt0 -64.95 -44.42 89.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.413 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -69.45 -13.21 62.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.815 -172.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.61 -65.17 1.74 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.441 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 m -144.77 17.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HB1' ' HA ' ' A' ' 137' ' ' GLU . . . -122.17 122.2 38.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.949 -0.469 . . . . 0.0 111.944 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -159.93 30.01 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.944 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.814 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 27.6 tt0 64.55 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.588 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.778 ' HG2' ' HG2' ' A' ' 143' ' ' GLU . 9.5 pt-20 177.93 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.83 -165.8 26.52 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 119.57 -21.68 9.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 t -106.96 146.04 31.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.2 t80 72.89 -66.48 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.919 0.762 . . . . 0.0 110.623 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 62.66 21.89 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.731 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.05 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.584 0.707 . . . . 0.0 111.608 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -79.34 -57.8 3.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.32 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -101.25 -40.0 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.883 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.22 -52.15 54.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.12 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -76.01 -26.56 56.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.607 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' O ' HG22 ' A' ' 14' ' ' VAL . 28.7 mt -74.2 -54.2 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.603 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -67.62 -29.54 68.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.95 -34.27 77.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -76.11 -37.89 57.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.114 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 10' ' ' LEU . 76.6 t -60.45 -48.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 13.4 tt -70.26 -28.51 35.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.027 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 51.3 ttp -79.13 -32.12 44.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.351 . . . . 0.0 110.771 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.652 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 t70 -67.92 -32.81 73.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 110.025 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -85.34 -19.42 31.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.32 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 27.1 t80 -70.28 -23.32 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.703 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 90.8 mttt -59.74 -31.98 70.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.266 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -129.08 80.47 72.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.699 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.71 100.79 1.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.83 2.353 . . . . 0.0 111.759 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -132.27 22.13 4.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.153 0.501 . . . . 0.0 110.035 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.61 76.65 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -164.52 106.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.506 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.689 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -175.74 140.36 5.12 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.207 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.52 95.27 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.738 0.78 . . . . 0.0 109.662 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.05 132.94 46.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.534 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -117.16 100.46 7.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -164.34 -57.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.319 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.687 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 39.6 t -115.63 -77.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.56 -177.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.524 HD11 HD23 ' A' ' 51' ' ' LEU . 62.9 mt -111.08 129.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.781 0.324 . . . . 0.0 110.481 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.664 ' HA ' HG23 ' A' ' 48' ' ' THR . 40.7 t -131.08 98.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.912 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.589 HG21 ' HA2' ' A' ' 139' ' ' GLY . 58.7 t -121.96 122.89 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.888 0.375 . . . . 0.0 110.852 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -122.72 148.29 45.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.437 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -113.49 117.63 32.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.174 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -117.43 86.62 22.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -34.27 122.74 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 124.603 3.536 . . . . 0.0 114.981 -167.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 m 77.32 -7.57 1.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.398 171.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.7 t -130.86 -46.67 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.823 -0.548 . . . . 0.0 111.855 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.57 58.81 0.66 Allowed Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -52.87 -61.01 2.57 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.11 -1.045 . . . . 0.0 113.661 -163.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.631 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 46.1 mtm-85 -142.6 97.44 3.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.874 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.743 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 9.4 tt -95.48 92.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.238 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 78.4 mtt180 -93.87 97.72 10.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.269 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 77' ' ' THR . 66.2 tp -99.91 100.83 11.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.317 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 33' ' ' VAL . 22.3 p -115.52 117.23 29.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.369 -174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.557 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.2 mpp? -114.2 162.07 17.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.036 -171.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.687 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 7.5 tmtm? -129.88 100.85 5.62 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 32' ' ' ILE . 3.9 pp -100.36 121.12 40.99 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.16 66.33 0.69 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.713 0.768 . . . . 0.0 109.476 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.91 -109.49 0.52 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.53 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -134.9 32.34 3.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.683 HD13 ' O ' ' A' ' 55' ' ' ILE . 2.0 pp -131.83 129.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.896 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.9 t -81.09 84.57 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.571 ' HB2' HD12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -80.03 -64.18 1.24 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.787 -172.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 38.7 t70 -94.18 147.18 23.42 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.219 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.73 122.24 9.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.968 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.612 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 22.3 mmtp -122.7 110.44 15.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.4 p90 -122.05 93.32 3.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.338 0.589 . . . . 0.0 111.859 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.689 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 39.3 tt0 -98.72 98.86 9.93 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -115.97 103.82 1.22 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.769 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.09 95.86 10.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.13 -131.34 1.32 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.131 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.24 177.62 4.82 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.265 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -46.9 -54.82 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.77 HD13 ' HB3' ' A' ' 128' ' ' CYS . 0.1 OUTLIER -70.77 -24.52 25.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.143 -172.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.457 ' N ' HD11 ' A' ' 68' ' ' ILE . 1.6 m -67.89 -47.66 68.2 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.1 mtt -73.55 -21.83 60.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.763 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 68' ' ' ILE . . . -86.66 -60.58 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.385 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.8 m -74.79 -37.96 62.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.799 -169.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.76 67.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.53 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -66.86 -24.21 66.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 52.7 tpp -73.06 -53.14 11.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.11 -33.72 76.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.777 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 39.7 m -72.19 -19.52 61.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -69.07 -43.26 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.45 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.615 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.777 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.4 mm -67.59 -38.15 80.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.154 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 64.5 tttp -60.86 -18.33 55.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.514 0.673 . . . . 0.0 110.352 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.3 26.38 7.8 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.953 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -128.92 -176.37 3.84 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.68 -177.97 3.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.68 -49.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.158 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.31 -32.67 70.27 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.481 0.658 . . . . 0.0 110.057 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 m -76.79 -24.47 52.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.981 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 91' ' ' MET . . . -74.53 -41.18 61.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.37 -42.23 99.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.594 0.712 . . . . 0.0 109.675 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -68.76 -24.95 64.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.145 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.456 ' HA ' HG23 ' A' ' 94' ' ' ILE . 52.4 ttm -66.44 -28.52 68.67 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.119 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.727 ' OG ' ' HB2' ' A' ' 141' ' ' ALA . 13.4 m -82.3 -39.82 22.37 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 8.5 tmtm? -55.41 -42.46 74.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 11.9 tt -82.92 -25.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 91' ' ' MET . 54.9 t80 -58.04 -46.65 84.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.482 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 p -78.89 -37.54 39.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.33 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 12.9 t70 -57.63 -52.32 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.904 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -61.31 -33.88 74.32 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.997 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -19.78 61.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.068 0.461 . . . . 0.0 110.829 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -101.75 8.75 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.54 -53.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.225 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 59.04 89.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 111.915 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -162.87 -28.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.153 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -154.31 150.73 28.29 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.459 0.647 . . . . 0.0 110.259 -173.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.62 ' HB3' ' HA ' ' A' ' 108' ' ' ILE . 10.5 t70 -133.66 144.33 49.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 168.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -52.36 -38.76 59.61 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.972 0.795 . . . . 0.0 111.514 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -111.64 -2.4 15.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.781 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.62 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . 4.0 mp 51.57 48.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.719 0.771 . . . . 0.0 110.131 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -111.93 85.09 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.595 HD23 HD13 ' A' ' 113' ' ' ILE . 36.7 mt -113.19 13.02 19.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.617 -171.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.67 -62.59 3.55 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.059 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.74 -34.49 78.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.874 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.595 HD13 HD23 ' A' ' 110' ' ' LEU . 59.5 mt -58.17 -41.03 79.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.389 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.56 -41.35 85.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' HG21 ' A' ' 119' ' ' VAL . . . -71.72 -47.6 52.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.022 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -57.29 -42.47 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.014 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -57.21 -44.99 84.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.881 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.47 -44.61 96.45 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.874 HG12 ' HB3' ' A' ' 125' ' ' ARG . 41.3 t -61.97 -34.73 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.614 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . 67.0 m -61.05 -14.18 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -172.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -125.32 -27.45 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.114 -161.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -65.64 126.78 92.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.36 -16.59 13.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.545 2.163 . . . . 0.0 112.29 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.05 -17.9 23.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.347 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.874 ' HB3' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -126.87 5.22 6.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -176.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 120' ' ' SER . 9.7 tt -72.64 -30.06 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.953 0.882 . . . . 0.0 109.31 -170.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.481 ' HG3' HG22 ' A' ' 126' ' ' ILE . 66.2 mttm -85.43 -18.63 33.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.941 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.77 ' HB3' HD13 ' A' ' 68' ' ' ILE . 66.8 m -81.44 -33.22 32.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.343 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 120' ' ' SER . . . -77.7 -48.51 16.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.848 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 133' ' ' TRP . 18.8 p -61.71 -28.7 69.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.6 tt -54.9 -53.59 53.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.455 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.6 m -75.56 -37.0 60.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.256 0.551 . . . . 0.0 110.754 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 22.5 t90 -62.11 -52.29 64.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 79.0 mttt -72.17 -19.8 61.69 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.346 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.53 80.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.671 HD11 HG13 ' A' ' 80' ' ' ILE . 3.0 mm? -88.87 -50.33 6.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.76 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 4.4 tp10 -63.1 -28.38 70.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.309 -172.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 63.5 tttm -106.56 -18.75 13.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.808 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.589 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -75.8 -64.77 2.17 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.724 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.06 -17.48 6.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.0 110.857 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.727 ' HB2' ' OG ' ' A' ' 92' ' ' SER . . . -97.68 -172.41 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 10.1 tmtt? 176.76 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.305 0.378 . . . . 0.0 111.212 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 1.2 tt0 157.09 -166.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -163.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.482 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -100.16 -37.71 8.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.22 0.464 . . . . 0.0 112.235 -177.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -158.5 -26.78 0.03 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.402 -1.38 . . . . 0.0 114.035 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.21 53.19 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.513 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.791 0.295 . . . . 0.0 110.386 178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.861 0.362 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -70.66 105.09 3.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.801 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -164.19 -79.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.496 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -175.06 137.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.55 99.11 11.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.394 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -80.14 9.59 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.514 0.673 . . . . 0.0 109.943 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 57.9 tp -82.17 -32.4 29.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.971 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 -47.53 75.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -72.32 -36.03 68.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' O ' HG22 ' A' ' 14' ' ' VAL . 10.3 tt -69.77 -53.35 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.447 ' HD1' ' O ' ' A' ' 7' ' ' LEU . 2.1 p90 -71.5 -32.54 68.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.955 -0.111 . . . . 0.0 111.153 -171.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -67.82 -30.43 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.294 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -78.5 -38.31 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.449 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 10' ' ' LEU . 60.0 t -62.58 -47.49 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.702 0.287 . . . . 0.0 110.791 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.3 mm -63.37 -36.2 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.63 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.02 -52.57 62.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 14.2 t70 -69.55 -26.94 64.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.635 ' HA ' ' ND2' ' A' ' 21' ' ' ASN . 26.0 t-80 -73.1 -19.33 61.17 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -82.44 -22.68 35.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.742 0.782 . . . . 0.0 109.206 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 30.8 ttpt -72.53 -19.33 61.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.32 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.64 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 p30 -132.74 175.17 3.91 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.621 -175.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' A' ' 21' ' ' ASN . 68.1 Cg_exo -41.58 136.6 2.89 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.265 2.643 . . . . 0.0 114.348 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -108.9 -174.09 2.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.784 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.583 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 4.5 m-20 -82.03 90.45 6.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.852 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 17.0 ptpt -163.13 19.91 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.131 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -97.78 123.23 7.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.201 -173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.23 97.11 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.931 ' HB2' ' HD3' ' A' ' 60' ' ' LYS . 53.9 tp -92.78 90.86 7.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.108 0.48 . . . . 0.0 109.93 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' C ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -78.33 51.16 0.99 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.954 -175.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.61 -87.1 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.864 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 t -92.68 -80.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.429 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.753 HD12 HD22 ' A' ' 51' ' ' LEU . 64.6 mt -88.81 130.41 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.011 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.07 92.47 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 110.171 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.718 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.8 t -109.54 119.27 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -124.86 144.12 50.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.708 0.29 . . . . 0.0 110.835 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.532 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 14.5 tpt -151.34 155.1 38.0 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.11 139.19 30.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.1 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -134.14 97.73 14.76 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -25.15 -64.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 125.24 3.96 . . . . 0.0 115.506 -167.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -109.67 6.17 23.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 128' ' ' CYS . 46.7 t -131.96 4.01 4.11 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.886 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 131' ' ' LEU . . . 167.72 57.88 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -38.4 -40.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.792 1.237 . . . . 0.0 113.611 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -149.02 140.33 23.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 6.1 tt -146.45 96.98 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.736 0.779 . . . . 0.0 109.421 166.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -104.42 105.96 16.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.93 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 ' HE2' ' A' ' 49' ' ' MET . 62.8 tp -102.23 104.47 15.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.808 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 28' ' ' LEU . 1.8 p -117.73 108.81 15.84 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.965 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.691 ' HE2' HD22 ' A' ' 47' ' ' LEU . 65.1 mtt -110.5 163.1 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.919 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HB2' HD23 ' A' ' 28' ' ' LEU . 28.0 ttpp -130.12 91.12 3.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.753 HD22 HD12 ' A' ' 32' ' ' ILE . 1.7 pp -95.99 112.88 24.49 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.11 68.61 0.71 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.594 0.711 . . . . 0.0 109.948 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.51 -105.61 0.35 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.177 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.86 15.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.579 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.574 HD12 ' HG3' ' A' ' 57' ' ' GLU . 1.3 pp -125.84 -166.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.999 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.446 HG13 HG23 ' A' ' 80' ' ' ILE . 36.5 t -126.73 106.85 16.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.477 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' HG3' HD12 ' A' ' 55' ' ' ILE . 72.8 mt-10 -85.95 -53.88 4.83 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.22 0.534 . . . . 0.0 109.685 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -130.11 163.35 26.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.797 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -165.61 132.28 2.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.5 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.931 ' HD3' ' HB2' ' A' ' 28' ' ' LEU . 2.0 mptp? -128.31 144.15 51.1 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -127.86 110.04 12.19 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.058 -175.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' HG2' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -103.57 97.82 7.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 171.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.583 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -138.54 121.15 2.1 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.162 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.08 155.24 28.51 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.5 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 153.96 -131.95 3.4 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.362 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.0 p -104.26 162.5 13.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -44.22 -48.95 9.39 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.279 0.987 . . . . 0.0 112.537 -171.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.693 HD11 ' HG ' ' A' ' 69' ' ' SER . 2.6 pp -75.38 -24.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.693 ' HG ' HD11 ' A' ' 68' ' ' ILE . 4.9 m -75.11 -40.02 60.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.703 0.763 . . . . 0.0 109.307 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.9 ttp -70.77 -25.95 63.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.767 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.51 -56.23 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.175 -174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.7 p -66.41 -44.91 81.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.52 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.56 -55.25 35.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.982 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -65.14 -37.48 87.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.9 tpt -70.02 -43.93 70.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 109.975 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.8 mmm -67.7 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.7 m -69.58 -20.23 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.766 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -75.56 -39.17 58.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.02 -31.54 72.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.147 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG23 HG13 ' A' ' 56' ' ' VAL . 18.3 mm -75.67 -33.54 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.667 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -55.55 -20.29 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.47 41.66 1.64 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.992 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' HE3' HG22 ' A' ' 87' ' ' THR . 2.6 tptp -133.66 -156.91 0.77 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.268 0.556 . . . . 0.0 111.515 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -140.66 147.81 39.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -170.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.46 -34.47 61.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.226 0.536 . . . . 0.0 109.714 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -57.86 -46.7 84.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.009 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.54 HG22 ' HE3' ' A' ' 83' ' ' LYS . 2.1 m -76.63 -20.81 56.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.134 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.707 ' O ' ' HG2' ' A' ' 91' ' ' MET . . . -69.9 -49.94 47.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.329 0.585 . . . . 0.0 110.96 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 142' ' ' LYS . 10.1 mp -65.38 -28.63 69.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.181 0.515 . . . . 0.0 109.623 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -77.67 -20.48 53.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.239 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.722 ' HA ' HG21 ' A' ' 94' ' ' ILE . 9.2 ptt? -77.63 -22.24 51.04 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.585 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 8.2 t -86.11 -29.58 23.22 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.96 -50.8 69.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.185 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.722 HG21 ' HA ' ' A' ' 91' ' ' MET . 10.4 tt -69.82 -28.43 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.103 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 91' ' ' MET . 81.2 t80 -54.63 -45.11 73.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.872 0.368 . . . . 0.0 110.528 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.8 p -85.26 -34.1 22.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 21.1 t70 -63.9 -44.53 92.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.615 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -64.46 -19.66 65.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 110.993 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.8 mtp -80.27 -5.46 56.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.07 -42.13 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.752 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -83.2 -20.45 60.66 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.878 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 25.6 mmtm 73.11 -37.32 0.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.187 0.595 . . . . 0.0 111.67 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 101' ' ' GLY . 11.3 pt-20 -91.38 156.71 17.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.19 -154.32 0.58 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -118.22 93.83 4.27 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.76 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.0 t70 86.04 -4.7 0.79 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.142 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m 64.19 26.5 13.84 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 106' ' ' ASP . 7.8 pt -41.06 -57.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.932 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.561 ' H ' HG13 ' A' ' 108' ' ' ILE . 11.6 t70 -141.12 139.71 34.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.9 mt -147.74 -55.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 0.0 111.304 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.61 82.96 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.736 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.87 -32.53 65.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.178 0.513 . . . . 0.0 110.364 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 58.8 mt -69.32 -27.6 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.88 -21.44 66.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.33 59.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.08 -32.0 64.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.35 0.595 . . . . 0.0 110.112 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 117' ' ' GLN . 5.0 tt0 -53.76 -35.16 60.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.904 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.23 53.79 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.631 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 68' ' ' ILE . 28.9 m -85.74 -17.95 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -175.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.502 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.1 t -46.44 -17.34 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -164.04 26.63 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.177 0.899 . . . . 0.0 110.271 -164.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.16 140.65 22.92 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.28 -41.75 4.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.45 2.767 . . . . 0.0 113.501 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.4 9.52 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.417 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 98.5 mtt180 -125.13 4.16 7.9 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.053 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.8 tt -83.55 -29.87 7.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.485 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.816 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.536 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 33.5 t -85.99 -19.63 30.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.453 175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -79.44 -45.01 20.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.868 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 p -66.02 -30.65 71.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.303 0.573 . . . . 0.0 109.801 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.558 HD12 ' HA3' ' A' ' 42' ' ' GLY . 8.0 tt -56.64 -67.34 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.764 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 m -70.88 -56.01 7.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.588 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -72.94 -51.59 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.966 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 130' ' ' THR . 48.3 tttm -75.69 -22.76 56.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.664 -168.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.31 -27.0 35.21 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.485 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -79.29 -48.31 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 109.945 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.575 ' HG2' ' HG2' ' A' ' 142' ' ' LYS . 34.7 tt0 -65.96 -27.69 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -88.02 -15.01 37.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.093 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.718 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -57.83 -43.47 94.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.786 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.12 11.57 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.64 172.46 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.844 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.575 ' HG2' ' HG2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -150.64 -172.37 4.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.201 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.585 ' HG3' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER -66.35 -164.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.048 0.452 . . . . 0.0 111.373 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.3 77.74 1.12 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.614 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.4 135.5 5.83 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.544 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.56 99.05 0.15 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 C--O 1.239 0.539 0 CA-C-O 120.734 0.302 . . . . 0.0 110.867 -178.076 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtm . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -135.49 -84.74 0.39 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.936 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 60.46 23.07 12.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.172 0.511 . . . . 0.0 110.825 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -139.0 175.97 9.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.383 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.36 20.75 12.28 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.063 0.545 . . . . 0.0 111.427 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.3 t30 63.05 8.58 3.31 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.37 0.605 . . . . 0.0 111.279 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.71 -48.03 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.048 -0.408 . . . . 0.0 111.065 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.778 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.4 t70 -59.13 -47.37 85.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.493 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -73.26 -23.69 60.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 14' ' ' VAL . 60.6 tp -70.52 -53.68 15.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 8.8 p90 -75.03 -19.72 59.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.355 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 12' ' ' ARG . 38.9 ttp180 -66.98 -35.84 80.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -73.26 -38.31 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.716 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 10' ' ' LEU . 93.9 t -60.64 -50.13 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.548 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 11' ' ' TYR . 32.6 mm -57.95 -52.35 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.825 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.4 ttm -60.23 -54.69 42.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.896 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.4 -37.66 74.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.113 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -77.46 -18.77 56.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.609 0.242 . . . . 0.0 110.802 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.09 -31.88 70.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -73.35 -22.82 60.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.496 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -86.85 170.19 12.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.321 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.99 126.36 21.41 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.86 1.706 . . . . 0.0 110.792 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -57.71 -74.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.442 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 4.3 p30 -177.53 114.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.84 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -148.98 111.42 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.887 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . 153.48 142.27 3.43 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.737 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.09 104.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 48' ' ' THR . 3.4 tt -103.12 87.66 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.122 0.487 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.86 100.38 5.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.21 -71.31 0.18 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.468 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.0 -70.7 0.78 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.679 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.512 HG21 ' HE3' ' A' ' 49' ' ' MET . 35.9 mt -87.31 116.86 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.001 0.429 . . . . 0.0 109.894 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' HA ' HG21 ' A' ' 48' ' ' THR . 45.7 t -131.86 91.16 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.627 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 135' ' ' ALA . 41.6 t -114.19 105.71 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 0.0 110.654 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -105.52 123.16 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.848 ' HA ' ' HE1' ' A' ' 36' ' ' MET . 2.0 tpt -124.98 159.06 32.13 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.72 139.31 15.97 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.96 -172.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.851 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 42.3 t-20 -136.72 94.39 13.2 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.2 Cg_exo -65.69 48.78 0.22 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.758 3.639 . . . . 0.0 114.975 -163.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.6 m -159.72 -45.94 0.05 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.407 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.843 ' HB3' ' HB3' ' A' ' 127' ' ' LYS . 10.4 t -133.54 7.35 3.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.245 0.545 . . . . 0.0 111.078 -171.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.28 0.45 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.473 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 31.2 t70 -38.9 -67.01 0.23 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.473 ' HG3' ' OD2' ' A' ' 43' ' ' ASP . 67.2 mtt180 -135.88 140.25 43.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.668 -0.645 . . . . 0.0 112.024 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.622 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 7.9 tt -139.92 108.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 164.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 25.6 mmm-85 -93.03 107.67 19.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.5 tp -122.64 106.21 10.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.331 0.586 . . . . 0.0 109.782 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 33' ' ' VAL . 1.6 p -125.56 115.6 20.44 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.454 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.512 ' HE3' HG21 ' A' ' 32' ' ' ILE . 72.9 mtm -114.33 147.3 39.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.395 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 4.9 tmtt? -106.57 86.16 2.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.33 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.12 83.1 5.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.487 0.66 . . . . 0.0 109.408 171.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -86.9 63.15 7.8 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.07 -100.02 0.22 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.362 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' C ' HD11 ' A' ' 85' ' ' ILE . 4.5 p-10 -150.43 33.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.403 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -136.98 148.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.736 HG13 HG23 ' A' ' 80' ' ' ILE . 45.7 t -85.46 89.23 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 171.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -80.93 -65.03 1.06 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.338 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t0 -119.1 163.87 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.6 130.92 8.64 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.393 . . . . 0.0 110.394 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 12.4 mptt -114.19 131.88 56.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 16.3 p90 -140.53 135.93 32.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.218 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 31.0 tt0 -148.73 119.95 7.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.72 134.23 9.52 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -124.38 120.41 32.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.15 -129.86 2.17 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.772 -170.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.61 166.77 13.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.961 0.41 . . . . 0.0 110.689 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.643 ' HA ' ' HE1' ' A' ' 70' ' ' MET . 2.9 m -59.76 -41.17 90.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.592 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.61 HD11 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -75.15 -35.18 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.61 ' N ' HD11 ' A' ' 68' ' ' ILE . 9.7 p -71.97 -38.73 69.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.643 ' HE1' ' HA ' ' A' ' 67' ' ' SER . 25.7 ptt? -77.42 -17.91 57.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.737 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.89 -55.3 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -60.31 -49.7 76.56 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.905 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.32 -43.16 43.29 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -71.62 -30.35 65.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.572 0.225 . . . . 0.0 111.56 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.6 mmm -77.41 -41.54 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.765 ' HE3' HD22 ' A' ' 136' ' ' LEU . 69.3 mtp -58.12 -37.0 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.61 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.461 HG22 ' CD1' ' A' ' 61' ' ' PHE . 97.1 m -64.95 -33.26 75.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.192 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -76.99 -40.78 45.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.4 87.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.921 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.736 HG23 HG13 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -76.86 -28.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.152 -177.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.75 -19.48 65.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.125 0.488 . . . . 0.0 110.835 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.15 31.18 9.03 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.975 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.05 166.88 22.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -116.3 -162.37 0.84 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.487 ' O ' HD13 ' A' ' 89' ' ' LEU . 1.6 mp -85.62 -46.23 17.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -61.8 -37.76 85.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.086 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -83.01 -23.78 33.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.78 -43.67 24.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 110.741 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 144' ' ' GLU . 9.8 mp -64.56 -39.17 93.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.448 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 94' ' ' ILE . 10.7 p -72.44 -35.62 68.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.171 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.6 tpp -61.25 -32.15 71.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 29.6 t -84.66 -31.08 24.36 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.21 -47.29 83.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.51 HD13 ' HA ' ' A' ' 105' ' ' ASP . 37.7 pt -74.92 -23.95 17.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.47 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 90.5 t80 -64.04 -42.08 97.19 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 109.819 172.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -80.14 -30.63 39.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.792 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.61 -44.55 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.308 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 24.9 ptt? -53.72 -18.54 3.2 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.0 ttt -60.56 -36.27 78.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.946 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -140.78 -40.41 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.6 0.238 . . . . 0.0 111.481 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 -29.05 73.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.485 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.7 tttp 79.48 10.15 1.5 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 109.907 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.35 99.74 10.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.763 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -95.54 -148.24 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.51 ' HA ' HD13 ' A' ' 94' ' ' ILE . 13.7 t0 -101.75 109.43 21.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.45 -10.96 19.77 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.85 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.2 m -83.63 -16.58 44.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 108' ' ' ILE . 19.5 mm 66.05 32.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.48 0.657 . . . . 0.0 110.201 173.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -81.37 66.25 6.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.8 mt -121.99 2.97 9.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.17 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.65 45.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.268 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 0.0 110.247 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.404 HG23 ' HE1' ' A' ' 95' ' ' PHE . 55.7 mt -80.58 -19.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.705 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.19 -30.41 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.061 0.457 . . . . 0.0 110.251 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.4 -21.68 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.649 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD11 ' HE2' ' A' ' 76' ' ' MET . 96.6 mt -90.22 -38.63 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.724 0.774 . . . . 0.0 109.639 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -29.57 67.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.798 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.38 -52.95 19.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 125' ' ' ARG . 13.8 p -73.28 -19.52 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.57 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 91.8 p -55.83 -15.36 3.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -116.89 34.88 4.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 0.0 110.59 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.543 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 71.8 m-85 -131.63 177.3 2.31 Favored Pre-proline 0 C--O 1.219 -0.519 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.437 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 122' ' ' PHE . 57.3 Cg_endo -73.9 -2.83 12.81 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.448 1.432 . . . . 0.0 110.363 165.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.52 -18.83 17.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.516 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.57 ' HB3' ' HA ' ' A' ' 120' ' ' SER . 1.9 ppt_? -55.79 -59.56 4.69 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 119.441 -0.314 . . . . 0.0 111.433 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.509 ' H ' ' HD2' ' A' ' 125' ' ' ARG . 9.0 tt -47.68 -32.42 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.151 0.5 . . . . 0.0 110.573 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.851 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 50.3 mttp -81.93 -58.48 2.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.649 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.4 m -86.72 -21.43 26.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.065 0.46 . . . . 0.0 111.273 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.06 -32.63 21.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.599 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 5.0 t -62.94 -35.65 80.82 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.502 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 69' ' ' SER . 9.4 tt -61.13 -67.73 0.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.984 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.9 m -65.76 -54.68 23.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.291 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.43 ' NE1' ' HG3' ' A' ' 137' ' ' GLU . 84.1 t90 -71.91 -48.73 43.42 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -171.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 130' ' ' THR . 23.0 tptm -68.97 -25.4 64.51 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.148 -172.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.499 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -78.41 -36.36 45.84 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.948 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.765 HD22 ' HE3' ' A' ' 76' ' ' MET . 2.9 tp -80.51 -47.18 14.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 0.0 110.015 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' NE1' ' A' ' 133' ' ' TRP . 22.2 mm-40 -75.49 -19.74 59.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.443 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.87 -18.89 28.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.741 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.38 -54.29 27.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.291 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.424 ' O ' HD12 ' A' ' 89' ' ' LEU . 26.1 m -93.04 -1.19 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.58 94.28 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.283 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.501 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -50.58 144.79 7.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.83 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 92' ' ' SER . 30.9 tt0 70.11 -75.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.319 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.507 ' HA ' HD22 ' A' ' 89' ' ' LEU . 34.4 tt0 -177.97 95.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.71 -174.92 54.19 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.46 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.14 35.71 0.33 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.668 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 -179.778 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.609 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.254 0.55 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -131.98 -38.73 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -88.23 36.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 11.4 m120 -87.66 -14.49 39.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.323 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.53 128.8 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.696 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -134.94 135.87 41.83 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.876 HD12 ' HA3' ' A' ' 118' ' ' GLY . 93.8 mt -52.11 -38.95 59.05 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.119 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.7 t70 -54.21 -45.23 72.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.62 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -74.35 -40.76 61.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.636 0.731 . . . . 0.0 109.937 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.508 ' O ' HG22 ' A' ' 14' ' ' VAL . 94.9 mt -68.95 -56.51 7.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.385 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.548 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 1.2 p90 -67.53 -27.11 66.7 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 -60.86 -41.61 96.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.665 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -77.59 -41.51 38.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.267 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 81.7 t -61.6 -46.62 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.173 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 tp -71.38 -30.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.616 0.246 . . . . 0.0 110.613 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.3 tpt -70.16 -47.14 62.91 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.44 -38.4 89.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.198 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -68.8 -27.69 66.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.956 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -74.71 -20.57 59.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 0.0 110.02 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -79.54 -21.44 45.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.093 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.47 ' HB3' ' CD ' ' A' ' 22' ' ' PRO . 41.0 m-80 -107.23 177.76 1.24 Allowed Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.47 ' CD ' ' HB3' ' A' ' 21' ' ' ASN . 23.8 Cg_exo -66.02 175.29 4.84 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -79.96 -142.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.328 0.585 . . . . 0.0 110.289 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -120.03 83.62 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.509 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -144.2 109.49 5.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.523 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -168.53 125.71 1.31 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.801 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.97 103.19 8.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.464 0.65 . . . . 0.0 110.493 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.752 ' O ' ' HB ' ' A' ' 48' ' ' THR . 4.2 tt -125.35 83.73 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.78 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.64 99.34 6.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.487 0.66 . . . . 0.0 110.04 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -127.62 -75.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.43 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -101.32 -56.88 2.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 49' ' ' MET . 46.3 pt -122.79 139.2 50.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.228 0.537 . . . . 0.0 110.743 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 48' ' ' THR . 2.3 p -136.27 108.46 7.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.675 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG21 ' CA ' ' A' ' 139' ' ' GLY . 24.4 t -109.5 142.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.901 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -135.04 135.84 41.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.356 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.505 ' O ' HG23 ' A' ' 45' ' ' ILE . 14.5 tpt -152.56 147.82 26.64 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.39 161.16 27.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 127' ' ' LYS . 11.8 m120 -106.75 129.68 24.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 165.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.584 ' O ' ' HB ' ' A' ' 40' ' ' THR . 59.7 Cg_endo -70.46 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.913 2.409 . . . . 0.0 114.199 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 39' ' ' PRO . 14.8 t 158.22 -10.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.792 0.837 . . . . 0.0 111.064 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.63 19.34 4.27 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.071 0.462 . . . . 0.0 111.179 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.21 48.61 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.15 -31.3 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.636 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 4.0 ptm180 -159.15 137.97 11.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.679 1.127 . . . . 0.0 112.374 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 36' ' ' MET . 11.0 tt -133.48 95.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 162.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 38.4 ttm-85 -95.89 107.71 20.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.927 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.754 HD21 ' HE1' ' A' ' 49' ' ' MET . 61.8 tp -104.54 103.69 13.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.801 ' HG1' ' HB2' ' A' ' 60' ' ' LYS . 18.1 p -114.58 106.14 13.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.843 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.754 ' HE1' HD21 ' A' ' 47' ' ' LEU . 61.7 mtt -105.19 167.23 9.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.219 0.533 . . . . 0.0 111.097 -175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -126.94 86.81 2.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.254 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -95.35 82.02 3.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.843 0.83 . . . . 0.0 109.414 174.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.31 68.79 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.841 0.829 . . . . 0.0 109.273 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.1 -99.9 0.22 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.776 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -145.38 21.25 1.53 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.442 0.639 . . . . 0.0 109.395 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.57 HD13 ' O ' ' A' ' 55' ' ' ILE . 1.9 pp -133.87 151.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.808 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.03 89.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 168.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HB2' HD12 ' A' ' 55' ' ' ILE . 13.1 tp10 -75.38 -57.54 3.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 110.04 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -125.01 160.44 28.98 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.263 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -156.83 119.24 3.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.801 ' HB2' ' HG1' ' A' ' 48' ' ' THR . 45.9 mmtm -112.75 138.13 50.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -129.06 100.25 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 38.8 tt0 -90.77 99.81 12.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -126.28 115.51 2.31 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.77 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -127.39 126.63 42.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 169.78 -130.76 2.1 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.634 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.45 162.53 13.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.612 0.244 . . . . 0.0 110.466 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -57.8 -37.86 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -73.72 -35.38 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.635 ' N ' HD13 ' A' ' 68' ' ' ILE . 24.8 p -79.13 -33.58 44.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.328 0.585 . . . . 0.0 110.131 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 90.4 mtp -74.26 -15.68 60.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.405 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.23 -51.56 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.003 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 p -59.23 -44.88 92.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.4 -62.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.532 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -55.74 -42.77 75.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.358 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.8 tpt -68.97 -51.27 41.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.57 ' HB3' HD23 ' A' ' 136' ' ' LEU . 92.4 mtp -72.29 -37.93 68.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.241 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 90.9 m -62.73 -29.26 70.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 111.264 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -86.03 -37.61 18.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.804 0.335 . . . . 0.0 110.327 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.94 89.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 0.0 110.064 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.66 -22.02 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.462 0.648 . . . . 0.0 109.4 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' THR . 81.4 tttt -64.63 -21.74 66.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.629 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.62 40.04 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.942 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 80' ' ' ILE . 98.4 mttt -133.95 -172.79 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.03 -168.96 1.51 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -80.69 -45.69 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.471 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.14 -39.92 91.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.168 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -62.74 -36.03 81.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.842 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.34 60.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.461 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 45.3 mt -61.05 -42.44 98.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.198 0.523 . . . . 0.0 109.667 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 t -63.96 -36.1 82.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.319 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.417 ' HA ' HG21 ' A' ' 94' ' ' ILE . 27.9 ttt -68.25 -28.31 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 0.0 110.843 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 31.0 t -86.22 -35.06 20.26 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.87 -49.84 73.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.821 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 13.3 tt -72.87 -22.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 98' ' ' MET . 48.6 t80 -59.23 -45.08 92.09 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.54 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.6 p -85.95 -28.45 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.082 0.468 . . . . 0.0 111.379 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 33.6 t70 -71.1 -19.45 62.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.58 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 24.2 ptm -48.92 -31.6 7.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.0 -44.15 94.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.386 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.907 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -110.22 -4.25 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.23 -31.33 78.7 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 46.5 tptt 73.23 -69.03 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.243 0.617 . . . . 0.0 111.726 170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.14 120.95 36.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.07 166.7 15.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -132.96 119.44 20.12 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.044 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -49.76 96.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 124.022 0.826 . . . . 0.0 110.19 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.3 m 61.32 23.79 13.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.257 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm 75.28 -15.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.212 0.605 . . . . 0.0 111.04 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -142.65 105.29 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' H ' HD13 ' A' ' 110' ' ' LEU . 1.3 mp -89.81 36.04 0.85 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.587 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.88 -27.06 73.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.691 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.85 -48.0 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.62 -31.32 52.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.365 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 8.0 mm-40 -66.08 -28.15 68.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.651 0.263 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.0 71.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 110.593 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.19 -15.16 24.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.822 0.344 . . . . 0.0 110.5 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 4.2 tp-100 -49.02 -43.85 40.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.653 -173.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.876 ' HA3' HD12 ' A' ' 7' ' ' LEU . . . -78.74 -33.83 36.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.553 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.535 HG12 HD12 ' A' ' 68' ' ' ILE . 29.0 m -87.55 -17.79 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 26.6 t -50.71 -18.89 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -165.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -169.34 27.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.439 1.018 . . . . 0.0 111.15 -167.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -93.46 138.42 23.0 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.96 -34.91 6.74 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.191 2.594 . . . . 0.0 113.303 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.05 5.96 20.58 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 119' ' ' VAL . 84.2 mtt180 -121.72 -9.03 8.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.423 -0.798 . . . . 0.0 110.374 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.559 HG22 ' HD2' ' A' ' 127' ' ' LYS . 15.5 tt -77.42 -29.35 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.567 -167.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.559 ' HD2' HG22 ' A' ' 126' ' ' ILE . 14.0 mptt -74.74 -22.88 58.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 67.7 m -85.89 -22.54 27.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.158 0.504 . . . . 0.0 110.017 174.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 120' ' ' SER . . . -72.73 -47.73 44.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.533 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.6 p -65.42 -30.74 71.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.062 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HA ' ' CG ' ' A' ' 36' ' ' MET . 6.5 tt -49.8 -53.65 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -71.52 -51.01 25.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -67.59 -41.61 83.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.948 0.404 . . . . 0.0 111.643 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 71.8 mmtt -73.5 -17.61 61.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.35 -44.64 11.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.174 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 76' ' ' MET . 3.0 tp -84.19 -63.27 1.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.02 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.41 -30.89 60.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.054 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.702 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 49.3 tttm -85.17 -4.32 59.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.355 0.598 . . . . 0.0 109.621 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.434 ' CA ' HG21 ' A' ' 34' ' ' VAL . . . -73.6 -50.57 11.28 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.452 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.497 HG22 ' H ' ' A' ' 141' ' ' ALA . 9.8 m -76.0 -57.04 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.202 . . . . 0.0 110.501 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 89' ' ' LEU . . . 169.59 152.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.704 0.802 . . . . 0.0 109.054 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -96.19 127.93 42.65 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.152 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.442 ' H ' ' HB3' ' A' ' 92' ' ' SER . 35.5 tt0 67.5 -76.13 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 111.608 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.38 95.21 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.41 -73.38 1.01 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.776 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.26 77.16 1.19 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.923 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.46 ' C ' HD21 ' A' ' 147' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 110.834 -0.062 . . . . 0.0 110.834 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.67 0.272 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -75.76 110.24 10.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 110.933 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -94.81 126.41 40.11 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -152.59 117.14 5.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.069 0.461 . . . . 0.0 111.272 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.59 13.65 2.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.045 174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -115.53 -29.16 6.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.583 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.606 HD13 ' HA3' ' A' ' 118' ' ' GLY . 94.0 mt -86.1 -37.75 18.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.62 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.03 -46.99 61.76 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.466 0.479 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.89 -24.92 52.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' O ' HG22 ' A' ' 14' ' ' VAL . 3.1 tm? -78.32 -58.69 3.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.445 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -76.57 -21.77 55.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.438 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.1 ttp180 -69.15 -35.74 76.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -69.12 -41.04 77.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.667 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 10' ' ' LEU . 94.7 t -69.05 -48.59 68.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 67' ' ' SER . 13.9 tt -66.29 -29.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.965 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -61.94 -49.02 77.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 110.051 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.55 -34.77 65.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -74.27 -19.31 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -77.23 -32.8 56.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -31.65 62.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.762 175.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -129.76 84.62 60.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.267 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.69 140.33 2.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.946 2.431 . . . . 0.0 111.886 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.423 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 16.4 ttm180 -145.44 17.2 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.412 0.625 . . . . 0.0 110.654 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 14.9 m120 -84.08 83.79 7.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.56 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 tptm -165.64 24.81 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 111.181 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.1 6.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.874 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.26 104.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 48' ' ' THR . 60.9 tp -105.71 95.93 6.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.985 0.422 . . . . 0.0 111.825 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -84.18 91.27 7.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' CG ' ' HG2' ' A' ' 50' ' ' LYS . 13.4 t70 -127.58 -69.7 0.73 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.583 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -127.04 -51.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.059 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 71.4 mt -106.84 129.42 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.044 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG13 HG23 ' A' ' 48' ' ' THR . 3.1 m -142.2 82.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.508 0.67 . . . . 0.0 110.928 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG13 ' HA ' ' A' ' 135' ' ' ALA . 49.1 t -98.81 134.69 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.272 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -128.34 147.01 50.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.438 ' HG3' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -153.1 151.2 29.91 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -152.04 145.32 24.7 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 111.898 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' CG ' ' HB3' ' A' ' 41' ' ' CYS . 47.0 t-20 -124.23 111.77 28.36 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -21.56 -64.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 125.688 4.259 . . . . 0.0 115.679 -169.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 m -126.6 23.65 6.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.551 0.691 . . . . 0.0 110.904 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.516 ' HB3' ' CG ' ' A' ' 38' ' ' ASN . 38.3 t -129.43 -36.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.687 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' N ' ' HB3' ' A' ' 38' ' ' ASN . . . -140.88 62.16 0.54 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -34.82 -53.3 0.55 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.399 1.08 . . . . 0.0 113.666 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -156.7 141.75 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.357 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.44 105.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.448 0.642 . . . . 0.0 110.053 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.713 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 18.8 mmt180 -93.34 110.89 22.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.787 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.2 tp -104.57 94.94 5.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.802 HG23 HG13 ' A' ' 33' ' ' VAL . 10.9 p -115.66 111.2 20.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.584 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 65.5 mtt -109.34 161.34 15.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.913 0.387 . . . . 0.0 111.452 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.818 ' HE3' ' HB2' ' A' ' 52' ' ' ASP . 8.7 tmtm? -126.06 100.46 6.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pp -100.35 108.16 20.12 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.614 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.818 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 35.6 t70 -100.06 65.77 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.764 0.792 . . . . 0.0 109.263 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.36 -101.45 0.27 Allowed Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.838 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.631 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 7.7 m-20 -142.63 28.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.711 -0.745 . . . . 0.0 109.811 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 55' ' ' ILE . 1.9 pp -132.5 151.71 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.206 0.527 . . . . 0.0 110.193 -170.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -86.56 96.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.958 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.48 -69.98 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -112.46 159.02 19.17 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.21 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -157.58 132.76 8.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.636 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -123.96 120.36 32.27 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.713 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -115.96 81.13 1.55 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.415 0.626 . . . . 0.0 111.436 -176.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.95 117.31 24.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.548 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.39 161.06 29.97 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.259 -1.448 . . . . 0.0 113.586 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.03 164.39 27.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.55 -130.46 3.33 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.255 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 34.0 m -81.25 159.35 24.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.903 0.382 . . . . 0.0 110.797 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.553 ' HB2' HD11 ' A' ' 15' ' ' ILE . 5.7 p -61.82 -32.94 73.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.975 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -90.57 -24.49 5.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.694 -176.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.483 ' N ' HD11 ' A' ' 68' ' ' ILE . 31.2 p -76.68 -40.15 49.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.072 0.463 . . . . 0.0 110.913 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.5 ptp -72.03 -17.22 62.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.304 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.54 -46.72 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.119 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 76' ' ' MET . 13.7 p -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.59 -51.94 43.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.26 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -70.57 -27.24 63.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.445 ' HE2' ' HA ' ' A' ' 112' ' ' ASP . 27.5 ttt -79.04 -49.18 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.083 0.468 . . . . 0.0 110.288 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.67 ' SD ' ' HB2' ' A' ' 112' ' ' ASP . 90.2 mmm -63.65 -39.84 95.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.192 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.548 HG23 ' HE2' ' A' ' 49' ' ' MET . 31.5 m -75.12 -21.21 59.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.44 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.88 -41.26 78.59 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.23 -26.9 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.298 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.443 ' CD1' HG21 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -72.38 -31.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.667 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.95 -24.58 67.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.579 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.465 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -85.68 19.7 23.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.814 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 1.6 mptm? -133.69 -179.25 5.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 109.984 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 5.6 p-10 -116.36 -171.37 1.99 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.34 -40.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.491 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -64.23 -40.97 97.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 109.688 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.555 ' O ' ' HG3' ' A' ' 91' ' ' MET . 23.2 m -74.86 -32.02 61.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.001 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.758 ' HA ' ' HE1' ' A' ' 91' ' ' MET . . . -61.28 -48.65 80.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.847 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 141' ' ' ALA . 72.2 mt -59.14 -39.75 83.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.577 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 m -70.51 -19.89 62.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.232 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.758 ' HE1' ' HA ' ' A' ' 88' ' ' ALA . 67.1 mtm -79.32 -19.38 50.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.723 ' HB2' ' HB3' ' A' ' 141' ' ' ALA . 23.6 t -85.46 -32.62 22.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -58.62 -43.13 89.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.245 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.696 HG12 ' HA ' ' A' ' 91' ' ' MET . 40.5 pt -82.87 -23.94 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.105 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 91' ' ' MET . 37.7 t80 -58.11 -46.97 84.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.131 0.491 . . . . 0.0 110.172 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 p -79.85 -27.85 40.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 22.0 t70 -66.1 -31.22 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.7 ttt -54.33 -21.83 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.0 ttm -82.34 -24.52 34.52 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -134.4 -42.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.79 -37.42 7.37 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.571 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 tptp 71.52 25.37 3.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.304 0.642 . . . . 0.0 111.114 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.75 137.56 51.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.082 0.468 . . . . 0.0 110.753 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.574 ' HB3' HD11 ' A' ' 94' ' ' ILE . 2.2 m-85 -117.02 -145.99 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -127.18 75.08 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 70.35 -4.34 1.61 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.774 169.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 109' ' ' ASP . 13.4 p -70.79 -55.5 8.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.412 ' HA ' ' CD2' ' A' ' 104' ' ' TYR . 1.7 mp 71.32 -36.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 123.578 0.549 . . . . 0.0 111.564 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 107' ' ' SER . 4.6 p-10 -127.15 152.85 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 113' ' ' ILE . 2.4 mp -150.84 74.21 1.15 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.4 0.619 . . . . 0.0 109.644 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -57.35 -19.74 34.13 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.67 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 1.2 p-10 -65.27 -48.57 72.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.57 0.348 . . . . 0.0 111.506 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 110' ' ' LEU . 10.6 tt -71.87 -19.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.453 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 70.2 mm-40 -57.51 -31.03 65.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.594 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.22 59.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.148 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.75 -39.22 18.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 114' ' ' GLU . 12.0 pt20 -62.1 -19.88 63.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -75.67 -51.19 7.35 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.596 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 129' ' ' ALA . 23.2 m -78.51 -17.04 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.447 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 75.3 m -43.52 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -147.34 6.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.365 0.984 . . . . 0.0 112.584 -163.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.797 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 36.3 m-85 -81.38 142.5 50.52 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.96 -37.16 12.01 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.218 2.612 . . . . 0.0 113.384 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.93 -1.27 15.52 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.797 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 95.5 mtt180 -114.34 -3.29 13.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 -174.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 120' ' ' SER . 11.9 tt -70.58 -31.0 44.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.727 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.524 ' HA ' ' OG1' ' A' ' 130' ' ' THR . 97.2 mttt -81.88 -22.08 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 55.9 m -69.54 -34.84 74.82 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.832 ' HB3' HG21 ' A' ' 119' ' ' VAL . . . -78.77 -46.53 18.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.275 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 127' ' ' LYS . 22.8 p -62.6 -33.96 76.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.711 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 128' ' ' CYS . 4.3 pp -67.68 -41.61 83.4 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.281 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.441 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 m -71.73 -48.29 48.04 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.616 0.722 . . . . 0.0 110.481 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -63.34 -55.35 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.801 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.812 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 68.7 mmtt -72.6 -19.34 61.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -61.3 -45.26 95.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 110.063 173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 76' ' ' MET . 6.5 mp -86.52 -34.16 20.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.223 0.535 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.812 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 8.3 tp10 -63.96 -20.84 66.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.681 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -109.67 -41.56 4.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.941 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.14 -50.91 60.77 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.203 -0.522 . . . . 0.0 114.138 -172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 80' ' ' ILE . 15.5 m -125.27 -8.05 6.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.38 . . . . 0.0 111.753 -172.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 92' ' ' SER . . . -128.15 162.63 26.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.028 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.459 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 2.4 ttpm? 179.68 54.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.69 0.619 . . . . 0.0 109.88 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.417 ' H ' ' CB ' ' A' ' 92' ' ' SER . 36.8 mt-10 60.51 -99.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.004 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -171.15 -66.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -159.98 106.37 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.581 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.18 96.35 0.11 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.87 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 110.37 -179.736 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 tp . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.351 0.12 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.594 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 19.2 t70 -56.23 -57.12 13.57 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.681 -174.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -70.2 -25.36 63.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.001 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.9 tp -70.03 -54.48 12.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.324 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 4.3 p90 -72.28 -24.2 61.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 13.6 tpp180 -56.99 -49.62 75.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.03 -36.86 80.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.555 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' A' ' 71' ' ' ALA . 84.2 t -60.25 -45.5 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.61 -31.42 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.7 mtt -68.38 -40.65 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 0.0 110.906 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.89 -34.49 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -71.33 -21.3 62.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.535 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -85.97 -31.19 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 0.0 110.934 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -67.37 -21.36 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.084 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.35 80.16 72.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.198 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.65 71.55 3.95 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.275 2.65 . . . . 0.0 113.034 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -134.45 125.53 27.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.005 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 70' ' ' MET . 57.7 t30 -167.2 152.41 7.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 1.123 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 55.8 tttm 72.64 94.33 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.334 1.021 . . . . 0.0 110.818 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.07 162.97 31.66 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -136.94 119.47 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.39 0.595 . . . . 0.0 110.435 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 48' ' ' THR . 2.4 tt -115.41 101.16 8.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.23 108.82 19.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.04 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -152.98 -72.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.376 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.88 -71.89 0.73 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 49' ' ' MET . 41.8 pt -108.25 127.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.3 0.572 . . . . 0.0 111.896 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 48' ' ' THR . 87.3 t -126.44 104.9 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.96 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.05 114.33 29.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.627 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 46' ' ' ARG . 4.2 p30 -113.93 154.06 28.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.045 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.514 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 14.9 tpt -140.83 123.39 16.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -109.71 152.04 26.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.1 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 131' ' ' LEU . 41.7 t-20 -122.05 83.08 44.27 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.8 -6.71 11.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.236 2.624 . . . . 0.0 113.152 -171.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.5 m -86.11 -43.18 13.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 49.8 t -99.82 -24.93 14.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.67 0.04 36.78 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.654 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 2.8 m-20 -70.52 145.83 50.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -154.09 114.24 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 64.6 mt -122.4 110.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.494 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 62' ' ' GLU . 32.3 mtp180 -94.42 109.45 21.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.728 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.843 HD11 ' HE3' ' A' ' 49' ' ' MET . 52.3 tp -99.55 104.4 16.2 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.502 0.668 . . . . 0.0 109.331 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.69 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 3.2 p -115.75 103.56 10.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.034 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.843 ' HE3' HD11 ' A' ' 47' ' ' LEU . 60.7 mtt -107.77 163.45 13.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.072 0.463 . . . . 0.0 110.939 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 87.7 tttt -130.01 100.46 5.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.572 174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.33 105.25 17.22 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -109.72 72.54 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 -172.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.05 -101.17 0.25 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.366 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.66 20.48 2.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.116 0.96 . . . . 0.0 108.601 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.6 pp -127.37 -162.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.588 -174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.481 HG11 HG22 ' A' ' 80' ' ' ILE . 57.6 t -123.76 117.74 52.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.387 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 50.6 mm-40 -86.11 -48.99 8.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.9 174.76 12.74 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.052 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -162.04 131.46 4.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.528 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -121.76 118.99 30.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -106.41 99.45 9.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.839 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.123 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 31.5 tt0 -81.27 79.43 7.91 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -104.18 114.69 4.81 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.637 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 10.1 tp10 -121.01 150.76 40.65 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.44 -132.5 4.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.626 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.58 -175.66 2.92 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.902 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 m -61.48 -40.82 95.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.478 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -79.61 -42.93 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -171.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.7 p -65.51 -52.35 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.922 0.391 . . . . 0.0 112.048 -170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.461 ' HB2' HD21 ' A' ' 24' ' ' ASN . 0.0 OUTLIER -68.39 -22.38 64.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.016 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -85.28 -48.61 8.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.341 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.4 p -59.22 -46.77 87.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 110.848 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.97 83.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.0 m -61.29 -34.25 74.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.432 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.19 -43.72 27.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 0.0 109.835 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 95.0 mmm -73.75 -32.08 63.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.527 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.8 p -74.6 -19.97 60.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.994 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -72.04 -38.37 69.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 83' ' ' LYS . . . -71.29 -34.11 70.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.728 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 56' ' ' VAL . 14.6 mm -71.99 -41.07 68.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -57.29 -19.0 19.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.322 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.53 25.6 10.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 79' ' ' ALA . 13.2 mptt -127.55 -168.6 1.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.501 . . . . 0.0 110.784 -173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -120.15 -165.98 1.25 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.2 mm -87.27 -38.42 12.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.881 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.36 -49.79 76.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.256 0.551 . . . . 0.0 109.987 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 p -67.55 -32.59 73.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.252 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.72 -43.6 68.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 79.9 mt -65.79 -36.16 82.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.718 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 t -68.11 -45.48 73.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.292 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.51 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 51.1 ttm -58.11 -35.18 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.03 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 7.6 p -87.69 -30.26 20.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.481 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.729 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 83.2 tttt -61.83 -48.2 81.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 tt -71.67 -32.32 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.047 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 91' ' ' MET . 31.7 t80 -57.22 -44.99 84.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.176 0.512 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -77.99 -33.97 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.899 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.286 -177.411 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.689 HD23 HD12 ' A' ' 113' ' ' ILE . 83.9 mt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -50.05 -57.72 9.63 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.231 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.38 -35.01 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.689 HD12 HD23 ' A' ' 110' ' ' LEU . 59.0 mt -59.78 -39.51 80.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.519 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 40.0 mt-10 -77.61 -23.35 49.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.006 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -43.17 25.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.306 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.7 tp -65.03 -37.4 87.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.286 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 9.4 pt20 -73.37 -23.49 60.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.7 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 -47.98 76.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.189 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 129' ' ' ALA . 19.3 m -81.99 -18.58 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.868 0.366 . . . . 0.0 111.28 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 t -52.15 -12.64 0.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -117.92 -25.08 6.87 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.689 -0.632 . . . . 0.0 111.043 -163.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -74.58 129.6 83.47 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.49 -29.96 19.89 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.995 2.463 . . . . 0.0 113.022 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.53 -15.32 28.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.68 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 8.5 mmt180 -113.65 -4.98 13.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.633 -172.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.93 -32.05 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.482 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.692 ' HG3' HD21 ' A' ' 38' ' ' ASN . 13.3 pttt -81.14 -19.03 44.38 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.625 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 68' ' ' ILE . 56.9 m -85.61 -28.12 25.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.23 -50.36 16.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.245 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.9 p -64.92 -26.34 68.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.099 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 38' ' ' ASN . 9.9 tt -54.18 -64.67 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 24.9 m -63.94 -34.12 77.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.045 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -66.42 -58.02 6.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.493 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.92 -32.93 74.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.703 0.287 . . . . 0.0 111.377 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 76' ' ' MET . 14.2 tp -79.06 -38.42 36.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.518 ' CD ' ' HD3' ' A' ' 142' ' ' LYS . 74.0 mt-10 -70.26 -21.91 62.92 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.731 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -86.98 -22.48 25.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.347 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.64 -60.19 8.57 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.814 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.48 11.49 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.747 -0.267 . . . . 0.0 110.975 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.86 -175.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.031 0.832 . . . . 0.0 109.955 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 59.5 pttt -145.33 166.7 24.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.302 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.729 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 52.4 mt-10 60.15 -104.89 0.2 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.938 0.774 . . . . 0.0 110.201 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.66 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.436 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 47.7 tp . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.63 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.8 m-20 -59.92 -45.26 93.13 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.34 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -59.81 -45.88 90.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.138 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 80.8 mt -70.4 -60.72 2.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.955 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.9 p90 -63.73 -36.09 82.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 12.8 ttp180 -74.65 -28.63 60.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.29 -42.16 46.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.4 t -63.4 -46.47 95.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.207 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.6 tt -67.27 -32.75 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.76 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -68.77 -47.31 66.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.86 -48.24 79.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.04 -17.9 61.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.15 -42.49 80.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.592 0.71 . . . . 0.0 109.285 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 1.8 tmmt? -71.15 -27.04 63.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.723 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.96 85.57 28.61 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 121.035 0.445 . . . . 0.0 111.867 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.52 167.78 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.402 2.735 . . . . 0.0 112.88 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -162.99 25.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.83 36.93 1.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.586 -165.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -141.75 108.87 5.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 111.381 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.65 ' HA3' ' HD2' ' A' ' 60' ' ' LYS . . . 167.4 144.83 4.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.136 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HD2' ' A' ' 46' ' ' ARG . 15.4 m -127.82 111.16 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.0 109.864 171.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.632 ' O ' ' HB ' ' A' ' 48' ' ' THR . 47.2 tp -109.53 85.24 2.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.69 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.06 80.07 3.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -141.94 -73.35 0.32 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.635 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 49' ' ' MET . 14.5 m -95.26 -85.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 48' ' ' THR . 78.2 mt -93.35 130.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.051 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.01 95.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.649 HG13 ' HB2' ' A' ' 47' ' ' LEU . 3.6 p -131.21 108.08 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 111.224 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 5.0 t70 -95.34 145.05 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.959 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 9.7 tpt -144.17 115.22 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 4.9 p30 -120.27 158.04 27.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.564 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HB2' HD12 ' A' ' 131' ' ' LEU . 10.8 t-20 -135.06 105.88 10.4 Favored Pre-proline 0 CA--C 1.52 -0.184 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.87 -16.94 57.86 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.919 2.413 . . . . 0.0 112.795 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -61.6 -38.91 89.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.411 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 6.4 p -131.0 -14.13 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.76 42.5 4.43 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.557 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB2' HD11 ' A' ' 131' ' ' LEU . 5.3 m-20 -87.07 145.96 26.26 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' HG2' ' HB3' ' A' ' 37' ' ' ASN . 30.0 mtm180 -143.18 113.74 7.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 131' ' ' LEU . 64.7 mt -121.52 93.94 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.764 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 42.1 ttm105 -89.12 99.22 12.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.882 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 61' ' ' PHE . 62.5 mt -88.1 106.63 18.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 123.843 0.715 . . . . 0.0 109.466 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 p -115.77 96.16 5.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.337 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.622 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 42.1 mtp -104.38 156.13 18.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.202 -167.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -120.81 87.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.52 0.676 . . . . 0.0 109.47 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 32' ' ' ILE . 2.4 pt? -87.38 105.06 17.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.698 173.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.93 67.14 0.74 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.721 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.35 -101.5 0.25 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -139.01 18.2 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -120.26 150.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.65 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.3 112.5 39.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.12 -45.78 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -109.09 147.71 31.98 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.728 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -151.65 118.63 5.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.65 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 47.8 mmtm -111.7 111.23 22.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.818 ' HB3' HD23 ' A' ' 47' ' ' LEU . 7.8 p90 -127.01 105.22 8.45 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.318 0.58 . . . . 0.0 110.884 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.89 82.56 2.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 170.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -103.61 109.25 3.39 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.533 -172.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.74 159.58 34.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 145.47 -131.44 4.2 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.064 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.8 p -102.37 169.1 8.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -52.29 -48.16 65.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.73 0.644 . . . . 0.0 112.452 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -69.6 -36.23 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -171.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 m -72.11 -43.83 64.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 109.802 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.2 ttt -70.84 -23.93 62.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.584 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -88.69 -61.04 1.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.76 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -67.19 -50.47 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.842 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.57 94.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 110.328 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -69.41 -31.96 70.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.542 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.5 tpt -73.24 -41.4 63.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.163 0.506 . . . . 0.0 109.827 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 88.3 mtp -62.86 -30.86 71.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.879 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CE1' ' A' ' 61' ' ' PHE . 50.8 m -72.91 -22.31 60.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.894 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.53 -33.44 71.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.418 0.627 . . . . 0.0 109.317 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.47 25.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.292 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.4 OUTLIER -73.17 -32.02 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.089 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.06 -17.11 63.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.308 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.22 27.79 7.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.935 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 95.4 mttt -134.12 -155.53 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 111.633 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.18 156.7 48.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -170.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 85' ' ' ILE . 2.3 mp -61.49 -42.87 95.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -41.48 73.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.177 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.0 m -79.23 -33.9 43.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.94 88.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.362 . . . . 0.0 110.779 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 144' ' ' GLU . 7.6 mp -64.74 -31.36 72.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.526 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.9 m -72.76 -33.92 66.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.129 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.0 ttm -67.81 -34.73 77.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.794 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 p -82.09 -30.02 31.46 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.98 -42.1 97.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.5 tt -78.95 -25.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.054 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.64 -40.71 97.86 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.3 m -65.6 -31.99 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.875 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.712 -178.27 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 110' ' ' LEU . 2.6 mm? . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.25 0.072 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.58 36.22 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.733 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.72 -38.94 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.067 0.46 . . . . 0.0 111.119 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.62 -34.9 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.936 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 117' ' ' GLN . 40.6 tt0 -62.68 -30.83 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.0 110.239 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.71 -9.97 59.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.4 -44.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.496 0.665 . . . . 0.0 109.773 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -77.95 -19.04 55.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.881 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.09 -50.37 63.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.314 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.1 m -71.87 -19.16 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.232 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 126' ' ' ILE . 58.7 m -55.92 -12.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.769 0.827 . . . . 0.0 112.947 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.29 -8.44 7.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 111.274 -163.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.886 ' HB2' ' HG2' ' A' ' 125' ' ' ARG . 34.3 m-85 -84.5 131.59 49.59 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.68 -18.98 6.88 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.163 2.576 . . . . 0.0 112.943 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.484 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -104.87 -8.53 18.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.886 ' HG2' ' HB2' ' A' ' 122' ' ' PHE . 6.8 mmm-85 -123.55 9.85 9.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.008 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 122' ' ' PHE . 26.3 pt -74.22 -28.65 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.024 0.916 . . . . 0.0 108.889 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -85.2 -25.09 27.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.806 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 26.4 t -86.32 -28.84 23.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.367 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.79 -46.34 31.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 p -61.49 -30.15 70.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 38' ' ' ASN . 6.9 tt -50.29 -63.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.417 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 m -67.73 -45.21 75.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.509 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.62 -52.18 64.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.829 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 137' ' ' GLU . 37.4 ttmt -74.15 -19.42 60.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.28 91.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.392 . . . . 0.0 110.282 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.91 -39.6 23.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.185 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 8.4 mm-40 -64.2 -20.35 65.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.211 0.529 . . . . 0.0 110.863 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.24 -34.98 10.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.2 -55.78 19.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.892 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 34.9 m -101.43 6.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 122.704 -0.292 . . . . 0.0 111.316 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 74.43 178.21 0.22 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.224 0.953 . . . . 0.0 110.642 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.735 ' HD3' ' HB3' ' A' ' 137' ' ' GLU . 19.1 pttm -143.76 141.33 30.39 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 65.89 -67.64 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.107 0.963 . . . . 0.0 111.551 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.718 ' HA ' HD23 ' A' ' 89' ' ' LEU . 42.5 tt0 . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.208 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 115' ' ' ALA . 67.7 tp . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.741 0.305 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.27 -46.76 76.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.22 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -59.02 -33.69 71.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.346 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.4 mt -75.38 -50.27 16.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 15' ' ' ILE . 4.5 m-85 -55.18 -42.44 73.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.858 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -51.42 -45.52 62.6 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.703 0.627 . . . . 0.0 109.911 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -73.43 -42.72 61.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.554 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 83.7 t -58.76 -48.54 85.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 111.421 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.9 pp -73.99 -21.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.626 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 78.0 mmm -73.53 -43.31 60.28 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.194 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.81 -39.13 93.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.112 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -76.33 -19.24 58.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -72.05 -39.43 69.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.197 0.522 . . . . 0.0 109.753 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -72.25 -19.97 61.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.759 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -119.44 81.29 22.91 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.19 20.49 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.842 2.361 . . . . 0.0 112.847 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 2.1 mpt_? -93.47 95.21 9.13 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 1.1 t-20 -118.38 24.38 10.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.0 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.819 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 51.2 mttp -137.59 114.33 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.861 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -157.34 133.22 3.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.49 105.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.862 0.839 . . . . 0.0 111.699 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 50' ' ' LYS . 3.5 tt -115.8 79.22 1.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.726 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HA ' HG22 ' A' ' 33' ' ' VAL . 4.3 t30 -82.53 8.71 11.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.853 -171.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -94.02 3.65 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.872 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -144.56 -104.31 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.364 -0.21 . . . . 0.0 110.579 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 48' ' ' THR . 63.6 mt -83.87 128.32 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.273 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 29' ' ' ASN . 24.8 t -128.49 101.23 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.439 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.014 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.6 t -116.98 120.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -126.05 145.68 50.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.81 0.338 . . . . 0.0 110.163 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.445 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 25.5 mmt -138.37 126.47 22.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.93 135.87 43.81 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.158 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . 2.6 t-20 -132.91 97.92 16.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -16.81 -79.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 1 C-N-CA 125.886 4.391 . . . . 0.0 115.669 -162.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.1 p -117.0 17.87 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.933 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.1 15.02 4.69 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.791 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.17 54.95 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.86 -71.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.123 1.369 . . . . 0.0 113.307 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 10.4 ptt180 -159.84 119.24 2.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.516 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.669 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 5.7 tt -104.33 106.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.38 171.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.445 HH21 ' CD ' ' A' ' 62' ' ' GLU . 51.4 mtm180 -96.68 102.72 14.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.973 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.0 104.75 14.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 1.9 p -117.18 121.74 42.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.93 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.524 ' HG2' ' CB ' ' A' ' 59' ' ' ALA . 56.7 mtm -124.17 136.69 54.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.396 -169.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HB2' HD13 ' A' ' 28' ' ' LEU . 7.1 tmtt? -109.49 87.47 2.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.3 pt? -77.82 115.0 17.23 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.25 66.33 0.67 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.156 0.503 . . . . 0.0 110.128 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.38 -103.07 0.29 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.58 4.67 5.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.756 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.1 pp -110.21 -164.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.627 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 140' ' ' VAL . 25.7 t -126.48 104.2 12.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.635 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 40.9 tt0 -81.7 -71.37 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.956 -171.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' MET . 34.3 t0 -109.68 104.14 13.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.502 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 49' ' ' MET . . . -102.44 113.59 27.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.166 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 12.7 mtpp -112.04 131.85 55.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 74' ' ' SER . 2.7 p90 -123.05 102.87 8.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.275 0.56 . . . . 0.0 111.434 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.819 ' HG3' ' HG2' ' A' ' 25' ' ' LYS . 23.9 tt0 -104.84 94.57 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.603 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -111.29 130.11 9.56 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.824 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.19 131.9 56.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.791 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 161.31 -132.25 2.81 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.465 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 70' ' ' MET . 3.5 p -99.65 155.71 17.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -55.63 -36.27 66.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.925 0.765 . . . . 0.0 112.321 -168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -81.83 -35.75 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.644 ' N ' HD12 ' A' ' 68' ' ' ILE . 35.2 p -73.73 -39.58 64.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.018 0.437 . . . . 0.0 110.693 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.1 ptt? -82.07 -8.21 59.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.6 -57.82 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.502 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -64.02 -53.64 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.585 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.76 82.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.317 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 20.1 m -63.16 -34.11 76.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.21 -47.43 64.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.5 69.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.7 m -66.18 -25.36 66.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.144 0.497 . . . . 0.0 110.654 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 74' ' ' SER . 79.1 mt-30 -73.47 -34.54 65.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -69.0 -33.87 74.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.674 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 80' ' ' ILE . 1.3 mm -72.32 -30.45 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.63 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.01 -17.29 37.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.506 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.32 31.17 5.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.623 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 66.5 mttm -133.23 -174.89 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.692 -0.299 . . . . 0.0 110.934 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.756 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.7 -175.91 2.99 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -175.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.437 ' O ' HD23 ' A' ' 89' ' ' LEU . 1.7 mp -86.01 -46.79 16.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.978 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -59.19 -40.22 85.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.1 p -73.4 -33.46 65.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.999 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.97 90.89 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.418 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 142' ' ' LYS . 4.5 mm? -64.76 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.95 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.0 m -85.03 -29.94 24.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' THR . 92.6 mmm -69.07 -26.31 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.593 176.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 p -85.41 -31.35 22.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -58.28 -47.33 83.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 mt -57.83 -42.67 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.715 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -55.83 -48.14 75.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.831 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.6 p -70.16 -35.96 74.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.948 179.56 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.752 0.311 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.26 -24.79 69.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.488 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.08 -28.94 43.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.771 0.32 . . . . 0.0 111.332 -175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.06 -35.57 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.224 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.92 -34.74 75.16 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.199 0.524 . . . . 0.0 109.928 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 7' ' ' LEU . . . -70.37 -20.65 62.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.872 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.28 -34.41 15.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 109.757 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -61.5 -31.12 71.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.013 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.23 -41.68 98.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.751 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.785 HG12 ' HD3' ' A' ' 125' ' ' ARG . 34.5 m -85.91 -20.44 8.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 111.404 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 33.0 t -54.04 -15.14 1.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -130.36 -23.37 2.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.841 0.746 . . . . 0.0 112.78 -162.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 68.5 m-85 -70.96 135.63 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.29 -25.07 45.33 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.737 2.292 . . . . 0.0 111.844 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.46 -3.7 39.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.402 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.785 ' HD3' HG12 ' A' ' 119' ' ' VAL . 99.6 mtt180 -123.16 0.82 9.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.605 -0.684 . . . . 0.0 110.327 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 tt -72.43 -31.59 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.528 0.68 . . . . 0.0 109.78 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -79.96 -19.49 47.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.033 175.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.5 t -85.32 -19.54 31.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 120' ' ' SER . . . -75.27 -46.56 32.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.41 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.6 m -58.39 -37.79 76.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 69' ' ' SER . 6.8 tt -52.95 -70.92 0.08 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.442 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -58.39 3.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.53 0.681 . . . . 0.0 111.087 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 62.6 t90 -66.06 -49.83 66.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.205 -171.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 37.3 tttp -83.51 -21.07 32.89 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.184 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.57 -30.11 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.392 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -86.63 -40.83 14.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 1.132 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 2.9 tm-20 -63.68 -47.6 80.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.883 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -92.87 -11.27 33.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.982 -171.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 1.014 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -59.22 -54.77 35.14 Favored Glycine 0 C--O 1.23 -0.143 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.095 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 56' ' ' VAL . 18.1 m -114.52 21.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 142' ' ' LYS . . . 68.15 155.82 0.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.417 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 1.132 ' HE2' ' HA ' ' A' ' 137' ' ' GLU . 8.9 mtmm -173.33 151.58 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 31.6 tt0 66.73 117.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.744 0.652 . . . . 0.0 110.123 -172.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.612 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 m-20 -49.12 -45.78 44.04 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.839 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.3 m -62.36 -43.69 98.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.174 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mm? -76.46 -56.92 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.116 -171.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.612 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 9.8 p90 -68.73 -37.49 79.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.797 -169.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -68.59 -37.2 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.91 -46.06 72.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.179 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.7 t -62.69 -46.48 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.789 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.4 mm -64.0 -44.4 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.061 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.1 ttt -61.81 -49.03 77.96 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.72 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.946 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -74.59 -16.99 60.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.395 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -76.73 -32.31 57.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 0.0 109.796 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -76.82 -21.46 55.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -117.95 71.23 8.01 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.85 38.5 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.529 2.819 . . . . 0.0 114.929 -161.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.01 92.52 4.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.932 0.396 . . . . 0.0 110.565 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 74' ' ' SER . 2.8 t-20 -125.51 15.37 8.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.701 . . . . 0.0 109.27 175.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -118.85 85.22 2.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.56 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.445 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -119.2 122.97 5.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.09 100.04 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.0 111.708 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.535 ' O ' HG21 ' A' ' 48' ' ' THR . 20.4 tp -108.07 175.52 5.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.488 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.525 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.2 p-10 -156.93 97.65 1.7 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -141.73 -90.85 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.702 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -108.39 -65.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.821 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 65.4 mt -87.83 121.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.7 t -136.04 90.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.47 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.68 112.27 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.532 0.682 . . . . 0.0 111.231 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -109.19 123.87 49.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.566 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.23 118.59 24.55 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.66 132.4 56.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.417 0.627 . . . . 0.0 112.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 19.7 t-20 -106.02 105.88 55.03 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.8 Cg_exo -65.58 40.31 0.13 Allowed 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.809 3.673 . . . . 0.0 115.364 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.6 t -178.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.697 0.284 . . . . 0.0 110.742 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 t -133.91 18.94 3.81 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -168.77 42.16 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -33.2 -54.21 0.39 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.403 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 27.1 ttm180 -146.97 136.47 22.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.902 1.228 . . . . 0.0 112.268 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' MET . 8.1 tt -130.66 94.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 10.4 ttm180 -88.0 115.99 25.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.996 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.65 106.33 9.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.1 p -117.72 112.36 20.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.193 0.521 . . . . 0.0 110.978 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.701 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 81.1 mtp -103.97 162.46 13.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.24 -173.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -130.77 104.58 7.25 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.759 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -108.62 94.82 5.26 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.829 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.06 63.52 4.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.525 1.155 . . . . 0.0 109.911 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.74 -100.97 0.25 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.571 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 8.4 m-20 -143.15 30.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.829 -0.685 . . . . 0.0 109.291 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.7 pp -137.1 156.46 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.36 102.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.39 -46.13 16.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -153.59 169.72 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.684 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -158.37 129.81 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.061 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 28' ' ' LEU . 67.9 mmtt -112.59 129.54 56.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 27.7 p90 -128.03 128.79 45.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.075 0.464 . . . . 0.0 111.804 -174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.31 108.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.39 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -116.09 138.31 14.41 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.455 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -132.41 104.2 6.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.13 -130.3 1.29 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.218 -172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 158.45 19.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -52.14 -38.31 57.13 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.611 0.569 . . . . 0.0 111.882 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 69' ' ' SER . 2.3 pp -72.11 -44.0 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 68' ' ' ILE . 7.4 p -70.9 -38.33 73.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.04 -38.22 82.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.089 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -85.49 -45.65 11.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.066 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -55.32 -45.53 76.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.351 . . . . 0.0 110.352 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -56.67 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.527 ' HB3' ' ND2' ' A' ' 24' ' ' ASN . 40.5 p -58.04 -40.76 81.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.781 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.7 ttt -73.37 -41.81 62.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.146 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.53 ' HB3' HD22 ' A' ' 136' ' ' LEU . 94.8 mtp -73.42 -31.93 64.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.749 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -73.44 -20.36 60.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 74' ' ' SER . 85.3 mt-30 -81.03 -41.33 22.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.51 95.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.067 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.43 -20.91 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.851 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -66.01 -21.86 66.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.56 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.72 29.56 10.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.911 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -135.16 -172.63 3.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.337 0.568 . . . . 0.0 110.626 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.767 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.3 p-10 -112.36 -172.0 1.96 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.2 mm -85.93 -35.2 9.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.1 -39.58 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.694 0.283 . . . . 0.0 110.66 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.38 -23.68 61.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.286 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.982 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 86.8 mt -66.39 -34.14 77.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.653 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG12 ' A' ' 94' ' ' ILE . 4.5 p -78.07 -35.36 49.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 19.0 ttt -60.34 -37.89 82.07 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.081 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 28.2 p -84.71 -27.72 26.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 109.867 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.994 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 17.8 tptp -57.77 -53.29 59.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 97' ' ' ASP . 17.5 pt -75.58 -22.85 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 91' ' ' MET . 34.3 t80 -69.72 -26.79 64.51 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.8 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -85.27 -26.61 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.344 0.593 . . . . 0.0 109.966 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 94' ' ' ILE . 2.0 m-20 . . . . . 0 C--O 1.22 -0.498 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.601 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.807 0.336 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -70.24 -32.15 68.83 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.868 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -45.96 91.73 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.905 0.482 . . . . 0.0 110.292 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.1 -37.73 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mm-40 -61.34 -36.0 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.48 68.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -91.35 -21.07 21.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.856 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -50.96 -35.25 32.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.19 46.1 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.851 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 125' ' ' ARG . 29.6 m -86.27 -18.32 8.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.446 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 65.9 m -52.96 -18.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -169.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -157.37 5.04 0.14 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.931 -165.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.743 ' HD2' ' HD2' ' A' ' 125' ' ' ARG . 17.0 m-85 -85.7 132.61 43.82 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 172.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.89 -16.1 11.1 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.91 2.407 . . . . 0.0 112.335 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.83 -11.59 17.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.342 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.743 ' HD2' ' HD2' ' A' ' 122' ' ' PHE . 94.8 mtt180 -123.74 1.33 8.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.682 -0.636 . . . . 0.0 110.271 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -79.73 -24.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.537 -168.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -76.3 -19.56 58.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.386 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 95.5 m -85.88 -24.52 26.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.796 172.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -71.9 -48.03 48.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.708 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -60.98 -30.06 70.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.831 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 9.9 tt -60.02 -66.79 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 t -71.02 -42.26 69.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.407 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -67.95 -55.33 13.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.661 0.267 . . . . 0.0 110.833 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.57 -25.38 63.96 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.123 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.11 93.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.298 . . . . 0.0 110.771 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 76' ' ' MET . 2.3 tp -76.1 -43.79 41.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.84 -19.79 65.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.957 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -85.07 -14.62 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.461 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.56 -68.3 1.69 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.196 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' HB ' HG23 ' A' ' 85' ' ' ILE . 35.6 m -103.47 5.58 10.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 122.843 -0.21 . . . . 0.0 111.158 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 72.96 162.25 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.223 0.952 . . . . 0.0 110.351 -173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 14.5 pttp -121.1 148.36 44.3 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.314 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.994 ' HG2' ' HA ' ' A' ' 93' ' ' LYS . 41.4 mt-10 65.39 -161.27 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.884 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.427 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.404 0.621 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.566 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 30.2 t70 -71.46 -43.48 66.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.436 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -69.56 -26.83 64.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.587 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.0 mt -71.75 -30.48 65.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.218 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 8' ' ' ASP . 15.3 m-85 -59.23 -49.63 77.12 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.893 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 1.8 mpt_? -59.1 -33.79 71.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.725 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -71.4 -49.98 36.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HB1' ' A' ' 71' ' ' ALA . 59.5 t -75.25 -39.86 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.806 -173.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 11' ' ' TYR . 12.2 tt -71.7 -27.96 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.294 -0.254 . . . . 0.0 110.648 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.4 ttt -66.87 -39.19 87.46 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.27 -43.23 74.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.775 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.1 -27.62 69.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.758 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -71.61 -39.71 70.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.518 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -63.71 -32.04 73.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.193 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -83.88 166.96 30.94 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.852 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.48 16.92 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.021 2.481 . . . . 0.0 113.445 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 59.33 -159.67 0.29 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.865 0.466 . . . . 0.0 111.062 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -103.27 80.09 1.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.88 0.372 . . . . 0.0 111.391 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -145.67 94.22 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.799 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.23 133.73 2.98 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.778 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.58 104.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 0.0 110.428 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 48' ' ' THR . 1.1 tt -111.02 88.88 2.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.03 98.94 8.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 21.2 t70 -143.71 -73.45 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.943 0.401 . . . . 0.0 111.145 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -124.67 -62.37 1.25 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.667 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 37.0 mt -92.35 118.74 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.054 0.454 . . . . 0.0 110.846 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.4 t -136.85 97.01 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.541 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 135' ' ' ALA . 24.1 t -104.19 130.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.104 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -132.92 118.6 19.1 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -128.74 116.02 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.047 0.451 . . . . 0.0 109.823 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -114.06 140.58 48.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.055 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 34.5 t30 -139.97 105.61 6.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.4 Cg_endo -42.15 113.35 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.984 3.123 . . . . 0.0 113.867 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.8 m 78.93 -22.68 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.663 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 t -121.87 -18.33 7.07 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.296 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -143.68 48.78 0.73 Allowed Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -29.71 -67.26 0.08 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 125.567 1.392 . . . . 0.0 113.392 -164.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 41.4 ptt85 -167.76 138.69 2.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.23 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.3 115.22 25.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.237 0.541 . . . . 0.0 109.932 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 29.6 ttp180 -106.21 105.99 16.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.845 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD21 ' CE ' ' A' ' 49' ' ' MET . 10.0 tt -106.85 107.75 18.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 14.5 p -113.27 133.21 55.22 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.718 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.721 ' HE1' HG21 ' A' ' 80' ' ' ILE . 68.2 mtt -126.67 158.06 37.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.488 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 28.4 tttm -130.23 95.74 3.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 176.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -88.18 97.43 11.0 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.39 63.26 1.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.0 -104.3 0.31 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.55 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.31 30.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.802 0.334 . . . . 0.0 110.21 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -137.63 157.71 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.82 88.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 11.7 tp10 -75.87 -56.95 4.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.244 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -131.81 153.13 50.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.757 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -156.01 131.08 9.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.606 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.5 mttp -140.6 136.13 32.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.2 p90 -132.18 106.52 8.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.822 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 30.7 tt0 -95.82 114.33 26.05 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -151.03 150.91 22.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.173 -1.489 . . . . 0.0 114.563 -173.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.61 142.72 39.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.05 2.46 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.869 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.8 m -94.06 159.1 15.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -56.82 -39.45 74.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.838 0.711 . . . . 0.0 111.027 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -72.99 -32.63 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.689 ' HB3' HD11 ' A' ' 131' ' ' LEU . 1.5 m -68.25 -54.82 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.752 0.786 . . . . 0.0 110.289 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.4 -5.11 51.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.594 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -86.9 -50.48 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 p -72.9 -47.45 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.275 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.13 81.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.294 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 p -68.25 -30.89 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -47.05 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.498 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 96.3 mmm -61.95 -35.88 79.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 m -71.83 -24.1 61.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.042 0.449 . . . . 0.0 111.057 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -46.68 57.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.88 65.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.721 HG21 ' HE1' ' A' ' 49' ' ' MET . 0.5 OUTLIER -74.88 -27.66 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.298 0.571 . . . . 0.0 110.329 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.23 36.32 3.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.659 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.71 174.01 11.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -120.39 -162.53 0.95 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.87 -37.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.81 -46.24 88.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.526 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 p -81.28 -19.18 43.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.753 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.6 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 -46.38 87.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 m -67.57 -28.58 67.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.146 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 44.9 ttp -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.149 0.499 . . . . 0.0 110.106 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.658 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 48.0 t -85.65 -28.03 25.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.267 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.844 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 3.5 tmtp? -60.25 -49.62 76.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 tt -76.24 -25.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.443 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 76.4 t80 -57.99 -44.24 87.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.075 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -82.1 -34.97 29.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 110.638 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.073 -174.008 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.226 -0.142 0 CA-C-O 120.408 0.147 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.71 -42.84 97.02 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.299 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.17 -44.25 80.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.191 0.52 . . . . 0.0 110.216 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.7 mm -64.86 -32.5 58.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.41 -36.89 81.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.17 0.51 . . . . 0.0 110.314 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.78 -12.66 61.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.728 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.07 -6.33 17.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.807 0.813 . . . . 0.0 109.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.967 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.47 98.83 Favored Glycine 0 C--N 1.329 0.179 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.15 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 129' ' ' ALA . 27.6 m -69.59 -19.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 29.3 t -59.03 -13.7 7.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 -18.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.378 -165.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -61.95 126.89 88.32 Favored Pre-proline 0 CA--C 1.518 -0.279 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -18.89 9.37 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.829 2.352 . . . . 0.0 112.919 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -101.13 -10.46 20.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 5.9 mpt_? -128.27 -1.75 5.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.359 -0.838 . . . . 0.0 110.052 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' SER . 8.0 tt -60.92 -36.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.344 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.559 ' HA ' ' HB ' ' A' ' 130' ' ' THR . 82.2 mttt -85.9 -21.01 28.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.526 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . 82.7 m -71.57 -32.45 68.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.714 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -80.04 -39.7 29.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.525 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 127' ' ' LYS . 51.9 m -59.32 -43.97 92.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.855 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 69' ' ' SER . 4.4 pp -63.82 -36.02 82.54 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.492 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.436 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.4 m -72.65 -52.64 14.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.907 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 -49.75 64.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.454 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.18 -26.9 65.98 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.373 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.886 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -69.23 -32.66 72.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 0.0 110.596 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 tp -85.48 -39.22 17.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -64.95 -44.42 89.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.413 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -69.45 -13.21 62.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.815 -172.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.61 -65.17 1.74 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.441 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 m -144.77 17.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -122.17 122.2 38.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.949 -0.469 . . . . 0.0 111.944 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -159.93 30.01 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.944 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.844 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 27.6 tt0 64.55 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.588 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.796 ' HG2' ' HG2' ' A' ' 143' ' ' GLU . 9.5 pt-20 . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.22 -52.15 54.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.12 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -76.01 -26.56 56.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.607 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.7 mt -74.2 -54.2 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.603 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -67.62 -29.54 68.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.95 -34.27 77.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -76.11 -37.89 57.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.114 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 76.6 t -60.45 -48.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 13.4 tt -70.26 -28.51 35.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.027 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 51.3 ttp -79.13 -32.12 44.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.351 . . . . 0.0 110.771 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.652 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 t70 -67.92 -32.81 73.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 110.025 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -85.34 -19.42 31.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.32 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 27.1 t80 -70.28 -23.32 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.703 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 90.8 mttt -59.74 -31.98 70.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.266 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -129.08 80.47 72.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.699 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.71 100.79 1.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.83 2.353 . . . . 0.0 111.759 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -132.27 22.13 4.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.153 0.501 . . . . 0.0 110.035 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.61 76.65 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -164.52 106.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.506 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -175.74 140.36 5.12 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.207 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.52 95.27 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.738 0.78 . . . . 0.0 109.662 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.05 132.94 46.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.534 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -117.16 100.46 7.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -164.34 -57.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.319 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 39.6 t -115.63 -77.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.56 -177.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.537 HD11 HD23 ' A' ' 51' ' ' LEU . 62.9 mt -111.08 129.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.781 0.324 . . . . 0.0 110.481 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 48' ' ' THR . 40.7 t -131.08 98.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.912 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG21 ' HA2' ' A' ' 139' ' ' GLY . 58.7 t -121.96 122.89 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.888 0.375 . . . . 0.0 110.852 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -122.72 148.29 45.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -113.49 117.63 32.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.174 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -117.43 86.62 22.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -34.27 122.74 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 124.603 3.536 . . . . 0.0 114.981 -167.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 m 77.32 -7.57 1.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.398 171.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.7 t -130.86 -46.67 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.823 -0.548 . . . . 0.0 111.855 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.57 58.81 0.66 Allowed Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -52.87 -61.01 2.57 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.11 -1.045 . . . . 0.0 113.661 -163.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.635 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 46.1 mtm-85 -142.6 97.44 3.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.874 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.773 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 9.4 tt -95.48 92.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.238 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 78.4 mtt180 -93.87 97.72 10.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.269 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.536 HD11 HG21 ' A' ' 77' ' ' THR . 66.2 tp -99.91 100.83 11.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.317 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 33' ' ' VAL . 22.3 p -115.52 117.23 29.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.369 -174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.561 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.2 mpp? -114.2 162.07 17.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.036 -171.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 7.5 tmtm? -129.88 100.85 5.62 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 32' ' ' ILE . 3.9 pp -100.36 121.12 40.99 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.16 66.33 0.69 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.713 0.768 . . . . 0.0 109.476 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.91 -109.49 0.52 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.53 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -134.9 32.34 3.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.0 pp -131.83 129.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.896 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 22.9 t -81.09 84.57 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -80.03 -64.18 1.24 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.787 -172.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 38.7 t70 -94.18 147.18 23.42 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.219 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.73 122.24 9.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.968 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 22.3 mmtp -122.7 110.44 15.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.4 p90 -122.05 93.32 3.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.338 0.589 . . . . 0.0 111.859 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.741 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 39.3 tt0 -98.72 98.86 9.93 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.773 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -115.97 103.82 1.22 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.769 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.09 95.86 10.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.13 -131.34 1.32 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.131 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.24 177.62 4.82 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.265 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -46.9 -54.82 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 128' ' ' CYS . 0.1 OUTLIER -70.77 -24.52 25.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.143 -172.246 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.6 m -67.89 -47.66 68.2 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.1 mtt -73.55 -21.83 60.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.763 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 68' ' ' ILE . . . -86.66 -60.58 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.385 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.8 m -74.79 -37.96 62.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.799 -169.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.76 67.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.53 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -66.86 -24.21 66.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 52.7 tpp -73.06 -53.14 11.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.11 -33.72 76.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.789 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 39.7 m -72.19 -19.52 61.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -69.07 -43.26 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.45 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.615 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.789 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.4 mm -67.59 -38.15 80.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.154 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 64.5 tttp -60.86 -18.33 55.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.514 0.673 . . . . 0.0 110.352 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.3 26.38 7.8 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.953 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.427 ' HE3' HG21 ' A' ' 87' ' ' THR . 15.0 tptt -128.92 -176.37 3.84 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.68 -177.97 3.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.68 -49.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.158 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.31 -32.67 70.27 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.481 0.658 . . . . 0.0 110.057 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.427 HG21 ' HE3' ' A' ' 83' ' ' LYS . 4.7 m -76.79 -24.47 52.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.981 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 91' ' ' MET . . . -74.53 -41.18 61.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.37 -42.23 99.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.594 0.712 . . . . 0.0 109.675 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -68.76 -24.95 64.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.145 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.466 ' HA ' HG22 ' A' ' 94' ' ' ILE . 52.4 ttm -66.44 -28.52 68.67 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.119 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' A' ' 141' ' ' ALA . 13.4 m -82.3 -39.82 22.37 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 8.5 tmtm? -55.41 -42.46 74.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 11.9 tt -82.92 -25.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 91' ' ' MET . 54.9 t80 -58.04 -46.65 84.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.482 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 p -78.89 -37.54 39.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.33 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 12.9 t70 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.904 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 HD12 ' A' ' 113' ' ' ILE . 36.7 mt . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.998 0.428 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.67 -62.59 3.55 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.059 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.74 -34.49 78.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.874 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.624 HD12 HD23 ' A' ' 110' ' ' LEU . 59.5 mt -58.17 -41.03 79.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.389 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.56 -41.35 85.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -71.72 -47.6 52.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.022 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -57.29 -42.47 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.014 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -57.21 -44.99 84.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.881 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.47 -44.61 96.45 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 125' ' ' ARG . 41.3 t -61.97 -34.73 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 67.0 m -61.05 -14.18 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -172.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -125.32 -27.45 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.114 -161.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -65.64 126.78 92.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.36 -16.59 13.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.545 2.163 . . . . 0.0 112.29 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.05 -17.9 23.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.347 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.9 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -126.87 5.22 6.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -176.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 127' ' ' LYS . 9.7 tt -72.64 -30.06 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.953 0.882 . . . . 0.0 109.31 -170.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.499 ' HG3' HG23 ' A' ' 126' ' ' ILE . 66.2 mttm -85.43 -18.63 33.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.941 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' A' ' 68' ' ' ILE . 66.8 m -81.44 -33.22 32.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.343 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 120' ' ' SER . . . -77.7 -48.51 16.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.848 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.481 ' HA ' ' HB3' ' A' ' 133' ' ' TRP . 18.8 p -61.71 -28.7 69.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.6 tt -54.9 -53.59 53.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.455 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.6 m -75.56 -37.0 60.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.256 0.551 . . . . 0.0 110.754 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 22.5 t90 -62.11 -52.29 64.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 79.0 mttt -72.17 -19.8 61.69 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.346 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.53 80.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.682 HD12 HG13 ' A' ' 80' ' ' ILE . 3.0 mm? -88.87 -50.33 6.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.76 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 4.4 tp10 -63.1 -28.38 70.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.309 -172.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 63.5 tttm -106.56 -18.75 13.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.808 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -75.8 -64.77 2.17 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.724 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.06 -17.48 6.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.0 110.857 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' A' ' 92' ' ' SER . . . -97.68 -172.41 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 10.1 tmtt? 176.76 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.305 0.378 . . . . 0.0 111.212 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 1.2 tt0 157.09 -166.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -163.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 118.22 0.464 . . . . 0.0 112.235 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.446 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 57.9 tp . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 -47.53 75.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -72.32 -36.03 68.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.3 tt -69.77 -53.35 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 7' ' ' LEU . 2.1 p90 -71.5 -32.54 68.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.955 -0.111 . . . . 0.0 111.153 -171.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -67.82 -30.43 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.294 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -78.5 -38.31 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.449 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' LEU . 60.0 t -62.58 -47.49 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.702 0.287 . . . . 0.0 110.791 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.3 mm -63.37 -36.2 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.63 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.02 -52.57 62.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 14.2 t70 -69.55 -26.94 64.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' OD1' ' A' ' 21' ' ' ASN . 26.0 t-80 -73.1 -19.33 61.17 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -82.44 -22.68 35.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.742 0.782 . . . . 0.0 109.206 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 30.8 ttpt -72.53 -19.33 61.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.32 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.653 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 1.5 p-10 -132.74 175.17 3.91 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.621 -175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 21' ' ' ASN . 68.1 Cg_exo -41.58 136.6 2.89 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.265 2.643 . . . . 0.0 114.348 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -108.9 -174.09 2.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.784 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.67 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 4.5 m-20 -82.03 90.45 6.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.852 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 17.0 ptpt -163.13 19.91 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.131 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -97.78 123.23 7.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.201 -173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.23 97.11 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.956 ' HB2' ' HD3' ' A' ' 60' ' ' LYS . 53.9 tp -92.78 90.86 7.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.108 0.48 . . . . 0.0 109.93 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -78.33 51.16 0.99 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.954 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.61 -87.1 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.864 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 t -92.68 -80.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.429 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.776 HD11 HD23 ' A' ' 51' ' ' LEU . 64.6 mt -88.81 130.41 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.011 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.07 92.47 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 110.171 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.8 t -109.54 119.27 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -124.86 144.12 50.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.708 0.29 . . . . 0.0 110.835 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.539 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 14.5 tpt -151.34 155.1 38.0 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.11 139.19 30.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.1 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -134.14 97.73 14.76 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -25.15 -64.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 125.24 3.96 . . . . 0.0 115.506 -167.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -109.67 6.17 23.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 128' ' ' CYS . 46.7 t -131.96 4.01 4.11 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.886 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 131' ' ' LEU . . . 167.72 57.88 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -38.4 -40.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.792 1.237 . . . . 0.0 113.611 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -149.02 140.33 23.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 6.1 tt -146.45 96.98 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.736 0.779 . . . . 0.0 109.421 166.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -104.42 105.96 16.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.93 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.475 HD11 ' HE3' ' A' ' 49' ' ' MET . 62.8 tp -102.23 104.47 15.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.808 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.8 p -117.73 108.81 15.84 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.965 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 65.1 mtt -110.5 163.1 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.919 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.732 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.0 ttpp -130.12 91.12 3.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 32' ' ' ILE . 1.7 pp -95.99 112.88 24.49 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.11 68.61 0.71 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.594 0.711 . . . . 0.0 109.948 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.51 -105.61 0.35 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.177 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.86 15.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.579 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' HG3' ' A' ' 57' ' ' GLU . 1.3 pp -125.84 -166.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.999 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 80' ' ' ILE . 36.5 t -126.73 106.85 16.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.477 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HG3' HD13 ' A' ' 55' ' ' ILE . 72.8 mt-10 -85.95 -53.88 4.83 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.22 0.534 . . . . 0.0 109.685 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 9.1 t0 -130.11 163.35 26.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.797 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -165.61 132.28 2.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.5 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.956 ' HD3' ' HB2' ' A' ' 28' ' ' LEU . 2.0 mptp? -128.31 144.15 51.1 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -127.86 110.04 12.19 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.058 -175.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -103.57 97.82 7.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 171.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.67 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -138.54 121.15 2.1 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.162 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.08 155.24 28.51 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 153.96 -131.95 3.4 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.362 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.454 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 9.0 p -104.26 162.5 13.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -44.22 -48.95 9.39 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.279 0.987 . . . . 0.0 112.537 -171.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -75.38 -24.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 68' ' ' ILE . 4.9 m -75.11 -40.02 60.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.703 0.763 . . . . 0.0 109.307 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.9 ttp -70.77 -25.95 63.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.767 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.51 -56.23 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.175 -174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.7 p -66.41 -44.91 81.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.52 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.56 -55.25 35.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.982 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -65.14 -37.48 87.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.9 tpt -70.02 -43.93 70.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 109.975 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.8 mmm -67.7 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.7 m -69.58 -20.23 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.766 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -75.56 -39.17 58.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.02 -31.54 72.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.147 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.472 HG22 HG11 ' A' ' 56' ' ' VAL . 18.3 mm -75.67 -33.54 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.667 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -55.55 -20.29 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.47 41.66 1.64 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.992 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HE3' HG21 ' A' ' 87' ' ' THR . 2.6 tptp -133.66 -156.91 0.77 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.268 0.556 . . . . 0.0 111.515 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -140.66 147.81 39.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -170.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.46 -34.47 61.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.226 0.536 . . . . 0.0 109.714 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -57.86 -46.7 84.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.009 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.561 HG21 ' HE3' ' A' ' 83' ' ' LYS . 2.1 m -76.63 -20.81 56.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.134 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.71 ' O ' ' HG2' ' A' ' 91' ' ' MET . . . -69.9 -49.94 47.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.329 0.585 . . . . 0.0 110.96 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 142' ' ' LYS . 10.1 mp -65.38 -28.63 69.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.181 0.515 . . . . 0.0 109.623 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -77.67 -20.48 53.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.239 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.717 ' HA ' HG22 ' A' ' 94' ' ' ILE . 9.2 ptt? -77.63 -22.24 51.04 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.591 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 8.2 t -86.11 -29.58 23.22 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.96 -50.8 69.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.185 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 91' ' ' MET . 10.4 tt -69.82 -28.43 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.103 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 91' ' ' MET . 81.2 t80 -54.63 -45.11 73.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.872 0.368 . . . . 0.0 110.528 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.8 p -85.26 -34.1 22.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 21.1 t70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.615 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.801 0.334 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.41 ' HA2' ' OE1' ' A' ' 114' ' ' GLU . . . -59.73 -34.61 82.96 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.736 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.87 -32.53 65.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.178 0.513 . . . . 0.0 110.364 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 58.8 mt -69.32 -27.6 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' OE1' ' HA2' ' A' ' 111' ' ' GLY . 44.3 mt-10 -63.88 -21.44 66.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.33 59.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.08 -32.0 64.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.35 0.595 . . . . 0.0 110.112 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -53.76 -35.16 60.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.904 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.23 53.79 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.631 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 68' ' ' ILE . 28.9 m -85.74 -17.95 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.552 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.1 t -46.44 -17.34 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -164.04 26.63 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.177 0.899 . . . . 0.0 110.271 -164.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.16 140.65 22.92 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.28 -41.75 4.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.45 2.767 . . . . 0.0 113.501 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.4 9.52 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 98.5 mtt180 -125.13 4.16 7.9 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.053 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.8 tt -83.55 -29.87 7.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.485 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.816 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 33.5 t -85.99 -19.63 30.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.453 175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -79.44 -45.01 20.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.868 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 p -66.02 -30.65 71.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.303 0.573 . . . . 0.0 109.801 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.574 HD11 ' HA3' ' A' ' 42' ' ' GLY . 8.0 tt -56.64 -67.34 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.764 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 m -70.88 -56.01 7.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.588 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -72.94 -51.59 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.966 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 130' ' ' THR . 48.3 tttm -75.69 -22.76 56.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.664 -168.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.31 -27.0 35.21 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.485 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -79.29 -48.31 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 109.945 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 142' ' ' LYS . 34.7 tt0 -65.96 -27.69 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -88.02 -15.01 37.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.093 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -57.83 -43.47 94.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.786 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.12 11.57 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.64 172.46 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.844 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.64 -172.37 4.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.201 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER -66.35 -164.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.048 0.452 . . . . 0.0 111.373 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 . . . . . 0 C--N 1.322 -0.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.614 178.76 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.543 0.211 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.789 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.4 t70 -59.13 -47.37 85.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.493 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -73.26 -23.69 60.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 60.6 tp -70.52 -53.68 15.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.789 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 8.8 p90 -75.03 -19.72 59.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.355 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 38.9 ttp180 -66.98 -35.84 80.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -73.26 -38.31 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.716 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 10' ' ' LEU . 93.9 t -60.64 -50.13 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.548 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 11' ' ' TYR . 32.6 mm -57.95 -52.35 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.825 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.4 ttm -60.23 -54.69 42.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.896 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.4 -37.66 74.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.113 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -77.46 -18.77 56.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.609 0.242 . . . . 0.0 110.802 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.09 -31.88 70.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -73.35 -22.82 60.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.496 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 13.1 m120 -86.85 170.19 12.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.321 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 42.1 Cg_exo -57.99 126.36 21.41 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.86 1.706 . . . . 0.0 110.792 169.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -57.71 -74.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.442 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -177.53 114.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.84 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -148.98 111.42 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.887 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . 153.48 142.27 3.43 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.737 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.09 104.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 48' ' ' THR . 3.4 tt -103.12 87.66 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.122 0.487 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.86 100.38 5.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.21 -71.31 0.18 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.468 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.0 -70.7 0.78 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.679 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' A' ' 49' ' ' MET . 35.9 mt -87.31 116.86 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.001 0.429 . . . . 0.0 109.894 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.625 ' HA ' HG22 ' A' ' 48' ' ' THR . 45.7 t -131.86 91.16 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.627 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 135' ' ' ALA . 41.6 t -114.19 105.71 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 0.0 110.654 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -105.52 123.16 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.633 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 2.0 tpt -124.98 159.06 32.13 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.605 ' H ' ' HE2' ' A' ' 36' ' ' MET . 9.7 p30 -155.72 139.31 15.97 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.96 -172.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.855 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 42.3 t-20 -136.72 94.39 13.2 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 48.78 0.22 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.758 3.639 . . . . 0.0 114.975 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.6 m -159.72 -45.94 0.05 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.407 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 127' ' ' LYS . 10.4 t -133.54 7.35 3.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.245 0.545 . . . . 0.0 111.078 -171.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.28 0.45 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 31.2 t70 -38.9 -67.01 0.23 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' OD2' ' A' ' 43' ' ' ASP . 67.2 mtt180 -135.88 140.25 43.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.668 -0.645 . . . . 0.0 112.024 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.633 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 7.9 tt -139.92 108.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 164.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.711 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 25.6 mmm-85 -93.03 107.67 19.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.5 tp -122.64 106.21 10.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.331 0.586 . . . . 0.0 109.782 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 33' ' ' VAL . 1.6 p -125.56 115.6 20.44 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.454 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.483 ' HB2' HD12 ' A' ' 32' ' ' ILE . 72.9 mtm -114.33 147.3 39.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.395 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 4.9 tmtt? -106.57 86.16 2.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.33 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.12 83.1 5.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.487 0.66 . . . . 0.0 109.408 171.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -86.9 63.15 7.8 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.07 -100.02 0.22 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.362 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.439 ' C ' HD13 ' A' ' 85' ' ' ILE . 4.5 p-10 -150.43 33.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.403 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -136.98 148.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 80' ' ' ILE . 45.7 t -85.46 89.23 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 171.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -80.93 -65.03 1.06 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.338 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t0 -119.1 163.87 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.6 130.92 8.64 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.393 . . . . 0.0 110.394 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 12.4 mptt -114.19 131.88 56.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 16.3 p90 -140.53 135.93 32.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.218 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -148.73 119.95 7.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.72 134.23 9.52 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -124.38 120.41 32.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.15 -129.86 2.17 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.772 -170.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.61 166.77 13.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.961 0.41 . . . . 0.0 110.689 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -59.76 -41.17 90.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.592 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -75.15 -35.18 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 68' ' ' ILE . 9.7 p -71.97 -38.73 69.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -77.42 -17.91 57.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.737 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.89 -55.3 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -60.31 -49.7 76.56 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.905 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.32 -43.16 43.29 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -71.62 -30.35 65.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.572 0.225 . . . . 0.0 111.56 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.6 mmm -77.41 -41.54 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.536 ' CE ' HD22 ' A' ' 136' ' ' LEU . 69.3 mtp -58.12 -37.0 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.61 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 61' ' ' PHE . 97.1 m -64.95 -33.26 75.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.192 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -76.99 -40.78 45.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.4 87.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.921 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -76.86 -28.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.152 -177.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.75 -19.48 65.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.125 0.488 . . . . 0.0 110.835 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.15 31.18 9.03 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.975 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.05 166.88 22.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -116.3 -162.37 0.84 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' HD13 ' A' ' 89' ' ' LEU . 1.6 mp -85.62 -46.23 17.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -61.8 -37.76 85.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.086 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -83.01 -23.78 33.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.78 -43.67 24.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 110.741 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 144' ' ' GLU . 9.8 mp -64.56 -39.17 93.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.448 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 94' ' ' ILE . 10.7 p -72.44 -35.62 68.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.171 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.6 tpp -61.25 -32.15 71.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 29.6 t -84.66 -31.08 24.36 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.21 -47.29 83.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 90' ' ' SER . 37.7 pt -74.92 -23.95 17.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.47 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 90.5 t80 -64.04 -42.08 97.19 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 109.819 172.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -80.14 -30.63 39.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.792 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.308 -177.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.425 0.155 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.65 45.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.268 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 0.0 110.247 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.419 HG21 ' HE1' ' A' ' 95' ' ' PHE . 55.7 mt -80.58 -19.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.705 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.19 -30.41 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.061 0.457 . . . . 0.0 110.251 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.4 -21.68 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.649 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.22 -38.63 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.724 0.774 . . . . 0.0 109.639 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -29.57 67.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.798 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.38 -52.95 19.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 125' ' ' ARG . 13.8 p -73.28 -19.52 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 91.8 p -55.83 -15.36 3.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -116.89 34.88 4.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 0.0 110.59 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.558 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 71.8 m-85 -131.63 177.3 2.31 Favored Pre-proline 0 C--O 1.219 -0.519 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.437 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 122' ' ' PHE . 57.3 Cg_endo -73.9 -2.83 12.81 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.448 1.432 . . . . 0.0 110.363 165.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.52 -18.83 17.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.516 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.623 ' HB3' ' HA ' ' A' ' 120' ' ' SER . 1.9 ppt_? -55.79 -59.56 4.69 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 119.441 -0.314 . . . . 0.0 111.433 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.556 ' H ' ' HD2' ' A' ' 125' ' ' ARG . 9.0 tt -47.68 -32.42 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.151 0.5 . . . . 0.0 110.573 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 50.3 mttp -81.93 -58.48 2.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.649 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.4 m -86.72 -21.43 26.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.065 0.46 . . . . 0.0 111.273 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.06 -32.63 21.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.619 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 5.0 t -62.94 -35.65 80.82 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.502 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 69' ' ' SER . 9.4 tt -61.13 -67.73 0.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.984 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.9 m -65.76 -54.68 23.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.291 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.449 ' NE1' ' HG3' ' A' ' 137' ' ' GLU . 84.1 t90 -71.91 -48.73 43.42 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -171.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 130' ' ' THR . 23.0 tptm -68.97 -25.4 64.51 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.148 -172.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -78.41 -36.36 45.84 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.948 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.536 HD22 ' CE ' ' A' ' 76' ' ' MET . 2.9 tp -80.51 -47.18 14.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 0.0 110.015 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.449 ' HG3' ' NE1' ' A' ' 133' ' ' TRP . 22.2 mm-40 -75.49 -19.74 59.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.443 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.87 -18.89 28.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.741 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -65.38 -54.29 27.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.291 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' O ' HD11 ' A' ' 89' ' ' LEU . 26.1 m -93.04 -1.19 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.58 94.28 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.283 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -50.58 144.79 7.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.83 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.532 ' H ' ' HB3' ' A' ' 92' ' ' SER . 30.9 tt0 70.11 -75.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.319 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HA ' HD23 ' A' ' 89' ' ' LEU . 34.4 tt0 . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.9 HD11 ' HA3' ' A' ' 118' ' ' GLY . 93.8 mt . . . . . 0 CA--C 1.514 -0.434 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.479 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.7 t70 -54.21 -45.23 72.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.62 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -74.35 -40.76 61.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.636 0.731 . . . . 0.0 109.937 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 94.9 mt -68.95 -56.51 7.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.385 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.546 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 1.2 p90 -67.53 -27.11 66.7 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 -60.86 -41.61 96.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.665 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -77.59 -41.51 38.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.267 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 81.7 t -61.6 -46.62 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.173 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 tp -71.38 -30.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.616 0.246 . . . . 0.0 110.613 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.3 tpt -70.16 -47.14 62.91 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.44 -38.4 89.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.198 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -68.8 -27.69 66.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.956 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -74.71 -20.57 59.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 0.0 110.02 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -79.54 -21.44 45.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.093 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 41.0 m-80 -107.23 177.76 1.24 Allowed Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 23.8 Cg_exo -66.02 175.29 4.84 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 23' ' ' ARG . 35.6 mtp-105 -79.96 -142.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.328 0.585 . . . . 0.0 110.289 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 41.4 m-80 -120.03 83.62 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.509 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -144.2 109.49 5.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.523 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -168.53 125.71 1.31 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.801 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.97 103.19 8.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.464 0.65 . . . . 0.0 110.493 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.76 ' O ' ' HB ' ' A' ' 48' ' ' THR . 4.2 tt -125.35 83.73 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.78 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.64 99.34 6.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.487 0.66 . . . . 0.0 110.04 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 35.9 t70 -127.62 -75.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.43 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -101.32 -56.88 2.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 49' ' ' MET . 46.3 pt -122.79 139.2 50.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.228 0.537 . . . . 0.0 110.743 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 48' ' ' THR . 2.3 p -136.27 108.46 7.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.675 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.456 HG21 ' HA2' ' A' ' 139' ' ' GLY . 24.4 t -109.5 142.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.901 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -135.04 135.84 41.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.356 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 14.5 tpt -152.56 147.82 26.64 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.39 161.16 27.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 127' ' ' LYS . 11.8 m120 -106.75 129.68 24.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 165.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 40' ' ' THR . 59.7 Cg_endo -70.46 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.913 2.409 . . . . 0.0 114.199 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 39' ' ' PRO . 14.8 t 158.22 -10.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.792 0.837 . . . . 0.0 111.064 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.63 19.34 4.27 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.071 0.462 . . . . 0.0 111.179 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.547 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.21 48.61 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.15 -31.3 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.647 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 4.0 ptm180 -159.15 137.97 11.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.679 1.127 . . . . 0.0 112.374 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 36' ' ' MET . 11.0 tt -133.48 95.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 162.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 38.4 ttm-85 -95.89 107.71 20.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.927 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 136' ' ' LEU . 61.8 tp -104.54 103.69 13.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 18.1 p -114.58 106.14 13.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.843 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.647 ' HB2' HD11 ' A' ' 32' ' ' ILE . 61.7 mtt -105.19 167.23 9.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.219 0.533 . . . . 0.0 111.097 -175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 62.0 tttp -126.94 86.81 2.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.254 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -95.35 82.02 3.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.843 0.83 . . . . 0.0 109.414 174.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.31 68.79 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.841 0.829 . . . . 0.0 109.273 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.1 -99.9 0.22 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.776 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -145.38 21.25 1.53 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.442 0.639 . . . . 0.0 109.395 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.9 pp -133.87 151.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.808 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.03 89.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 168.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.1 tp10 -75.38 -57.54 3.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 110.04 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -125.01 160.44 28.98 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.263 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -156.83 119.24 3.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.605 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 45.9 mmtm -112.75 138.13 50.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -129.06 100.25 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 38.8 tt0 -90.77 99.81 12.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -126.28 115.51 2.31 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.77 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -127.39 126.63 42.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 169.78 -130.76 2.1 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.634 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.45 162.53 13.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.612 0.244 . . . . 0.0 110.466 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -57.8 -37.86 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -73.72 -35.38 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' HD12 ' A' ' 68' ' ' ILE . 24.8 p -79.13 -33.58 44.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.328 0.585 . . . . 0.0 110.131 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 90.4 mtp -74.26 -15.68 60.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.405 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.23 -51.56 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.003 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 p -59.23 -44.88 92.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.4 -62.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.532 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -55.74 -42.77 75.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.358 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.8 tpt -68.97 -51.27 41.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.596 ' HB3' HD22 ' A' ' 136' ' ' LEU . 92.4 mtp -72.29 -37.93 68.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.241 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.58 ' HA ' HD11 ' A' ' 136' ' ' LEU . 90.9 m -62.73 -29.26 70.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 111.264 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -86.03 -37.61 18.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.804 0.335 . . . . 0.0 110.327 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.94 89.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 0.0 110.064 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.66 -22.02 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.462 0.648 . . . . 0.0 109.4 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' THR . 81.4 tttt -64.63 -21.74 66.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.629 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.62 40.04 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.942 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 80' ' ' ILE . 98.4 mttt -133.95 -172.79 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.03 -168.96 1.51 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -80.69 -45.69 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.471 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.14 -39.92 91.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.168 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -62.74 -36.03 81.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.842 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.34 60.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.461 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 45.3 mt -61.05 -42.44 98.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.198 0.523 . . . . 0.0 109.667 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 t -63.96 -36.1 82.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.319 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 27.9 ttt -68.25 -28.31 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 0.0 110.843 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 31.0 t -86.22 -35.06 20.26 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.87 -49.84 73.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.821 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 13.3 tt -72.87 -22.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 91' ' ' MET . 48.6 t80 -59.23 -45.08 92.09 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.54 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.6 p -85.95 -28.45 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.082 0.468 . . . . 0.0 111.379 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 33.6 t70 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.58 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 114' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 111.587 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.88 -27.06 73.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.691 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.85 -48.0 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.62 -31.32 52.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.365 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 8.0 mm-40 -66.08 -28.15 68.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.651 0.263 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.0 71.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 110.593 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.19 -15.16 24.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.822 0.344 . . . . 0.0 110.5 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.593 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 4.2 tp-100 -49.02 -43.85 40.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.653 -173.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.9 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -78.74 -33.83 36.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.553 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 HD13 ' A' ' 68' ' ' ILE . 29.0 m -87.55 -17.79 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 26.6 t -50.71 -18.89 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -165.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -169.34 27.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.439 1.018 . . . . 0.0 111.15 -167.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -93.46 138.42 23.0 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.4 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.96 -34.91 6.74 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.191 2.594 . . . . 0.0 113.303 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.05 5.96 20.58 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 84.2 mtt180 -121.72 -9.03 8.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.423 -0.798 . . . . 0.0 110.374 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' HD2' ' A' ' 127' ' ' LYS . 15.5 tt -77.42 -29.35 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.567 -167.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.584 ' HD2' HG23 ' A' ' 126' ' ' ILE . 14.0 mptt -74.74 -22.88 58.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 67.7 m -85.89 -22.54 27.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.158 0.504 . . . . 0.0 110.017 174.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -72.73 -47.73 44.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.533 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.6 p -65.42 -30.74 71.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.062 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -49.8 -53.65 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -71.52 -51.01 25.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -67.59 -41.61 83.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.948 0.404 . . . . 0.0 111.643 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.713 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 71.8 mmtt -73.5 -17.61 61.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.35 -44.64 11.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.174 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 76' ' ' MET . 3.0 tp -84.19 -63.27 1.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.02 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.41 -30.89 60.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.054 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 49.3 tttm -85.17 -4.32 59.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.355 0.598 . . . . 0.0 109.621 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -73.6 -50.57 11.28 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.452 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 141' ' ' ALA . 9.8 m -76.0 -57.04 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.202 . . . . 0.0 110.501 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . . . 169.59 152.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.704 0.802 . . . . 0.0 109.054 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -96.19 127.93 42.65 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.152 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 92' ' ' SER . 35.5 tt0 67.5 -76.13 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 111.608 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.824 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.614 HD11 ' HA3' ' A' ' 118' ' ' GLY . 94.0 mt . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.03 -46.99 61.76 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.466 0.479 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.89 -24.92 52.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.1 tm? -78.32 -58.69 3.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.445 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -76.57 -21.77 55.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.1 ttp180 -69.15 -35.74 76.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.12 -41.04 77.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.667 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 94.7 t -69.05 -48.59 68.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' A' ' 67' ' ' SER . 13.9 tt -66.29 -29.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.965 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -61.94 -49.02 77.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 110.051 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.55 -34.77 65.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -74.27 -19.31 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -77.23 -32.8 56.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -31.65 62.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.762 175.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -129.76 84.62 60.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.267 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.69 140.33 2.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.946 2.431 . . . . 0.0 111.886 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 16.4 ttm180 -145.44 17.2 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.412 0.625 . . . . 0.0 110.654 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 14.9 m120 -84.08 83.79 7.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.56 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 tptm -165.64 24.81 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 111.181 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.1 6.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.874 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.26 104.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 48' ' ' THR . 60.9 tp -105.71 95.93 6.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.985 0.422 . . . . 0.0 111.825 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -84.18 91.27 7.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' CG ' ' HG2' ' A' ' 50' ' ' LYS . 13.4 t70 -127.58 -69.7 0.73 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.583 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -127.04 -51.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.059 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 71.4 mt -106.84 129.42 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.044 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 48' ' ' THR . 3.1 m -142.2 82.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.508 0.67 . . . . 0.0 110.928 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 135' ' ' ALA . 49.1 t -98.81 134.69 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.272 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -128.34 147.01 50.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -153.1 151.2 29.91 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -152.04 145.32 24.7 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 111.898 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 41' ' ' CYS . 47.0 t-20 -124.23 111.77 28.36 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -21.56 -64.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 125.688 4.259 . . . . 0.0 115.679 -169.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 m -126.6 23.65 6.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.551 0.691 . . . . 0.0 110.904 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 38' ' ' ASN . 38.3 t -129.43 -36.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.687 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' HB3' ' A' ' 38' ' ' ASN . . . -140.88 62.16 0.54 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -34.82 -53.3 0.55 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.399 1.08 . . . . 0.0 113.666 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -156.7 141.75 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.357 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.44 105.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.448 0.642 . . . . 0.0 110.053 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 18.8 mmt180 -93.34 110.89 22.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.787 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.46 HD21 ' HE3' ' A' ' 49' ' ' MET . 52.2 tp -104.57 94.94 5.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.835 HG22 HG12 ' A' ' 33' ' ' VAL . 10.9 p -115.66 111.2 20.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.601 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 65.5 mtt -109.34 161.34 15.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.913 0.387 . . . . 0.0 111.452 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HE3' ' HB2' ' A' ' 52' ' ' ASP . 8.7 tmtm? -126.06 100.46 6.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pp -100.35 108.16 20.12 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.614 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.817 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 35.6 t70 -100.06 65.77 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.764 0.792 . . . . 0.0 109.263 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.36 -101.45 0.27 Allowed Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.838 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 7.7 m-20 -142.63 28.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.711 -0.745 . . . . 0.0 109.811 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.9 pp -132.5 151.71 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.206 0.527 . . . . 0.0 110.193 -170.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -86.56 96.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.958 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -91.48 -69.98 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -112.46 159.02 19.17 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.21 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -157.58 132.76 8.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.636 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -123.96 120.36 32.27 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -115.96 81.13 1.55 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.415 0.626 . . . . 0.0 111.436 -176.044 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.95 117.31 24.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.548 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.39 161.06 29.97 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.259 -1.448 . . . . 0.0 113.586 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.03 164.39 27.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.55 -130.46 3.33 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.255 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 34.0 m -81.25 159.35 24.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.903 0.382 . . . . 0.0 110.797 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.583 ' HB2' HD12 ' A' ' 15' ' ' ILE . 5.7 p -61.82 -32.94 73.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.975 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -90.57 -24.49 5.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.694 -176.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.493 ' N ' HD13 ' A' ' 68' ' ' ILE . 31.2 p -76.68 -40.15 49.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.072 0.463 . . . . 0.0 110.913 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.5 ptp -72.03 -17.22 62.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.304 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.54 -46.72 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.119 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' MET . 13.7 p -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.59 -51.94 43.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.26 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -70.57 -27.24 63.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.5 ttt -79.04 -49.18 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.083 0.468 . . . . 0.0 110.288 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 112' ' ' ASP . 90.2 mmm -63.65 -39.84 95.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.192 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.445 HG23 ' HE2' ' A' ' 49' ' ' MET . 31.5 m -75.12 -21.21 59.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.44 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.88 -41.26 78.59 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.23 -26.9 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.298 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.461 ' CD1' HG21 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -72.38 -31.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.667 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.95 -24.58 67.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.579 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -85.68 19.7 23.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.814 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 1.6 mptm? -133.69 -179.25 5.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 109.984 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 5.6 p-10 -116.36 -171.37 1.99 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.34 -40.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.491 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -64.23 -40.97 97.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 109.688 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 91' ' ' MET . 23.2 m -74.86 -32.02 61.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.001 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' CE ' ' A' ' 91' ' ' MET . . . -61.28 -48.65 80.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.847 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 141' ' ' ALA . 72.2 mt -59.14 -39.75 83.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.577 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 m -70.51 -19.89 62.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.232 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.678 ' HA ' HG12 ' A' ' 94' ' ' ILE . 67.1 mtm -79.32 -19.38 50.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.81 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 23.6 t -85.46 -32.62 22.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -58.62 -43.13 89.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.245 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.678 HG12 ' HA ' ' A' ' 91' ' ' MET . 40.5 pt -82.87 -23.94 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.105 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 37.7 t80 -58.11 -46.97 84.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.131 0.491 . . . . 0.0 110.172 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 p -79.85 -27.85 40.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 22.0 t70 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.4 0.619 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -57.35 -19.74 34.13 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.683 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 1.2 p-10 -65.27 -48.57 72.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.57 0.348 . . . . 0.0 111.506 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 110' ' ' LEU . 10.6 tt -71.87 -19.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.453 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 70.2 mm-40 -57.51 -31.03 65.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.594 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.22 59.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.148 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.75 -39.22 18.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -62.1 -19.88 63.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -75.67 -51.19 7.35 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.596 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.2 m -78.51 -17.04 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 75.3 m -43.52 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -147.34 6.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.365 0.984 . . . . 0.0 112.584 -163.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.788 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 36.3 m-85 -81.38 142.5 50.52 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.96 -37.16 12.01 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.218 2.612 . . . . 0.0 113.384 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.93 -1.27 15.52 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 95.5 mtt180 -114.34 -3.29 13.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 -174.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 120' ' ' SER . 11.9 tt -70.58 -31.0 44.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.727 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HA ' ' OG1' ' A' ' 130' ' ' THR . 97.2 mttt -81.88 -22.08 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 55.9 m -69.54 -34.84 74.82 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -78.77 -46.53 18.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.275 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 127' ' ' LYS . 22.8 p -62.6 -33.96 76.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.711 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 128' ' ' CYS . 4.3 pp -67.68 -41.61 83.4 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.281 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 m -71.73 -48.29 48.04 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.616 0.722 . . . . 0.0 110.481 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -63.34 -55.35 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.801 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.842 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 68.7 mmtt -72.6 -19.34 61.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.477 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -61.3 -45.26 95.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 110.063 173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 76' ' ' MET . 6.5 mp -86.52 -34.16 20.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.223 0.535 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 8.3 tp10 -63.96 -20.84 66.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.681 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -109.67 -41.56 4.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.941 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.14 -50.91 60.77 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.203 -0.522 . . . . 0.0 114.138 -172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 80' ' ' ILE . 15.5 m -125.27 -8.05 6.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.38 . . . . 0.0 111.753 -172.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -128.15 162.63 26.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.028 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 2.4 ttpm? 179.68 54.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.69 0.619 . . . . 0.0 109.88 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' CB ' ' A' ' 92' ' ' SER . 36.8 mt-10 60.51 -99.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.004 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.922 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -96.0 -58.23 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.625 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -127.77 128.47 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.68 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -153.1 129.06 10.29 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.41 ' HB1' ' HB ' ' A' ' 9' ' ' THR . . . -83.85 20.11 1.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.505 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.22 -52.84 62.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.844 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.01 -39.88 2.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.198 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.594 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 19.2 t70 -56.23 -57.12 13.57 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.681 -174.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.41 ' HB ' ' HB1' ' A' ' 5' ' ' ALA . 29.3 m -70.2 -25.36 63.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.001 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.9 tp -70.03 -54.48 12.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.324 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 4.3 p90 -72.28 -24.2 61.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 13.6 tpp180 -56.99 -49.62 75.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.03 -36.86 80.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.555 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' A' ' 71' ' ' ALA . 84.2 t -60.25 -45.5 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.61 -31.42 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.7 mtt -68.38 -40.65 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 0.0 110.906 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.89 -34.49 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -71.33 -21.3 62.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.535 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -85.97 -31.19 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 0.0 110.934 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -67.37 -21.36 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.084 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.35 80.16 72.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.198 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.65 71.55 3.95 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.275 2.65 . . . . 0.0 113.034 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -134.45 125.53 27.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.005 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 70' ' ' MET . 57.7 t30 -167.2 152.41 7.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 1.123 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 55.8 tttm 72.64 94.33 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.334 1.021 . . . . 0.0 110.818 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.07 162.97 31.66 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -136.94 119.47 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.39 0.595 . . . . 0.0 110.435 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 48' ' ' THR . 2.4 tt -115.41 101.16 8.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.23 108.82 19.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.04 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -152.98 -72.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.376 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.88 -71.89 0.73 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 49' ' ' MET . 41.8 pt -108.25 127.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.3 0.572 . . . . 0.0 111.896 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 48' ' ' THR . 87.3 t -126.44 104.9 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.96 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.05 114.33 29.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.627 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 46' ' ' ARG . 4.2 p30 -113.93 154.06 28.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.045 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.514 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 14.9 tpt -140.83 123.39 16.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -109.71 152.04 26.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.1 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 131' ' ' LEU . 41.7 t-20 -122.05 83.08 44.27 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.8 -6.71 11.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.236 2.624 . . . . 0.0 113.152 -171.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.5 m -86.11 -43.18 13.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 49.8 t -99.82 -24.93 14.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.67 0.04 36.78 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.654 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 2.8 m-20 -70.52 145.83 50.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -154.09 114.24 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 64.6 mt -122.4 110.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.494 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 62' ' ' GLU . 32.3 mtp180 -94.42 109.45 21.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.728 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.843 HD11 ' HE3' ' A' ' 49' ' ' MET . 52.3 tp -99.55 104.4 16.2 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.502 0.668 . . . . 0.0 109.331 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.69 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 3.2 p -115.75 103.56 10.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.034 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.843 ' HE3' HD11 ' A' ' 47' ' ' LEU . 60.7 mtt -107.77 163.45 13.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.072 0.463 . . . . 0.0 110.939 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 87.7 tttt -130.01 100.46 5.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.572 174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.33 105.25 17.22 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -109.72 72.54 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 -172.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.05 -101.17 0.25 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.366 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.66 20.48 2.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.116 0.96 . . . . 0.0 108.601 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.6 pp -127.37 -162.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.588 -174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG11 HG22 ' A' ' 80' ' ' ILE . 57.6 t -123.76 117.74 52.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.387 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 50.6 mm-40 -86.11 -48.99 8.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.9 174.76 12.74 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.052 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -162.04 131.46 4.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.528 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -121.76 118.99 30.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -106.41 99.45 9.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.839 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.123 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 31.5 tt0 -81.27 79.43 7.91 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -104.18 114.69 4.81 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.637 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 10.1 tp10 -121.01 150.76 40.65 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.44 -132.5 4.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.626 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.58 -175.66 2.92 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.902 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 m -61.48 -40.82 95.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.478 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -79.61 -42.93 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -171.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.7 p -65.51 -52.35 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.922 0.391 . . . . 0.0 112.048 -170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.461 ' HB2' HD21 ' A' ' 24' ' ' ASN . 0.0 OUTLIER -68.39 -22.38 64.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.016 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -85.28 -48.61 8.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.341 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.4 p -59.22 -46.77 87.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 110.848 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.97 83.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.0 m -61.29 -34.25 74.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.432 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.19 -43.72 27.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 0.0 109.835 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 95.0 mmm -73.75 -32.08 63.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.527 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.8 p -74.6 -19.97 60.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.994 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -72.04 -38.37 69.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 83' ' ' LYS . . . -71.29 -34.11 70.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.728 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 56' ' ' VAL . 14.6 mm -71.99 -41.07 68.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -57.29 -19.0 19.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.322 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.53 25.6 10.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 79' ' ' ALA . 13.2 mptt -127.55 -168.6 1.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.501 . . . . 0.0 110.784 -173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -120.15 -165.98 1.25 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.2 mm -87.27 -38.42 12.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.881 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.36 -49.79 76.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.256 0.551 . . . . 0.0 109.987 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 p -67.55 -32.59 73.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.252 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.72 -43.6 68.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 79.9 mt -65.79 -36.16 82.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.718 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 t -68.11 -45.48 73.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.292 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.51 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 51.1 ttm -58.11 -35.18 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.03 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 7.6 p -87.69 -30.26 20.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.481 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.729 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 83.2 tttt -61.83 -48.2 81.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 98' ' ' MET . 12.6 tt -71.67 -32.32 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.047 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 91' ' ' MET . 31.7 t80 -57.22 -44.99 84.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.176 0.512 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -77.99 -33.97 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.899 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.24 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.286 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 88.0 mtp -53.82 -32.88 54.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.442 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.6 ttp -76.66 -18.93 58.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.21 -38.95 9.91 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 102' ' ' LYS . . . -70.39 -67.8 1.81 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.712 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 101' ' ' GLY . 17.8 mmtm 169.94 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.815 0.846 . . . . 0.0 110.156 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -166.2 109.5 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.331 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' HE2' ' HA3' ' A' ' 101' ' ' GLY . 24.3 p90 -173.67 142.05 0.9 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.689 ' HB2' HD21 ' A' ' 110' ' ' LEU . 27.6 t70 -133.9 133.46 41.5 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.89 -26.57 62.32 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.515 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 16.1 m -107.78 -12.0 15.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 107' ' ' SER . 2.1 mp 71.75 4.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.445 1.117 . . . . 0.0 109.712 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.81 80.32 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.834 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 105' ' ' ASP . 83.9 mt -109.58 22.47 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.728 -173.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -50.05 -57.72 9.63 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.231 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.38 -35.01 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.689 HD12 HD23 ' A' ' 110' ' ' LEU . 59.0 mt -59.78 -39.51 80.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.519 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 40.0 mt-10 -77.61 -23.35 49.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.006 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -43.17 25.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.306 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.7 tp -65.03 -37.4 87.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.286 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 9.4 pt20 -73.37 -23.49 60.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.7 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 -47.98 76.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.189 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 129' ' ' ALA . 19.3 m -81.99 -18.58 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.868 0.366 . . . . 0.0 111.28 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 t -52.15 -12.64 0.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -117.92 -25.08 6.87 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.689 -0.632 . . . . 0.0 111.043 -163.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -74.58 129.6 83.47 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.49 -29.96 19.89 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.995 2.463 . . . . 0.0 113.022 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.53 -15.32 28.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.68 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 8.5 mmt180 -113.65 -4.98 13.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.633 -172.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.93 -32.05 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.482 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.692 ' HG3' HD21 ' A' ' 38' ' ' ASN . 13.3 pttt -81.14 -19.03 44.38 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.625 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 68' ' ' ILE . 56.9 m -85.61 -28.12 25.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.23 -50.36 16.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.245 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.9 p -64.92 -26.34 68.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.099 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 38' ' ' ASN . 9.9 tt -54.18 -64.67 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 24.9 m -63.94 -34.12 77.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.045 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -66.42 -58.02 6.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.493 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.92 -32.93 74.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.703 0.287 . . . . 0.0 111.377 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 76' ' ' MET . 14.2 tp -79.06 -38.42 36.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.518 ' CD ' ' HD3' ' A' ' 142' ' ' LYS . 74.0 mt-10 -70.26 -21.91 62.92 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.731 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -86.98 -22.48 25.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.347 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.64 -60.19 8.57 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.814 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.48 11.49 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.747 -0.267 . . . . 0.0 110.975 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.86 -175.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.031 0.832 . . . . 0.0 109.955 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 59.5 pttt -145.33 166.7 24.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.302 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.729 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 52.4 mt-10 60.15 -104.89 0.2 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.938 0.774 . . . . 0.0 110.201 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -138.74 19.55 2.68 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.9 -52.7 0.24 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.941 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.32 -75.74 1.74 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.035 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.235 0.308 0 C-N-CA 122.747 0.419 . . . . 0.0 111.051 178.661 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -75.53 104.29 6.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 0.0 110.544 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.23 147.92 31.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.845 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -82.93 90.48 6.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.292 0.568 . . . . 0.0 111.344 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.767 ' HB1' ' HB2' ' A' ' 8' ' ' ASP . . . -102.47 92.83 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -49.93 93.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.241 0.963 . . . . 0.0 112.165 -171.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.436 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 47.7 tp 76.61 -15.49 0.72 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.022 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.767 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 4.8 m-20 -59.92 -45.26 93.13 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.34 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -59.81 -45.88 90.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.138 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 80.8 mt -70.4 -60.72 2.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.955 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.9 p90 -63.73 -36.09 82.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 12.8 ttp180 -74.65 -28.63 60.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.29 -42.16 46.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.4 t -63.4 -46.47 95.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.207 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.6 tt -67.27 -32.75 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.76 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -68.77 -47.31 66.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.86 -48.24 79.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.04 -17.9 61.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.15 -42.49 80.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.592 0.71 . . . . 0.0 109.285 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 1.8 tmmt? -71.15 -27.04 63.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.723 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.96 85.57 28.61 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 121.035 0.445 . . . . 0.0 111.867 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.52 167.78 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.402 2.735 . . . . 0.0 112.88 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -162.99 25.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.83 36.93 1.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.586 -165.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -141.75 108.87 5.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 111.381 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.65 ' HA3' ' HD2' ' A' ' 60' ' ' LYS . . . 167.4 144.83 4.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.136 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HD2' ' A' ' 46' ' ' ARG . 15.4 m -127.82 111.16 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.0 109.864 171.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.632 ' O ' ' HB ' ' A' ' 48' ' ' THR . 47.2 tp -109.53 85.24 2.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.69 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.06 80.07 3.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -141.94 -73.35 0.32 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.635 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 49' ' ' MET . 14.5 m -95.26 -85.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 48' ' ' THR . 78.2 mt -93.35 130.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.051 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.01 95.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.649 HG13 ' HB2' ' A' ' 47' ' ' LEU . 3.6 p -131.21 108.08 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 111.224 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 5.0 t70 -95.34 145.05 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.959 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 9.7 tpt -144.17 115.22 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 4.9 p30 -120.27 158.04 27.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.564 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HB2' HD12 ' A' ' 131' ' ' LEU . 10.8 t-20 -135.06 105.88 10.4 Favored Pre-proline 0 CA--C 1.52 -0.184 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.87 -16.94 57.86 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.919 2.413 . . . . 0.0 112.795 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -61.6 -38.91 89.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.0 -14.13 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.76 42.5 4.43 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.557 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB2' HD11 ' A' ' 131' ' ' LEU . 5.3 m-20 -87.07 145.96 26.26 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' HG2' ' HB3' ' A' ' 37' ' ' ASN . 30.0 mtm180 -143.18 113.74 7.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 131' ' ' LEU . 64.7 mt -121.52 93.94 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.764 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 42.1 ttm105 -89.12 99.22 12.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.882 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 61' ' ' PHE . 62.5 mt -88.1 106.63 18.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 123.843 0.715 . . . . 0.0 109.466 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 p -115.77 96.16 5.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.337 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.622 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 42.1 mtp -104.38 156.13 18.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.202 -167.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -120.81 87.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.52 0.676 . . . . 0.0 109.47 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 32' ' ' ILE . 2.4 pt? -87.38 105.06 17.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.698 173.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.93 67.14 0.74 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.721 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.35 -101.5 0.25 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -139.01 18.2 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -120.26 150.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.65 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.3 112.5 39.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.12 -45.78 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -109.09 147.71 31.98 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.728 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -151.65 118.63 5.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.65 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 47.8 mmtm -111.7 111.23 22.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.818 ' HB3' HD23 ' A' ' 47' ' ' LEU . 7.8 p90 -127.01 105.22 8.45 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.318 0.58 . . . . 0.0 110.884 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.89 82.56 2.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 170.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -103.61 109.25 3.39 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.533 -172.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.74 159.58 34.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 145.47 -131.44 4.2 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.064 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.8 p -102.37 169.1 8.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -52.29 -48.16 65.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.73 0.644 . . . . 0.0 112.452 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -69.6 -36.23 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -171.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 m -72.11 -43.83 64.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 109.802 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.2 ttt -70.84 -23.93 62.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.584 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -88.69 -61.04 1.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.76 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -67.19 -50.47 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.842 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.57 94.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 110.328 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -69.41 -31.96 70.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.542 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.5 tpt -73.24 -41.4 63.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.163 0.506 . . . . 0.0 109.827 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 88.3 mtp -62.86 -30.86 71.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.879 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CE1' ' A' ' 61' ' ' PHE . 50.8 m -72.91 -22.31 60.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.894 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.53 -33.44 71.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.418 0.627 . . . . 0.0 109.317 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.47 25.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.292 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.4 OUTLIER -73.17 -32.02 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.089 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.06 -17.11 63.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.308 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.22 27.79 7.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.935 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 95.4 mttt -134.12 -155.53 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 111.633 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.18 156.7 48.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -170.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 85' ' ' ILE . 2.3 mp -61.49 -42.87 95.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -41.48 73.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.177 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.0 m -79.23 -33.9 43.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.94 88.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.362 . . . . 0.0 110.779 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 144' ' ' GLU . 7.6 mp -64.74 -31.36 72.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.526 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.9 m -72.76 -33.92 66.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.129 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.0 ttm -67.81 -34.73 77.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.794 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 p -82.09 -30.02 31.46 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.98 -42.1 97.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 106' ' ' ASP . 14.5 tt -78.95 -25.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.054 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.64 -40.71 97.86 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.3 m -65.6 -31.99 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.875 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.89 -25.8 40.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.712 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.651 ' HG3' ' H ' ' A' ' 104' ' ' TYR . 43.0 ttm -49.06 -39.67 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.028 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -77.0 -26.62 54.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.798 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -95.52 -37.05 11.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.745 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.8 -64.39 2.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.915 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -163.26 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.54 0.686 . . . . 0.0 110.567 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.691 ' HG2' ' HG ' ' A' ' 110' ' ' LEU . 36.8 tt0 177.71 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.651 ' H ' ' HG3' ' A' ' 98' ' ' MET . 11.7 p90 -165.17 140.04 5.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.5 106.63 8.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.878 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.805 ' H ' HD13 ' A' ' 94' ' ' ILE . 16.4 t70 58.1 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.817 0.847 . . . . 0.0 113.061 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.8 m -91.39 3.4 55.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 mp 59.03 58.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.968 0.89 . . . . 0.0 110.062 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -133.17 124.59 27.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.691 ' HG ' ' HG2' ' A' ' 103' ' ' GLU . 2.6 mm? -114.94 14.78 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.118 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.58 36.22 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.733 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.72 -38.94 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.067 0.46 . . . . 0.0 111.119 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.62 -34.9 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.936 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 117' ' ' GLN . 40.6 tt0 -62.68 -30.83 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.0 110.239 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.71 -9.97 59.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.4 -44.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.496 0.665 . . . . 0.0 109.773 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -77.95 -19.04 55.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.881 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.09 -50.37 63.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.314 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.1 m -71.87 -19.16 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.232 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 126' ' ' ILE . 58.7 m -55.92 -12.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.769 0.827 . . . . 0.0 112.947 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.29 -8.44 7.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 111.274 -163.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.886 ' HB2' ' HG2' ' A' ' 125' ' ' ARG . 34.3 m-85 -84.5 131.59 49.59 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.68 -18.98 6.88 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.163 2.576 . . . . 0.0 112.943 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -104.87 -8.53 18.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.886 ' HG2' ' HB2' ' A' ' 122' ' ' PHE . 6.8 mmm-85 -123.55 9.85 9.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.008 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 122' ' ' PHE . 26.3 pt -74.22 -28.65 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.024 0.916 . . . . 0.0 108.889 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -85.2 -25.09 27.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.806 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 26.4 t -86.32 -28.84 23.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.367 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.79 -46.34 31.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 p -61.49 -30.15 70.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 38' ' ' ASN . 6.9 tt -50.29 -63.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.417 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 m -67.73 -45.21 75.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.509 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.62 -52.18 64.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.829 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 137' ' ' GLU . 37.4 ttmt -74.15 -19.42 60.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.28 91.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.392 . . . . 0.0 110.282 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.91 -39.6 23.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.185 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 8.4 mm-40 -64.2 -20.35 65.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.211 0.529 . . . . 0.0 110.863 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.24 -34.98 10.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.2 -55.78 19.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.892 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 34.9 m -101.43 6.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 122.704 -0.292 . . . . 0.0 111.316 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 74.43 178.21 0.22 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.224 0.953 . . . . 0.0 110.642 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.735 ' HD3' ' HB3' ' A' ' 137' ' ' GLU . 19.1 pttm -143.76 141.33 30.39 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 65.89 -67.64 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.107 0.963 . . . . 0.0 111.551 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.718 ' HA ' HD23 ' A' ' 89' ' ' LEU . 42.5 tt0 -164.56 -44.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.208 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.36 -136.59 8.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.326 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.58 -5.41 12.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.967 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.554 0.216 . . . . 0.0 110.577 179.454 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -72.83 83.53 1.2 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.379 0.609 . . . . 0.0 111.467 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -146.25 86.71 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 -44.09 3.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.651 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.73 138.24 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -148.01 -79.7 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.917 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 115' ' ' ALA . 67.7 tp -141.43 -43.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.741 0.305 . . . . 0.0 110.284 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.27 -46.76 76.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.22 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -59.02 -33.69 71.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.346 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.4 mt -75.38 -50.27 16.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 15' ' ' ILE . 4.5 m-85 -55.18 -42.44 73.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.858 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -51.42 -45.52 62.6 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.703 0.627 . . . . 0.0 109.911 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -73.43 -42.72 61.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.554 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 83.7 t -58.76 -48.54 85.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 111.421 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.9 pp -73.99 -21.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.626 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 78.0 mmm -73.53 -43.31 60.28 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.194 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.81 -39.13 93.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.112 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -76.33 -19.24 58.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -72.05 -39.43 69.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.197 0.522 . . . . 0.0 109.753 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -72.25 -19.97 61.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.759 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -119.44 81.29 22.91 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.19 20.49 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.842 2.361 . . . . 0.0 112.847 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 2.1 mpt_? -93.47 95.21 9.13 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 1.1 t-20 -118.38 24.38 10.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.0 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.819 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 51.2 mttp -137.59 114.33 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.861 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -157.34 133.22 3.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.49 105.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.862 0.839 . . . . 0.0 111.699 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 50' ' ' LYS . 3.5 tt -115.8 79.22 1.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.726 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HA ' HG22 ' A' ' 33' ' ' VAL . 4.3 t30 -82.53 8.71 11.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.853 -171.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -94.02 3.65 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.872 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -144.56 -104.31 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.364 -0.21 . . . . 0.0 110.579 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 48' ' ' THR . 63.6 mt -83.87 128.32 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.273 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 29' ' ' ASN . 24.8 t -128.49 101.23 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.439 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.014 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.6 t -116.98 120.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -126.05 145.68 50.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.81 0.338 . . . . 0.0 110.163 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.445 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 25.5 mmt -138.37 126.47 22.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.93 135.87 43.81 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.158 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . 53.8 t30 -132.91 97.92 16.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -16.81 -79.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 1 C-N-CA 125.886 4.391 . . . . 0.0 115.669 -162.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.1 p -117.0 17.87 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.933 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.1 15.02 4.69 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.791 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.17 54.95 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.86 -71.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.123 1.369 . . . . 0.0 113.307 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 10.4 ptt180 -159.84 119.24 2.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.516 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.669 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 5.7 tt -104.33 106.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.38 171.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.445 HH21 ' CD ' ' A' ' 62' ' ' GLU . 51.4 mtm180 -96.68 102.72 14.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.973 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.0 104.75 14.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 1.9 p -117.18 121.74 42.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.93 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.524 ' HG2' ' CB ' ' A' ' 59' ' ' ALA . 56.7 mtm -124.17 136.69 54.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.396 -169.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HB2' HD13 ' A' ' 28' ' ' LEU . 7.1 tmtt? -109.49 87.47 2.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.3 pt? -77.82 115.0 17.23 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.25 66.33 0.67 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.156 0.503 . . . . 0.0 110.128 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.38 -103.07 0.29 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.58 4.67 5.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.756 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.1 pp -110.21 -164.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.627 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 140' ' ' VAL . 25.7 t -126.48 104.2 12.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.635 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 40.9 tt0 -81.7 -71.37 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.956 -171.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' MET . 34.3 t0 -109.68 104.14 13.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.502 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 49' ' ' MET . . . -102.44 113.59 27.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.166 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 12.7 mtpp -112.04 131.85 55.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 74' ' ' SER . 2.7 p90 -123.05 102.87 8.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.275 0.56 . . . . 0.0 111.434 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.819 ' HG3' ' HG2' ' A' ' 25' ' ' LYS . 23.9 tt0 -104.84 94.57 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.603 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -111.29 130.11 9.56 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.824 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.19 131.9 56.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.791 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 161.31 -132.25 2.81 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.465 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 70' ' ' MET . 3.5 p -99.65 155.71 17.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -55.63 -36.27 66.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.925 0.765 . . . . 0.0 112.321 -168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -81.83 -35.75 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.644 ' N ' HD12 ' A' ' 68' ' ' ILE . 35.2 p -73.73 -39.58 64.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.018 0.437 . . . . 0.0 110.693 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.1 ptt? -82.07 -8.21 59.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.6 -57.82 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.502 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -64.02 -53.64 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.585 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.76 82.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.317 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 20.1 m -63.16 -34.11 76.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.21 -47.43 64.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.5 69.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.7 m -66.18 -25.36 66.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.144 0.497 . . . . 0.0 110.654 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 74' ' ' SER . 79.1 mt-30 -73.47 -34.54 65.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -69.0 -33.87 74.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.674 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 80' ' ' ILE . 1.3 mm -72.32 -30.45 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.63 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.01 -17.29 37.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.506 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.32 31.17 5.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.623 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 66.5 mttm -133.23 -174.89 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.692 -0.299 . . . . 0.0 110.934 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.756 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.7 -175.91 2.99 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -175.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.437 ' O ' HD23 ' A' ' 89' ' ' LEU . 1.7 mp -86.01 -46.79 16.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.978 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -59.19 -40.22 85.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.1 p -73.4 -33.46 65.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.999 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.97 90.89 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.418 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 142' ' ' LYS . 4.5 mm? -64.76 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.95 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.0 m -85.03 -29.94 24.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' THR . 92.6 mmm -69.07 -26.31 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.593 176.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 p -85.41 -31.35 22.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -58.28 -47.33 83.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 mt -57.83 -42.67 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.715 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -55.83 -48.14 75.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.831 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.6 p -70.16 -35.96 74.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -27.95 62.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.948 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 19.4 ttt -69.8 -51.71 31.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.202 0.525 . . . . 0.0 110.948 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.7 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 26.6 ptt? -82.33 -5.85 58.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.569 -171.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.7 ' HG3' ' HG3' ' A' ' 99' ' ' MET . 83.5 mt-30 -132.57 13.06 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.958 0.409 . . . . 0.0 110.286 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.33 -80.32 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.752 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 98' ' ' MET . 52.5 tttp -152.76 155.13 36.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.926 -167.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.39 113.76 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.338 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -173.43 141.89 0.93 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.108 0.48 . . . . 0.0 110.11 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' HD11 ' A' ' 110' ' ' LEU . 39.0 t0 -135.36 130.04 34.33 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.77 -24.04 67.61 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.07 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.0 m -98.89 -19.54 17.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 108' ' ' ILE . 25.3 mm 60.11 33.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.644 0.735 . . . . 0.0 110.466 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -141.31 82.51 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 105' ' ' ASP . 94.9 mt -121.82 16.62 11.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.26 -24.79 69.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.488 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.08 -28.94 43.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.771 0.32 . . . . 0.0 111.332 -175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.06 -35.57 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.224 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.92 -34.74 75.16 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.199 0.524 . . . . 0.0 109.928 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 7' ' ' LEU . . . -70.37 -20.65 62.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.872 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.28 -34.41 15.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 109.757 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -61.5 -31.12 71.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.013 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.23 -41.68 98.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.751 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.785 HG12 ' HD3' ' A' ' 125' ' ' ARG . 34.5 m -85.91 -20.44 8.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 111.404 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 33.0 t -54.04 -15.14 1.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -130.36 -23.37 2.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.841 0.746 . . . . 0.0 112.78 -162.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 68.5 m-85 -70.96 135.63 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.29 -25.07 45.33 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.737 2.292 . . . . 0.0 111.844 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.46 -3.7 39.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.402 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.785 ' HD3' HG12 ' A' ' 119' ' ' VAL . 99.6 mtt180 -123.16 0.82 9.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.605 -0.684 . . . . 0.0 110.327 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 tt -72.43 -31.59 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.528 0.68 . . . . 0.0 109.78 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -79.96 -19.49 47.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.033 175.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.5 t -85.32 -19.54 31.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 120' ' ' SER . . . -75.27 -46.56 32.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.41 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.6 m -58.39 -37.79 76.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 69' ' ' SER . 6.8 tt -52.95 -70.92 0.08 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.442 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -58.39 3.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.53 0.681 . . . . 0.0 111.087 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 62.6 t90 -66.06 -49.83 66.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.205 -171.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 37.3 tttp -83.51 -21.07 32.89 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.184 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.57 -30.11 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.392 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -86.63 -40.83 14.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 1.132 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 2.9 tm-20 -63.68 -47.6 80.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.883 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -92.87 -11.27 33.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.982 -171.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 1.014 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -59.22 -54.77 35.14 Favored Glycine 0 C--O 1.23 -0.143 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.095 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 56' ' ' VAL . 18.1 m -114.52 21.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 142' ' ' LYS . . . 68.15 155.82 0.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.417 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 1.132 ' HE2' ' HA ' ' A' ' 137' ' ' GLU . 8.9 mtmm -173.33 151.58 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 31.6 tt0 66.73 117.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.744 0.652 . . . . 0.0 110.123 -172.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 0.3 OUTLIER -78.07 -88.3 0.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 144' ' ' GLU . . . 53.48 33.68 47.8 Favored Glycine 0 CA--C 1.521 0.461 0 O-C-N 123.474 0.484 . . . . 0.0 113.685 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.35 46.28 21.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.936 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 N--CA 1.467 0.425 0 C-N-CA 123.422 0.689 . . . . 0.0 111.835 -179.274 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 121.213 0.53 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -150.25 40.11 0.77 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.686 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -64.08 -4.79 3.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.916 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -64.22 -31.04 72.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.766 ' HB1' ' HB2' ' A' ' 8' ' ' ASP . . . -97.68 111.18 23.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -59.14 -76.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.723 0.639 . . . . 0.0 112.292 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.48 -21.49 15.33 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.766 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 5.1 m-20 -49.12 -45.78 44.04 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.839 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.3 m -62.36 -43.69 98.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.174 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mm? -76.46 -56.92 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.116 -171.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.612 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 9.8 p90 -68.73 -37.49 79.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.797 -169.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -68.59 -37.2 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.91 -46.06 72.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.179 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.7 t -62.69 -46.48 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.789 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.4 mm -64.0 -44.4 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.061 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.1 ttt -61.81 -49.03 77.96 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.72 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.946 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -74.59 -16.99 60.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.395 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -76.73 -32.31 57.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 0.0 109.796 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -76.82 -21.46 55.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -117.95 71.23 8.01 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.85 38.5 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.529 2.819 . . . . 0.0 114.929 -161.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.01 92.52 4.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.932 0.396 . . . . 0.0 110.565 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 74' ' ' SER . 2.8 t-20 -125.51 15.37 8.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.701 . . . . 0.0 109.27 175.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -118.85 85.22 2.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.56 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.445 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -119.2 122.97 5.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.09 100.04 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.0 111.708 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.535 ' O ' HG21 ' A' ' 48' ' ' THR . 20.4 tp -108.07 175.52 5.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.488 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.525 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.2 p-10 -156.93 97.65 1.7 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -141.73 -90.85 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.702 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -108.39 -65.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.821 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 65.4 mt -87.83 121.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.7 t -136.04 90.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.47 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.68 112.27 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.532 0.682 . . . . 0.0 111.231 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -109.19 123.87 49.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.566 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.23 118.59 24.55 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.66 132.4 56.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.417 0.627 . . . . 0.0 112.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 19.7 t-20 -106.02 105.88 55.03 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.8 Cg_exo -65.58 40.31 0.13 Allowed 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.809 3.673 . . . . 0.0 115.364 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.6 t -178.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.697 0.284 . . . . 0.0 110.742 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 t -133.91 18.94 3.81 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -168.77 42.16 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -33.2 -54.21 0.39 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 27.1 ttm180 -146.97 136.47 22.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.902 1.228 . . . . 0.0 112.268 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' MET . 8.1 tt -130.66 94.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 10.4 ttm180 -88.0 115.99 25.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.996 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.65 106.33 9.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.1 p -117.72 112.36 20.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.193 0.521 . . . . 0.0 110.978 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.701 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 81.1 mtp -103.97 162.46 13.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.24 -173.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -130.77 104.58 7.25 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.759 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -108.62 94.82 5.26 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.829 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.06 63.52 4.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.525 1.155 . . . . 0.0 109.911 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.74 -100.97 0.25 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.571 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 8.4 m-20 -143.15 30.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.829 -0.685 . . . . 0.0 109.291 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.7 pp -137.1 156.46 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.36 102.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.39 -46.13 16.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -153.59 169.72 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.684 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -158.37 129.81 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.061 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 28' ' ' LEU . 67.9 mmtt -112.59 129.54 56.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 27.7 p90 -128.03 128.79 45.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.075 0.464 . . . . 0.0 111.804 -174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.31 108.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.39 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -116.09 138.31 14.41 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.455 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -132.41 104.2 6.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.13 -130.3 1.29 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.218 -172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 158.45 19.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -52.14 -38.31 57.13 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.611 0.569 . . . . 0.0 111.882 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 69' ' ' SER . 2.3 pp -72.11 -44.0 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 68' ' ' ILE . 7.4 p -70.9 -38.33 73.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.04 -38.22 82.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.089 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -85.49 -45.65 11.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.066 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -55.32 -45.53 76.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.351 . . . . 0.0 110.352 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -56.67 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.527 ' HB3' ' ND2' ' A' ' 24' ' ' ASN . 40.5 p -58.04 -40.76 81.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.781 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.7 ttt -73.37 -41.81 62.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.146 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.53 ' HB3' HD22 ' A' ' 136' ' ' LEU . 94.8 mtp -73.42 -31.93 64.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.749 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -73.44 -20.36 60.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 74' ' ' SER . 85.3 mt-30 -81.03 -41.33 22.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.51 95.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.067 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.43 -20.91 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.851 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -66.01 -21.86 66.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.56 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.72 29.56 10.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.911 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -135.16 -172.63 3.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.337 0.568 . . . . 0.0 110.626 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.767 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.3 p-10 -112.36 -172.0 1.96 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.2 mm -85.93 -35.2 9.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.1 -39.58 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.694 0.283 . . . . 0.0 110.66 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.38 -23.68 61.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.286 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.982 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 86.8 mt -66.39 -34.14 77.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.653 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG12 ' A' ' 94' ' ' ILE . 4.5 p -78.07 -35.36 49.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 19.0 ttt -60.34 -37.89 82.07 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.081 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 28.2 p -84.71 -27.72 26.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 109.867 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.994 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 17.8 tptp -57.77 -53.29 59.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 97' ' ' ASP . 17.5 pt -75.58 -22.85 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 98' ' ' MET . 34.3 t80 -69.72 -26.79 64.51 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.8 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -85.27 -26.61 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.344 0.593 . . . . 0.0 109.966 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 94' ' ' ILE . 2.0 m-20 -83.89 -18.17 38.33 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.601 -177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -52.26 -18.88 1.73 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -73.99 -58.69 3.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.492 0.187 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -104.1 -43.57 5.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.755 0.312 . . . . 0.0 111.203 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.44 -37.17 85.4 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.7 tttt 70.37 28.53 3.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.277 0.631 . . . . 0.0 110.394 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -102.55 152.37 21.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.643 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.608 ' C ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.89 165.69 27.01 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' O ' HD13 ' A' ' 108' ' ' ILE . 28.1 t70 -75.46 79.16 2.5 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.845 0.355 . . . . 0.0 110.055 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 108' ' ' ILE . 17.6 t0 73.81 27.42 1.7 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.406 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.573 ' HA ' ' CD1' ' A' ' 104' ' ' TYR . 8.2 t 65.06 47.24 2.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.216 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -103.29 -46.18 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.26 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.34 96.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.882 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -148.48 -55.31 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.308 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -70.24 -32.15 68.83 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.868 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -45.96 91.73 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.905 0.482 . . . . 0.0 110.292 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.1 -37.73 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mm-40 -61.34 -36.0 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.48 68.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -91.35 -21.07 21.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.856 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -50.96 -35.25 32.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.19 46.1 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.851 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 125' ' ' ARG . 29.6 m -86.27 -18.32 8.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.446 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 65.9 m -52.96 -18.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -169.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -157.37 5.04 0.14 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.931 -165.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.743 ' HD2' ' HD2' ' A' ' 125' ' ' ARG . 17.0 m-85 -85.7 132.61 43.82 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 172.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.89 -16.1 11.1 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.91 2.407 . . . . 0.0 112.335 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.83 -11.59 17.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.342 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.743 ' HD2' ' HD2' ' A' ' 122' ' ' PHE . 94.8 mtt180 -123.74 1.33 8.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.682 -0.636 . . . . 0.0 110.271 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -79.73 -24.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.537 -168.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -76.3 -19.56 58.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.386 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 95.5 m -85.88 -24.52 26.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.796 172.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -71.9 -48.03 48.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.708 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -60.98 -30.06 70.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.831 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 9.9 tt -60.02 -66.79 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 t -71.02 -42.26 69.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.407 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -67.95 -55.33 13.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.661 0.267 . . . . 0.0 110.833 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.57 -25.38 63.96 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.123 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.11 93.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.298 . . . . 0.0 110.771 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 76' ' ' MET . 2.3 tp -76.1 -43.79 41.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.84 -19.79 65.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.957 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -85.07 -14.62 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.461 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.56 -68.3 1.69 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.196 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' HB ' HG23 ' A' ' 85' ' ' ILE . 35.6 m -103.47 5.58 10.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 122.843 -0.21 . . . . 0.0 111.158 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 72.96 162.25 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.223 0.952 . . . . 0.0 110.351 -173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 14.5 pttp -121.1 148.36 44.3 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.314 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.994 ' HG2' ' HA ' ' A' ' 93' ' ' LYS . 41.4 mt-10 65.39 -161.27 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.884 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.65 87.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.39 126.98 8.24 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.545 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.21 169.29 51.4 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.156 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 120.615 0.245 . . . . 0.0 110.756 -177.351 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.928 0.394 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -81.88 82.61 7.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -149.04 -34.53 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.928 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.64 101.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.054 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.04 54.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.928 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 8' ' ' ASP . 12.8 t-20 -158.57 -114.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp 72.67 -18.32 0.35 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.727 0.811 . . . . 0.0 110.523 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.566 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 30.2 t70 -71.46 -43.48 66.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.436 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -69.56 -26.83 64.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.587 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.0 mt -71.75 -30.48 65.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.218 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 8' ' ' ASP . 15.3 m-85 -59.23 -49.63 77.12 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.893 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 1.8 mpt_? -59.1 -33.79 71.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.725 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -71.4 -49.98 36.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HB1' ' A' ' 71' ' ' ALA . 59.5 t -75.25 -39.86 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.806 -173.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 11' ' ' TYR . 12.2 tt -71.7 -27.96 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.294 -0.254 . . . . 0.0 110.648 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.4 ttt -66.87 -39.19 87.46 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.27 -43.23 74.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.775 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.1 -27.62 69.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.758 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -71.61 -39.71 70.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.518 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -63.71 -32.04 73.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.193 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -83.88 166.96 30.94 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.852 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.48 16.92 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.021 2.481 . . . . 0.0 113.445 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 59.33 -159.67 0.29 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.865 0.466 . . . . 0.0 111.062 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -103.27 80.09 1.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.88 0.372 . . . . 0.0 111.391 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -145.67 94.22 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.799 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.23 133.73 2.98 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.778 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.58 104.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 0.0 110.428 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 48' ' ' THR . 1.1 tt -111.02 88.88 2.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.03 98.94 8.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 21.2 t70 -143.71 -73.45 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.943 0.401 . . . . 0.0 111.145 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -124.67 -62.37 1.25 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.667 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 37.0 mt -92.35 118.74 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.054 0.454 . . . . 0.0 110.846 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.4 t -136.85 97.01 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.541 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 135' ' ' ALA . 24.1 t -104.19 130.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.104 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -132.92 118.6 19.1 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -128.74 116.02 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.047 0.451 . . . . 0.0 109.823 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -114.06 140.58 48.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.055 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 34.5 t30 -139.97 105.61 6.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.4 Cg_endo -42.15 113.35 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.984 3.123 . . . . 0.0 113.867 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.8 m 78.93 -22.68 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.663 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 t -121.87 -18.33 7.07 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.296 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -143.68 48.78 0.73 Allowed Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -29.71 -67.26 0.08 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 125.567 1.392 . . . . 0.0 113.392 -164.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 41.4 ptt85 -167.76 138.69 2.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.23 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.3 115.22 25.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.237 0.541 . . . . 0.0 109.932 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 29.6 ttp180 -106.21 105.99 16.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.845 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.503 HD21 ' CE ' ' A' ' 49' ' ' MET . 10.0 tt -106.85 107.75 18.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 14.5 p -113.27 133.21 55.22 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.718 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.721 ' HE1' HG21 ' A' ' 80' ' ' ILE . 68.2 mtt -126.67 158.06 37.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.488 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 28.4 tttm -130.23 95.74 3.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 176.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -88.18 97.43 11.0 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.39 63.26 1.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.0 -104.3 0.31 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.55 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.31 30.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.802 0.334 . . . . 0.0 110.21 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -137.63 157.71 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.82 88.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 11.7 tp10 -75.87 -56.95 4.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.244 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -131.81 153.13 50.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.757 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -156.01 131.08 9.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.606 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.5 mttp -140.6 136.13 32.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.2 p90 -132.18 106.52 8.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.822 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 30.7 tt0 -95.82 114.33 26.05 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -151.03 150.91 22.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.173 -1.489 . . . . 0.0 114.563 -173.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.61 142.72 39.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.05 2.46 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.869 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.8 m -94.06 159.1 15.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -56.82 -39.45 74.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.838 0.711 . . . . 0.0 111.027 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -72.99 -32.63 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.689 ' HB3' HD11 ' A' ' 131' ' ' LEU . 1.5 m -68.25 -54.82 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.752 0.786 . . . . 0.0 110.289 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.4 -5.11 51.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.594 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -86.9 -50.48 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 p -72.9 -47.45 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.275 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.13 81.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.294 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 p -68.25 -30.89 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -47.05 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.498 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 96.3 mmm -61.95 -35.88 79.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 m -71.83 -24.1 61.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.042 0.449 . . . . 0.0 111.057 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -46.68 57.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.88 65.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.721 HG21 ' HE1' ' A' ' 49' ' ' MET . 0.5 OUTLIER -74.88 -27.66 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.298 0.571 . . . . 0.0 110.329 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.23 36.32 3.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.659 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.71 174.01 11.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -120.39 -162.53 0.95 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.87 -37.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.81 -46.24 88.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.526 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 p -81.28 -19.18 43.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.753 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.6 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 -46.38 87.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 m -67.57 -28.58 67.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.146 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 44.9 ttp -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.149 0.499 . . . . 0.0 110.106 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.658 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 48.0 t -85.65 -28.03 25.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.267 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.844 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 3.5 tmtp? -60.25 -49.62 76.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 tt -76.24 -25.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.443 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 76.4 t80 -57.99 -44.24 87.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.075 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -82.1 -34.97 29.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 110.638 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -30.95 67.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.073 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.461 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -58.33 -37.24 74.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 tpt -79.81 -25.88 40.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.687 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -84.21 -38.67 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.868 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.73 -55.22 6.07 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.423 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 102' ' ' LYS . 34.7 ttpt -177.89 -82.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.918 0.389 . . . . 0.0 111.172 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -176.36 97.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.246 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 98' ' ' MET . 9.5 p90 -164.67 122.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.179 0.514 . . . . 0.0 111.577 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 107' ' ' SER . 25.4 t70 -125.44 82.28 2.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.871 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.73 -82.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.19 0.931 . . . . 0.0 112.418 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' ASP . 10.9 p -83.22 -2.28 55.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.735 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 108' ' ' ILE . 24.6 mm 70.8 33.62 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.973 0.892 . . . . 0.0 110.076 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.13 4.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.585 172.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.28 0.22 57.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.042 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.71 -42.84 97.02 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.299 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.17 -44.25 80.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.191 0.52 . . . . 0.0 110.216 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.7 mm -64.86 -32.5 58.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.41 -36.89 81.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.17 0.51 . . . . 0.0 110.314 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.78 -12.66 61.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.728 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.07 -6.33 17.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.807 0.813 . . . . 0.0 109.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.967 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.47 98.83 Favored Glycine 0 C--N 1.329 0.179 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.15 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 129' ' ' ALA . 27.6 m -69.59 -19.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 29.3 t -59.03 -13.7 7.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 -18.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.378 -165.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -61.95 126.89 88.32 Favored Pre-proline 0 CA--C 1.518 -0.279 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -18.89 9.37 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.829 2.352 . . . . 0.0 112.919 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -101.13 -10.46 20.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 5.9 mpt_? -128.27 -1.75 5.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.359 -0.838 . . . . 0.0 110.052 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' SER . 8.0 tt -60.92 -36.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.344 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.559 ' HA ' ' HB ' ' A' ' 130' ' ' THR . 82.2 mttt -85.9 -21.01 28.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.526 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . 82.7 m -71.57 -32.45 68.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.714 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -80.04 -39.7 29.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.525 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 127' ' ' LYS . 51.9 m -59.32 -43.97 92.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.855 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 69' ' ' SER . 4.4 pp -63.82 -36.02 82.54 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.492 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.436 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.4 m -72.65 -52.64 14.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.907 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 -49.75 64.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.454 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.18 -26.9 65.98 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.373 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.886 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -69.23 -32.66 72.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 0.0 110.596 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 tp -85.48 -39.22 17.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -64.95 -44.42 89.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.413 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -69.45 -13.21 62.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.815 -172.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.61 -65.17 1.74 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.441 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 m -144.77 17.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -122.17 122.2 38.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.949 -0.469 . . . . 0.0 111.944 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -159.93 30.01 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.944 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.844 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 27.6 tt0 64.55 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.588 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.796 ' HG2' ' HG2' ' A' ' 143' ' ' GLU . 9.5 pt-20 177.93 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.83 -165.8 26.52 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 119.57 -21.68 9.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.95 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 t -106.96 146.04 31.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.2 t80 72.89 -66.48 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.919 0.762 . . . . 0.0 110.623 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 62.66 21.89 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.731 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.05 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.584 0.707 . . . . 0.0 111.608 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -79.34 -57.8 3.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.32 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -101.25 -40.0 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.883 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.22 -52.15 54.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.12 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -76.01 -26.56 56.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.607 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.7 mt -74.2 -54.2 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.603 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -67.62 -29.54 68.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.95 -34.27 77.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -76.11 -37.89 57.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.114 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 76.6 t -60.45 -48.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 13.4 tt -70.26 -28.51 35.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.027 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 51.3 ttp -79.13 -32.12 44.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.351 . . . . 0.0 110.771 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.652 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 t70 -67.92 -32.81 73.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 110.025 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -85.34 -19.42 31.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.32 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 27.1 t80 -70.28 -23.32 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.703 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 90.8 mttt -59.74 -31.98 70.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.266 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -129.08 80.47 72.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.699 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.71 100.79 1.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.83 2.353 . . . . 0.0 111.759 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -132.27 22.13 4.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.153 0.501 . . . . 0.0 110.035 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.61 76.65 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -164.52 106.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.506 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -175.74 140.36 5.12 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.207 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.52 95.27 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.738 0.78 . . . . 0.0 109.662 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.05 132.94 46.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.534 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -117.16 100.46 7.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -164.34 -57.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.319 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 39.6 t -115.63 -77.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.56 -177.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.537 HD11 HD23 ' A' ' 51' ' ' LEU . 62.9 mt -111.08 129.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.781 0.324 . . . . 0.0 110.481 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 48' ' ' THR . 40.7 t -131.08 98.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.912 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG21 ' HA2' ' A' ' 139' ' ' GLY . 58.7 t -121.96 122.89 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.888 0.375 . . . . 0.0 110.852 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -122.72 148.29 45.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -113.49 117.63 32.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.174 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -117.43 86.62 22.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -34.27 122.74 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 124.603 3.536 . . . . 0.0 114.981 -167.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 m 77.32 -7.57 1.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.398 171.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.7 t -130.86 -46.67 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.823 -0.548 . . . . 0.0 111.855 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.57 58.81 0.66 Allowed Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -52.87 -61.01 2.57 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.11 -1.045 . . . . 0.0 113.661 -163.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.635 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 46.1 mtm-85 -142.6 97.44 3.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.874 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.773 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 9.4 tt -95.48 92.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.238 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 78.4 mtt180 -93.87 97.72 10.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.269 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.536 HD11 HG21 ' A' ' 77' ' ' THR . 66.2 tp -99.91 100.83 11.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.317 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 33' ' ' VAL . 22.3 p -115.52 117.23 29.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.369 -174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.561 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.2 mpp? -114.2 162.07 17.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.036 -171.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 7.5 tmtm? -129.88 100.85 5.62 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 32' ' ' ILE . 3.9 pp -100.36 121.12 40.99 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.16 66.33 0.69 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.713 0.768 . . . . 0.0 109.476 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.91 -109.49 0.52 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.53 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -134.9 32.34 3.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.0 pp -131.83 129.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.896 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 22.9 t -81.09 84.57 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -80.03 -64.18 1.24 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.787 -172.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 38.7 t70 -94.18 147.18 23.42 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.219 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.73 122.24 9.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.968 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 22.3 mmtp -122.7 110.44 15.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.4 p90 -122.05 93.32 3.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.338 0.589 . . . . 0.0 111.859 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.741 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 39.3 tt0 -98.72 98.86 9.93 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.773 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -115.97 103.82 1.22 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.769 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.09 95.86 10.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.13 -131.34 1.32 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.131 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.24 177.62 4.82 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.265 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -46.9 -54.82 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 128' ' ' CYS . 0.1 OUTLIER -70.77 -24.52 25.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.143 -172.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.6 m -67.89 -47.66 68.2 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.1 mtt -73.55 -21.83 60.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.763 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 68' ' ' ILE . . . -86.66 -60.58 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.385 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.8 m -74.79 -37.96 62.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.799 -169.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.76 67.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.53 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -66.86 -24.21 66.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 52.7 tpp -73.06 -53.14 11.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.11 -33.72 76.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.789 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 39.7 m -72.19 -19.52 61.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -69.07 -43.26 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.45 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.615 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.789 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.4 mm -67.59 -38.15 80.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.154 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 64.5 tttp -60.86 -18.33 55.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.514 0.673 . . . . 0.0 110.352 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.3 26.38 7.8 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.953 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.427 ' HE3' HG21 ' A' ' 87' ' ' THR . 15.0 tptt -128.92 -176.37 3.84 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.68 -177.97 3.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.68 -49.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.158 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.31 -32.67 70.27 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.481 0.658 . . . . 0.0 110.057 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.427 HG21 ' HE3' ' A' ' 83' ' ' LYS . 4.7 m -76.79 -24.47 52.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.981 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 91' ' ' MET . . . -74.53 -41.18 61.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.37 -42.23 99.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.594 0.712 . . . . 0.0 109.675 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -68.76 -24.95 64.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.145 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.466 ' HA ' HG22 ' A' ' 94' ' ' ILE . 52.4 ttm -66.44 -28.52 68.67 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.119 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' A' ' 141' ' ' ALA . 13.4 m -82.3 -39.82 22.37 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 8.5 tmtm? -55.41 -42.46 74.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 11.9 tt -82.92 -25.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 91' ' ' MET . 54.9 t80 -58.04 -46.65 84.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.482 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 p -78.89 -37.54 39.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.33 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 12.9 t70 -57.63 -52.32 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.904 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -61.31 -33.88 74.32 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.997 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -19.78 61.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.068 0.461 . . . . 0.0 110.829 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -101.75 8.75 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.54 -53.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.225 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 59.04 89.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 111.915 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 104' ' ' TYR . 32.7 tt0 -162.87 -28.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.153 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.405 ' H ' ' H ' ' A' ' 103' ' ' GLU . 36.9 p90 -154.31 150.73 28.29 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.459 0.647 . . . . 0.0 110.259 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 108' ' ' ILE . 10.5 t70 -133.66 144.33 49.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 168.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -52.36 -38.76 59.61 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.972 0.795 . . . . 0.0 111.514 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -111.64 -2.4 15.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.781 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . 4.0 mp 51.57 48.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.719 0.771 . . . . 0.0 110.131 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -111.93 85.09 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 HD12 ' A' ' 113' ' ' ILE . 36.7 mt -113.19 13.02 19.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.617 -171.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.67 -62.59 3.55 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.059 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.74 -34.49 78.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.874 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.624 HD12 HD23 ' A' ' 110' ' ' LEU . 59.5 mt -58.17 -41.03 79.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.389 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.56 -41.35 85.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -71.72 -47.6 52.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.022 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -57.29 -42.47 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.014 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -57.21 -44.99 84.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.881 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.47 -44.61 96.45 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 125' ' ' ARG . 41.3 t -61.97 -34.73 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 67.0 m -61.05 -14.18 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -172.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -125.32 -27.45 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.114 -161.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -65.64 126.78 92.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.36 -16.59 13.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.545 2.163 . . . . 0.0 112.29 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.05 -17.9 23.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.347 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.9 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -126.87 5.22 6.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -176.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 127' ' ' LYS . 9.7 tt -72.64 -30.06 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.953 0.882 . . . . 0.0 109.31 -170.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.499 ' HG3' HG23 ' A' ' 126' ' ' ILE . 66.2 mttm -85.43 -18.63 33.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.941 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' A' ' 68' ' ' ILE . 66.8 m -81.44 -33.22 32.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.343 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 120' ' ' SER . . . -77.7 -48.51 16.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.848 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.481 ' HA ' ' HB3' ' A' ' 133' ' ' TRP . 18.8 p -61.71 -28.7 69.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.6 tt -54.9 -53.59 53.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.455 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.6 m -75.56 -37.0 60.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.256 0.551 . . . . 0.0 110.754 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 22.5 t90 -62.11 -52.29 64.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 79.0 mttt -72.17 -19.8 61.69 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.346 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.53 80.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.682 HD12 HG13 ' A' ' 80' ' ' ILE . 3.0 mm? -88.87 -50.33 6.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.76 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 4.4 tp10 -63.1 -28.38 70.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.309 -172.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 63.5 tttm -106.56 -18.75 13.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.808 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -75.8 -64.77 2.17 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.724 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.06 -17.48 6.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.0 110.857 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' A' ' 92' ' ' SER . . . -97.68 -172.41 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 10.1 tmtt? 176.76 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.305 0.378 . . . . 0.0 111.212 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 1.2 tt0 157.09 -166.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -163.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -100.16 -37.71 8.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.22 0.464 . . . . 0.0 112.235 -177.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -158.5 -26.78 0.03 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.402 -1.38 . . . . 0.0 114.035 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.21 53.19 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.513 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.791 0.295 . . . . 0.0 110.386 178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.861 0.362 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -70.66 105.09 3.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.801 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -164.19 -79.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.496 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -175.06 137.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.55 99.11 11.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.394 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -80.14 9.59 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.514 0.673 . . . . 0.0 109.943 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.446 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 57.9 tp -82.17 -32.4 29.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.971 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 -47.53 75.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -72.32 -36.03 68.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.3 tt -69.77 -53.35 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 7' ' ' LEU . 2.1 p90 -71.5 -32.54 68.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.955 -0.111 . . . . 0.0 111.153 -171.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -67.82 -30.43 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.294 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -78.5 -38.31 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.449 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' LEU . 60.0 t -62.58 -47.49 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.702 0.287 . . . . 0.0 110.791 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.3 mm -63.37 -36.2 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.63 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.02 -52.57 62.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 14.2 t70 -69.55 -26.94 64.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' OD1' ' A' ' 21' ' ' ASN . 26.0 t-80 -73.1 -19.33 61.17 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -82.44 -22.68 35.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.742 0.782 . . . . 0.0 109.206 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 30.8 ttpt -72.53 -19.33 61.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.32 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.653 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 1.5 p-10 -132.74 175.17 3.91 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.621 -175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 21' ' ' ASN . 68.1 Cg_exo -41.58 136.6 2.89 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.265 2.643 . . . . 0.0 114.348 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -108.9 -174.09 2.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.784 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.67 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 4.5 m-20 -82.03 90.45 6.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.852 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 17.0 ptpt -163.13 19.91 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.131 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -97.78 123.23 7.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.201 -173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.23 97.11 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.956 ' HB2' ' HD3' ' A' ' 60' ' ' LYS . 53.9 tp -92.78 90.86 7.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.108 0.48 . . . . 0.0 109.93 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -78.33 51.16 0.99 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.954 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.61 -87.1 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.864 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 t -92.68 -80.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.429 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.776 HD11 HD23 ' A' ' 51' ' ' LEU . 64.6 mt -88.81 130.41 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.011 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.07 92.47 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 110.171 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.8 t -109.54 119.27 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -124.86 144.12 50.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.708 0.29 . . . . 0.0 110.835 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.539 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 14.5 tpt -151.34 155.1 38.0 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.11 139.19 30.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.1 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -134.14 97.73 14.76 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -25.15 -64.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 125.24 3.96 . . . . 0.0 115.506 -167.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -109.67 6.17 23.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 128' ' ' CYS . 46.7 t -131.96 4.01 4.11 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.886 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 131' ' ' LEU . . . 167.72 57.88 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -38.4 -40.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.792 1.237 . . . . 0.0 113.611 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -149.02 140.33 23.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 6.1 tt -146.45 96.98 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.736 0.779 . . . . 0.0 109.421 166.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -104.42 105.96 16.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.93 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.475 HD11 ' HE3' ' A' ' 49' ' ' MET . 62.8 tp -102.23 104.47 15.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.808 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.8 p -117.73 108.81 15.84 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.965 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 65.1 mtt -110.5 163.1 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.919 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.732 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.0 ttpp -130.12 91.12 3.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 32' ' ' ILE . 1.7 pp -95.99 112.88 24.49 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.11 68.61 0.71 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.594 0.711 . . . . 0.0 109.948 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.51 -105.61 0.35 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.177 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.86 15.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.579 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' HG3' ' A' ' 57' ' ' GLU . 1.3 pp -125.84 -166.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.999 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 80' ' ' ILE . 36.5 t -126.73 106.85 16.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.477 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HG3' HD13 ' A' ' 55' ' ' ILE . 72.8 mt-10 -85.95 -53.88 4.83 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.22 0.534 . . . . 0.0 109.685 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 9.1 t0 -130.11 163.35 26.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.797 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -165.61 132.28 2.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.5 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.956 ' HD3' ' HB2' ' A' ' 28' ' ' LEU . 2.0 mptp? -128.31 144.15 51.1 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -127.86 110.04 12.19 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.058 -175.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -103.57 97.82 7.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 171.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.67 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -138.54 121.15 2.1 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.162 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.08 155.24 28.51 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 153.96 -131.95 3.4 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.362 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.0 p -104.26 162.5 13.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -44.22 -48.95 9.39 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.279 0.987 . . . . 0.0 112.537 -171.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -75.38 -24.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 68' ' ' ILE . 4.9 m -75.11 -40.02 60.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.703 0.763 . . . . 0.0 109.307 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.9 ttp -70.77 -25.95 63.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.767 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.51 -56.23 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.175 -174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.7 p -66.41 -44.91 81.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.52 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.56 -55.25 35.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.982 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -65.14 -37.48 87.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.9 tpt -70.02 -43.93 70.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 109.975 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.8 mmm -67.7 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.7 m -69.58 -20.23 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.766 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -75.56 -39.17 58.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.02 -31.54 72.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.147 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.472 HG22 HG11 ' A' ' 56' ' ' VAL . 18.3 mm -75.67 -33.54 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.667 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -55.55 -20.29 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.47 41.66 1.64 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.992 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HE3' HG21 ' A' ' 87' ' ' THR . 2.6 tptp -133.66 -156.91 0.77 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.268 0.556 . . . . 0.0 111.515 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -140.66 147.81 39.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -170.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.46 -34.47 61.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.226 0.536 . . . . 0.0 109.714 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -57.86 -46.7 84.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.009 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.561 HG21 ' HE3' ' A' ' 83' ' ' LYS . 2.1 m -76.63 -20.81 56.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.134 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.71 ' O ' ' HG2' ' A' ' 91' ' ' MET . . . -69.9 -49.94 47.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.329 0.585 . . . . 0.0 110.96 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 142' ' ' LYS . 10.1 mp -65.38 -28.63 69.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.181 0.515 . . . . 0.0 109.623 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -77.67 -20.48 53.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.239 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.717 ' HA ' HG22 ' A' ' 94' ' ' ILE . 9.2 ptt? -77.63 -22.24 51.04 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.591 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 8.2 t -86.11 -29.58 23.22 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.96 -50.8 69.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.185 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 91' ' ' MET . 10.4 tt -69.82 -28.43 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.103 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 91' ' ' MET . 81.2 t80 -54.63 -45.11 73.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.872 0.368 . . . . 0.0 110.528 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.8 p -85.26 -34.1 22.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 21.1 t70 -63.9 -44.53 92.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.615 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -64.46 -19.66 65.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 110.993 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.8 mtp -80.27 -5.46 56.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.07 -42.13 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.752 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -83.2 -20.45 60.66 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.878 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 25.6 mmtm 73.11 -37.32 0.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.187 0.595 . . . . 0.0 111.67 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -91.38 156.71 17.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.19 -154.32 0.58 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -118.22 93.83 4.27 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.798 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.0 t70 86.04 -4.7 0.79 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.142 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m 64.19 26.5 13.84 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.798 HG23 ' HB3' ' A' ' 106' ' ' ASP . 7.8 pt -41.06 -57.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.932 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.588 ' H ' HG13 ' A' ' 108' ' ' ILE . 11.6 t70 -141.12 139.71 34.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.9 mt -147.74 -55.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 0.0 111.304 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.41 ' HA2' ' OE1' ' A' ' 114' ' ' GLU . . . -59.73 -34.61 82.96 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.736 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.87 -32.53 65.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.178 0.513 . . . . 0.0 110.364 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 58.8 mt -69.32 -27.6 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' OE1' ' HA2' ' A' ' 111' ' ' GLY . 44.3 mt-10 -63.88 -21.44 66.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.33 59.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.08 -32.0 64.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.35 0.595 . . . . 0.0 110.112 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -53.76 -35.16 60.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.904 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.23 53.79 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.631 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 68' ' ' ILE . 28.9 m -85.74 -17.95 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.552 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.1 t -46.44 -17.34 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -164.04 26.63 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.177 0.899 . . . . 0.0 110.271 -164.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.16 140.65 22.92 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.28 -41.75 4.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.45 2.767 . . . . 0.0 113.501 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.4 9.52 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 98.5 mtt180 -125.13 4.16 7.9 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.053 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.8 tt -83.55 -29.87 7.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.485 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.816 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 33.5 t -85.99 -19.63 30.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.453 175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -79.44 -45.01 20.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.868 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 p -66.02 -30.65 71.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.303 0.573 . . . . 0.0 109.801 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.574 HD11 ' HA3' ' A' ' 42' ' ' GLY . 8.0 tt -56.64 -67.34 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.764 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 m -70.88 -56.01 7.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.588 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -72.94 -51.59 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.966 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 130' ' ' THR . 48.3 tttm -75.69 -22.76 56.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.664 -168.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.31 -27.0 35.21 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.485 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -79.29 -48.31 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 109.945 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 142' ' ' LYS . 34.7 tt0 -65.96 -27.69 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -88.02 -15.01 37.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.093 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -57.83 -43.47 94.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.786 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.12 11.57 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.64 172.46 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.844 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.64 -172.37 4.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.201 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER -66.35 -164.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.048 0.452 . . . . 0.0 111.373 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.3 77.74 1.12 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.614 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.4 135.5 5.83 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.544 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.56 99.05 0.15 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 C--O 1.239 0.539 0 CA-C-O 120.734 0.302 . . . . 0.0 110.867 -178.076 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtm . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -135.49 -84.74 0.39 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.936 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 60.46 23.07 12.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.172 0.511 . . . . 0.0 110.825 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -139.0 175.97 9.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.383 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.36 20.75 12.28 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.063 0.545 . . . . 0.0 111.427 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.3 t30 63.05 8.58 3.31 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.37 0.605 . . . . 0.0 111.279 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.71 -48.03 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.048 -0.408 . . . . 0.0 111.065 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.789 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.4 t70 -59.13 -47.37 85.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.493 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -73.26 -23.69 60.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 60.6 tp -70.52 -53.68 15.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.789 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 8.8 p90 -75.03 -19.72 59.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.355 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 38.9 ttp180 -66.98 -35.84 80.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -73.26 -38.31 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.716 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 10' ' ' LEU . 93.9 t -60.64 -50.13 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.548 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 11' ' ' TYR . 32.6 mm -57.95 -52.35 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.825 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.4 ttm -60.23 -54.69 42.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.896 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.4 -37.66 74.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.113 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -77.46 -18.77 56.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.609 0.242 . . . . 0.0 110.802 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.09 -31.88 70.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -73.35 -22.82 60.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.496 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 13.1 m120 -86.85 170.19 12.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.321 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 42.1 Cg_exo -57.99 126.36 21.41 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.86 1.706 . . . . 0.0 110.792 169.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -57.71 -74.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.442 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -177.53 114.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.84 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -148.98 111.42 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.887 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . 153.48 142.27 3.43 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.737 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.09 104.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 48' ' ' THR . 3.4 tt -103.12 87.66 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.122 0.487 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.86 100.38 5.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.21 -71.31 0.18 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.468 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.0 -70.7 0.78 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.679 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' A' ' 49' ' ' MET . 35.9 mt -87.31 116.86 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.001 0.429 . . . . 0.0 109.894 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.625 ' HA ' HG22 ' A' ' 48' ' ' THR . 45.7 t -131.86 91.16 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.627 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 135' ' ' ALA . 41.6 t -114.19 105.71 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 0.0 110.654 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -105.52 123.16 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.633 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 2.0 tpt -124.98 159.06 32.13 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.605 ' H ' ' HE2' ' A' ' 36' ' ' MET . 9.7 p30 -155.72 139.31 15.97 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.96 -172.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.855 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 42.3 t-20 -136.72 94.39 13.2 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 48.78 0.22 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.758 3.639 . . . . 0.0 114.975 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.6 m -159.72 -45.94 0.05 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.407 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 127' ' ' LYS . 10.4 t -133.54 7.35 3.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.245 0.545 . . . . 0.0 111.078 -171.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.28 0.45 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 31.2 t70 -38.9 -67.01 0.23 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' OD2' ' A' ' 43' ' ' ASP . 67.2 mtt180 -135.88 140.25 43.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.668 -0.645 . . . . 0.0 112.024 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.633 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 7.9 tt -139.92 108.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 164.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.711 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 25.6 mmm-85 -93.03 107.67 19.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.5 tp -122.64 106.21 10.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.331 0.586 . . . . 0.0 109.782 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 33' ' ' VAL . 1.6 p -125.56 115.6 20.44 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.454 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.483 ' HB2' HD12 ' A' ' 32' ' ' ILE . 72.9 mtm -114.33 147.3 39.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.395 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 4.9 tmtt? -106.57 86.16 2.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.33 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.12 83.1 5.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.487 0.66 . . . . 0.0 109.408 171.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -86.9 63.15 7.8 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.07 -100.02 0.22 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.362 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.439 ' C ' HD13 ' A' ' 85' ' ' ILE . 4.5 p-10 -150.43 33.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.403 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -136.98 148.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 80' ' ' ILE . 45.7 t -85.46 89.23 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 171.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -80.93 -65.03 1.06 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.338 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t0 -119.1 163.87 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.6 130.92 8.64 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.393 . . . . 0.0 110.394 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 12.4 mptt -114.19 131.88 56.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 16.3 p90 -140.53 135.93 32.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.218 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -148.73 119.95 7.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.72 134.23 9.52 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -124.38 120.41 32.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.15 -129.86 2.17 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.772 -170.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.61 166.77 13.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.961 0.41 . . . . 0.0 110.689 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -59.76 -41.17 90.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.592 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -75.15 -35.18 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 68' ' ' ILE . 9.7 p -71.97 -38.73 69.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -77.42 -17.91 57.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.737 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.89 -55.3 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -60.31 -49.7 76.56 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.905 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.32 -43.16 43.29 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -71.62 -30.35 65.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.572 0.225 . . . . 0.0 111.56 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.6 mmm -77.41 -41.54 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.536 ' CE ' HD22 ' A' ' 136' ' ' LEU . 69.3 mtp -58.12 -37.0 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.61 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 61' ' ' PHE . 97.1 m -64.95 -33.26 75.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.192 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -76.99 -40.78 45.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.4 87.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.921 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -76.86 -28.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.152 -177.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.75 -19.48 65.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.125 0.488 . . . . 0.0 110.835 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.15 31.18 9.03 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.975 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.05 166.88 22.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -116.3 -162.37 0.84 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' HD13 ' A' ' 89' ' ' LEU . 1.6 mp -85.62 -46.23 17.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -61.8 -37.76 85.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.086 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -83.01 -23.78 33.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.78 -43.67 24.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 110.741 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 144' ' ' GLU . 9.8 mp -64.56 -39.17 93.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.448 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 94' ' ' ILE . 10.7 p -72.44 -35.62 68.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.171 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.6 tpp -61.25 -32.15 71.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 29.6 t -84.66 -31.08 24.36 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.21 -47.29 83.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 105' ' ' ASP . 37.7 pt -74.92 -23.95 17.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.47 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 90.5 t80 -64.04 -42.08 97.19 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 109.819 172.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -80.14 -30.63 39.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.792 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.61 -44.55 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.308 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 24.9 ptt? -53.72 -18.54 3.2 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.0 ttt -60.56 -36.27 78.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.946 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -140.78 -40.41 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.6 0.238 . . . . 0.0 111.481 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 -29.05 73.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.485 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.7 tttp 79.48 10.15 1.5 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 109.907 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.35 99.74 10.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.763 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -95.54 -148.24 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.525 ' HA ' HD12 ' A' ' 94' ' ' ILE . 13.7 t0 -101.75 109.43 21.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.45 -10.96 19.77 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.85 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.2 m -83.63 -16.58 44.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 108' ' ' ILE . 19.5 mm 66.05 32.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.48 0.657 . . . . 0.0 110.201 173.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -81.37 66.25 6.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.8 mt -121.99 2.97 9.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.17 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.65 45.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.268 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 0.0 110.247 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.419 HG21 ' HE1' ' A' ' 95' ' ' PHE . 55.7 mt -80.58 -19.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.705 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.19 -30.41 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.061 0.457 . . . . 0.0 110.251 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.4 -21.68 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.649 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.22 -38.63 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.724 0.774 . . . . 0.0 109.639 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -29.57 67.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.798 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.38 -52.95 19.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 125' ' ' ARG . 13.8 p -73.28 -19.52 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 91.8 p -55.83 -15.36 3.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -116.89 34.88 4.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 0.0 110.59 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.558 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 71.8 m-85 -131.63 177.3 2.31 Favored Pre-proline 0 C--O 1.219 -0.519 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.437 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 122' ' ' PHE . 57.3 Cg_endo -73.9 -2.83 12.81 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.448 1.432 . . . . 0.0 110.363 165.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.52 -18.83 17.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.516 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.623 ' HB3' ' HA ' ' A' ' 120' ' ' SER . 1.9 ppt_? -55.79 -59.56 4.69 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 119.441 -0.314 . . . . 0.0 111.433 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.556 ' H ' ' HD2' ' A' ' 125' ' ' ARG . 9.0 tt -47.68 -32.42 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.151 0.5 . . . . 0.0 110.573 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 50.3 mttp -81.93 -58.48 2.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.649 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.4 m -86.72 -21.43 26.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.065 0.46 . . . . 0.0 111.273 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.06 -32.63 21.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.619 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 5.0 t -62.94 -35.65 80.82 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.502 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 69' ' ' SER . 9.4 tt -61.13 -67.73 0.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.984 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.9 m -65.76 -54.68 23.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.291 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.449 ' NE1' ' HG3' ' A' ' 137' ' ' GLU . 84.1 t90 -71.91 -48.73 43.42 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -171.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 130' ' ' THR . 23.0 tptm -68.97 -25.4 64.51 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.148 -172.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -78.41 -36.36 45.84 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.948 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.536 HD22 ' CE ' ' A' ' 76' ' ' MET . 2.9 tp -80.51 -47.18 14.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 0.0 110.015 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.449 ' HG3' ' NE1' ' A' ' 133' ' ' TRP . 22.2 mm-40 -75.49 -19.74 59.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.443 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.87 -18.89 28.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.741 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -65.38 -54.29 27.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.291 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' O ' HD11 ' A' ' 89' ' ' LEU . 26.1 m -93.04 -1.19 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.58 94.28 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.283 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -50.58 144.79 7.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.83 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.532 ' H ' ' HB3' ' A' ' 92' ' ' SER . 30.9 tt0 70.11 -75.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.319 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HA ' HD23 ' A' ' 89' ' ' LEU . 34.4 tt0 -177.97 95.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.71 -174.92 54.19 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.46 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.14 35.71 0.33 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.668 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 -179.778 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.254 0.55 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -131.98 -38.73 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -88.23 36.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 11.4 m120 -87.66 -14.49 39.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.323 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.53 128.8 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.696 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -134.94 135.87 41.83 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.9 HD11 ' HA3' ' A' ' 118' ' ' GLY . 93.8 mt -52.11 -38.95 59.05 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.119 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.7 t70 -54.21 -45.23 72.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.62 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -74.35 -40.76 61.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.636 0.731 . . . . 0.0 109.937 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 94.9 mt -68.95 -56.51 7.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.385 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.546 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 1.2 p90 -67.53 -27.11 66.7 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 -60.86 -41.61 96.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.665 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -77.59 -41.51 38.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.267 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 81.7 t -61.6 -46.62 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.173 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 tp -71.38 -30.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.616 0.246 . . . . 0.0 110.613 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.3 tpt -70.16 -47.14 62.91 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.44 -38.4 89.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.198 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -68.8 -27.69 66.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.956 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -74.71 -20.57 59.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 0.0 110.02 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -79.54 -21.44 45.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.093 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 41.0 m-80 -107.23 177.76 1.24 Allowed Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 23.8 Cg_exo -66.02 175.29 4.84 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 23' ' ' ARG . 35.6 mtp-105 -79.96 -142.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.328 0.585 . . . . 0.0 110.289 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 41.4 m-80 -120.03 83.62 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.509 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -144.2 109.49 5.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.523 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -168.53 125.71 1.31 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.801 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.97 103.19 8.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.464 0.65 . . . . 0.0 110.493 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.76 ' O ' ' HB ' ' A' ' 48' ' ' THR . 4.2 tt -125.35 83.73 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.78 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.64 99.34 6.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.487 0.66 . . . . 0.0 110.04 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 35.9 t70 -127.62 -75.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.43 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -101.32 -56.88 2.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 49' ' ' MET . 46.3 pt -122.79 139.2 50.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.228 0.537 . . . . 0.0 110.743 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 48' ' ' THR . 2.3 p -136.27 108.46 7.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.675 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.456 HG21 ' HA2' ' A' ' 139' ' ' GLY . 24.4 t -109.5 142.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.901 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -135.04 135.84 41.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.356 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 14.5 tpt -152.56 147.82 26.64 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.39 161.16 27.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 127' ' ' LYS . 11.8 m120 -106.75 129.68 24.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 165.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 40' ' ' THR . 59.7 Cg_endo -70.46 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.913 2.409 . . . . 0.0 114.199 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 39' ' ' PRO . 14.8 t 158.22 -10.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.792 0.837 . . . . 0.0 111.064 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.63 19.34 4.27 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.071 0.462 . . . . 0.0 111.179 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.547 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.21 48.61 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.15 -31.3 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.647 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 4.0 ptm180 -159.15 137.97 11.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.679 1.127 . . . . 0.0 112.374 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 36' ' ' MET . 11.0 tt -133.48 95.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 162.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 38.4 ttm-85 -95.89 107.71 20.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.927 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 136' ' ' LEU . 61.8 tp -104.54 103.69 13.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 18.1 p -114.58 106.14 13.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.843 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.647 ' HB2' HD11 ' A' ' 32' ' ' ILE . 61.7 mtt -105.19 167.23 9.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.219 0.533 . . . . 0.0 111.097 -175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 62.0 tttp -126.94 86.81 2.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.254 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -95.35 82.02 3.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.843 0.83 . . . . 0.0 109.414 174.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.31 68.79 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.841 0.829 . . . . 0.0 109.273 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.1 -99.9 0.22 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.776 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -145.38 21.25 1.53 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.442 0.639 . . . . 0.0 109.395 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.9 pp -133.87 151.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.808 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.03 89.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 168.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.1 tp10 -75.38 -57.54 3.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 110.04 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -125.01 160.44 28.98 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.263 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -156.83 119.24 3.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.605 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 45.9 mmtm -112.75 138.13 50.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -129.06 100.25 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 38.8 tt0 -90.77 99.81 12.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -126.28 115.51 2.31 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.77 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -127.39 126.63 42.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 169.78 -130.76 2.1 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.634 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.45 162.53 13.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.612 0.244 . . . . 0.0 110.466 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -57.8 -37.86 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -73.72 -35.38 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' HD12 ' A' ' 68' ' ' ILE . 24.8 p -79.13 -33.58 44.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.328 0.585 . . . . 0.0 110.131 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 90.4 mtp -74.26 -15.68 60.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.405 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.23 -51.56 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.003 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 p -59.23 -44.88 92.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.4 -62.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.532 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -55.74 -42.77 75.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.358 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.8 tpt -68.97 -51.27 41.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.596 ' HB3' HD22 ' A' ' 136' ' ' LEU . 92.4 mtp -72.29 -37.93 68.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.241 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.58 ' HA ' HD11 ' A' ' 136' ' ' LEU . 90.9 m -62.73 -29.26 70.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 111.264 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -86.03 -37.61 18.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.804 0.335 . . . . 0.0 110.327 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.94 89.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 0.0 110.064 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.66 -22.02 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.462 0.648 . . . . 0.0 109.4 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' THR . 81.4 tttt -64.63 -21.74 66.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.629 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.62 40.04 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.942 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 80' ' ' ILE . 98.4 mttt -133.95 -172.79 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.03 -168.96 1.51 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -80.69 -45.69 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.471 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.14 -39.92 91.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.168 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -62.74 -36.03 81.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.842 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.34 60.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.461 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 45.3 mt -61.05 -42.44 98.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.198 0.523 . . . . 0.0 109.667 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 t -63.96 -36.1 82.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.319 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 27.9 ttt -68.25 -28.31 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 0.0 110.843 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 31.0 t -86.22 -35.06 20.26 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.87 -49.84 73.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.821 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 13.3 tt -72.87 -22.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 98' ' ' MET . 48.6 t80 -59.23 -45.08 92.09 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.54 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.6 p -85.95 -28.45 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.082 0.468 . . . . 0.0 111.379 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 33.6 t70 -71.1 -19.45 62.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.58 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 24.2 ptm -48.92 -31.6 7.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.0 -44.15 94.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.386 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -110.22 -4.25 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.23 -31.33 78.7 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 46.5 tptt 73.23 -69.03 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.243 0.617 . . . . 0.0 111.726 170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.14 120.95 36.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.07 166.7 15.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -132.96 119.44 20.12 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.044 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -49.76 96.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 124.022 0.826 . . . . 0.0 110.19 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.3 m 61.32 23.79 13.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.257 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm 75.28 -15.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.212 0.605 . . . . 0.0 111.04 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -142.65 105.29 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 110' ' ' LEU . 1.3 mp -89.81 36.04 0.85 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.587 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.88 -27.06 73.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.691 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.85 -48.0 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.62 -31.32 52.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.365 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 8.0 mm-40 -66.08 -28.15 68.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.651 0.263 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.0 71.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 110.593 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.19 -15.16 24.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.822 0.344 . . . . 0.0 110.5 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.593 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 4.2 tp-100 -49.02 -43.85 40.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.653 -173.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.9 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -78.74 -33.83 36.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.553 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 HD13 ' A' ' 68' ' ' ILE . 29.0 m -87.55 -17.79 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 26.6 t -50.71 -18.89 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -165.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -169.34 27.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.439 1.018 . . . . 0.0 111.15 -167.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -93.46 138.42 23.0 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.96 -34.91 6.74 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.191 2.594 . . . . 0.0 113.303 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.05 5.96 20.58 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 84.2 mtt180 -121.72 -9.03 8.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.423 -0.798 . . . . 0.0 110.374 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' HD2' ' A' ' 127' ' ' LYS . 15.5 tt -77.42 -29.35 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.567 -167.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.584 ' HD2' HG23 ' A' ' 126' ' ' ILE . 14.0 mptt -74.74 -22.88 58.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 67.7 m -85.89 -22.54 27.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.158 0.504 . . . . 0.0 110.017 174.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -72.73 -47.73 44.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.533 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.6 p -65.42 -30.74 71.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.062 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -49.8 -53.65 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -71.52 -51.01 25.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -67.59 -41.61 83.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.948 0.404 . . . . 0.0 111.643 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.713 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 71.8 mmtt -73.5 -17.61 61.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.35 -44.64 11.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.174 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 76' ' ' MET . 3.0 tp -84.19 -63.27 1.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.02 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.41 -30.89 60.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.054 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 49.3 tttm -85.17 -4.32 59.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.355 0.598 . . . . 0.0 109.621 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -73.6 -50.57 11.28 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.452 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 141' ' ' ALA . 9.8 m -76.0 -57.04 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.202 . . . . 0.0 110.501 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . . . 169.59 152.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.704 0.802 . . . . 0.0 109.054 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -96.19 127.93 42.65 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.152 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 92' ' ' SER . 35.5 tt0 67.5 -76.13 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 111.608 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.38 95.21 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.41 -73.38 1.01 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.776 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.26 77.16 1.19 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.923 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 p30 . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 110.834 -0.062 . . . . 0.0 110.834 -178.701 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.67 0.272 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -75.76 110.24 10.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 110.933 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -94.81 126.41 40.11 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -152.59 117.14 5.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.069 0.461 . . . . 0.0 111.272 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.59 13.65 2.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.045 174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -115.53 -29.16 6.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.583 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.614 HD11 ' HA3' ' A' ' 118' ' ' GLY . 94.0 mt -86.1 -37.75 18.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.62 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.03 -46.99 61.76 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.466 0.479 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.89 -24.92 52.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.1 tm? -78.32 -58.69 3.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.445 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -76.57 -21.77 55.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.1 ttp180 -69.15 -35.74 76.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.12 -41.04 77.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.667 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 94.7 t -69.05 -48.59 68.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' A' ' 67' ' ' SER . 13.9 tt -66.29 -29.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.965 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -61.94 -49.02 77.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 110.051 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.55 -34.77 65.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -74.27 -19.31 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -77.23 -32.8 56.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -31.65 62.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.762 175.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -129.76 84.62 60.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.267 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.69 140.33 2.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.946 2.431 . . . . 0.0 111.886 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 16.4 ttm180 -145.44 17.2 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.412 0.625 . . . . 0.0 110.654 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 14.9 m120 -84.08 83.79 7.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.56 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 tptm -165.64 24.81 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 111.181 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.1 6.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.874 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.26 104.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 48' ' ' THR . 60.9 tp -105.71 95.93 6.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.985 0.422 . . . . 0.0 111.825 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -84.18 91.27 7.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' CG ' ' HG2' ' A' ' 50' ' ' LYS . 13.4 t70 -127.58 -69.7 0.73 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.583 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -127.04 -51.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.059 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 71.4 mt -106.84 129.42 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.044 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 48' ' ' THR . 3.1 m -142.2 82.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.508 0.67 . . . . 0.0 110.928 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 135' ' ' ALA . 49.1 t -98.81 134.69 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.272 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -128.34 147.01 50.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -153.1 151.2 29.91 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -152.04 145.32 24.7 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 111.898 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 41' ' ' CYS . 47.0 t-20 -124.23 111.77 28.36 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -21.56 -64.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 125.688 4.259 . . . . 0.0 115.679 -169.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 m -126.6 23.65 6.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.551 0.691 . . . . 0.0 110.904 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 38' ' ' ASN . 38.3 t -129.43 -36.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.687 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' HB3' ' A' ' 38' ' ' ASN . . . -140.88 62.16 0.54 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -34.82 -53.3 0.55 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.399 1.08 . . . . 0.0 113.666 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -156.7 141.75 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.357 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.44 105.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.448 0.642 . . . . 0.0 110.053 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 18.8 mmt180 -93.34 110.89 22.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.787 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD21 ' HE3' ' A' ' 49' ' ' MET . 52.2 tp -104.57 94.94 5.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.835 HG22 HG12 ' A' ' 33' ' ' VAL . 10.9 p -115.66 111.2 20.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.601 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 65.5 mtt -109.34 161.34 15.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.913 0.387 . . . . 0.0 111.452 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HE3' ' HB2' ' A' ' 52' ' ' ASP . 8.7 tmtm? -126.06 100.46 6.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pp -100.35 108.16 20.12 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.614 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.817 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 35.6 t70 -100.06 65.77 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.764 0.792 . . . . 0.0 109.263 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.36 -101.45 0.27 Allowed Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.838 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 7.7 m-20 -142.63 28.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.711 -0.745 . . . . 0.0 109.811 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.9 pp -132.5 151.71 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.206 0.527 . . . . 0.0 110.193 -170.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -86.56 96.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.958 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -91.48 -69.98 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -112.46 159.02 19.17 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.21 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -157.58 132.76 8.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.636 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -123.96 120.36 32.27 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -115.96 81.13 1.55 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.415 0.626 . . . . 0.0 111.436 -176.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.95 117.31 24.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.548 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.39 161.06 29.97 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.259 -1.448 . . . . 0.0 113.586 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.03 164.39 27.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.55 -130.46 3.33 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.255 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 34.0 m -81.25 159.35 24.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.903 0.382 . . . . 0.0 110.797 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.583 ' HB2' HD12 ' A' ' 15' ' ' ILE . 5.7 p -61.82 -32.94 73.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.975 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -90.57 -24.49 5.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.694 -176.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.493 ' N ' HD13 ' A' ' 68' ' ' ILE . 31.2 p -76.68 -40.15 49.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.072 0.463 . . . . 0.0 110.913 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.5 ptp -72.03 -17.22 62.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.304 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.54 -46.72 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.119 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' MET . 13.7 p -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.59 -51.94 43.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.26 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -70.57 -27.24 63.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.5 ttt -79.04 -49.18 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.083 0.468 . . . . 0.0 110.288 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 112' ' ' ASP . 90.2 mmm -63.65 -39.84 95.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.192 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.445 HG23 ' HE2' ' A' ' 49' ' ' MET . 31.5 m -75.12 -21.21 59.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.44 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -68.88 -41.26 78.59 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.23 -26.9 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.298 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.461 ' CD1' HG21 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -72.38 -31.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.667 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.95 -24.58 67.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.579 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -85.68 19.7 23.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.814 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 1.6 mptm? -133.69 -179.25 5.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 109.984 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 5.6 p-10 -116.36 -171.37 1.99 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.34 -40.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.491 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -64.23 -40.97 97.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 109.688 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 91' ' ' MET . 23.2 m -74.86 -32.02 61.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.001 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' CE ' ' A' ' 91' ' ' MET . . . -61.28 -48.65 80.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.847 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 141' ' ' ALA . 72.2 mt -59.14 -39.75 83.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.577 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 m -70.51 -19.89 62.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.232 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.678 ' HA ' HG12 ' A' ' 94' ' ' ILE . 67.1 mtm -79.32 -19.38 50.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.81 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 23.6 t -85.46 -32.62 22.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -58.62 -43.13 89.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.245 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.678 HG12 ' HA ' ' A' ' 91' ' ' MET . 40.5 pt -82.87 -23.94 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.105 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 37.7 t80 -58.11 -46.97 84.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.131 0.491 . . . . 0.0 110.172 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 p -79.85 -27.85 40.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 22.0 t70 -66.1 -31.22 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.7 ttt -54.33 -21.83 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.0 ttm -82.34 -24.52 34.52 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -134.4 -42.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.79 -37.42 7.37 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.571 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 tptp 71.52 25.37 3.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.304 0.642 . . . . 0.0 111.114 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.75 137.56 51.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.082 0.468 . . . . 0.0 110.753 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' HD12 ' A' ' 94' ' ' ILE . 2.2 m-85 -117.02 -145.99 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -127.18 75.08 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 70.35 -4.34 1.61 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.774 169.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 109' ' ' ASP . 13.4 p -70.79 -55.5 8.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 104' ' ' TYR . 1.7 mp 71.32 -36.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 123.578 0.549 . . . . 0.0 111.564 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 107' ' ' SER . 4.6 p-10 -127.15 152.85 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' ILE . 2.4 mp -150.84 74.21 1.15 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.4 0.619 . . . . 0.0 109.644 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -57.35 -19.74 34.13 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.683 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 1.2 p-10 -65.27 -48.57 72.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.57 0.348 . . . . 0.0 111.506 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 110' ' ' LEU . 10.6 tt -71.87 -19.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.453 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 70.2 mm-40 -57.51 -31.03 65.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.594 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.22 59.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.148 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.75 -39.22 18.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -62.1 -19.88 63.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -75.67 -51.19 7.35 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.596 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.2 m -78.51 -17.04 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 75.3 m -43.52 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -147.34 6.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.365 0.984 . . . . 0.0 112.584 -163.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.788 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 36.3 m-85 -81.38 142.5 50.52 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.96 -37.16 12.01 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.218 2.612 . . . . 0.0 113.384 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.93 -1.27 15.52 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 95.5 mtt180 -114.34 -3.29 13.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 -174.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 120' ' ' SER . 11.9 tt -70.58 -31.0 44.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.727 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HA ' ' OG1' ' A' ' 130' ' ' THR . 97.2 mttt -81.88 -22.08 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 55.9 m -69.54 -34.84 74.82 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -78.77 -46.53 18.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.275 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 127' ' ' LYS . 22.8 p -62.6 -33.96 76.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.711 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 128' ' ' CYS . 4.3 pp -67.68 -41.61 83.4 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.281 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 m -71.73 -48.29 48.04 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.616 0.722 . . . . 0.0 110.481 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -63.34 -55.35 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.801 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.842 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 68.7 mmtt -72.6 -19.34 61.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.477 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -61.3 -45.26 95.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 110.063 173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 76' ' ' MET . 6.5 mp -86.52 -34.16 20.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.223 0.535 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 8.3 tp10 -63.96 -20.84 66.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.681 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -109.67 -41.56 4.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.941 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.14 -50.91 60.77 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.203 -0.522 . . . . 0.0 114.138 -172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 80' ' ' ILE . 15.5 m -125.27 -8.05 6.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.38 . . . . 0.0 111.753 -172.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -128.15 162.63 26.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.028 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 2.4 ttpm? 179.68 54.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.69 0.619 . . . . 0.0 109.88 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' CB ' ' A' ' 92' ' ' SER . 36.8 mt-10 60.51 -99.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.004 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -171.15 -66.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -159.98 106.37 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.581 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.18 96.35 0.11 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.87 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 45.9 t30 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 110.37 -179.736 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 tp . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.351 0.12 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.594 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 19.2 t70 -56.23 -57.12 13.57 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.681 -174.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -70.2 -25.36 63.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.001 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.9 tp -70.03 -54.48 12.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.324 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 4.3 p90 -72.28 -24.2 61.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 13.6 tpp180 -56.99 -49.62 75.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.03 -36.86 80.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.555 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' A' ' 71' ' ' ALA . 84.2 t -60.25 -45.5 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.61 -31.42 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.7 mtt -68.38 -40.65 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 0.0 110.906 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.89 -34.49 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.602 ' HE1' ' HB2' ' A' ' 24' ' ' ASN . 40.9 t-80 -71.33 -21.3 62.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.535 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -85.97 -31.19 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 0.0 110.934 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -67.37 -21.36 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.084 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.35 80.16 72.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.198 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.65 71.55 3.95 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.275 2.65 . . . . 0.0 113.034 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -134.45 125.53 27.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.005 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.602 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 57.7 t30 -167.2 152.41 7.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 1.123 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 55.8 tttm 72.64 94.33 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.334 1.021 . . . . 0.0 110.818 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.07 162.97 31.66 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -136.94 119.47 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.39 0.595 . . . . 0.0 110.435 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 48' ' ' THR . 2.4 tt -115.41 101.16 8.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.23 108.82 19.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.04 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -152.98 -72.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.376 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.88 -71.89 0.73 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 49' ' ' MET . 41.8 pt -108.25 127.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.3 0.572 . . . . 0.0 111.896 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 48' ' ' THR . 87.3 t -126.44 104.9 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.96 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.05 114.33 29.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.627 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 46' ' ' ARG . 4.2 p30 -113.93 154.06 28.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.045 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.514 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 14.9 tpt -140.83 123.39 16.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.71 152.04 26.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.1 -177.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 131' ' ' LEU . 41.7 t-20 -122.05 83.08 44.27 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.8 -6.71 11.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.236 2.624 . . . . 0.0 113.152 -171.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.5 m -86.11 -43.18 13.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 49.8 t -99.82 -24.93 14.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.67 0.04 36.78 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.654 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 2.8 m-20 -70.52 145.83 50.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HG3' ' ND2' ' A' ' 37' ' ' ASN . 20.3 ttm-85 -154.09 114.24 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 64.6 mt -122.4 110.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.494 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 62' ' ' GLU . 32.3 mtp180 -94.42 109.45 21.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.728 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.843 HD11 ' HE3' ' A' ' 49' ' ' MET . 52.3 tp -99.55 104.4 16.2 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.502 0.668 . . . . 0.0 109.331 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.69 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 3.2 p -115.75 103.56 10.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.034 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.843 ' HE3' HD11 ' A' ' 47' ' ' LEU . 60.7 mtt -107.77 163.45 13.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.072 0.463 . . . . 0.0 110.939 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 87.7 tttt -130.01 100.46 5.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.572 174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.33 105.25 17.22 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -109.72 72.54 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 -172.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.05 -101.17 0.25 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.366 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.66 20.48 2.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.116 0.96 . . . . 0.0 108.601 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.6 pp -127.37 -162.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.588 -174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.481 HG11 HG22 ' A' ' 80' ' ' ILE . 57.6 t -123.76 117.74 52.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.387 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 50.6 mm-40 -86.11 -48.99 8.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.9 174.76 12.74 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.052 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -162.04 131.46 4.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.528 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -121.76 118.99 30.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -106.41 99.45 9.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.839 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.123 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 31.5 tt0 -81.27 79.43 7.91 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -104.18 114.69 4.81 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.637 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 10.1 tp10 -121.01 150.76 40.65 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.44 -132.5 4.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.626 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.58 -175.66 2.92 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.902 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 m -61.48 -40.82 95.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.478 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -79.61 -42.93 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -171.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.7 p -65.51 -52.35 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.922 0.391 . . . . 0.0 112.048 -170.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.461 ' HB2' HD21 ' A' ' 24' ' ' ASN . 0.0 OUTLIER -68.39 -22.38 64.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.016 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -85.28 -48.61 8.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.341 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.4 p -59.22 -46.77 87.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 110.848 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.97 83.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.0 m -61.29 -34.25 74.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.432 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.19 -43.72 27.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 0.0 109.835 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 95.0 mmm -73.75 -32.08 63.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.527 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.8 p -74.6 -19.97 60.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.994 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -72.04 -38.37 69.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 83' ' ' LYS . . . -71.29 -34.11 70.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.728 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 56' ' ' VAL . 14.6 mm -71.99 -41.07 68.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -57.29 -19.0 19.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.322 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.53 25.6 10.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 79' ' ' ALA . 13.2 mptt -127.55 -168.6 1.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.501 . . . . 0.0 110.784 -173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -120.15 -165.98 1.25 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.2 mm -87.27 -38.42 12.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.881 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.36 -49.79 76.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.256 0.551 . . . . 0.0 109.987 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 p -67.55 -32.59 73.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.252 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.72 -43.6 68.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 79.9 mt -65.79 -36.16 82.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.718 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 t -68.11 -45.48 73.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.292 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.51 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 51.1 ttm -58.11 -35.18 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.03 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 7.6 p -87.69 -30.26 20.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.481 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.729 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 83.2 tttt -61.83 -48.2 81.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.6 tt -71.67 -32.32 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.047 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 91' ' ' MET . 31.7 t80 -57.22 -44.99 84.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.176 0.512 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -77.99 -33.97 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.899 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.286 -177.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.689 HD23 HD12 ' A' ' 113' ' ' ILE . 83.9 mt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -50.05 -57.72 9.63 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.231 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.38 -35.01 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.689 HD12 HD23 ' A' ' 110' ' ' LEU . 59.0 mt -59.78 -39.51 80.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.519 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 40.0 mt-10 -77.61 -23.35 49.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.006 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -43.17 25.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.306 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.7 tp -65.03 -37.4 87.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.286 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 1.8 pt20 -73.37 -23.49 60.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.7 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 -47.98 76.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.189 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 129' ' ' ALA . 19.3 m -81.99 -18.58 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.868 0.366 . . . . 0.0 111.28 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 t -52.15 -12.64 0.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -117.92 -25.08 6.87 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.689 -0.632 . . . . 0.0 111.043 -163.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -74.58 129.6 83.47 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.49 -29.96 19.89 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.995 2.463 . . . . 0.0 113.022 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.53 -15.32 28.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.68 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 8.5 mmt180 -113.65 -4.98 13.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.633 -172.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.93 -32.05 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.482 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.692 ' HG3' HD21 ' A' ' 38' ' ' ASN . 13.3 pttt -81.14 -19.03 44.38 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.625 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 68' ' ' ILE . 56.9 m -85.61 -28.12 25.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.23 -50.36 16.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.245 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.9 p -64.92 -26.34 68.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.099 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 38' ' ' ASN . 9.9 tt -54.18 -64.67 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 24.9 m -63.94 -34.12 77.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.045 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -66.42 -58.02 6.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.493 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.92 -32.93 74.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.703 0.287 . . . . 0.0 111.377 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 76' ' ' MET . 14.2 tp -79.06 -38.42 36.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.518 ' CD ' ' HD3' ' A' ' 142' ' ' LYS . 74.0 mt-10 -70.26 -21.91 62.92 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.731 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -86.98 -22.48 25.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.347 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.64 -60.19 8.57 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.814 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.48 11.49 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.747 -0.267 . . . . 0.0 110.975 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.86 -175.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.031 0.832 . . . . 0.0 109.955 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 59.5 pttt -145.33 166.7 24.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.302 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.729 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 52.4 mt-10 60.15 -104.89 0.2 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.938 0.774 . . . . 0.0 110.201 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.66 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.436 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 47.7 tp . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.833 0.349 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.63 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.8 m-20 -59.92 -45.26 93.13 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.34 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -59.81 -45.88 90.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.138 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 80.8 mt -70.4 -60.72 2.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.955 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.9 p90 -63.73 -36.09 82.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 12.8 ttp180 -74.65 -28.63 60.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.29 -42.16 46.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.4 t -63.4 -46.47 95.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.207 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.6 tt -67.27 -32.75 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.76 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -68.77 -47.31 66.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.86 -48.24 79.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.04 -17.9 61.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.15 -42.49 80.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.592 0.71 . . . . 0.0 109.285 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 1.8 tmmt? -71.15 -27.04 63.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.723 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.96 85.57 28.61 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 121.035 0.445 . . . . 0.0 111.867 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.52 167.78 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.402 2.735 . . . . 0.0 112.88 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -162.99 25.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.83 36.93 1.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.586 -165.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -141.75 108.87 5.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 111.381 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.65 ' HA3' ' HD2' ' A' ' 60' ' ' LYS . . . 167.4 144.83 4.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.136 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HD2' ' A' ' 46' ' ' ARG . 15.4 m -127.82 111.16 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.0 109.864 171.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.632 ' O ' ' HB ' ' A' ' 48' ' ' THR . 47.2 tp -109.53 85.24 2.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.69 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.06 80.07 3.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -141.94 -73.35 0.32 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.635 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 49' ' ' MET . 14.5 m -95.26 -85.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 48' ' ' THR . 78.2 mt -93.35 130.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.051 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.01 95.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.649 HG13 ' HB2' ' A' ' 47' ' ' LEU . 3.6 p -131.21 108.08 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 111.224 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 5.0 t70 -95.34 145.05 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.959 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 9.7 tpt -144.17 115.22 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 4.9 p30 -120.27 158.04 27.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.564 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HB2' HD12 ' A' ' 131' ' ' LEU . 10.8 t-20 -135.06 105.88 10.4 Favored Pre-proline 0 CA--C 1.52 -0.184 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.87 -16.94 57.86 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.919 2.413 . . . . 0.0 112.795 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -61.6 -38.91 89.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.411 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 6.4 p -131.0 -14.13 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.76 42.5 4.43 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.557 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB2' HD11 ' A' ' 131' ' ' LEU . 5.3 m-20 -87.07 145.96 26.26 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.477 ' HG2' ' HB3' ' A' ' 37' ' ' ASN . 30.0 mtm180 -143.18 113.74 7.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 131' ' ' LEU . 64.7 mt -121.52 93.94 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.764 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 42.1 ttm105 -89.12 99.22 12.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.882 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 61' ' ' PHE . 62.5 mt -88.1 106.63 18.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 123.843 0.715 . . . . 0.0 109.466 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 p -115.77 96.16 5.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.337 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.622 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 42.1 mtp -104.38 156.13 18.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.202 -167.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -120.81 87.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.52 0.676 . . . . 0.0 109.47 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 32' ' ' ILE . 2.4 pt? -87.38 105.06 17.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.698 173.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.93 67.14 0.74 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.721 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.35 -101.5 0.25 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -139.01 18.2 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -120.26 150.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.65 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.3 112.5 39.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.12 -45.78 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -109.09 147.71 31.98 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.728 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -151.65 118.63 5.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.65 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 47.8 mmtm -111.7 111.23 22.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.818 ' HB3' HD23 ' A' ' 47' ' ' LEU . 7.8 p90 -127.01 105.22 8.45 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.318 0.58 . . . . 0.0 110.884 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.89 82.56 2.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 170.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -103.61 109.25 3.39 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.533 -172.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.74 159.58 34.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 145.47 -131.44 4.2 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.064 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.8 p -102.37 169.1 8.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -52.29 -48.16 65.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.73 0.644 . . . . 0.0 112.452 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -69.6 -36.23 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -171.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 m -72.11 -43.83 64.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 109.802 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.2 ttt -70.84 -23.93 62.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.584 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -88.69 -61.04 1.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.76 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -67.19 -50.47 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.842 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.57 94.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 110.328 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -69.41 -31.96 70.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.542 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.5 tpt -73.24 -41.4 63.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.163 0.506 . . . . 0.0 109.827 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 88.3 mtp -62.86 -30.86 71.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.879 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CE1' ' A' ' 61' ' ' PHE . 50.8 m -72.91 -22.31 60.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.894 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.53 -33.44 71.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.418 0.627 . . . . 0.0 109.317 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.47 25.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.292 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.4 OUTLIER -73.17 -32.02 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.089 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.06 -17.11 63.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.308 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.22 27.79 7.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.935 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 95.4 mttt -134.12 -155.53 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 111.633 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.18 156.7 48.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -170.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 85' ' ' ILE . 2.3 mp -61.49 -42.87 95.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -41.48 73.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.177 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.0 m -79.23 -33.9 43.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.94 88.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.362 . . . . 0.0 110.779 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 144' ' ' GLU . 7.6 mp -64.74 -31.36 72.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.526 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.9 m -72.76 -33.92 66.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.129 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.0 ttm -67.81 -34.73 77.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.794 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 p -82.09 -30.02 31.46 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.98 -42.1 97.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.5 tt -78.95 -25.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.054 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.64 -40.71 97.86 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.3 m -65.6 -31.99 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.875 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.712 -178.27 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 110' ' ' LEU . 2.6 mm? . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.25 0.072 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.58 36.22 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.733 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.72 -38.94 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.067 0.46 . . . . 0.0 111.119 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.62 -34.9 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.936 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 117' ' ' GLN . 40.6 tt0 -62.68 -30.83 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.0 110.239 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.71 -9.97 59.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.4 -44.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.496 0.665 . . . . 0.0 109.773 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -77.95 -19.04 55.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.881 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.09 -50.37 63.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.314 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.1 m -71.87 -19.16 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.232 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 126' ' ' ILE . 58.7 m -55.92 -12.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.769 0.827 . . . . 0.0 112.947 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.29 -8.44 7.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 111.274 -163.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.886 ' HB2' ' HG2' ' A' ' 125' ' ' ARG . 34.3 m-85 -84.5 131.59 49.59 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.68 -18.98 6.88 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.163 2.576 . . . . 0.0 112.943 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.484 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -104.87 -8.53 18.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.886 ' HG2' ' HB2' ' A' ' 122' ' ' PHE . 6.8 mmm-85 -123.55 9.85 9.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.008 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 122' ' ' PHE . 26.3 pt -74.22 -28.65 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.024 0.916 . . . . 0.0 108.889 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -85.2 -25.09 27.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.806 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 26.4 t -86.32 -28.84 23.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.367 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.79 -46.34 31.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 p -61.49 -30.15 70.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 38' ' ' ASN . 6.9 tt -50.29 -63.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.417 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 m -67.73 -45.21 75.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.509 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.62 -52.18 64.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.829 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 137' ' ' GLU . 37.4 ttmt -74.15 -19.42 60.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.28 91.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.392 . . . . 0.0 110.282 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.91 -39.6 23.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.185 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 8.4 mm-40 -64.2 -20.35 65.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.211 0.529 . . . . 0.0 110.863 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.24 -34.98 10.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.2 -55.78 19.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.892 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 34.9 m -101.43 6.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 122.704 -0.292 . . . . 0.0 111.316 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 74.43 178.21 0.22 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.224 0.953 . . . . 0.0 110.642 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.735 ' HD3' ' HB3' ' A' ' 137' ' ' GLU . 19.1 pttm -143.76 141.33 30.39 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 65.89 -67.64 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.107 0.963 . . . . 0.0 111.551 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.718 ' HA ' HD23 ' A' ' 89' ' ' LEU . 42.5 tt0 . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.208 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 115' ' ' ALA . 67.7 tp . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.741 0.305 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.27 -46.76 76.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.22 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -59.02 -33.69 71.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.346 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.4 mt -75.38 -50.27 16.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 15' ' ' ILE . 4.5 m-85 -55.18 -42.44 73.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.858 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -51.42 -45.52 62.6 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.703 0.627 . . . . 0.0 109.911 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -73.43 -42.72 61.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.554 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 83.7 t -58.76 -48.54 85.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 111.421 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.9 pp -73.99 -21.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.626 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 78.0 mmm -73.53 -43.31 60.28 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.194 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.81 -39.13 93.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.112 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -76.33 -19.24 58.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -72.05 -39.43 69.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.197 0.522 . . . . 0.0 109.753 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -72.25 -19.97 61.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.759 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -119.44 81.29 22.91 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.19 20.49 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.842 2.361 . . . . 0.0 112.847 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 2.1 mpt_? -93.47 95.21 9.13 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.884 HD21 ' HB2' ' A' ' 70' ' ' MET . 36.6 t30 -118.38 24.38 10.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.0 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.819 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 51.2 mttp -137.59 114.33 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.861 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -157.34 133.22 3.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.49 105.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.862 0.839 . . . . 0.0 111.699 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 50' ' ' LYS . 3.5 tt -115.8 79.22 1.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.726 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HA ' HG22 ' A' ' 33' ' ' VAL . 4.3 t30 -82.53 8.71 11.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.853 -171.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -94.02 3.65 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.872 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -144.56 -104.31 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.364 -0.21 . . . . 0.0 110.579 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 48' ' ' THR . 63.6 mt -83.87 128.32 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.273 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 29' ' ' ASN . 24.8 t -128.49 101.23 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.439 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.014 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.6 t -116.98 120.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -126.05 145.68 50.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.81 0.338 . . . . 0.0 110.163 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.445 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 25.5 mmt -138.37 126.47 22.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.93 135.87 43.81 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.158 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . 2.6 t-20 -132.91 97.92 16.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -16.81 -79.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 1 C-N-CA 125.886 4.391 . . . . 0.0 115.669 -162.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.1 p -117.0 17.87 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.933 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.1 15.02 4.69 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.791 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.17 54.95 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.86 -71.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.123 1.369 . . . . 0.0 113.307 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 10.4 ptt180 -159.84 119.24 2.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.516 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.669 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 5.7 tt -104.33 106.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.38 171.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.445 HH21 ' CD ' ' A' ' 62' ' ' GLU . 51.4 mtm180 -96.68 102.72 14.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.973 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.0 104.75 14.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 1.9 p -117.18 121.74 42.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.93 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.524 ' HG2' ' CB ' ' A' ' 59' ' ' ALA . 56.7 mtm -124.17 136.69 54.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.396 -169.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HB2' HD13 ' A' ' 28' ' ' LEU . 7.1 tmtt? -109.49 87.47 2.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.3 pt? -77.82 115.0 17.23 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.25 66.33 0.67 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.156 0.503 . . . . 0.0 110.128 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.38 -103.07 0.29 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.58 4.67 5.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.756 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.1 pp -110.21 -164.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.627 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 140' ' ' VAL . 25.7 t -126.48 104.2 12.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.635 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 40.9 tt0 -81.7 -71.37 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.956 -171.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' MET . 34.3 t0 -109.68 104.14 13.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.502 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 49' ' ' MET . . . -102.44 113.59 27.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.166 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 12.7 mtpp -112.04 131.85 55.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 74' ' ' SER . 2.7 p90 -123.05 102.87 8.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.275 0.56 . . . . 0.0 111.434 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.819 ' HG3' ' HG2' ' A' ' 25' ' ' LYS . 23.9 tt0 -104.84 94.57 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.603 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -111.29 130.11 9.56 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.824 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.19 131.9 56.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.791 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 161.31 -132.25 2.81 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.465 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 70' ' ' MET . 3.5 p -99.65 155.71 17.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -55.63 -36.27 66.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.925 0.765 . . . . 0.0 112.321 -168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -81.83 -35.75 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.644 ' N ' HD12 ' A' ' 68' ' ' ILE . 35.2 p -73.73 -39.58 64.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.018 0.437 . . . . 0.0 110.693 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.884 ' HB2' HD21 ' A' ' 24' ' ' ASN . 26.1 ptt? -82.07 -8.21 59.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.6 -57.82 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.502 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -64.02 -53.64 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.585 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.76 82.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.317 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 20.1 m -63.16 -34.11 76.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.21 -47.43 64.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.5 69.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.7 m -66.18 -25.36 66.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.144 0.497 . . . . 0.0 110.654 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 74' ' ' SER . 79.1 mt-30 -73.47 -34.54 65.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -69.0 -33.87 74.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.674 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 80' ' ' ILE . 1.3 mm -72.32 -30.45 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.63 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.01 -17.29 37.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.506 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.32 31.17 5.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.623 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 66.5 mttm -133.23 -174.89 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.692 -0.299 . . . . 0.0 110.934 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.756 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.7 -175.91 2.99 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -175.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.437 ' O ' HD23 ' A' ' 89' ' ' LEU . 1.7 mp -86.01 -46.79 16.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.978 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -59.19 -40.22 85.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.1 p -73.4 -33.46 65.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.999 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.97 90.89 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.418 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 142' ' ' LYS . 4.5 mm? -64.76 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.95 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.0 m -85.03 -29.94 24.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' THR . 92.6 mmm -69.07 -26.31 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.593 176.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 p -85.41 -31.35 22.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -58.28 -47.33 83.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 mt -57.83 -42.67 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.715 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -55.83 -48.14 75.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.831 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.6 p -70.16 -35.96 74.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.948 179.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.752 0.311 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.26 -24.79 69.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.488 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.08 -28.94 43.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.771 0.32 . . . . 0.0 111.332 -175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.06 -35.57 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.224 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.92 -34.74 75.16 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.199 0.524 . . . . 0.0 109.928 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 7' ' ' LEU . . . -70.37 -20.65 62.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.872 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.28 -34.41 15.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 109.757 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -61.5 -31.12 71.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.013 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.23 -41.68 98.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.751 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.785 HG12 ' HD3' ' A' ' 125' ' ' ARG . 34.5 m -85.91 -20.44 8.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 111.404 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 33.0 t -54.04 -15.14 1.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -130.36 -23.37 2.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.841 0.746 . . . . 0.0 112.78 -162.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 68.5 m-85 -70.96 135.63 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.29 -25.07 45.33 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.737 2.292 . . . . 0.0 111.844 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.46 -3.7 39.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.402 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.785 ' HD3' HG12 ' A' ' 119' ' ' VAL . 99.6 mtt180 -123.16 0.82 9.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.605 -0.684 . . . . 0.0 110.327 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 tt -72.43 -31.59 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.528 0.68 . . . . 0.0 109.78 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -79.96 -19.49 47.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.033 175.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.5 t -85.32 -19.54 31.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 120' ' ' SER . . . -75.27 -46.56 32.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.41 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.6 m -58.39 -37.79 76.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 69' ' ' SER . 6.8 tt -52.95 -70.92 0.08 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.442 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -58.39 3.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.53 0.681 . . . . 0.0 111.087 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 62.6 t90 -66.06 -49.83 66.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.205 -171.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 37.3 tttp -83.51 -21.07 32.89 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.184 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.57 -30.11 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.392 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -86.63 -40.83 14.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 1.132 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 2.9 tm-20 -63.68 -47.6 80.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.883 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -92.87 -11.27 33.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.982 -171.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 1.014 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -59.22 -54.77 35.14 Favored Glycine 0 C--O 1.23 -0.143 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.095 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 56' ' ' VAL . 18.1 m -114.52 21.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 142' ' ' LYS . . . 68.15 155.82 0.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.417 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 1.132 ' HE2' ' HA ' ' A' ' 137' ' ' GLU . 8.9 mtmm -173.33 151.58 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 31.6 tt0 66.73 117.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.744 0.652 . . . . 0.0 110.123 -172.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.612 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 m-20 -49.12 -45.78 44.04 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.839 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.3 m -62.36 -43.69 98.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.174 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mm? -76.46 -56.92 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.116 -171.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.612 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 9.8 p90 -68.73 -37.49 79.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.797 -169.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -68.59 -37.2 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.91 -46.06 72.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.179 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.7 t -62.69 -46.48 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.789 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.4 mm -64.0 -44.4 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.061 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.1 ttt -61.81 -49.03 77.96 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.72 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.946 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -74.59 -16.99 60.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.395 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -76.73 -32.31 57.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 0.0 109.796 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -76.82 -21.46 55.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -117.95 71.23 8.01 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.85 38.5 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.529 2.819 . . . . 0.0 114.929 -161.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.01 92.52 4.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.932 0.396 . . . . 0.0 110.565 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.51 15.37 8.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.701 . . . . 0.0 109.27 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -118.85 85.22 2.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.56 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.445 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -119.2 122.97 5.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.09 100.04 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.0 111.708 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.535 ' O ' HG21 ' A' ' 48' ' ' THR . 20.4 tp -108.07 175.52 5.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.488 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.525 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.2 p-10 -156.93 97.65 1.7 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -141.73 -90.85 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.702 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -108.39 -65.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.821 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 65.4 mt -87.83 121.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.7 t -136.04 90.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.47 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.68 112.27 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.532 0.682 . . . . 0.0 111.231 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -109.19 123.87 49.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.566 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.23 118.59 24.55 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.66 132.4 56.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.417 0.627 . . . . 0.0 112.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 19.7 t-20 -106.02 105.88 55.03 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.8 Cg_exo -65.58 40.31 0.13 Allowed 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.809 3.673 . . . . 0.0 115.364 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.6 t -178.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.697 0.284 . . . . 0.0 110.742 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 t -133.91 18.94 3.81 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -168.77 42.16 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -33.2 -54.21 0.39 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.403 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 27.1 ttm180 -146.97 136.47 22.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.902 1.228 . . . . 0.0 112.268 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' MET . 8.1 tt -130.66 94.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 10.4 ttm180 -88.0 115.99 25.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.996 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.65 106.33 9.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.1 p -117.72 112.36 20.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.193 0.521 . . . . 0.0 110.978 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.701 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 81.1 mtp -103.97 162.46 13.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.24 -173.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -130.77 104.58 7.25 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.759 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -108.62 94.82 5.26 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.829 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.06 63.52 4.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.525 1.155 . . . . 0.0 109.911 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.74 -100.97 0.25 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.571 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 8.4 m-20 -143.15 30.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.829 -0.685 . . . . 0.0 109.291 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.7 pp -137.1 156.46 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.36 102.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.39 -46.13 16.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -153.59 169.72 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.684 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -158.37 129.81 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.061 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 28' ' ' LEU . 67.9 mmtt -112.59 129.54 56.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 27.7 p90 -128.03 128.79 45.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.075 0.464 . . . . 0.0 111.804 -174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.31 108.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.39 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -116.09 138.31 14.41 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.455 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -132.41 104.2 6.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.13 -130.3 1.29 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.218 -172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 158.45 19.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -52.14 -38.31 57.13 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.611 0.569 . . . . 0.0 111.882 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 69' ' ' SER . 2.3 pp -72.11 -44.0 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 68' ' ' ILE . 7.4 p -70.9 -38.33 73.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.04 -38.22 82.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.089 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -85.49 -45.65 11.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.066 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -55.32 -45.53 76.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.351 . . . . 0.0 110.352 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -56.67 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 40.5 p -58.04 -40.76 81.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.781 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.7 ttt -73.37 -41.81 62.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.146 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.53 ' HB3' HD22 ' A' ' 136' ' ' LEU . 94.8 mtp -73.42 -31.93 64.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.749 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -73.44 -20.36 60.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 74' ' ' SER . 85.3 mt-30 -81.03 -41.33 22.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.51 95.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.067 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.43 -20.91 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.851 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -66.01 -21.86 66.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.56 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.72 29.56 10.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.911 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -135.16 -172.63 3.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.337 0.568 . . . . 0.0 110.626 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.767 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.3 p-10 -112.36 -172.0 1.96 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.2 mm -85.93 -35.2 9.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.1 -39.58 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.694 0.283 . . . . 0.0 110.66 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.38 -23.68 61.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.286 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.982 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 86.8 mt -66.39 -34.14 77.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.653 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG12 ' A' ' 94' ' ' ILE . 4.5 p -78.07 -35.36 49.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 19.0 ttt -60.34 -37.89 82.07 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.081 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 28.2 p -84.71 -27.72 26.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 109.867 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.994 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 17.8 tptp -57.77 -53.29 59.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 97' ' ' ASP . 17.5 pt -75.58 -22.85 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 91' ' ' MET . 34.3 t80 -69.72 -26.79 64.51 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.8 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -85.27 -26.61 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.344 0.593 . . . . 0.0 109.966 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 94' ' ' ILE . 2.0 m-20 . . . . . 0 C--O 1.22 -0.498 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.601 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.807 0.336 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -70.24 -32.15 68.83 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.868 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -45.96 91.73 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.905 0.482 . . . . 0.0 110.292 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.1 -37.73 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mm-40 -61.34 -36.0 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.48 68.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -91.35 -21.07 21.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.856 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -50.96 -35.25 32.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.19 46.1 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.851 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 125' ' ' ARG . 29.6 m -86.27 -18.32 8.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.446 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 65.9 m -52.96 -18.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -169.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -157.37 5.04 0.14 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.931 -165.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.743 ' HD2' ' HD2' ' A' ' 125' ' ' ARG . 17.0 m-85 -85.7 132.61 43.82 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 172.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.89 -16.1 11.1 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.91 2.407 . . . . 0.0 112.335 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.83 -11.59 17.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.342 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.743 ' HD2' ' HD2' ' A' ' 122' ' ' PHE . 94.8 mtt180 -123.74 1.33 8.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.682 -0.636 . . . . 0.0 110.271 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -79.73 -24.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.537 -168.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -76.3 -19.56 58.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.386 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 95.5 m -85.88 -24.52 26.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.796 172.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -71.9 -48.03 48.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.708 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -60.98 -30.06 70.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.831 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 9.9 tt -60.02 -66.79 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 t -71.02 -42.26 69.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.407 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -67.95 -55.33 13.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.661 0.267 . . . . 0.0 110.833 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.57 -25.38 63.96 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.123 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.11 93.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.298 . . . . 0.0 110.771 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 76' ' ' MET . 2.3 tp -76.1 -43.79 41.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.84 -19.79 65.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.957 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -85.07 -14.62 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.461 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.56 -68.3 1.69 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.196 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' HB ' HG23 ' A' ' 85' ' ' ILE . 35.6 m -103.47 5.58 10.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 122.843 -0.21 . . . . 0.0 111.158 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 72.96 162.25 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.223 0.952 . . . . 0.0 110.351 -173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 14.5 pttp -121.1 148.36 44.3 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.314 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.994 ' HG2' ' HA ' ' A' ' 93' ' ' LYS . 41.4 mt-10 65.39 -161.27 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.884 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 121.404 0.621 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.566 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 30.2 t70 -71.46 -43.48 66.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.436 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -69.56 -26.83 64.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.587 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.0 mt -71.75 -30.48 65.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.218 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 8' ' ' ASP . 15.3 m-85 -59.23 -49.63 77.12 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.893 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 1.8 mpt_? -59.1 -33.79 71.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.725 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -71.4 -49.98 36.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HB1' ' A' ' 71' ' ' ALA . 59.5 t -75.25 -39.86 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.806 -173.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 11' ' ' TYR . 12.2 tt -71.7 -27.96 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.294 -0.254 . . . . 0.0 110.648 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.4 ttt -66.87 -39.19 87.46 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.27 -43.23 74.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.775 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.1 -27.62 69.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.758 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -71.61 -39.71 70.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.518 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -63.71 -32.04 73.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.193 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -83.88 166.96 30.94 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.852 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.48 16.92 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.021 2.481 . . . . 0.0 113.445 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 59.33 -159.67 0.29 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.865 0.466 . . . . 0.0 111.062 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -103.27 80.09 1.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.88 0.372 . . . . 0.0 111.391 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -145.67 94.22 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.799 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.23 133.73 2.98 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.778 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.58 104.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 0.0 110.428 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 48' ' ' THR . 1.1 tt -111.02 88.88 2.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.03 98.94 8.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 21.2 t70 -143.71 -73.45 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.943 0.401 . . . . 0.0 111.145 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -124.67 -62.37 1.25 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.667 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 37.0 mt -92.35 118.74 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.054 0.454 . . . . 0.0 110.846 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.4 t -136.85 97.01 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.541 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 135' ' ' ALA . 24.1 t -104.19 130.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.104 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -132.92 118.6 19.1 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -128.74 116.02 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.047 0.451 . . . . 0.0 109.823 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -114.06 140.58 48.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.055 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 34.5 t30 -139.97 105.61 6.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.4 Cg_endo -42.15 113.35 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.984 3.123 . . . . 0.0 113.867 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.8 m 78.93 -22.68 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.663 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 t -121.87 -18.33 7.07 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.296 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -143.68 48.78 0.73 Allowed Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -29.71 -67.26 0.08 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 125.567 1.392 . . . . 0.0 113.392 -164.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 41.4 ptt85 -167.76 138.69 2.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.23 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.3 115.22 25.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.237 0.541 . . . . 0.0 109.932 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 29.6 ttp180 -106.21 105.99 16.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.845 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD21 ' CE ' ' A' ' 49' ' ' MET . 10.0 tt -106.85 107.75 18.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 14.5 p -113.27 133.21 55.22 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.718 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.721 ' HE1' HG21 ' A' ' 80' ' ' ILE . 68.2 mtt -126.67 158.06 37.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.488 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 28.4 tttm -130.23 95.74 3.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 176.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -88.18 97.43 11.0 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.39 63.26 1.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.0 -104.3 0.31 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.55 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.31 30.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.802 0.334 . . . . 0.0 110.21 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -137.63 157.71 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.82 88.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 11.7 tp10 -75.87 -56.95 4.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.244 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -131.81 153.13 50.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.757 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -156.01 131.08 9.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.606 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.5 mttp -140.6 136.13 32.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.2 p90 -132.18 106.52 8.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.822 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 30.7 tt0 -95.82 114.33 26.05 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -151.03 150.91 22.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.173 -1.489 . . . . 0.0 114.563 -173.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.61 142.72 39.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.05 2.46 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.869 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.8 m -94.06 159.1 15.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -56.82 -39.45 74.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.838 0.711 . . . . 0.0 111.027 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -72.99 -32.63 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.689 ' HB3' HD11 ' A' ' 131' ' ' LEU . 1.5 m -68.25 -54.82 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.752 0.786 . . . . 0.0 110.289 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.4 -5.11 51.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.594 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -86.9 -50.48 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 p -72.9 -47.45 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.275 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.13 81.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.294 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 p -68.25 -30.89 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -47.05 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.498 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 96.3 mmm -61.95 -35.88 79.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 m -71.83 -24.1 61.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.042 0.449 . . . . 0.0 111.057 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -46.68 57.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.88 65.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.721 HG21 ' HE1' ' A' ' 49' ' ' MET . 0.5 OUTLIER -74.88 -27.66 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.298 0.571 . . . . 0.0 110.329 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.23 36.32 3.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.659 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.71 174.01 11.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -120.39 -162.53 0.95 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.87 -37.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.81 -46.24 88.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.526 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 p -81.28 -19.18 43.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.753 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.6 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 -46.38 87.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 m -67.57 -28.58 67.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.146 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 44.9 ttp -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.149 0.499 . . . . 0.0 110.106 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.658 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 48.0 t -85.65 -28.03 25.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.267 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.844 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 3.5 tmtp? -60.25 -49.62 76.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 tt -76.24 -25.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.443 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 76.4 t80 -57.99 -44.24 87.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.075 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -82.1 -34.97 29.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 110.638 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.073 -174.008 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.226 -0.142 0 CA-C-O 120.408 0.147 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.71 -42.84 97.02 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.299 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.17 -44.25 80.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.191 0.52 . . . . 0.0 110.216 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.7 mm -64.86 -32.5 58.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.41 -36.89 81.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.17 0.51 . . . . 0.0 110.314 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.78 -12.66 61.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.728 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.07 -6.33 17.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.807 0.813 . . . . 0.0 109.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.967 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.47 98.83 Favored Glycine 0 C--N 1.329 0.179 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.15 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 129' ' ' ALA . 27.6 m -69.59 -19.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 29.3 t -59.03 -13.7 7.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 -18.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.378 -165.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -61.95 126.89 88.32 Favored Pre-proline 0 CA--C 1.518 -0.279 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -18.89 9.37 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.829 2.352 . . . . 0.0 112.919 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -101.13 -10.46 20.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 5.9 mpt_? -128.27 -1.75 5.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.359 -0.838 . . . . 0.0 110.052 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' SER . 8.0 tt -60.92 -36.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.344 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.559 ' HA ' ' HB ' ' A' ' 130' ' ' THR . 82.2 mttt -85.9 -21.01 28.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.526 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . 82.7 m -71.57 -32.45 68.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.714 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -80.04 -39.7 29.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.525 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 127' ' ' LYS . 51.9 m -59.32 -43.97 92.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.855 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 69' ' ' SER . 4.4 pp -63.82 -36.02 82.54 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.492 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.436 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.4 m -72.65 -52.64 14.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.907 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 -49.75 64.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.454 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.18 -26.9 65.98 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.373 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.886 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -69.23 -32.66 72.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 0.0 110.596 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 tp -85.48 -39.22 17.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -64.95 -44.42 89.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.413 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -69.45 -13.21 62.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.815 -172.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.61 -65.17 1.74 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.441 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 m -144.77 17.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -122.17 122.2 38.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.949 -0.469 . . . . 0.0 111.944 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -159.93 30.01 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.944 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.844 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 27.6 tt0 64.55 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.588 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.796 ' HG2' ' HG2' ' A' ' 143' ' ' GLU . 9.5 pt-20 . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.22 -52.15 54.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.12 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -76.01 -26.56 56.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.607 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.7 mt -74.2 -54.2 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.603 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -67.62 -29.54 68.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.95 -34.27 77.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -76.11 -37.89 57.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.114 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 76.6 t -60.45 -48.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 13.4 tt -70.26 -28.51 35.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.027 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 51.3 ttp -79.13 -32.12 44.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.351 . . . . 0.0 110.771 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.652 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 t70 -67.92 -32.81 73.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 110.025 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -85.34 -19.42 31.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.32 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 27.1 t80 -70.28 -23.32 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.703 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 90.8 mttt -59.74 -31.98 70.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.266 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -129.08 80.47 72.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.699 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.71 100.79 1.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.83 2.353 . . . . 0.0 111.759 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -132.27 22.13 4.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.153 0.501 . . . . 0.0 110.035 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.61 76.65 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -164.52 106.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.506 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -175.74 140.36 5.12 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.207 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.52 95.27 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.738 0.78 . . . . 0.0 109.662 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.05 132.94 46.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.534 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -117.16 100.46 7.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -164.34 -57.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.319 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 39.6 t -115.63 -77.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.56 -177.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.537 HD11 HD23 ' A' ' 51' ' ' LEU . 62.9 mt -111.08 129.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.781 0.324 . . . . 0.0 110.481 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 48' ' ' THR . 40.7 t -131.08 98.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.912 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG21 ' HA2' ' A' ' 139' ' ' GLY . 58.7 t -121.96 122.89 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.888 0.375 . . . . 0.0 110.852 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -122.72 148.29 45.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -113.49 117.63 32.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.174 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -117.43 86.62 22.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -34.27 122.74 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 124.603 3.536 . . . . 0.0 114.981 -167.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 m 77.32 -7.57 1.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.398 171.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.7 t -130.86 -46.67 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.823 -0.548 . . . . 0.0 111.855 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.57 58.81 0.66 Allowed Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -52.87 -61.01 2.57 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.11 -1.045 . . . . 0.0 113.661 -163.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.635 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 46.1 mtm-85 -142.6 97.44 3.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.874 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.773 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 9.4 tt -95.48 92.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.238 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 78.4 mtt180 -93.87 97.72 10.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.269 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.536 HD11 HG21 ' A' ' 77' ' ' THR . 66.2 tp -99.91 100.83 11.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.317 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 33' ' ' VAL . 22.3 p -115.52 117.23 29.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.369 -174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.561 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.2 mpp? -114.2 162.07 17.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.036 -171.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 7.5 tmtm? -129.88 100.85 5.62 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 32' ' ' ILE . 3.9 pp -100.36 121.12 40.99 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.16 66.33 0.69 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.713 0.768 . . . . 0.0 109.476 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.91 -109.49 0.52 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.53 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -134.9 32.34 3.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.0 pp -131.83 129.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.896 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 22.9 t -81.09 84.57 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -80.03 -64.18 1.24 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.787 -172.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 38.7 t70 -94.18 147.18 23.42 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.219 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.73 122.24 9.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.968 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 22.3 mmtp -122.7 110.44 15.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.4 p90 -122.05 93.32 3.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.338 0.589 . . . . 0.0 111.859 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.741 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 39.3 tt0 -98.72 98.86 9.93 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.773 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -115.97 103.82 1.22 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.769 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.09 95.86 10.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.13 -131.34 1.32 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.131 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.24 177.62 4.82 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.265 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -46.9 -54.82 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 128' ' ' CYS . 0.1 OUTLIER -70.77 -24.52 25.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.143 -172.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.6 m -67.89 -47.66 68.2 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.1 mtt -73.55 -21.83 60.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.763 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 68' ' ' ILE . . . -86.66 -60.58 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.385 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.8 m -74.79 -37.96 62.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.799 -169.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.76 67.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.53 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -66.86 -24.21 66.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 52.7 tpp -73.06 -53.14 11.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.11 -33.72 76.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.789 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 39.7 m -72.19 -19.52 61.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -69.07 -43.26 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.45 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.615 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.789 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.4 mm -67.59 -38.15 80.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.154 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 64.5 tttp -60.86 -18.33 55.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.514 0.673 . . . . 0.0 110.352 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.3 26.38 7.8 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.953 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.427 ' HE3' HG21 ' A' ' 87' ' ' THR . 15.0 tptt -128.92 -176.37 3.84 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.68 -177.97 3.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.68 -49.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.158 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.31 -32.67 70.27 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.481 0.658 . . . . 0.0 110.057 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.427 HG21 ' HE3' ' A' ' 83' ' ' LYS . 4.7 m -76.79 -24.47 52.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.981 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 91' ' ' MET . . . -74.53 -41.18 61.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.37 -42.23 99.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.594 0.712 . . . . 0.0 109.675 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -68.76 -24.95 64.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.145 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.466 ' HA ' HG22 ' A' ' 94' ' ' ILE . 52.4 ttm -66.44 -28.52 68.67 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.119 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' A' ' 141' ' ' ALA . 13.4 m -82.3 -39.82 22.37 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 8.5 tmtm? -55.41 -42.46 74.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 11.9 tt -82.92 -25.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 91' ' ' MET . 54.9 t80 -58.04 -46.65 84.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.482 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 p -78.89 -37.54 39.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.33 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 12.9 t70 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.904 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 HD12 ' A' ' 113' ' ' ILE . 36.7 mt . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.998 0.428 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.67 -62.59 3.55 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.059 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.74 -34.49 78.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.874 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.624 HD12 HD23 ' A' ' 110' ' ' LEU . 59.5 mt -58.17 -41.03 79.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.389 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.56 -41.35 85.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -71.72 -47.6 52.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.022 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -57.29 -42.47 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.014 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -57.21 -44.99 84.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.881 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.47 -44.61 96.45 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 125' ' ' ARG . 41.3 t -61.97 -34.73 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 67.0 m -61.05 -14.18 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -172.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -125.32 -27.45 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.114 -161.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -65.64 126.78 92.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.36 -16.59 13.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.545 2.163 . . . . 0.0 112.29 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.05 -17.9 23.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.347 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.9 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -126.87 5.22 6.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -176.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 127' ' ' LYS . 9.7 tt -72.64 -30.06 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.953 0.882 . . . . 0.0 109.31 -170.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.499 ' HG3' HG23 ' A' ' 126' ' ' ILE . 66.2 mttm -85.43 -18.63 33.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.941 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' A' ' 68' ' ' ILE . 66.8 m -81.44 -33.22 32.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.343 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 120' ' ' SER . . . -77.7 -48.51 16.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.848 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.481 ' HA ' ' HB3' ' A' ' 133' ' ' TRP . 18.8 p -61.71 -28.7 69.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.6 tt -54.9 -53.59 53.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.455 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.6 m -75.56 -37.0 60.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.256 0.551 . . . . 0.0 110.754 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 22.5 t90 -62.11 -52.29 64.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 79.0 mttt -72.17 -19.8 61.69 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.346 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.53 80.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.682 HD12 HG13 ' A' ' 80' ' ' ILE . 3.0 mm? -88.87 -50.33 6.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.76 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 4.4 tp10 -63.1 -28.38 70.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.309 -172.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 63.5 tttm -106.56 -18.75 13.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.808 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -75.8 -64.77 2.17 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.724 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.06 -17.48 6.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.0 110.857 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' A' ' 92' ' ' SER . . . -97.68 -172.41 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 10.1 tmtt? 176.76 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.305 0.378 . . . . 0.0 111.212 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 1.2 tt0 157.09 -166.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -163.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 118.22 0.464 . . . . 0.0 112.235 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.446 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 57.9 tp . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 -47.53 75.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -72.32 -36.03 68.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.3 tt -69.77 -53.35 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 7' ' ' LEU . 2.1 p90 -71.5 -32.54 68.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.955 -0.111 . . . . 0.0 111.153 -171.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -67.82 -30.43 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.294 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -78.5 -38.31 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.449 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' LEU . 60.0 t -62.58 -47.49 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.702 0.287 . . . . 0.0 110.791 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.3 mm -63.37 -36.2 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.63 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.02 -52.57 62.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 14.2 t70 -69.55 -26.94 64.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.64 ' HA ' ' ND2' ' A' ' 21' ' ' ASN . 26.0 t-80 -73.1 -19.33 61.17 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -82.44 -22.68 35.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.742 0.782 . . . . 0.0 109.206 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 30.8 ttpt -72.53 -19.33 61.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.32 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.653 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 p30 -132.74 175.17 3.91 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.621 -175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 21' ' ' ASN . 68.1 Cg_exo -41.58 136.6 2.89 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.265 2.643 . . . . 0.0 114.348 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -108.9 -174.09 2.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.784 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.67 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 4.5 m-20 -82.03 90.45 6.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.852 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 17.0 ptpt -163.13 19.91 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.131 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -97.78 123.23 7.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.201 -173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.23 97.11 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.956 ' HB2' ' HD3' ' A' ' 60' ' ' LYS . 53.9 tp -92.78 90.86 7.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.108 0.48 . . . . 0.0 109.93 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.413 HD22 ' C ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -78.33 51.16 0.99 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.954 -175.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.61 -87.1 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.864 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 t -92.68 -80.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.429 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.776 HD11 HD23 ' A' ' 51' ' ' LEU . 64.6 mt -88.81 130.41 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.011 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.07 92.47 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 110.171 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.8 t -109.54 119.27 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -124.86 144.12 50.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.708 0.29 . . . . 0.0 110.835 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.539 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 14.5 tpt -151.34 155.1 38.0 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.11 139.19 30.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.1 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -134.14 97.73 14.76 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -25.15 -64.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 125.24 3.96 . . . . 0.0 115.506 -167.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -109.67 6.17 23.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 128' ' ' CYS . 46.7 t -131.96 4.01 4.11 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.886 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 131' ' ' LEU . . . 167.72 57.88 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -38.4 -40.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.792 1.237 . . . . 0.0 113.611 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -149.02 140.33 23.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 6.1 tt -146.45 96.98 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.736 0.779 . . . . 0.0 109.421 166.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -104.42 105.96 16.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.93 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.475 HD11 ' HE3' ' A' ' 49' ' ' MET . 62.8 tp -102.23 104.47 15.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.808 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.8 p -117.73 108.81 15.84 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.965 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 65.1 mtt -110.5 163.1 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.919 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.732 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.0 ttpp -130.12 91.12 3.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 32' ' ' ILE . 1.7 pp -95.99 112.88 24.49 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.11 68.61 0.71 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.594 0.711 . . . . 0.0 109.948 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.51 -105.61 0.35 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.177 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.86 15.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.579 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' HG3' ' A' ' 57' ' ' GLU . 1.3 pp -125.84 -166.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.999 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 80' ' ' ILE . 36.5 t -126.73 106.85 16.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.477 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HG3' HD13 ' A' ' 55' ' ' ILE . 72.8 mt-10 -85.95 -53.88 4.83 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.22 0.534 . . . . 0.0 109.685 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 9.1 t0 -130.11 163.35 26.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.797 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -165.61 132.28 2.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.5 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.956 ' HD3' ' HB2' ' A' ' 28' ' ' LEU . 2.0 mptp? -128.31 144.15 51.1 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -127.86 110.04 12.19 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.058 -175.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -103.57 97.82 7.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 171.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.67 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -138.54 121.15 2.1 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.162 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.08 155.24 28.51 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 153.96 -131.95 3.4 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.362 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.454 ' SG ' ' OG ' ' A' ' 69' ' ' SER . 9.0 p -104.26 162.5 13.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -44.22 -48.95 9.39 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.279 0.987 . . . . 0.0 112.537 -171.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -75.38 -24.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 68' ' ' ILE . 4.9 m -75.11 -40.02 60.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.703 0.763 . . . . 0.0 109.307 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.9 ttp -70.77 -25.95 63.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.767 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.51 -56.23 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.175 -174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.7 p -66.41 -44.91 81.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.52 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.56 -55.25 35.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.982 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -65.14 -37.48 87.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.9 tpt -70.02 -43.93 70.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 109.975 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.8 mmm -67.7 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.7 m -69.58 -20.23 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.766 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -75.56 -39.17 58.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.02 -31.54 72.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.147 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.472 HG22 HG11 ' A' ' 56' ' ' VAL . 18.3 mm -75.67 -33.54 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.667 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -55.55 -20.29 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.47 41.66 1.64 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.992 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HE3' HG21 ' A' ' 87' ' ' THR . 2.6 tptp -133.66 -156.91 0.77 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.268 0.556 . . . . 0.0 111.515 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -140.66 147.81 39.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -170.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.46 -34.47 61.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.226 0.536 . . . . 0.0 109.714 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -57.86 -46.7 84.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.009 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.561 HG21 ' HE3' ' A' ' 83' ' ' LYS . 2.1 m -76.63 -20.81 56.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.134 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.71 ' O ' ' HG2' ' A' ' 91' ' ' MET . . . -69.9 -49.94 47.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.329 0.585 . . . . 0.0 110.96 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 142' ' ' LYS . 10.1 mp -65.38 -28.63 69.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.181 0.515 . . . . 0.0 109.623 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -77.67 -20.48 53.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.239 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.717 ' HA ' HG22 ' A' ' 94' ' ' ILE . 9.2 ptt? -77.63 -22.24 51.04 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.591 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 8.2 t -86.11 -29.58 23.22 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.96 -50.8 69.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.185 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 91' ' ' MET . 10.4 tt -69.82 -28.43 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.103 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 91' ' ' MET . 81.2 t80 -54.63 -45.11 73.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.872 0.368 . . . . 0.0 110.528 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.8 p -85.26 -34.1 22.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 21.1 t70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.615 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.801 0.334 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.41 ' HA2' ' OE1' ' A' ' 114' ' ' GLU . . . -59.73 -34.61 82.96 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.736 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.87 -32.53 65.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.178 0.513 . . . . 0.0 110.364 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 58.8 mt -69.32 -27.6 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' OE1' ' HA2' ' A' ' 111' ' ' GLY . 44.3 mt-10 -63.88 -21.44 66.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.33 59.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.08 -32.0 64.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.35 0.595 . . . . 0.0 110.112 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -53.76 -35.16 60.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.904 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.23 53.79 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.631 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 68' ' ' ILE . 28.9 m -85.74 -17.95 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.552 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.1 t -46.44 -17.34 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -164.04 26.63 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.177 0.899 . . . . 0.0 110.271 -164.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.16 140.65 22.92 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.28 -41.75 4.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.45 2.767 . . . . 0.0 113.501 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.4 9.52 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 98.5 mtt180 -125.13 4.16 7.9 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.053 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.8 tt -83.55 -29.87 7.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.485 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.816 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 33.5 t -85.99 -19.63 30.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.453 175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -79.44 -45.01 20.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.868 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 p -66.02 -30.65 71.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.303 0.573 . . . . 0.0 109.801 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.574 HD11 ' HA3' ' A' ' 42' ' ' GLY . 8.0 tt -56.64 -67.34 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.764 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 m -70.88 -56.01 7.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.588 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -72.94 -51.59 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.966 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 130' ' ' THR . 48.3 tttm -75.69 -22.76 56.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.664 -168.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.31 -27.0 35.21 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.485 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -79.29 -48.31 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 109.945 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 142' ' ' LYS . 34.7 tt0 -65.96 -27.69 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -88.02 -15.01 37.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.093 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -57.83 -43.47 94.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.786 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.12 11.57 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.64 172.46 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.844 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.64 -172.37 4.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.201 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER -66.35 -164.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.048 0.452 . . . . 0.0 111.373 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 . . . . . 0 C--N 1.322 -0.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.614 178.76 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.543 0.211 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.789 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.4 t70 -59.13 -47.37 85.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.493 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -73.26 -23.69 60.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 60.6 tp -70.52 -53.68 15.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.789 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 8.8 p90 -75.03 -19.72 59.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.355 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 38.9 ttp180 -66.98 -35.84 80.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -73.26 -38.31 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.716 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 10' ' ' LEU . 93.9 t -60.64 -50.13 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.548 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 11' ' ' TYR . 32.6 mm -57.95 -52.35 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.825 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.4 ttm -60.23 -54.69 42.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.896 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.4 -37.66 74.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.113 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -77.46 -18.77 56.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.609 0.242 . . . . 0.0 110.802 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.09 -31.88 70.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -73.35 -22.82 60.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.496 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 13.1 m120 -86.85 170.19 12.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.321 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 42.1 Cg_exo -57.99 126.36 21.41 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.86 1.706 . . . . 0.0 110.792 169.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -57.71 -74.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.442 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -177.53 114.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.84 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -148.98 111.42 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.887 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . 153.48 142.27 3.43 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.737 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.09 104.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 48' ' ' THR . 3.4 tt -103.12 87.66 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.122 0.487 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.86 100.38 5.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.21 -71.31 0.18 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.468 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.0 -70.7 0.78 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.679 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' A' ' 49' ' ' MET . 35.9 mt -87.31 116.86 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.001 0.429 . . . . 0.0 109.894 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.625 ' HA ' HG22 ' A' ' 48' ' ' THR . 45.7 t -131.86 91.16 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.627 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 135' ' ' ALA . 41.6 t -114.19 105.71 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 0.0 110.654 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -105.52 123.16 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.633 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 2.0 tpt -124.98 159.06 32.13 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.605 ' H ' ' HE2' ' A' ' 36' ' ' MET . 9.7 p30 -155.72 139.31 15.97 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.96 -172.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.855 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 42.3 t-20 -136.72 94.39 13.2 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 48.78 0.22 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.758 3.639 . . . . 0.0 114.975 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.6 m -159.72 -45.94 0.05 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.407 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 127' ' ' LYS . 10.4 t -133.54 7.35 3.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.245 0.545 . . . . 0.0 111.078 -171.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.28 0.45 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 31.2 t70 -38.9 -67.01 0.23 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' OD2' ' A' ' 43' ' ' ASP . 67.2 mtt180 -135.88 140.25 43.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.668 -0.645 . . . . 0.0 112.024 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.633 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 7.9 tt -139.92 108.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 164.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.711 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 25.6 mmm-85 -93.03 107.67 19.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.5 tp -122.64 106.21 10.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.331 0.586 . . . . 0.0 109.782 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 33' ' ' VAL . 1.6 p -125.56 115.6 20.44 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.454 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.483 ' HB2' HD12 ' A' ' 32' ' ' ILE . 72.9 mtm -114.33 147.3 39.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.395 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 4.9 tmtt? -106.57 86.16 2.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.33 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.12 83.1 5.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.487 0.66 . . . . 0.0 109.408 171.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -86.9 63.15 7.8 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.07 -100.02 0.22 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.362 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.439 ' C ' HD13 ' A' ' 85' ' ' ILE . 4.5 p-10 -150.43 33.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.403 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -136.98 148.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 80' ' ' ILE . 45.7 t -85.46 89.23 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 171.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -80.93 -65.03 1.06 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.338 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t0 -119.1 163.87 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.6 130.92 8.64 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.393 . . . . 0.0 110.394 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 12.4 mptt -114.19 131.88 56.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 16.3 p90 -140.53 135.93 32.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.218 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -148.73 119.95 7.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.72 134.23 9.52 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -124.38 120.41 32.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.15 -129.86 2.17 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.772 -170.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.61 166.77 13.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.961 0.41 . . . . 0.0 110.689 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -59.76 -41.17 90.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.592 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -75.15 -35.18 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 68' ' ' ILE . 9.7 p -71.97 -38.73 69.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -77.42 -17.91 57.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.737 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.89 -55.3 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -60.31 -49.7 76.56 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.905 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.32 -43.16 43.29 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -71.62 -30.35 65.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.572 0.225 . . . . 0.0 111.56 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.6 mmm -77.41 -41.54 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.536 ' CE ' HD22 ' A' ' 136' ' ' LEU . 69.3 mtp -58.12 -37.0 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.61 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 61' ' ' PHE . 97.1 m -64.95 -33.26 75.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.192 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -76.99 -40.78 45.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.4 87.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.921 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -76.86 -28.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.152 -177.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.75 -19.48 65.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.125 0.488 . . . . 0.0 110.835 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.15 31.18 9.03 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.975 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.05 166.88 22.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -116.3 -162.37 0.84 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' HD13 ' A' ' 89' ' ' LEU . 1.6 mp -85.62 -46.23 17.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -61.8 -37.76 85.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.086 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -83.01 -23.78 33.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.78 -43.67 24.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 110.741 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 144' ' ' GLU . 9.8 mp -64.56 -39.17 93.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.448 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 94' ' ' ILE . 10.7 p -72.44 -35.62 68.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.171 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.6 tpp -61.25 -32.15 71.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 29.6 t -84.66 -31.08 24.36 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.21 -47.29 83.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 90' ' ' SER . 37.7 pt -74.92 -23.95 17.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.47 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 90.5 t80 -64.04 -42.08 97.19 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 109.819 172.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -80.14 -30.63 39.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.792 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.308 -177.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.425 0.155 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.65 45.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.268 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 0.0 110.247 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.419 HG21 ' HE1' ' A' ' 95' ' ' PHE . 55.7 mt -80.58 -19.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.705 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.19 -30.41 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.061 0.457 . . . . 0.0 110.251 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.4 -21.68 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.649 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.22 -38.63 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.724 0.774 . . . . 0.0 109.639 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -29.57 67.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.798 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.38 -52.95 19.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 125' ' ' ARG . 13.8 p -73.28 -19.52 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 91.8 p -55.83 -15.36 3.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -116.89 34.88 4.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 0.0 110.59 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.558 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 71.8 m-85 -131.63 177.3 2.31 Favored Pre-proline 0 C--O 1.219 -0.519 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.437 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 122' ' ' PHE . 57.3 Cg_endo -73.9 -2.83 12.81 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.448 1.432 . . . . 0.0 110.363 165.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.52 -18.83 17.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.516 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.623 ' HB3' ' HA ' ' A' ' 120' ' ' SER . 1.9 ppt_? -55.79 -59.56 4.69 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 119.441 -0.314 . . . . 0.0 111.433 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.556 ' H ' ' HD2' ' A' ' 125' ' ' ARG . 9.0 tt -47.68 -32.42 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.151 0.5 . . . . 0.0 110.573 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 50.3 mttp -81.93 -58.48 2.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.649 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.4 m -86.72 -21.43 26.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.065 0.46 . . . . 0.0 111.273 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.06 -32.63 21.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.619 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 5.0 t -62.94 -35.65 80.82 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.502 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 69' ' ' SER . 9.4 tt -61.13 -67.73 0.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.984 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.9 m -65.76 -54.68 23.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.291 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.449 ' NE1' ' HG3' ' A' ' 137' ' ' GLU . 84.1 t90 -71.91 -48.73 43.42 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -171.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 130' ' ' THR . 23.0 tptm -68.97 -25.4 64.51 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.148 -172.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -78.41 -36.36 45.84 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.948 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.536 HD22 ' CE ' ' A' ' 76' ' ' MET . 2.9 tp -80.51 -47.18 14.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 0.0 110.015 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.449 ' HG3' ' NE1' ' A' ' 133' ' ' TRP . 22.2 mm-40 -75.49 -19.74 59.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.443 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.87 -18.89 28.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.741 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -65.38 -54.29 27.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.291 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' O ' HD11 ' A' ' 89' ' ' LEU . 26.1 m -93.04 -1.19 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.58 94.28 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.283 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -50.58 144.79 7.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.83 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.532 ' H ' ' HB3' ' A' ' 92' ' ' SER . 30.9 tt0 70.11 -75.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.319 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HA ' HD23 ' A' ' 89' ' ' LEU . 34.4 tt0 . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.9 HD11 ' HA3' ' A' ' 118' ' ' GLY . 93.8 mt . . . . . 0 CA--C 1.514 -0.434 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.479 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.7 t70 -54.21 -45.23 72.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.62 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -74.35 -40.76 61.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.636 0.731 . . . . 0.0 109.937 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 94.9 mt -68.95 -56.51 7.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.385 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.546 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 1.2 p90 -67.53 -27.11 66.7 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 -60.86 -41.61 96.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.665 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -77.59 -41.51 38.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.267 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 81.7 t -61.6 -46.62 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.173 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 tp -71.38 -30.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.616 0.246 . . . . 0.0 110.613 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.3 tpt -70.16 -47.14 62.91 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.44 -38.4 89.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.198 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -68.8 -27.69 66.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.956 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -74.71 -20.57 59.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 0.0 110.02 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -79.54 -21.44 45.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.093 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 41.0 m-80 -107.23 177.76 1.24 Allowed Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 23.8 Cg_exo -66.02 175.29 4.84 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 23' ' ' ARG . 35.6 mtp-105 -79.96 -142.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.328 0.585 . . . . 0.0 110.289 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 41.4 m-80 -120.03 83.62 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.509 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -144.2 109.49 5.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.523 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -168.53 125.71 1.31 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.801 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.97 103.19 8.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.464 0.65 . . . . 0.0 110.493 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.76 ' O ' ' HB ' ' A' ' 48' ' ' THR . 4.2 tt -125.35 83.73 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.78 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.64 99.34 6.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.487 0.66 . . . . 0.0 110.04 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 35.9 t70 -127.62 -75.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.43 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -101.32 -56.88 2.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 49' ' ' MET . 46.3 pt -122.79 139.2 50.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.228 0.537 . . . . 0.0 110.743 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 48' ' ' THR . 2.3 p -136.27 108.46 7.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.675 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.456 HG21 ' HA2' ' A' ' 139' ' ' GLY . 24.4 t -109.5 142.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.901 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -135.04 135.84 41.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.356 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 14.5 tpt -152.56 147.82 26.64 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.39 161.16 27.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 127' ' ' LYS . 11.8 m120 -106.75 129.68 24.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 165.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 40' ' ' THR . 59.7 Cg_endo -70.46 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.913 2.409 . . . . 0.0 114.199 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 39' ' ' PRO . 14.8 t 158.22 -10.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.792 0.837 . . . . 0.0 111.064 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.63 19.34 4.27 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.071 0.462 . . . . 0.0 111.179 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.547 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.21 48.61 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.15 -31.3 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.647 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 4.0 ptm180 -159.15 137.97 11.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.679 1.127 . . . . 0.0 112.374 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 36' ' ' MET . 11.0 tt -133.48 95.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 162.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 38.4 ttm-85 -95.89 107.71 20.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.927 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 136' ' ' LEU . 61.8 tp -104.54 103.69 13.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 18.1 p -114.58 106.14 13.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.843 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.647 ' HB2' HD11 ' A' ' 32' ' ' ILE . 61.7 mtt -105.19 167.23 9.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.219 0.533 . . . . 0.0 111.097 -175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 62.0 tttp -126.94 86.81 2.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.254 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -95.35 82.02 3.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.843 0.83 . . . . 0.0 109.414 174.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.31 68.79 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.841 0.829 . . . . 0.0 109.273 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.1 -99.9 0.22 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.776 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -145.38 21.25 1.53 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.442 0.639 . . . . 0.0 109.395 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.9 pp -133.87 151.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.808 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.03 89.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 168.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.1 tp10 -75.38 -57.54 3.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 110.04 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -125.01 160.44 28.98 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.263 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -156.83 119.24 3.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.605 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 45.9 mmtm -112.75 138.13 50.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -129.06 100.25 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 38.8 tt0 -90.77 99.81 12.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -126.28 115.51 2.31 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.77 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -127.39 126.63 42.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 169.78 -130.76 2.1 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.634 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.45 162.53 13.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.612 0.244 . . . . 0.0 110.466 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -57.8 -37.86 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -73.72 -35.38 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' HD12 ' A' ' 68' ' ' ILE . 24.8 p -79.13 -33.58 44.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.328 0.585 . . . . 0.0 110.131 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 90.4 mtp -74.26 -15.68 60.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.405 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.23 -51.56 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.003 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 p -59.23 -44.88 92.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.4 -62.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.532 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -55.74 -42.77 75.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.358 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.8 tpt -68.97 -51.27 41.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.596 ' HB3' HD22 ' A' ' 136' ' ' LEU . 92.4 mtp -72.29 -37.93 68.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.241 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.58 ' HA ' HD11 ' A' ' 136' ' ' LEU . 90.9 m -62.73 -29.26 70.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 111.264 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -86.03 -37.61 18.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.804 0.335 . . . . 0.0 110.327 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.94 89.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 0.0 110.064 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.66 -22.02 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.462 0.648 . . . . 0.0 109.4 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' THR . 81.4 tttt -64.63 -21.74 66.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.629 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.62 40.04 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.942 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 80' ' ' ILE . 98.4 mttt -133.95 -172.79 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.03 -168.96 1.51 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -80.69 -45.69 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.471 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.14 -39.92 91.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.168 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -62.74 -36.03 81.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.842 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.34 60.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.461 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 45.3 mt -61.05 -42.44 98.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.198 0.523 . . . . 0.0 109.667 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 t -63.96 -36.1 82.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.319 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 27.9 ttt -68.25 -28.31 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 0.0 110.843 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 31.0 t -86.22 -35.06 20.26 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.87 -49.84 73.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.821 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 13.3 tt -72.87 -22.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 91' ' ' MET . 48.6 t80 -59.23 -45.08 92.09 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.54 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.6 p -85.95 -28.45 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.082 0.468 . . . . 0.0 111.379 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 33.6 t70 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.58 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 114' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 111.587 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.88 -27.06 73.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.691 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.85 -48.0 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.62 -31.32 52.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.365 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 8.0 mm-40 -66.08 -28.15 68.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.651 0.263 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.0 71.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 110.593 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.19 -15.16 24.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.822 0.344 . . . . 0.0 110.5 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.593 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 4.2 tp-100 -49.02 -43.85 40.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.653 -173.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.9 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -78.74 -33.83 36.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.553 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 HD13 ' A' ' 68' ' ' ILE . 29.0 m -87.55 -17.79 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 26.6 t -50.71 -18.89 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -165.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -169.34 27.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.439 1.018 . . . . 0.0 111.15 -167.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -93.46 138.42 23.0 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.96 -34.91 6.74 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.191 2.594 . . . . 0.0 113.303 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.05 5.96 20.58 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 84.2 mtt180 -121.72 -9.03 8.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.423 -0.798 . . . . 0.0 110.374 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' HD2' ' A' ' 127' ' ' LYS . 15.5 tt -77.42 -29.35 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.567 -167.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.584 ' HD2' HG23 ' A' ' 126' ' ' ILE . 14.0 mptt -74.74 -22.88 58.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 67.7 m -85.89 -22.54 27.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.158 0.504 . . . . 0.0 110.017 174.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -72.73 -47.73 44.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.533 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.6 p -65.42 -30.74 71.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.062 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -49.8 -53.65 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -71.52 -51.01 25.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -67.59 -41.61 83.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.948 0.404 . . . . 0.0 111.643 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.713 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 71.8 mmtt -73.5 -17.61 61.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.35 -44.64 11.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.174 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 76' ' ' MET . 3.0 tp -84.19 -63.27 1.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.02 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.41 -30.89 60.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.054 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 49.3 tttm -85.17 -4.32 59.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.355 0.598 . . . . 0.0 109.621 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -73.6 -50.57 11.28 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.452 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 141' ' ' ALA . 9.8 m -76.0 -57.04 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.202 . . . . 0.0 110.501 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . . . 169.59 152.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.704 0.802 . . . . 0.0 109.054 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -96.19 127.93 42.65 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.152 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 92' ' ' SER . 35.5 tt0 67.5 -76.13 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 111.608 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.614 HD11 ' HA3' ' A' ' 118' ' ' GLY . 94.0 mt . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.03 -46.99 61.76 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.466 0.479 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.89 -24.92 52.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.1 tm? -78.32 -58.69 3.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.445 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -76.57 -21.77 55.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.1 ttp180 -69.15 -35.74 76.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -69.12 -41.04 77.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.667 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 94.7 t -69.05 -48.59 68.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' A' ' 67' ' ' SER . 13.9 tt -66.29 -29.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.965 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -61.94 -49.02 77.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 110.051 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.55 -34.77 65.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -74.27 -19.31 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -77.23 -32.8 56.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -31.65 62.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.762 175.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -129.76 84.62 60.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.267 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.69 140.33 2.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.946 2.431 . . . . 0.0 111.886 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 16.4 ttm180 -145.44 17.2 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.412 0.625 . . . . 0.0 110.654 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 14.9 m120 -84.08 83.79 7.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.56 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 tptm -165.64 24.81 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 111.181 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.1 6.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.874 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.26 104.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 48' ' ' THR . 60.9 tp -105.71 95.93 6.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.985 0.422 . . . . 0.0 111.825 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -84.18 91.27 7.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' CG ' ' HG2' ' A' ' 50' ' ' LYS . 13.4 t70 -127.58 -69.7 0.73 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.583 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -127.04 -51.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.059 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 71.4 mt -106.84 129.42 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.044 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 48' ' ' THR . 3.1 m -142.2 82.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.508 0.67 . . . . 0.0 110.928 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 135' ' ' ALA . 49.1 t -98.81 134.69 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.272 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -128.34 147.01 50.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -153.1 151.2 29.91 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -152.04 145.32 24.7 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 111.898 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 41' ' ' CYS . 47.0 t-20 -124.23 111.77 28.36 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -21.56 -64.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 125.688 4.259 . . . . 0.0 115.679 -169.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 m -126.6 23.65 6.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.551 0.691 . . . . 0.0 110.904 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 38' ' ' ASN . 38.3 t -129.43 -36.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.687 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' HB3' ' A' ' 38' ' ' ASN . . . -140.88 62.16 0.54 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -34.82 -53.3 0.55 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.399 1.08 . . . . 0.0 113.666 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -156.7 141.75 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.357 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.44 105.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.448 0.642 . . . . 0.0 110.053 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 18.8 mmt180 -93.34 110.89 22.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.787 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.46 HD21 ' HE3' ' A' ' 49' ' ' MET . 52.2 tp -104.57 94.94 5.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.835 HG22 HG12 ' A' ' 33' ' ' VAL . 10.9 p -115.66 111.2 20.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.601 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 65.5 mtt -109.34 161.34 15.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.913 0.387 . . . . 0.0 111.452 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HE3' ' HB2' ' A' ' 52' ' ' ASP . 8.7 tmtm? -126.06 100.46 6.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pp -100.35 108.16 20.12 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.614 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.817 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 35.6 t70 -100.06 65.77 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.764 0.792 . . . . 0.0 109.263 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.36 -101.45 0.27 Allowed Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.838 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 7.7 m-20 -142.63 28.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.711 -0.745 . . . . 0.0 109.811 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.9 pp -132.5 151.71 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.206 0.527 . . . . 0.0 110.193 -170.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -86.56 96.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.958 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -91.48 -69.98 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -112.46 159.02 19.17 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.21 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -157.58 132.76 8.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.636 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -123.96 120.36 32.27 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -115.96 81.13 1.55 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.415 0.626 . . . . 0.0 111.436 -176.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.95 117.31 24.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.548 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.39 161.06 29.97 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.259 -1.448 . . . . 0.0 113.586 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.03 164.39 27.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.55 -130.46 3.33 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.255 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 34.0 m -81.25 159.35 24.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.903 0.382 . . . . 0.0 110.797 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.583 ' HB2' HD12 ' A' ' 15' ' ' ILE . 5.7 p -61.82 -32.94 73.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.975 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -90.57 -24.49 5.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.694 -176.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.493 ' N ' HD13 ' A' ' 68' ' ' ILE . 31.2 p -76.68 -40.15 49.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.072 0.463 . . . . 0.0 110.913 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.5 ptp -72.03 -17.22 62.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.304 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.54 -46.72 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.119 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' MET . 13.7 p -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.59 -51.94 43.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.26 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -70.57 -27.24 63.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.5 ttt -79.04 -49.18 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.083 0.468 . . . . 0.0 110.288 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 112' ' ' ASP . 90.2 mmm -63.65 -39.84 95.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.192 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.445 HG23 ' HE2' ' A' ' 49' ' ' MET . 31.5 m -75.12 -21.21 59.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.44 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.88 -41.26 78.59 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.23 -26.9 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.298 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.461 ' CD1' HG21 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -72.38 -31.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.667 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.95 -24.58 67.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.579 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -85.68 19.7 23.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.814 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 1.6 mptm? -133.69 -179.25 5.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 109.984 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 5.6 p-10 -116.36 -171.37 1.99 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.34 -40.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.491 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -64.23 -40.97 97.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 109.688 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 91' ' ' MET . 23.2 m -74.86 -32.02 61.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.001 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' CE ' ' A' ' 91' ' ' MET . . . -61.28 -48.65 80.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.847 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 141' ' ' ALA . 72.2 mt -59.14 -39.75 83.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.577 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 m -70.51 -19.89 62.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.232 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.678 ' HA ' HG12 ' A' ' 94' ' ' ILE . 67.1 mtm -79.32 -19.38 50.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.81 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 23.6 t -85.46 -32.62 22.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -58.62 -43.13 89.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.245 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.678 HG12 ' HA ' ' A' ' 91' ' ' MET . 40.5 pt -82.87 -23.94 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.105 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 37.7 t80 -58.11 -46.97 84.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.131 0.491 . . . . 0.0 110.172 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 p -79.85 -27.85 40.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 22.0 t70 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.449 -0.512 0 CA-C-O 121.4 0.619 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -57.35 -19.74 34.13 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.683 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 1.2 p-10 -65.27 -48.57 72.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.57 0.348 . . . . 0.0 111.506 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 110' ' ' LEU . 10.6 tt -71.87 -19.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.453 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 70.2 mm-40 -57.51 -31.03 65.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.594 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.22 59.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.148 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.75 -39.22 18.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 114' ' ' GLU . 12.0 pt20 -62.1 -19.88 63.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -75.67 -51.19 7.35 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.596 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.2 m -78.51 -17.04 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 75.3 m -43.52 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -147.34 6.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.365 0.984 . . . . 0.0 112.584 -163.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.788 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 36.3 m-85 -81.38 142.5 50.52 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.96 -37.16 12.01 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.218 2.612 . . . . 0.0 113.384 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.93 -1.27 15.52 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 95.5 mtt180 -114.34 -3.29 13.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 -174.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 120' ' ' SER . 11.9 tt -70.58 -31.0 44.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.727 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HA ' ' OG1' ' A' ' 130' ' ' THR . 97.2 mttt -81.88 -22.08 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 55.9 m -69.54 -34.84 74.82 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -78.77 -46.53 18.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.275 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 127' ' ' LYS . 22.8 p -62.6 -33.96 76.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.711 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 128' ' ' CYS . 4.3 pp -67.68 -41.61 83.4 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.281 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 m -71.73 -48.29 48.04 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.616 0.722 . . . . 0.0 110.481 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -63.34 -55.35 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.801 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.842 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 68.7 mmtt -72.6 -19.34 61.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.477 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -61.3 -45.26 95.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 110.063 173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 76' ' ' MET . 6.5 mp -86.52 -34.16 20.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.223 0.535 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 8.3 tp10 -63.96 -20.84 66.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.681 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -109.67 -41.56 4.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.941 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.14 -50.91 60.77 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.203 -0.522 . . . . 0.0 114.138 -172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 80' ' ' ILE . 15.5 m -125.27 -8.05 6.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.38 . . . . 0.0 111.753 -172.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -128.15 162.63 26.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.028 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 2.4 ttpm? 179.68 54.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.69 0.619 . . . . 0.0 109.88 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' CB ' ' A' ' 92' ' ' SER . 36.8 mt-10 60.51 -99.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.004 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -96.0 -58.23 2.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.625 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -127.77 128.47 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.68 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -153.1 129.06 10.29 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.41 ' HB1' ' HB ' ' A' ' 9' ' ' THR . . . -83.85 20.11 1.56 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.505 -175.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.22 -52.84 62.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.844 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.1 tp -126.01 -39.88 2.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.198 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.594 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 19.2 t70 -56.23 -57.12 13.57 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.681 -174.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.41 ' HB ' ' HB1' ' A' ' 5' ' ' ALA . 29.3 m -70.2 -25.36 63.38 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.001 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 14' ' ' VAL . 22.9 tp -70.03 -54.48 12.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.324 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 4.3 p90 -72.28 -24.2 61.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 13.6 tpp180 -56.99 -49.62 75.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 173.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.03 -36.86 80.64 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.555 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' A' ' 71' ' ' ALA . 84.2 t -60.25 -45.5 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 tt -78.61 -31.42 15.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.476 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.7 mtt -68.38 -40.65 81.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.619 0.247 . . . . 0.0 110.906 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -64.89 -34.49 78.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.602 ' HE1' ' HB2' ' A' ' 24' ' ' ASN . 40.9 t-80 -71.33 -21.3 62.07 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.535 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -85.97 -31.19 22.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.811 0.338 . . . . 0.0 110.934 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -67.37 -21.36 65.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.084 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -128.35 80.16 72.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.198 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.65 71.55 3.95 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.275 2.65 . . . . 0.0 113.034 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -134.45 125.53 27.64 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.005 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.602 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 57.7 t30 -167.2 152.41 7.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 1.123 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 55.8 tttm 72.64 94.33 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.334 1.021 . . . . 0.0 110.818 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.07 162.97 31.66 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -136.94 119.47 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.39 0.595 . . . . 0.0 110.435 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 48' ' ' THR . 2.4 tt -115.41 101.16 8.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.23 108.82 19.1 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.04 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -152.98 -72.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.376 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -113.88 -71.89 0.73 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -174.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 49' ' ' MET . 41.8 pt -108.25 127.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.3 0.572 . . . . 0.0 111.896 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 48' ' ' THR . 87.3 t -126.44 104.9 13.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.96 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.05 114.33 29.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.627 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 46' ' ' ARG . 4.2 p30 -113.93 154.06 28.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.045 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.514 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 14.9 tpt -140.83 123.39 16.04 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.71 152.04 26.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.1 -177.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.729 ' HB2' HD12 ' A' ' 131' ' ' LEU . 41.7 t-20 -122.05 83.08 44.27 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 169.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.8 -6.71 11.38 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.236 2.624 . . . . 0.0 113.152 -171.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.5 m -86.11 -43.18 13.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.305 0.574 . . . . 0.0 110.398 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 49.8 t -99.82 -24.93 14.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -172.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.67 0.04 36.78 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.654 173.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 2.8 m-20 -70.52 145.83 50.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.807 0.337 . . . . 0.0 110.945 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HG3' ' ND2' ' A' ' 37' ' ' ASN . 20.3 ttm-85 -154.09 114.24 3.9 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.455 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 64.6 mt -122.4 110.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.494 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.739 ' HB2' ' HB3' ' A' ' 62' ' ' GLU . 32.3 mtp180 -94.42 109.45 21.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.728 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.843 HD11 ' HE3' ' A' ' 49' ' ' MET . 52.3 tp -99.55 104.4 16.2 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.502 0.668 . . . . 0.0 109.331 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.69 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 3.2 p -115.75 103.56 10.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.034 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.843 ' HE3' HD11 ' A' ' 47' ' ' LEU . 60.7 mtt -107.77 163.45 13.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.072 0.463 . . . . 0.0 110.939 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 57' ' ' GLU . 87.7 tttt -130.01 100.46 5.45 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.572 174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.33 105.25 17.22 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -109.72 72.54 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.003 -172.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.05 -101.17 0.25 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.366 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -142.66 20.48 2.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.116 0.96 . . . . 0.0 108.601 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.6 pp -127.37 -162.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.588 -174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG11 HG22 ' A' ' 80' ' ' ILE . 57.6 t -123.76 117.74 52.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.975 -1.012 . . . . 0.0 108.387 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 50.6 mm-40 -86.11 -48.99 8.11 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 121.033 0.444 . . . . 0.0 110.23 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.9 174.76 12.74 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.052 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -162.04 131.46 4.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.528 -177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -121.76 118.99 30.42 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -106.41 99.45 9.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.839 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.123 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 31.5 tt0 -81.27 79.43 7.91 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -104.18 114.69 4.81 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.637 -175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ASP . 10.1 tp10 -121.01 150.76 40.65 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.44 -132.5 4.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.825 -1.179 . . . . 0.0 112.626 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 p -101.58 -175.66 2.92 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.902 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 m -61.48 -40.82 95.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.478 -168.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -79.61 -42.93 23.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -171.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.7 p -65.51 -52.35 53.37 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.922 0.391 . . . . 0.0 112.048 -170.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.461 ' HB2' HD21 ' A' ' 24' ' ' ASN . 0.0 OUTLIER -68.39 -22.38 64.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.016 -178.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -85.28 -48.61 8.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.341 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.4 p -59.22 -46.77 87.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.179 0.514 . . . . 0.0 110.848 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.97 83.41 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.459 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.0 m -61.29 -34.25 74.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.432 . . . . 0.0 111.175 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.19 -43.72 27.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.165 0.507 . . . . 0.0 109.835 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 95.0 mmm -73.75 -32.08 63.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.527 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.8 p -74.6 -19.97 60.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.994 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -72.04 -38.37 69.55 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' HD3' ' A' ' 83' ' ' LYS . . . -71.29 -34.11 70.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.728 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.481 HG22 HG11 ' A' ' 56' ' ' VAL . 14.6 mm -71.99 -41.07 68.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.753 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -57.29 -19.0 19.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.322 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.53 25.6 10.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.476 -0.869 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 79' ' ' ALA . 13.2 mptt -127.55 -168.6 1.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.501 . . . . 0.0 110.784 -173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -120.15 -165.98 1.25 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.2 mm -87.27 -38.42 12.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.881 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -59.36 -49.79 76.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.256 0.551 . . . . 0.0 109.987 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.5 p -67.55 -32.59 73.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.252 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.72 -43.6 68.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 79.9 mt -65.79 -36.16 82.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.718 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.5 t -68.11 -45.48 73.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.292 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.51 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 51.1 ttm -58.11 -35.18 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.03 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 7.6 p -87.69 -30.26 20.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.481 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.729 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 83.2 tttt -61.83 -48.2 81.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.644 ' O ' ' HG3' ' A' ' 98' ' ' MET . 12.6 tt -71.67 -32.32 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.047 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 91' ' ' MET . 31.7 t80 -57.22 -44.99 84.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.176 0.512 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -77.99 -33.97 51.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.899 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.24 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.286 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 94' ' ' ILE . 88.0 mtp -53.82 -32.88 54.36 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.442 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.6 ttp -76.66 -18.93 58.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -96.21 -38.95 9.91 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 102' ' ' LYS . . . -70.39 -67.8 1.81 Allowed Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.712 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 101' ' ' GLY . 17.8 mmtm 169.94 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.815 0.846 . . . . 0.0 110.156 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -166.2 109.5 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.331 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' HE2' ' HA3' ' A' ' 101' ' ' GLY . 24.3 p90 -173.67 142.05 0.9 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.689 ' HB2' HD21 ' A' ' 110' ' ' LEU . 27.6 t70 -133.9 133.46 41.5 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -57.89 -26.57 62.32 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.515 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 16.1 m -107.78 -12.0 15.29 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 107' ' ' SER . 2.1 mp 71.75 4.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.445 1.117 . . . . 0.0 109.712 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.81 80.32 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.834 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' A' ' 105' ' ' ASP . 83.9 mt -109.58 22.47 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.728 -173.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -50.05 -57.72 9.63 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.231 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.38 -35.01 31.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.98 0.419 . . . . 0.0 110.725 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.689 HD12 HD23 ' A' ' 110' ' ' LEU . 59.0 mt -59.78 -39.51 80.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.519 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 40.0 mt-10 -77.61 -23.35 49.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.006 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -43.17 25.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.104 0.478 . . . . 0.0 110.306 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 25.7 tp -65.03 -37.4 87.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.286 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 114' ' ' GLU . 1.8 pt20 -73.37 -23.49 60.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.7 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 -47.98 76.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.189 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 129' ' ' ALA . 19.3 m -81.99 -18.58 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.868 0.366 . . . . 0.0 111.28 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.9 t -52.15 -12.64 0.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -117.92 -25.08 6.87 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.689 -0.632 . . . . 0.0 111.043 -163.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -74.58 129.6 83.47 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.49 -29.96 19.89 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.995 2.463 . . . . 0.0 113.022 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -91.53 -15.32 28.9 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.68 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 8.5 mmt180 -113.65 -4.98 13.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.633 -172.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.4 tt -75.93 -32.05 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.482 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.692 ' HG3' HD21 ' A' ' 38' ' ' ASN . 13.3 pttt -81.14 -19.03 44.38 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.625 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.473 ' HB3' HD11 ' A' ' 68' ' ' ILE . 56.9 m -85.61 -28.12 25.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 172.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.23 -50.36 16.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.245 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.9 p -64.92 -26.34 68.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.099 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 38' ' ' ASN . 9.9 tt -54.18 -64.67 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 24.9 m -63.94 -34.12 77.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 111.045 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -66.42 -58.02 6.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.493 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -66.92 -32.93 74.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.703 0.287 . . . . 0.0 111.377 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 76' ' ' MET . 14.2 tp -79.06 -38.42 36.45 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.518 ' CD ' ' HD3' ' A' ' 142' ' ' LYS . 74.0 mt-10 -70.26 -21.91 62.92 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.731 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -86.98 -22.48 25.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.347 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.64 -60.19 8.57 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.814 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -112.48 11.49 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 122.747 -0.267 . . . . 0.0 110.975 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.86 -175.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.031 0.832 . . . . 0.0 109.955 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 59.5 pttt -145.33 166.7 24.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.302 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.729 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 52.4 mt-10 60.15 -104.89 0.2 Allowed 'General case' 0 N--CA 1.462 0.14 0 O-C-N 123.938 0.774 . . . . 0.0 110.201 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -138.74 19.55 2.68 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.9 -52.7 0.24 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.941 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.32 -75.74 1.74 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.035 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.235 0.308 0 C-N-CA 122.747 0.419 . . . . 0.0 111.051 178.661 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -75.53 104.29 6.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.887 0.375 . . . . 0.0 110.544 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -109.23 147.92 31.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.845 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -82.93 90.48 6.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.292 0.568 . . . . 0.0 111.344 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.767 ' HB1' ' HB2' ' A' ' 8' ' ' ASP . . . -102.47 92.83 4.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -49.93 93.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.241 0.963 . . . . 0.0 112.165 -171.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.436 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 47.7 tp 76.61 -15.49 0.72 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.022 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.767 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 4.8 m-20 -59.92 -45.26 93.13 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.34 -176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -59.81 -45.88 90.96 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.138 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 14' ' ' VAL . 80.8 mt -70.4 -60.72 2.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.955 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.9 p90 -63.73 -36.09 82.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.693 -168.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 12.8 ttp180 -74.65 -28.63 60.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -76.29 -42.16 46.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 171.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.4 t -63.4 -46.47 95.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.207 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.6 tt -67.27 -32.75 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.76 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tpt -68.77 -47.31 66.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.86 -48.24 79.87 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.502 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -72.04 -17.9 61.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.267 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -68.15 -42.49 80.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.592 0.71 . . . . 0.0 109.285 171.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 1.8 tmmt? -71.15 -27.04 63.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.723 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.96 85.57 28.61 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 121.035 0.445 . . . . 0.0 111.867 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -94.52 167.78 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.402 2.735 . . . . 0.0 112.88 177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -162.99 25.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.83 36.93 1.25 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.586 -165.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -141.75 108.87 5.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 0.0 111.381 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.65 ' HA3' ' HD2' ' A' ' 60' ' ' LYS . . . 167.4 144.83 4.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.136 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG12 ' HD2' ' A' ' 46' ' ' ARG . 15.4 m -127.82 111.16 23.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.31 0.576 . . . . 0.0 109.864 171.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.632 ' O ' ' HB ' ' A' ' 48' ' ' THR . 47.2 tp -109.53 85.24 2.06 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.69 -178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -77.06 80.07 3.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -141.94 -73.35 0.32 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.635 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 49' ' ' MET . 14.5 m -95.26 -85.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.719 0.295 . . . . 0.0 110.969 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 48' ' ' THR . 78.2 mt -93.35 130.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.051 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.01 95.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.159 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.649 HG13 ' HB2' ' A' ' 47' ' ' LEU . 3.6 p -131.21 108.08 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.521 0.677 . . . . 0.0 111.224 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 5.0 t70 -95.34 145.05 25.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.959 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.478 ' HG3' ' HG ' ' A' ' 131' ' ' LEU . 9.7 tpt -144.17 115.22 7.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 4.9 p30 -120.27 158.04 27.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.564 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HB2' HD12 ' A' ' 131' ' ' LEU . 10.8 t-20 -135.06 105.88 10.4 Favored Pre-proline 0 CA--C 1.52 -0.184 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.87 -16.94 57.86 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.919 2.413 . . . . 0.0 112.795 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -61.6 -38.91 89.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.0 -14.13 3.5 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.76 42.5 4.43 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.557 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB2' HD11 ' A' ' 131' ' ' LEU . 5.3 m-20 -87.07 145.96 26.26 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.477 ' HG2' ' HB3' ' A' ' 37' ' ' ASN . 30.0 mtm180 -143.18 113.74 7.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.405 HD12 ' CD2' ' A' ' 131' ' ' LEU . 64.7 mt -121.52 93.94 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.764 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 42.1 ttm105 -89.12 99.22 12.26 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.882 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 61' ' ' PHE . 62.5 mt -88.1 106.63 18.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 123.843 0.715 . . . . 0.0 109.466 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.708 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 3.4 p -115.77 96.16 5.47 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.337 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.622 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 42.1 mtp -104.38 156.13 18.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.202 -167.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -120.81 87.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.52 0.676 . . . . 0.0 109.47 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 HG13 ' A' ' 32' ' ' ILE . 2.4 pt? -87.38 105.06 17.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.698 173.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.93 67.14 0.74 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.721 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.35 -101.5 0.25 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -139.01 18.2 2.63 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -120.26 150.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.65 -173.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.3 112.5 39.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -114.12 -45.78 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -109.09 147.71 31.98 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.728 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -151.65 118.63 5.84 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.65 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 47.8 mmtm -111.7 111.23 22.07 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.818 ' HB3' HD23 ' A' ' 47' ' ' LEU . 7.8 p90 -127.01 105.22 8.45 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.318 0.58 . . . . 0.0 110.884 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.89 82.56 2.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 170.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -103.61 109.25 3.39 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.533 -172.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.74 159.58 34.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 145.47 -131.44 4.2 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.064 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 19.8 p -102.37 169.1 8.9 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -52.29 -48.16 65.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.73 0.644 . . . . 0.0 112.452 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 69' ' ' SER . 2.4 pp -69.6 -36.23 69.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -171.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 m -72.11 -43.83 64.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.758 0.79 . . . . 0.0 109.802 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 27.2 ttt -70.84 -23.93 62.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.584 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -88.69 -61.04 1.8 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.76 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -67.19 -50.47 60.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.842 -169.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -40.57 94.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.309 0.576 . . . . 0.0 110.328 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -69.41 -31.96 70.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.542 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.5 tpt -73.24 -41.4 63.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.163 0.506 . . . . 0.0 109.827 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 88.3 mtp -62.86 -30.86 71.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.879 175.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CE1' ' A' ' 61' ' ' PHE . 50.8 m -72.91 -22.31 60.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.894 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.53 -33.44 71.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.418 0.627 . . . . 0.0 109.317 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.72 -33.47 25.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.292 174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.4 OUTLIER -73.17 -32.02 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.089 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -64.06 -17.11 63.07 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.308 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.22 27.79 7.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.935 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 95.4 mttt -134.12 -155.53 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 111.633 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -135.18 156.7 48.54 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -170.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 85' ' ' ILE . 2.3 mp -61.49 -42.87 95.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -41.48 73.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.177 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.0 m -79.23 -33.9 43.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.76 -40.94 88.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.362 . . . . 0.0 110.779 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 144' ' ' GLU . 7.6 mp -64.74 -31.36 72.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.526 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.9 m -72.76 -33.92 66.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.129 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 46.0 ttm -67.81 -34.73 77.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.794 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 p -82.09 -30.02 31.46 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.98 -42.1 97.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 106' ' ' ASP . 14.5 tt -78.95 -25.14 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.054 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -62.64 -40.71 97.86 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.3 m -65.6 -31.99 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.875 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.89 -25.8 40.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.712 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.651 ' HG3' ' H ' ' A' ' 104' ' ' TYR . 43.0 ttm -49.06 -39.67 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.028 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -77.0 -26.62 54.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.798 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.766 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -95.52 -37.05 11.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.745 -172.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.8 -64.39 2.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.915 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -163.26 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.54 0.686 . . . . 0.0 110.567 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.691 ' HG2' ' HG ' ' A' ' 110' ' ' LEU . 36.8 tt0 177.71 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.651 ' H ' ' HG3' ' A' ' 98' ' ' MET . 11.7 p90 -165.17 140.04 5.11 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -172.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -131.5 106.63 8.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.878 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.805 ' H ' HD13 ' A' ' 94' ' ' ILE . 16.4 t70 58.1 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.817 0.847 . . . . 0.0 113.061 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.8 m -91.39 3.4 55.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 -175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 mp 59.03 58.23 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.968 0.89 . . . . 0.0 110.062 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -133.17 124.59 27.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.691 ' HG ' ' HG2' ' A' ' 103' ' ' GLU . 2.6 mm? -114.94 14.78 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.118 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.58 36.22 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.733 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.72 -38.94 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.067 0.46 . . . . 0.0 111.119 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 64.6 mt -73.62 -34.9 42.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.936 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 117' ' ' GLN . 40.6 tt0 -62.68 -30.83 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.183 0.516 . . . . 0.0 110.239 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.71 -9.97 59.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.092 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.4 -44.3 6.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.496 0.665 . . . . 0.0 109.773 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -77.95 -19.04 55.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.881 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.09 -50.37 63.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.314 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.1 m -71.87 -19.16 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.381 . . . . 0.0 111.232 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.583 ' O ' HG22 ' A' ' 126' ' ' ILE . 58.7 m -55.92 -12.01 1.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.769 0.827 . . . . 0.0 112.947 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -124.29 -8.44 7.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.312 . . . . 0.0 111.274 -163.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.886 ' HB2' ' HG2' ' A' ' 125' ' ' ARG . 34.3 m-85 -84.5 131.59 49.59 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.68 -18.98 6.88 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.163 2.576 . . . . 0.0 112.943 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -104.87 -8.53 18.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.886 ' HG2' ' HB2' ' A' ' 122' ' ' PHE . 6.8 mmm-85 -123.55 9.85 9.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.074 -1.051 . . . . 0.0 110.008 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 122' ' ' PHE . 26.3 pt -74.22 -28.65 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.024 0.916 . . . . 0.0 108.889 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -85.2 -25.09 27.58 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.806 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 26.4 t -86.32 -28.84 23.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.367 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -75.79 -46.34 31.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.478 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 p -61.49 -30.15 70.43 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 38' ' ' ASN . 6.9 tt -50.29 -63.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.417 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 m -67.73 -45.21 75.65 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.09 0.471 . . . . 0.0 111.509 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -62.62 -52.18 64.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.829 -175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 137' ' ' GLU . 37.4 ttmt -74.15 -19.42 60.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.571 -175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.28 91.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.392 . . . . 0.0 110.282 175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.91 -39.6 23.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.185 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 142' ' ' LYS . 8.4 mm-40 -64.2 -20.35 65.97 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.211 0.529 . . . . 0.0 110.863 178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.24 -34.98 10.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.2 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -65.2 -55.78 19.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.892 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 34.9 m -101.43 6.73 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 122.704 -0.292 . . . . 0.0 111.316 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 74.43 178.21 0.22 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.224 0.953 . . . . 0.0 110.642 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.735 ' HD3' ' HB3' ' A' ' 137' ' ' GLU . 19.1 pttm -143.76 141.33 30.39 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 65.89 -67.64 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.107 0.963 . . . . 0.0 111.551 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.718 ' HA ' HD23 ' A' ' 89' ' ' LEU . 42.5 tt0 -164.56 -44.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.208 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.36 -136.59 8.89 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.326 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.58 -5.41 12.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.967 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.554 0.216 . . . . 0.0 110.577 179.454 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -72.83 83.53 1.2 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.379 0.609 . . . . 0.0 111.467 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -146.25 86.71 1.7 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 -44.09 3.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.651 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.73 138.24 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.6 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -148.01 -79.7 0.14 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.917 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 115' ' ' ALA . 67.7 tp -141.43 -43.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.741 0.305 . . . . 0.0 110.284 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -55.27 -46.76 76.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.22 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -59.02 -33.69 71.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.346 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.4 mt -75.38 -50.27 16.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 15' ' ' ILE . 4.5 m-85 -55.18 -42.44 73.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.858 177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -51.42 -45.52 62.6 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.703 0.627 . . . . 0.0 109.911 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -73.43 -42.72 61.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.554 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 83.7 t -58.76 -48.54 85.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.822 0.344 . . . . 0.0 111.421 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 11' ' ' TYR . 2.9 pp -73.99 -21.15 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.626 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 78.0 mmm -73.53 -43.31 60.28 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.194 176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.81 -39.13 93.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 110.112 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -76.33 -19.24 58.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -72.05 -39.43 69.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.197 0.522 . . . . 0.0 109.753 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -72.25 -19.97 61.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.759 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -119.44 81.29 22.91 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.001 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.19 20.49 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.842 2.361 . . . . 0.0 112.847 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 2.1 mpt_? -93.47 95.21 9.13 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.884 HD21 ' HB2' ' A' ' 70' ' ' MET . 36.6 t30 -118.38 24.38 10.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.0 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.819 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 51.2 mttp -137.59 114.33 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.861 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -157.34 133.22 3.47 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -134.49 105.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.862 0.839 . . . . 0.0 111.699 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 HD13 ' HB2' ' A' ' 50' ' ' LYS . 3.5 tt -115.8 79.22 1.27 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.726 175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HA ' HG22 ' A' ' 33' ' ' VAL . 4.3 t30 -82.53 8.71 11.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.853 -171.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -94.02 3.65 55.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.872 -173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -144.56 -104.31 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.364 -0.21 . . . . 0.0 110.579 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 48' ' ' THR . 63.6 mt -83.87 128.32 38.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.273 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 29' ' ' ASN . 24.8 t -128.49 101.23 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.439 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.014 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.6 t -116.98 120.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.216 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -126.05 145.68 50.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.81 0.338 . . . . 0.0 110.163 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.445 ' HB2' ' CG2' ' A' ' 45' ' ' ILE . 25.5 mmt -138.37 126.47 22.76 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.93 135.87 43.81 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.158 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 42' ' ' GLY . 2.6 t-20 -132.91 97.92 16.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -16.81 -79.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 1 C-N-CA 125.886 4.391 . . . . 0.0 115.669 -162.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.1 p -117.0 17.87 14.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 110.933 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.1 15.02 4.69 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 -174.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.791 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.17 54.95 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.86 -71.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.123 1.369 . . . . 0.0 113.307 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 44' ' ' ARG . 10.4 ptt180 -159.84 119.24 2.86 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.516 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.669 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 5.7 tt -104.33 106.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.38 171.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.445 HH21 ' CD ' ' A' ' 62' ' ' GLU . 51.4 mtm180 -96.68 102.72 14.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.973 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.0 104.75 14.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 1.9 p -117.18 121.74 42.1 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.93 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.524 ' HG2' ' CB ' ' A' ' 59' ' ' ALA . 56.7 mtm -124.17 136.69 54.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.396 -169.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.579 ' HB2' HD13 ' A' ' 28' ' ' LEU . 7.1 tmtt? -109.49 87.47 2.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.3 pt? -77.82 115.0 17.23 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.25 66.33 0.67 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.156 0.503 . . . . 0.0 110.128 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.38 -103.07 0.29 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.341 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -129.58 4.67 5.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.756 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.1 pp -110.21 -164.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.627 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.492 HG21 HG11 ' A' ' 140' ' ' VAL . 25.7 t -126.48 104.2 12.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.635 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 40.9 tt0 -81.7 -71.37 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.956 -171.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 49' ' ' MET . 34.3 t0 -109.68 104.14 13.09 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.502 -177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 49' ' ' MET . . . -102.44 113.59 27.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.166 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.482 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 12.7 mtpp -112.04 131.85 55.17 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 74' ' ' SER . 2.7 p90 -123.05 102.87 8.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.275 0.56 . . . . 0.0 111.434 -172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.819 ' HG3' ' HG2' ' A' ' 25' ' ' LYS . 23.9 tt0 -104.84 94.57 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.603 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -111.29 130.11 9.56 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.824 -176.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.19 131.9 56.76 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.791 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 161.31 -132.25 2.81 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.465 -175.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 70' ' ' MET . 3.5 p -99.65 155.71 17.46 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.3 m -55.63 -36.27 66.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.925 0.765 . . . . 0.0 112.321 -168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.644 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -81.83 -35.75 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -173.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.644 ' N ' HD12 ' A' ' 68' ' ' ILE . 35.2 p -73.73 -39.58 64.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.018 0.437 . . . . 0.0 110.693 -174.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.884 ' HB2' HD21 ' A' ' 24' ' ' ASN . 26.1 ptt? -82.07 -8.21 59.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.6 -57.82 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.502 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -64.02 -53.64 46.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.585 -173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.76 82.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.317 -175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 20.1 m -63.16 -34.11 76.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.0 ttp -69.21 -47.43 64.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.07 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -29.5 69.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.7 m -66.18 -25.36 66.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.144 0.497 . . . . 0.0 110.654 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 74' ' ' SER . 79.1 mt-30 -73.47 -34.54 65.41 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . -69.0 -33.87 74.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.674 173.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 80' ' ' ILE . 1.3 mm -72.32 -30.45 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.63 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -60.01 -17.29 37.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.506 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -120.32 31.17 5.36 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.623 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 66.5 mttm -133.23 -174.89 3.62 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.692 -0.299 . . . . 0.0 110.934 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.756 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -118.7 -175.91 2.99 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -175.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.437 ' O ' HD23 ' A' ' 89' ' ' LEU . 1.7 mp -86.01 -46.79 16.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.978 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -59.19 -40.22 85.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.524 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.46 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.1 p -73.4 -33.46 65.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.999 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.29 -45.97 90.89 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.418 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.62 HD13 ' HA ' ' A' ' 142' ' ' LYS . 4.5 mm? -64.76 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.95 177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 43.0 m -85.03 -29.94 24.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.517 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 87' ' ' THR . 92.6 mmm -69.07 -26.31 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.593 176.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 p -85.41 -31.35 22.94 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -58.28 -47.33 83.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 167.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 mt -57.83 -42.67 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.715 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -55.83 -48.14 75.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.831 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.6 p -70.16 -35.96 74.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -27.95 62.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.948 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.557 ' HA ' ' O ' ' A' ' 102' ' ' LYS . 19.4 ttt -69.8 -51.71 31.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.202 0.525 . . . . 0.0 110.948 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.7 ' HG3' ' HG3' ' A' ' 100' ' ' GLN . 26.6 ptt? -82.33 -5.85 58.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.569 -171.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.7 ' HG3' ' HG3' ' A' ' 99' ' ' MET . 18.7 mt-30 -132.57 13.06 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.958 0.409 . . . . 0.0 110.286 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -153.33 -80.32 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.752 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 98' ' ' MET . 52.5 tttp -152.76 155.13 36.59 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.926 -167.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.39 113.76 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.338 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -173.43 141.89 0.93 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.108 0.48 . . . . 0.0 110.11 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' HD11 ' A' ' 110' ' ' LEU . 39.0 t0 -135.36 130.04 34.33 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.77 -24.04 67.61 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.07 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.0 m -98.89 -19.54 17.3 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.043 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 108' ' ' ILE . 25.3 mm 60.11 33.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.644 0.735 . . . . 0.0 110.466 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -141.31 82.51 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.926 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 105' ' ' ASP . 94.9 mt -121.82 16.62 11.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.963 -178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.26 -24.79 69.28 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.488 -175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.08 -28.94 43.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.771 0.32 . . . . 0.0 111.332 -175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.06 -35.57 72.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.224 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.92 -34.74 75.16 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.199 0.524 . . . . 0.0 109.928 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' A' ' 7' ' ' LEU . . . -70.37 -20.65 62.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.872 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.9 mt -90.28 -34.41 15.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 109.757 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -61.5 -31.12 71.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.013 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.23 -41.68 98.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.751 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.785 HG12 ' HD3' ' A' ' 125' ' ' ARG . 34.5 m -85.91 -20.44 8.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.389 . . . . 0.0 111.404 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 33.0 t -54.04 -15.14 1.28 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -130.36 -23.37 2.67 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.841 0.746 . . . . 0.0 112.78 -162.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 68.5 m-85 -70.96 135.63 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.29 -25.07 45.33 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.737 2.292 . . . . 0.0 111.844 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -97.46 -3.7 39.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.402 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.785 ' HD3' HG12 ' A' ' 119' ' ' VAL . 99.6 mtt180 -123.16 0.82 9.09 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.605 -0.684 . . . . 0.0 110.327 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 tt -72.43 -31.59 38.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.528 0.68 . . . . 0.0 109.78 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -79.96 -19.49 47.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.033 175.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.5 t -85.32 -19.54 31.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.289 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 120' ' ' SER . . . -75.27 -46.56 32.83 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.41 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.6 m -58.39 -37.79 76.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 69' ' ' SER . 6.8 tt -52.95 -70.92 0.08 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.442 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -58.39 3.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.53 0.681 . . . . 0.0 111.087 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 62.6 t90 -66.06 -49.83 66.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.205 -171.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.69 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 37.3 tttp -83.51 -21.07 32.89 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.184 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.57 -30.11 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.392 172.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.0 tp -86.63 -40.83 14.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.143 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 1.132 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 2.9 tm-20 -63.68 -47.6 80.55 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.883 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -92.87 -11.27 33.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.982 -171.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 1.014 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -59.22 -54.77 35.14 Favored Glycine 0 C--O 1.23 -0.143 0 C-N-CA 121.291 -0.48 . . . . 0.0 113.095 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.492 HG11 HG21 ' A' ' 56' ' ' VAL . 18.1 m -114.52 21.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 142' ' ' LYS . . . 68.15 155.82 0.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.417 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 1.132 ' HE2' ' HA ' ' A' ' 137' ' ' GLU . 8.9 mtmm -173.33 151.58 2.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 31.6 tt0 66.73 117.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.744 0.652 . . . . 0.0 110.123 -172.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.447 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 0.3 OUTLIER -78.07 -88.3 0.05 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 144' ' ' GLU . . . 53.48 33.68 47.8 Favored Glycine 0 CA--C 1.521 0.461 0 O-C-N 123.474 0.484 . . . . 0.0 113.685 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.35 46.28 21.05 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.936 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 N--CA 1.467 0.425 0 C-N-CA 123.422 0.689 . . . . 0.0 111.835 -179.274 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 121.213 0.53 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -150.25 40.11 0.77 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.686 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -64.08 -4.79 3.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.916 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -64.22 -31.04 72.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.766 ' HB1' ' HB2' ' A' ' 8' ' ' ASP . . . -97.68 111.18 23.56 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 171.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -59.14 -76.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.723 0.639 . . . . 0.0 112.292 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -100.48 -21.49 15.33 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.766 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 5.1 m-20 -49.12 -45.78 44.04 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.839 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.3 m -62.36 -43.69 98.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.174 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 114' ' ' GLU . 3.4 mm? -76.46 -56.92 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.116 -171.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.612 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 9.8 p90 -68.73 -37.49 79.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.797 -169.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.7 ttm-85 -68.59 -37.2 79.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.91 -46.06 72.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.179 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 10' ' ' LEU . 78.7 t -62.69 -46.48 96.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.789 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.4 mm -64.0 -44.4 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.061 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 20.1 ttt -61.81 -49.03 77.96 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.852 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.72 -48.71 80.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.946 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -74.59 -16.99 60.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.395 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -76.73 -32.31 57.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 0.0 109.796 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -76.82 -21.46 55.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.454 0.645 . . . . 0.0 109.318 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -117.95 71.23 8.01 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.85 38.5 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.529 2.819 . . . . 0.0 114.929 -161.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -103.01 92.52 4.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.932 0.396 . . . . 0.0 110.565 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -125.51 15.37 8.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.701 . . . . 0.0 109.27 175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -118.85 85.22 2.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.56 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.445 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -119.2 122.97 5.5 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.09 100.04 4.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.0 111.708 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.535 ' O ' HG21 ' A' ' 48' ' ' THR . 20.4 tp -108.07 175.52 5.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.488 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.525 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.2 p-10 -156.93 97.65 1.7 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -141.73 -90.85 0.14 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.702 -170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 p -108.39 -65.59 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.821 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.701 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 65.4 mt -87.83 121.39 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 110.362 176.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.7 t -136.04 90.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.47 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.68 112.27 39.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.532 0.682 . . . . 0.0 111.231 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -109.19 123.87 49.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.566 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.546 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.23 118.59 24.55 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -115.66 132.4 56.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.417 0.627 . . . . 0.0 112.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 19.7 t-20 -106.02 105.88 55.03 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 167.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 38' ' ' ASN . 23.8 Cg_exo -65.58 40.31 0.13 Allowed 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 124.809 3.673 . . . . 0.0 115.364 -164.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.6 t -178.1 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.697 0.284 . . . . 0.0 110.742 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.5 t -133.91 18.94 3.81 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -168.77 42.16 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -33.2 -54.21 0.39 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 27.1 ttm180 -146.97 136.47 22.86 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.902 1.228 . . . . 0.0 112.268 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' MET . 8.1 tt -130.66 94.48 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 163.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 10.4 ttm180 -88.0 115.99 25.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.996 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.65 106.33 9.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 28' ' ' LEU . 1.1 p -117.72 112.36 20.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.193 0.521 . . . . 0.0 110.978 -177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.701 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 81.1 mtp -103.97 162.46 13.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.24 -173.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -130.77 104.58 7.25 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.759 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -108.62 94.82 5.26 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.829 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.06 63.52 4.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.525 1.155 . . . . 0.0 109.911 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.74 -100.97 0.25 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.571 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 8.4 m-20 -143.15 30.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.829 -0.685 . . . . 0.0 109.291 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.7 pp -137.1 156.46 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.2 t -89.36 102.28 12.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.39 -46.13 16.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -153.59 169.72 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.684 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -158.37 129.81 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.061 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' CG ' ' HB2' ' A' ' 28' ' ' LEU . 67.9 mmtt -112.59 129.54 56.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 27.7 p90 -128.03 128.79 45.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.075 0.464 . . . . 0.0 111.804 -174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.31 108.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.39 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -116.09 138.31 14.41 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.455 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -132.41 104.2 6.59 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.13 -130.3 1.29 Allowed Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.218 -172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 158.45 19.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -52.14 -38.31 57.13 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.611 0.569 . . . . 0.0 111.882 -175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 69' ' ' SER . 2.3 pp -72.11 -44.0 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.688 ' N ' HD12 ' A' ' 68' ' ' ILE . 7.4 p -70.9 -38.33 73.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.04 -38.22 82.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.089 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -85.49 -45.65 11.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.066 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -55.32 -45.53 76.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.836 0.351 . . . . 0.0 110.352 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -56.67 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.102 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 40.5 p -58.04 -40.76 81.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.781 -176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.7 ttt -73.37 -41.81 62.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.991 0.424 . . . . 0.0 110.146 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.53 ' HB3' HD22 ' A' ' 136' ' ' LEU . 94.8 mtp -73.42 -31.93 64.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.749 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.7 m -73.44 -20.36 60.74 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 74' ' ' SER . 85.3 mt-30 -81.03 -41.33 22.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.51 95.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.067 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 pp -79.43 -20.91 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.851 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -66.01 -21.86 66.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.56 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.72 29.56 10.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.911 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -135.16 -172.63 3.11 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.337 0.568 . . . . 0.0 110.626 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.767 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.3 p-10 -112.36 -172.0 1.96 Allowed 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.2 mm -85.93 -35.2 9.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.404 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.1 -39.58 63.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.694 0.283 . . . . 0.0 110.66 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.38 -23.68 61.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.18 0.514 . . . . 0.0 110.286 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.32 -34.3 59.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.982 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 86.8 mt -66.39 -34.14 77.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.653 177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG12 ' A' ' 94' ' ' ILE . 4.5 p -78.07 -35.36 49.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 19.0 ttt -60.34 -37.89 82.07 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.081 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . 28.2 p -84.71 -27.72 26.82 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.081 0.467 . . . . 0.0 109.867 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.994 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . 17.8 tptp -57.77 -53.29 59.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 97' ' ' ASP . 17.5 pt -75.58 -22.85 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.593 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' O ' ' HG3' ' A' ' 98' ' ' MET . 34.3 t80 -69.72 -26.79 64.51 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.8 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 50.1 m -85.27 -26.61 26.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.344 0.593 . . . . 0.0 109.966 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 94' ' ' ILE . 2.0 m-20 -83.89 -18.17 38.33 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.601 -177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -52.26 -18.88 1.73 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -174.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -73.99 -58.69 3.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.492 0.187 . . . . 0.0 110.535 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -104.1 -43.57 5.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.755 0.312 . . . . 0.0 111.203 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -68.44 -37.17 85.4 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.7 tttt 70.37 28.53 3.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.277 0.631 . . . . 0.0 110.394 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -102.55 152.37 21.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.643 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.608 ' C ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.89 165.69 27.01 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' O ' HD13 ' A' ' 108' ' ' ILE . 28.1 t70 -75.46 79.16 2.5 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 120.845 0.355 . . . . 0.0 110.055 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 108' ' ' ILE . 17.6 t0 73.81 27.42 1.7 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.406 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.573 ' HA ' ' CD1' ' A' ' 104' ' ' TYR . 8.2 t 65.06 47.24 2.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.216 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 105' ' ' ASP . 1.7 mp -103.29 -46.18 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.26 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.34 96.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.882 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.1 mt -148.48 -55.31 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.308 -175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -70.24 -32.15 68.83 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.868 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.7 -45.96 91.73 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.905 0.482 . . . . 0.0 110.292 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.1 -37.73 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.294 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.648 ' HB3' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mm-40 -61.34 -36.0 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.48 68.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -91.35 -21.07 21.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.856 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -50.96 -35.25 32.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.92 -42.19 46.1 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.851 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 125' ' ' ARG . 29.6 m -86.27 -18.32 8.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.446 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 65.9 m -52.96 -18.37 1.93 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -169.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -157.37 5.04 0.14 Allowed 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 118.666 -1.214 . . . . 0.0 113.931 -165.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.743 ' HD2' ' HD2' ' A' ' 125' ' ' ARG . 17.0 m-85 -85.7 132.61 43.82 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 172.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.89 -16.1 11.1 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.91 2.407 . . . . 0.0 112.335 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -103.83 -11.59 17.44 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.342 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.743 ' HD2' ' HD2' ' A' ' 122' ' ' PHE . 94.8 mtt180 -123.74 1.33 8.78 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.682 -0.636 . . . . 0.0 110.271 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -79.73 -24.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.537 -168.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -76.3 -19.56 58.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.386 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 95.5 m -85.88 -24.52 26.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.796 172.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -71.9 -48.03 48.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.708 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -60.98 -30.06 70.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.831 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 9.9 tt -60.02 -66.79 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.774 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 t -71.02 -42.26 69.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.407 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -67.95 -55.33 13.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.661 0.267 . . . . 0.0 110.833 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.57 -25.38 63.96 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.123 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.11 93.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.298 . . . . 0.0 110.771 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 76' ' ' MET . 2.3 tp -76.1 -43.79 41.73 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.84 -19.79 65.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.957 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -85.07 -14.62 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.461 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.56 -68.3 1.69 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.196 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' HB ' HG23 ' A' ' 85' ' ' ILE . 35.6 m -103.47 5.58 10.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 122.843 -0.21 . . . . 0.0 111.158 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 72.96 162.25 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.223 0.952 . . . . 0.0 110.351 -173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 92' ' ' SER . 14.5 pttp -121.1 148.36 44.3 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.314 -177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.994 ' HG2' ' HA ' ' A' ' 93' ' ' LYS . 41.4 mt-10 65.39 -161.27 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.884 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.65 87.06 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -87.39 126.98 8.24 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.545 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.21 169.29 51.4 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.156 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 120.615 0.245 . . . . 0.0 110.756 -177.351 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.928 0.394 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -81.88 82.61 7.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -149.04 -34.53 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.928 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -62.64 101.49 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.054 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.04 54.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.928 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 8' ' ' ASP . 12.8 t-20 -158.57 -114.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.4 tp 72.67 -18.32 0.35 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.727 0.811 . . . . 0.0 110.523 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.566 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 30.2 t70 -71.46 -43.48 66.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.436 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -69.56 -26.83 64.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.587 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.447 ' O ' HG23 ' A' ' 14' ' ' VAL . 92.0 mt -71.75 -30.48 65.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.218 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CD2' ' HA ' ' A' ' 8' ' ' ASP . 15.3 m-85 -59.23 -49.63 77.12 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.893 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 1.8 mpt_? -59.1 -33.79 71.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.725 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -71.4 -49.98 36.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.469 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG11 ' HB1' ' A' ' 71' ' ' ALA . 59.5 t -75.25 -39.86 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.806 -173.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 11' ' ' TYR . 12.2 tt -71.7 -27.96 29.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.294 -0.254 . . . . 0.0 110.648 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.4 ttt -66.87 -39.19 87.46 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.27 -43.23 74.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.775 175.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -63.1 -27.62 69.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.758 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -71.61 -39.71 70.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.518 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -63.71 -32.04 73.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.193 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -83.88 166.96 30.94 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.852 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.48 16.92 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.021 2.481 . . . . 0.0 113.445 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 59.33 -159.67 0.29 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 122.865 0.466 . . . . 0.0 111.062 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -103.27 80.09 1.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.88 0.372 . . . . 0.0 111.391 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -145.67 94.22 2.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.799 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.23 133.73 2.98 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.778 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.58 104.5 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 0.0 110.428 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 48' ' ' THR . 1.1 tt -111.02 88.88 2.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.03 98.94 8.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 21.2 t70 -143.71 -73.45 0.27 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.943 0.401 . . . . 0.0 111.145 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -124.67 -62.37 1.25 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.667 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 37.0 mt -92.35 118.74 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.054 0.454 . . . . 0.0 110.846 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HA ' HG22 ' A' ' 48' ' ' THR . 48.4 t -136.85 97.01 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.541 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 135' ' ' ALA . 24.1 t -104.19 130.38 54.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.104 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -132.92 118.6 19.1 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.4 mmt -128.74 116.02 18.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.047 0.451 . . . . 0.0 109.823 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -114.06 140.58 48.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.055 -176.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 34.5 t30 -139.97 105.61 6.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.4 Cg_endo -42.15 113.35 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.984 3.123 . . . . 0.0 113.867 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.8 m 78.93 -22.68 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.663 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.5 t -121.87 -18.33 7.07 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.296 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 38' ' ' ASN . . . -143.68 48.78 0.73 Allowed Glycine 0 C--N 1.311 -0.857 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 176.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -29.71 -67.26 0.08 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 125.567 1.392 . . . . 0.0 113.392 -164.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 41.4 ptt85 -167.76 138.69 2.89 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.23 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.3 115.22 25.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.237 0.541 . . . . 0.0 109.932 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.636 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 29.6 ttp180 -106.21 105.99 16.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.845 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.503 HD21 ' CE ' ' A' ' 49' ' ' MET . 10.0 tt -106.85 107.75 18.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 14.5 p -113.27 133.21 55.22 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.718 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.721 ' HE1' HG21 ' A' ' 80' ' ' ILE . 68.2 mtt -126.67 158.06 37.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.488 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 28.4 tttm -130.23 95.74 3.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.761 176.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -88.18 97.43 11.0 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.39 63.26 1.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.0 -104.3 0.31 Allowed Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.55 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -142.31 30.71 1.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.802 0.334 . . . . 0.0 110.21 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -137.63 157.71 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -83.82 88.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 50' ' ' LYS . 11.7 tp10 -75.87 -56.95 4.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.244 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -131.81 153.13 50.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.757 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -156.01 131.08 9.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.606 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.5 mttp -140.6 136.13 32.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.636 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.2 p90 -132.18 106.52 8.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.822 -172.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 30.7 tt0 -95.82 114.33 26.05 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -151.03 150.91 22.95 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.173 -1.489 . . . . 0.0 114.563 -173.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.61 142.72 39.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.05 2.46 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.869 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.8 m -94.06 159.1 15.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 p -56.82 -39.45 74.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.838 0.711 . . . . 0.0 111.027 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -72.99 -32.63 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 -176.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.689 ' HB3' HD11 ' A' ' 131' ' ' LEU . 1.5 m -68.25 -54.82 14.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.752 0.786 . . . . 0.0 110.289 -173.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.5 mmt -78.4 -5.11 51.38 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.594 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -86.9 -50.48 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 p -72.9 -47.45 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.275 -174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.13 81.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.294 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 p -68.25 -30.89 70.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.187 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -47.05 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.498 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 96.3 mmm -61.95 -35.88 79.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 m -71.83 -24.1 61.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.042 0.449 . . . . 0.0 111.057 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.75 -46.68 57.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.88 65.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.721 HG21 ' HE1' ' A' ' 49' ' ' MET . 0.5 OUTLIER -74.88 -27.66 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.298 0.571 . . . . 0.0 110.329 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.23 36.32 3.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.659 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -134.71 174.01 11.05 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -120.39 -162.53 0.95 Allowed 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.87 -37.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -58.81 -46.24 88.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.526 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.0 p -81.28 -19.18 43.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.753 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.06 -40.6 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.047 0.451 . . . . 0.0 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.23 -46.38 87.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 m -67.57 -28.58 67.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.146 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 44.9 ttp -65.91 -32.5 74.04 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.149 0.499 . . . . 0.0 110.106 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.658 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 48.0 t -85.65 -28.03 25.0 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.267 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.844 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 3.5 tmtp? -60.25 -49.62 76.88 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.9 tt -76.24 -25.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.443 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 76.4 t80 -57.99 -44.24 87.05 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.837 0.351 . . . . 0.0 111.075 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -82.1 -34.97 29.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.31 0.576 . . . . 0.0 110.638 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -70.72 -30.95 67.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.073 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.461 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -58.33 -37.24 74.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 tpt -79.81 -25.88 40.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.687 -175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -84.21 -38.67 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.868 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.73 -55.22 6.07 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.423 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 102' ' ' LYS . 34.7 ttpt -177.89 -82.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.918 0.389 . . . . 0.0 111.172 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -176.36 97.49 0.06 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.246 -174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 98' ' ' MET . 9.5 p90 -164.67 122.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.179 0.514 . . . . 0.0 111.577 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 107' ' ' SER . 25.4 t70 -125.44 82.28 2.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.871 177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.73 -82.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.19 0.931 . . . . 0.0 112.418 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' ASP . 10.9 p -83.22 -2.28 55.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.735 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 108' ' ' ILE . 24.6 mm 70.8 33.62 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.973 0.892 . . . . 0.0 110.076 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.13 4.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.585 172.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.28 0.22 57.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.042 -174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.71 -42.84 97.02 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.299 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.17 -44.25 80.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.191 0.52 . . . . 0.0 110.216 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 50.7 mm -64.86 -32.5 58.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -61.41 -36.89 81.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.17 0.51 . . . . 0.0 110.314 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.78 -12.66 61.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.728 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.2 tp -107.07 -6.33 17.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.807 0.813 . . . . 0.0 109.09 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.649 -1.159 . . . . 0.0 111.967 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.47 98.83 Favored Glycine 0 C--N 1.329 0.179 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.15 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 129' ' ' ALA . 27.6 m -69.59 -19.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 29.3 t -59.03 -13.7 7.46 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.71 -18.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.378 -165.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -61.95 126.89 88.32 Favored Pre-proline 0 CA--C 1.518 -0.279 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.63 -18.89 9.37 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.829 2.352 . . . . 0.0 112.919 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -101.13 -10.46 20.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 5.9 mpt_? -128.27 -1.75 5.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.359 -0.838 . . . . 0.0 110.052 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 120' ' ' SER . 8.0 tt -60.92 -36.49 72.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.344 -174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.559 ' HA ' ' HB ' ' A' ' 130' ' ' THR . 82.2 mttt -85.9 -21.01 28.19 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.526 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . 82.7 m -71.57 -32.45 68.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.714 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -80.04 -39.7 29.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.525 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 127' ' ' LYS . 51.9 m -59.32 -43.97 92.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.855 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 69' ' ' SER . 4.4 pp -63.82 -36.02 82.54 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.492 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.436 ' N ' HD12 ' A' ' 131' ' ' LEU . 14.4 m -72.65 -52.64 14.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.169 0.509 . . . . 0.0 110.907 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 -49.75 64.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.454 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -68.18 -26.9 65.98 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.373 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.886 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -69.23 -32.66 72.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.988 0.423 . . . . 0.0 110.596 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.0 tp -85.48 -39.22 17.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.899 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -64.95 -44.42 89.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.413 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -69.45 -13.21 62.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.815 -172.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.61 -65.17 1.74 Allowed Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.441 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.2 m -144.77 17.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.899 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -122.17 122.2 38.64 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.949 -0.469 . . . . 0.0 111.944 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -159.93 30.01 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.944 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.844 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 27.6 tt0 64.55 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.588 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.796 ' HG2' ' HG2' ' A' ' 143' ' ' GLU . 9.5 pt-20 177.93 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.83 -165.8 26.52 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.171 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 119.57 -21.68 9.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.679 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.59 0.233 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.8 t -106.96 146.04 31.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.2 t80 72.89 -66.48 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.919 0.762 . . . . 0.0 110.623 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 62.66 21.89 13.0 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.093 0.557 . . . . 0.0 111.731 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.05 145.9 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.584 0.707 . . . . 0.0 111.608 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -79.34 -57.8 3.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.32 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 tt -101.25 -40.0 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.883 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.22 -52.15 54.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.12 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.8 m -76.01 -26.56 56.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.607 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 28.7 mt -74.2 -54.2 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.603 -178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -67.62 -29.54 68.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.95 -34.27 77.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -76.11 -37.89 57.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.114 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 76.6 t -60.45 -48.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.84 0.352 . . . . 0.0 110.968 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 13.4 tt -70.26 -28.51 35.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.027 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 51.3 ttp -79.13 -32.12 44.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.836 0.351 . . . . 0.0 110.771 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.652 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 t70 -67.92 -32.81 73.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.538 0.685 . . . . 0.0 110.025 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -85.34 -19.42 31.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.32 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 27.1 t80 -70.28 -23.32 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.703 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 90.8 mttt -59.74 -31.98 70.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.266 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -129.08 80.47 72.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.699 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.71 100.79 1.37 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.83 2.353 . . . . 0.0 111.759 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -132.27 22.13 4.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.153 0.501 . . . . 0.0 110.035 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -85.61 76.65 9.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.357 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -164.52 106.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.506 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' GLU . . . -175.74 140.36 5.12 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.207 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -139.52 95.27 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.738 0.78 . . . . 0.0 109.662 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.05 132.94 46.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.534 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -117.16 100.46 7.73 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -164.34 -57.76 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.319 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.693 ' HB3' ' HA ' ' A' ' 50' ' ' LYS . 39.6 t -115.63 -77.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.56 -177.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.537 HD11 HD23 ' A' ' 51' ' ' LEU . 62.9 mt -111.08 129.69 65.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.781 0.324 . . . . 0.0 110.481 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 48' ' ' THR . 40.7 t -131.08 98.45 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.912 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG21 ' HA2' ' A' ' 139' ' ' GLY . 58.7 t -121.96 122.89 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.888 0.375 . . . . 0.0 110.852 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.7 p-10 -122.72 148.29 45.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.65 124.58 19.96 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -113.49 117.63 32.22 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.174 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -117.43 86.62 22.72 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -34.27 122.74 0.16 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 124.603 3.536 . . . . 0.0 114.981 -167.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 m 77.32 -7.57 1.82 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.398 171.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.7 t -130.86 -46.67 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.823 -0.548 . . . . 0.0 111.855 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.57 58.81 0.66 Allowed Glycine 0 C--O 1.224 -0.477 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -52.87 -61.01 2.57 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.11 -1.045 . . . . 0.0 113.661 -163.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.635 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 46.1 mtm-85 -142.6 97.44 3.11 Favored 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.874 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.773 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 9.4 tt -95.48 92.82 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.238 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 78.4 mtt180 -93.87 97.72 10.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.269 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.536 HD11 HG21 ' A' ' 77' ' ' THR . 66.2 tp -99.91 100.83 11.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.317 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 33' ' ' VAL . 22.3 p -115.52 117.23 29.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.369 -174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.561 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.2 mpp? -114.2 162.07 17.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.036 -171.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.693 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 7.5 tmtm? -129.88 100.85 5.62 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.537 HD23 HD11 ' A' ' 32' ' ' ILE . 3.9 pp -100.36 121.12 40.99 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -115.16 66.33 0.69 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.713 0.768 . . . . 0.0 109.476 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 144.91 -109.49 0.52 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.53 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -134.9 32.34 3.24 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.0 pp -131.83 129.01 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.896 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 22.9 t -81.09 84.57 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD13 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -80.03 -64.18 1.24 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.787 -172.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.635 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 38.7 t70 -94.18 147.18 23.42 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.219 -177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.73 122.24 9.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.968 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.617 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 22.3 mmtp -122.7 110.44 15.5 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.4 p90 -122.05 93.32 3.95 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.338 0.589 . . . . 0.0 111.859 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.741 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 39.3 tt0 -98.72 98.86 9.93 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.773 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -115.97 103.82 1.22 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.769 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -90.09 95.86 10.4 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.13 -131.34 1.32 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.131 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.24 177.62 4.82 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.265 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -46.9 -54.82 9.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.793 HD11 ' HB3' ' A' ' 128' ' ' CYS . 0.1 OUTLIER -70.77 -24.52 25.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.143 -172.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 68' ' ' ILE . 1.6 m -67.89 -47.66 68.2 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 59.1 mtt -73.55 -21.83 60.25 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.763 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 68' ' ' ILE . . . -86.66 -60.58 1.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.385 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.8 m -74.79 -37.96 62.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.799 -169.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -50.76 67.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.53 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.9 m -66.86 -24.21 66.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.697 0.284 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 52.7 tpp -73.06 -53.14 11.86 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.11 -33.72 76.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.789 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 39.7 m -72.19 -19.52 61.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -69.07 -43.26 74.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.45 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.615 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.789 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.4 mm -67.59 -38.15 80.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.154 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 64.5 tttp -60.86 -18.33 55.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.514 0.673 . . . . 0.0 110.352 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.3 26.38 7.8 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.953 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.427 ' HE3' HG21 ' A' ' 87' ' ' THR . 15.0 tptt -128.92 -176.37 3.84 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -116.68 -177.97 3.31 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.68 -49.13 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.158 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.31 -32.67 70.27 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.481 0.658 . . . . 0.0 110.057 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.427 HG21 ' HE3' ' A' ' 83' ' ' LYS . 4.7 m -76.79 -24.47 52.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.981 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 91' ' ' MET . . . -74.53 -41.18 61.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.37 -42.23 99.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.594 0.712 . . . . 0.0 109.675 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 m -68.76 -24.95 64.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.145 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.466 ' HA ' HG22 ' A' ' 94' ' ' ILE . 52.4 ttm -66.44 -28.52 68.67 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.119 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.743 ' OG ' ' HB1' ' A' ' 141' ' ' ALA . 13.4 m -82.3 -39.82 22.37 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 8.5 tmtm? -55.41 -42.46 74.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 11.9 tt -82.92 -25.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.7 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 91' ' ' MET . 54.9 t80 -58.04 -46.65 84.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.482 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 p -78.89 -37.54 39.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.33 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 12.9 t70 -57.63 -52.32 65.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.904 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -61.31 -33.88 74.32 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.997 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -19.78 61.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.068 0.461 . . . . 0.0 110.829 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -101.75 8.75 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -140.54 -53.77 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.225 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 62.0 mttm 59.04 89.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.73 . . . . 0.0 111.915 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.405 ' H ' ' H ' ' A' ' 104' ' ' TYR . 32.7 tt0 -162.87 -28.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.153 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.405 ' H ' ' H ' ' A' ' 103' ' ' GLU . 36.9 p90 -154.31 150.73 28.29 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.459 0.647 . . . . 0.0 110.259 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 108' ' ' ILE . 10.5 t70 -133.66 144.33 49.13 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 168.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -52.36 -38.76 59.61 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 123.972 0.795 . . . . 0.0 111.514 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.0 t -111.64 -2.4 15.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.781 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . 4.0 mp 51.57 48.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.719 0.771 . . . . 0.0 110.131 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -111.93 85.09 2.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.624 HD23 HD12 ' A' ' 113' ' ' ILE . 36.7 mt -113.19 13.02 19.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.617 -171.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.67 -62.59 3.55 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.059 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.74 -34.49 78.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.75 0.309 . . . . 0.0 110.874 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.624 HD12 HD23 ' A' ' 110' ' ' LEU . 59.5 mt -58.17 -41.03 79.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.389 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.56 -41.35 85.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -71.72 -47.6 52.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.022 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -57.29 -42.47 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.014 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -57.21 -44.99 84.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.881 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.47 -44.61 96.45 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 125' ' ' ARG . 41.3 t -61.97 -34.73 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.619 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 67.0 m -61.05 -14.18 21.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -172.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -125.32 -27.45 3.48 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.114 -161.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -65.64 126.78 92.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.36 -16.59 13.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.545 2.163 . . . . 0.0 112.29 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.05 -17.9 23.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.347 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.9 ' HB3' HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -126.87 5.22 6.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.429 -0.794 . . . . 0.0 110.348 -176.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG23 ' HG3' ' A' ' 127' ' ' LYS . 9.7 tt -72.64 -30.06 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.953 0.882 . . . . 0.0 109.31 -170.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.499 ' HG3' HG23 ' A' ' 126' ' ' ILE . 66.2 mttm -85.43 -18.63 33.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.941 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.793 ' HB3' HD11 ' A' ' 68' ' ' ILE . 66.8 m -81.44 -33.22 32.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.343 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 120' ' ' SER . . . -77.7 -48.51 16.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.848 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.481 ' HA ' ' HB3' ' A' ' 133' ' ' TRP . 18.8 p -61.71 -28.7 69.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.859 0.361 . . . . 0.0 110.282 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 128' ' ' CYS . 6.6 tt -54.9 -53.59 53.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.455 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.6 m -75.56 -37.0 60.28 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.256 0.551 . . . . 0.0 110.754 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 22.5 t90 -62.11 -52.29 64.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.206 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 79.0 mttt -72.17 -19.8 61.69 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.346 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.69 -43.53 80.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.682 HD12 HG13 ' A' ' 80' ' ' ILE . 3.0 mm? -88.87 -50.33 6.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.76 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 4.4 tp10 -63.1 -28.38 70.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.309 -172.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 63.5 tttm -106.56 -18.75 13.88 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.808 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -75.8 -64.77 2.17 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.724 -178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.06 -17.48 6.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.171 0.51 . . . . 0.0 110.857 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.743 ' HB1' ' OG ' ' A' ' 92' ' ' SER . . . -97.68 -172.41 2.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.829 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 10.1 tmtt? 176.76 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.305 0.378 . . . . 0.0 111.212 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 1.2 tt0 157.09 -166.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -163.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -100.16 -37.71 8.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.22 0.464 . . . . 0.0 112.235 -177.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -158.5 -26.78 0.03 OUTLIER Glycine 0 C--N 1.33 0.218 0 C-N-CA 119.402 -1.38 . . . . 0.0 114.035 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.03 22.21 53.19 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.513 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.791 0.295 . . . . 0.0 110.386 178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.861 0.362 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.6 m -70.66 105.09 3.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.801 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -164.19 -79.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.496 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -175.06 137.95 0.43 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.55 99.11 11.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.394 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -80.14 9.59 5.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.514 0.673 . . . . 0.0 109.943 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.446 ' O ' ' HD1' ' A' ' 11' ' ' TYR . 57.9 tp -82.17 -32.4 29.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.971 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 -47.53 75.96 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.088 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 p -72.32 -36.03 68.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 14' ' ' VAL . 10.3 tt -69.77 -53.35 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.476 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 7' ' ' LEU . 2.1 p90 -71.5 -32.54 68.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.955 -0.111 . . . . 0.0 111.153 -171.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -67.82 -30.43 69.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.294 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -78.5 -38.31 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.449 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 10' ' ' LEU . 60.0 t -62.58 -47.49 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-O 120.702 0.287 . . . . 0.0 110.791 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 11' ' ' TYR . 39.3 mm -63.37 -36.2 75.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.63 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.0 ttt -63.02 -52.57 62.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.712 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 14.2 t70 -69.55 -26.94 64.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 110.333 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.64 ' HA ' ' ND2' ' A' ' 21' ' ' ASN . 26.0 t-80 -73.1 -19.33 61.17 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.752 177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -82.44 -22.68 35.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.742 0.782 . . . . 0.0 109.206 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 30.8 ttpt -72.53 -19.33 61.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.32 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.653 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 6.3 p30 -132.74 175.17 3.91 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.621 -175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 21' ' ' ASN . 68.1 Cg_exo -41.58 136.6 2.89 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.265 2.643 . . . . 0.0 114.348 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -108.9 -174.09 2.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.784 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.67 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 4.5 m-20 -82.03 90.45 6.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.852 -172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . 17.0 ptpt -163.13 19.91 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.131 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -97.78 123.23 7.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.201 -173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.23 97.11 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.956 ' HB2' ' HD3' ' A' ' 60' ' ' LYS . 53.9 tp -92.78 90.86 7.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.108 0.48 . . . . 0.0 109.93 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.413 HD22 ' C ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -78.33 51.16 0.99 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.954 -175.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.61 -87.1 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.864 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.4 t -92.68 -80.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.429 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.776 HD11 HD23 ' A' ' 51' ' ' LEU . 64.6 mt -88.81 130.41 38.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.011 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.07 92.47 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.945 0.402 . . . . 0.0 110.171 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HA2' ' A' ' 139' ' ' GLY . 59.8 t -109.54 119.27 58.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -124.86 144.12 50.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.708 0.29 . . . . 0.0 110.835 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.539 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 14.5 tpt -151.34 155.1 38.0 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.11 139.19 30.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.1 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -134.14 97.73 14.76 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -25.15 -64.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 125.24 3.96 . . . . 0.0 115.506 -167.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -109.67 6.17 23.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 128' ' ' CYS . 46.7 t -131.96 4.01 4.11 Favored 'General case' 0 C--O 1.253 1.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.886 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 131' ' ' LEU . . . 167.72 57.88 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -38.4 -40.95 0.6 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.792 1.237 . . . . 0.0 113.611 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 0.6 OUTLIER -149.02 140.33 23.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 6.1 tt -146.45 96.98 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.736 0.779 . . . . 0.0 109.421 166.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -104.42 105.96 16.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.93 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.475 HD11 ' HE3' ' A' ' 49' ' ' MET . 62.8 tp -102.23 104.47 15.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.783 -1.098 . . . . 0.0 108.808 -176.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 32' ' ' ILE . 1.8 p -117.73 108.81 15.84 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.965 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.599 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 65.1 mtt -110.5 163.1 14.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.919 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.732 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.0 ttpp -130.12 91.12 3.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 32' ' ' ILE . 1.7 pp -95.99 112.88 24.49 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.11 68.61 0.71 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.594 0.711 . . . . 0.0 109.948 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.51 -105.61 0.35 Allowed Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.177 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.86 15.75 3.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.579 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' HG3' ' A' ' 57' ' ' GLU . 1.3 pp -125.84 -166.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.999 -171.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 80' ' ' ILE . 36.5 t -126.73 106.85 16.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.477 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HG3' HD13 ' A' ' 55' ' ' ILE . 72.8 mt-10 -85.95 -53.88 4.83 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.22 0.534 . . . . 0.0 109.685 -176.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 9.1 t0 -130.11 163.35 26.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.797 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -165.61 132.28 2.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.5 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.956 ' HD3' ' HB2' ' A' ' 28' ' ' LEU . 2.0 mptp? -128.31 144.15 51.1 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -127.86 110.04 12.19 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.058 -175.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -103.57 97.82 7.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 171.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.67 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -138.54 121.15 2.1 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.162 -172.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.08 155.24 28.51 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 153.96 -131.95 3.4 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 119.905 -1.141 . . . . 0.0 112.362 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 9.0 p -104.26 162.5 13.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.0 m -44.22 -48.95 9.39 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.279 0.987 . . . . 0.0 112.537 -171.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' N ' ' A' ' 69' ' ' SER . 2.6 pp -75.38 -24.32 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.591 ' N ' HD12 ' A' ' 68' ' ' ILE . 4.9 m -75.11 -40.02 60.17 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.703 0.763 . . . . 0.0 109.307 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.9 ttp -70.77 -25.95 63.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.767 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.51 -56.23 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.175 -174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.7 p -66.41 -44.91 81.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.52 -172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.56 -55.25 35.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.982 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.0 t -65.14 -37.48 87.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.9 tpt -70.02 -43.93 70.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 109.975 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 89.8 mmm -67.7 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 110.749 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.7 m -69.58 -20.23 63.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.089 0.471 . . . . 0.0 110.766 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -75.56 -39.17 58.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.02 -31.54 72.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.147 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.472 HG22 HG11 ' A' ' 56' ' ' VAL . 18.3 mm -75.67 -33.54 26.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.667 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -55.55 -20.29 12.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.47 41.66 1.64 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.992 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HE3' HG21 ' A' ' 87' ' ' THR . 2.6 tptp -133.66 -156.91 0.77 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.268 0.556 . . . . 0.0 111.515 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -140.66 147.81 39.85 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 -170.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.46 -34.47 61.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.226 0.536 . . . . 0.0 109.714 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -57.86 -46.7 84.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.009 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.561 HG21 ' HE3' ' A' ' 83' ' ' LYS . 2.1 m -76.63 -20.81 56.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.134 -177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.71 ' O ' ' HG2' ' A' ' 91' ' ' MET . . . -69.9 -49.94 47.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.329 0.585 . . . . 0.0 110.96 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 142' ' ' LYS . 10.1 mp -65.38 -28.63 69.41 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.181 0.515 . . . . 0.0 109.623 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -77.67 -20.48 53.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.239 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.717 ' HA ' HG22 ' A' ' 94' ' ' ILE . 9.2 ptt? -77.63 -22.24 51.04 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.591 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 8.2 t -86.11 -29.58 23.22 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.96 -50.8 69.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.185 173.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 91' ' ' MET . 10.4 tt -69.82 -28.43 36.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.103 177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 91' ' ' MET . 81.2 t80 -54.63 -45.11 73.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.872 0.368 . . . . 0.0 110.528 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.8 p -85.26 -34.1 22.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 21.1 t70 -63.9 -44.53 92.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.615 -177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -64.46 -19.66 65.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.66 0.267 . . . . 0.0 110.993 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 89.8 mtp -80.27 -5.46 56.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 0.0 110.484 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -120.07 -42.13 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.752 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . -83.2 -20.45 60.66 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.878 -178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 25.6 mmtm 73.11 -37.32 0.38 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.187 0.595 . . . . 0.0 111.67 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -91.38 156.71 17.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.19 -154.32 0.58 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -171.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -118.22 93.83 4.27 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.798 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.0 t70 86.04 -4.7 0.79 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.142 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.9 m 64.19 26.5 13.84 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.798 HG23 ' HB3' ' A' ' 106' ' ' ASP . 7.8 pt -41.06 -57.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.932 -174.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.588 ' H ' HG13 ' A' ' 108' ' ' ILE . 11.6 t70 -141.12 139.71 34.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.9 mt -147.74 -55.44 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.801 0.334 . . . . 0.0 111.304 -173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.41 ' HA2' ' OE1' ' A' ' 114' ' ' GLU . . . -59.73 -34.61 82.96 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.736 -175.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.87 -32.53 65.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.178 0.513 . . . . 0.0 110.364 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 58.8 mt -69.32 -27.6 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' OE1' ' HA2' ' A' ' 111' ' ' GLY . 44.3 mt-10 -63.88 -21.44 66.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.719 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.79 -37.33 59.27 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.738 176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.08 -32.0 64.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.35 0.595 . . . . 0.0 110.112 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -53.76 -35.16 60.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.904 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.24 -47.23 53.79 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.631 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.451 HG11 HD13 ' A' ' 68' ' ' ILE . 28.9 m -85.74 -17.95 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.552 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.1 t -46.44 -17.34 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -164.04 26.63 0.07 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.177 0.899 . . . . 0.0 110.271 -164.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.16 140.65 22.92 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.28 -41.75 4.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.45 2.767 . . . . 0.0 113.501 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.4 9.52 19.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 119' ' ' VAL . 98.5 mtt180 -125.13 4.16 7.9 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.053 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.8 tt -83.55 -29.87 7.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.485 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.52 -18.95 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.816 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 33.5 t -85.99 -19.63 30.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.453 175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -79.44 -45.01 20.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.868 176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 1.9 p -66.02 -30.65 71.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.303 0.573 . . . . 0.0 109.801 174.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.574 HD11 ' HA3' ' A' ' 42' ' ' GLY . 8.0 tt -56.64 -67.34 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.764 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 m -70.88 -56.01 7.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.588 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -72.94 -51.59 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.966 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 130' ' ' THR . 48.3 tttm -75.69 -22.76 56.37 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.664 -168.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.31 -27.0 35.21 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.485 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -79.29 -48.31 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 109.945 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 142' ' ' LYS . 34.7 tt0 -65.96 -27.69 68.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -88.02 -15.01 37.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.093 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -57.83 -43.47 94.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.786 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.12 11.57 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.64 172.46 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.844 -174.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.64 -172.37 4.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.201 -178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 92' ' ' SER . 0.0 OUTLIER -66.35 -164.58 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.048 0.452 . . . . 0.0 111.373 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.3 77.74 1.12 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.614 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.4 135.5 5.83 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.544 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.56 99.05 0.15 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 C--O 1.239 0.539 0 CA-C-O 120.734 0.302 . . . . 0.0 110.867 -178.076 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtm . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -135.49 -84.74 0.39 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.936 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 60.46 23.07 12.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.172 0.511 . . . . 0.0 110.825 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -139.0 175.97 9.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.383 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.36 20.75 12.28 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.063 0.545 . . . . 0.0 111.427 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.3 t30 63.05 8.58 3.31 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.37 0.605 . . . . 0.0 111.279 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.71 -48.03 42.16 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.048 -0.408 . . . . 0.0 111.065 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.789 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.4 t70 -59.13 -47.37 85.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.493 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -73.26 -23.69 60.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 14' ' ' VAL . 60.6 tp -70.52 -53.68 15.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.789 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 8.8 p90 -75.03 -19.72 59.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.355 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 12' ' ' ARG . 38.9 ttp180 -66.98 -35.84 80.86 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -73.26 -38.31 66.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.716 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 10' ' ' LEU . 93.9 t -60.64 -50.13 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.548 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 11' ' ' TYR . 32.6 mm -57.95 -52.35 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.825 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.4 ttm -60.23 -54.69 42.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.896 -174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.4 -37.66 74.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.113 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -77.46 -18.77 56.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.609 0.242 . . . . 0.0 110.802 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -69.09 -31.88 70.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -73.35 -22.82 60.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.496 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 13.1 m120 -86.85 170.19 12.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.321 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 42.1 Cg_exo -57.99 126.36 21.41 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.86 1.706 . . . . 0.0 110.792 169.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -57.71 -74.46 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.784 0.326 . . . . 0.0 110.442 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -177.53 114.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.84 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -148.98 111.42 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.887 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 60' ' ' LYS . . . 153.48 142.27 3.43 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.969 -1.11 . . . . 0.0 113.737 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -137.09 104.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 48' ' ' THR . 3.4 tt -103.12 87.66 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.122 0.487 . . . . 0.0 110.419 -174.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -76.86 100.38 5.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.21 -71.31 0.18 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.468 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.0 -70.7 0.78 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.679 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' A' ' 49' ' ' MET . 35.9 mt -87.31 116.86 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.001 0.429 . . . . 0.0 109.894 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.625 ' HA ' HG22 ' A' ' 48' ' ' THR . 45.7 t -131.86 91.16 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.627 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 135' ' ' ALA . 41.6 t -114.19 105.71 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.09 0.471 . . . . 0.0 110.654 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -105.52 123.16 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.633 ' HB3' ' CG2' ' A' ' 45' ' ' ILE . 2.0 tpt -124.98 159.06 32.13 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.605 ' H ' ' HE2' ' A' ' 36' ' ' MET . 9.7 p30 -155.72 139.31 15.97 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.96 -172.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.855 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 42.3 t-20 -136.72 94.39 13.2 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.69 48.78 0.22 Allowed 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 124.758 3.639 . . . . 0.0 114.975 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.6 m -159.72 -45.94 0.05 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.407 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 127' ' ' LYS . 10.4 t -133.54 7.35 3.84 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.245 0.545 . . . . 0.0 111.078 -171.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.28 0.45 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' OD2' ' HG3' ' A' ' 44' ' ' ARG . 31.2 t70 -38.9 -67.01 0.23 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' OD2' ' A' ' 43' ' ' ASP . 67.2 mtt180 -135.88 140.25 43.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 O-C-N 121.668 -0.645 . . . . 0.0 112.024 -174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.633 ' CG2' ' HB3' ' A' ' 36' ' ' MET . 7.9 tt -139.92 108.54 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 164.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.711 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 25.6 mmm-85 -93.03 107.67 19.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.5 tp -122.64 106.21 10.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.331 0.586 . . . . 0.0 109.782 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.625 HG22 ' HA ' ' A' ' 33' ' ' VAL . 1.6 p -125.56 115.6 20.44 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.454 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.483 ' HB2' HD12 ' A' ' 32' ' ' ILE . 72.9 mtm -114.33 147.3 39.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.395 -171.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 4.9 tmtt? -106.57 86.16 2.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.33 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -91.12 83.1 5.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.487 0.66 . . . . 0.0 109.408 171.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -86.9 63.15 7.8 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.07 -100.02 0.22 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.362 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.439 ' C ' HD13 ' A' ' 85' ' ' ILE . 4.5 p-10 -150.43 33.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.229 -0.486 . . . . 0.0 110.403 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -136.98 148.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -174.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.757 HG11 HG23 ' A' ' 80' ' ' ILE . 45.7 t -85.46 89.23 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 171.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -80.93 -65.03 1.06 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.338 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t0 -119.1 163.87 16.38 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.6 130.92 8.64 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.926 0.393 . . . . 0.0 110.394 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 12.4 mptt -114.19 131.88 56.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.711 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 16.3 p90 -140.53 135.93 32.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.218 -169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -148.73 119.95 7.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.72 134.23 9.52 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -124.38 120.41 32.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.15 -129.86 2.17 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.772 -170.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 60.1 m -90.61 166.77 13.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 120.961 0.41 . . . . 0.0 110.689 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.9 m -59.76 -41.17 90.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.592 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -75.15 -35.18 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 68' ' ' ILE . 9.7 p -71.97 -38.73 69.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 -175.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -77.42 -17.91 57.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.737 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.89 -55.3 4.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.182 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -60.31 -49.7 76.56 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.905 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.32 -43.16 43.29 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -71.62 -30.35 65.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.572 0.225 . . . . 0.0 111.56 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.6 mmm -77.41 -41.54 39.58 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.536 ' CE ' HD22 ' A' ' 136' ' ' LEU . 69.3 mtp -58.12 -37.0 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.61 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 61' ' ' PHE . 97.1 m -64.95 -33.26 75.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.192 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -76.99 -40.78 45.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.4 87.19 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.921 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.757 HG23 HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -76.86 -28.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.152 -177.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -64.75 -19.48 65.82 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.125 0.488 . . . . 0.0 110.835 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.15 31.18 9.03 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.975 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.05 166.88 22.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -116.3 -162.37 0.84 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' HD13 ' A' ' 89' ' ' LEU . 1.6 mp -85.62 -46.23 17.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -61.8 -37.76 85.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.086 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -83.01 -23.78 33.12 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.78 -43.67 24.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 110.741 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 144' ' ' GLU . 9.8 mp -64.56 -39.17 93.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.448 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 94' ' ' ILE . 10.7 p -72.44 -35.62 68.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.171 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.6 tpp -61.25 -32.15 71.95 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.344 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.532 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 29.6 t -84.66 -31.08 24.36 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.21 -47.29 83.17 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 105' ' ' ASP . 37.7 pt -74.92 -23.95 17.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.47 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 90.5 t80 -64.04 -42.08 97.19 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 109.819 172.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.9 t -80.14 -30.63 39.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.792 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.61 -44.55 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.308 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 24.9 ptt? -53.72 -18.54 3.2 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 26.0 ttt -60.56 -36.27 78.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.643 0.258 . . . . 0.0 110.946 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -140.78 -40.41 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.6 0.238 . . . . 0.0 111.481 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 -29.05 73.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.485 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.7 tttp 79.48 10.15 1.5 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.327 0.584 . . . . 0.0 109.907 172.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.35 99.74 10.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.763 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -95.54 -148.24 0.29 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.54 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.525 ' HA ' HD12 ' A' ' 94' ' ' ILE . 13.7 t0 -101.75 109.43 21.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.45 -10.96 19.77 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.85 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.451 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.2 m -83.63 -16.58 44.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 108' ' ' ILE . 19.5 mm 66.05 32.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.48 0.657 . . . . 0.0 110.201 173.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -81.37 66.25 6.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.8 mt -121.99 2.97 9.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.17 -173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.32 -38.65 45.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.268 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 0.0 110.247 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.419 HG21 ' HE1' ' A' ' 95' ' ' PHE . 55.7 mt -80.58 -19.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.705 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -62.19 -30.41 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.061 0.457 . . . . 0.0 110.251 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.4 -21.68 61.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.649 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.22 -38.63 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.724 0.774 . . . . 0.0 109.639 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -29.57 67.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.798 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.38 -52.95 19.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 125' ' ' ARG . 13.8 p -73.28 -19.52 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 91.8 p -55.83 -15.36 3.17 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -116.89 34.88 4.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 0.0 110.59 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.558 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 71.8 m-85 -131.63 177.3 2.31 Favored Pre-proline 0 C--O 1.219 -0.519 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.437 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 122' ' ' PHE . 57.3 Cg_endo -73.9 -2.83 12.81 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.448 1.432 . . . . 0.0 110.363 165.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.52 -18.83 17.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.516 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.623 ' HB3' ' HA ' ' A' ' 120' ' ' SER . 1.9 ppt_? -55.79 -59.56 4.69 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 119.441 -0.314 . . . . 0.0 111.433 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.556 ' H ' ' HD2' ' A' ' 125' ' ' ARG . 9.0 tt -47.68 -32.42 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.151 0.5 . . . . 0.0 110.573 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.855 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 50.3 mttp -81.93 -58.48 2.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.649 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.4 m -86.72 -21.43 26.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.065 0.46 . . . . 0.0 111.273 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.06 -32.63 21.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.619 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 5.0 t -62.94 -35.65 80.82 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.502 173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 69' ' ' SER . 9.4 tt -61.13 -67.73 0.38 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.984 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.9 m -65.76 -54.68 23.81 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.291 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.449 ' NE1' ' HG3' ' A' ' 137' ' ' GLU . 84.1 t90 -71.91 -48.73 43.42 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -171.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 130' ' ' THR . 23.0 tptm -68.97 -25.4 64.51 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.148 -172.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -78.41 -36.36 45.84 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.948 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.536 HD22 ' CE ' ' A' ' 76' ' ' MET . 2.9 tp -80.51 -47.18 14.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.959 0.409 . . . . 0.0 110.015 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.449 ' HG3' ' NE1' ' A' ' 133' ' ' TRP . 22.2 mm-40 -75.49 -19.74 59.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.443 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.87 -18.89 28.24 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.741 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -65.38 -54.29 27.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.291 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' O ' HD11 ' A' ' 89' ' ' LEU . 26.1 m -93.04 -1.19 10.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.58 94.28 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.768 0.667 . . . . 0.0 111.283 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -50.58 144.79 7.45 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.83 -179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.532 ' H ' ' HB3' ' A' ' 92' ' ' SER . 30.9 tt0 70.11 -75.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.319 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.524 ' HA ' HD23 ' A' ' 89' ' ' LEU . 34.4 tt0 -177.97 95.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.71 -174.92 54.19 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.46 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.14 35.71 0.33 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.668 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.864 0.364 . . . . 0.0 110.713 -179.778 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.254 0.55 . . . . 0.0 110.506 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -131.98 -38.73 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -88.23 36.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.442 0.639 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 11.4 m120 -87.66 -14.49 39.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.323 175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.53 128.8 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.696 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -134.94 135.87 41.83 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.9 HD11 ' HA3' ' A' ' 118' ' ' GLY . 93.8 mt -52.11 -38.95 59.05 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.119 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.7 t70 -54.21 -45.23 72.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.62 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -74.35 -40.76 61.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.636 0.731 . . . . 0.0 109.937 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 94.9 mt -68.95 -56.51 7.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.385 -175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.546 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 1.2 p90 -67.53 -27.11 66.7 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -173.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 -60.86 -41.61 96.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.665 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -77.59 -41.51 38.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.267 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 81.7 t -61.6 -46.62 96.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.173 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.9 tp -71.38 -30.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.616 0.246 . . . . 0.0 110.613 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.3 tpt -70.16 -47.14 62.91 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.11 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.44 -38.4 89.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.198 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -68.8 -27.69 66.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.956 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -74.71 -20.57 59.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 0.0 110.02 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -79.54 -21.44 45.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.093 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 41.0 m-80 -107.23 177.76 1.24 Allowed Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.947 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 23.8 Cg_exo -66.02 175.29 4.84 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 23' ' ' ARG . 35.6 mtp-105 -79.96 -142.53 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.328 0.585 . . . . 0.0 110.289 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 63' ' ' GLY . 41.4 m-80 -120.03 83.62 2.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.509 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -144.2 109.49 5.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.523 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 60' ' ' LYS . . . -168.53 125.71 1.31 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.801 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.97 103.19 8.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.464 0.65 . . . . 0.0 110.493 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.76 ' O ' ' HB ' ' A' ' 48' ' ' THR . 4.2 tt -125.35 83.73 2.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.78 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -78.64 99.34 6.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.487 0.66 . . . . 0.0 110.04 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 35.9 t70 -127.62 -75.64 0.57 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.43 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -101.32 -56.88 2.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 49' ' ' MET . 46.3 pt -122.79 139.2 50.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.228 0.537 . . . . 0.0 110.743 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 48' ' ' THR . 2.3 p -136.27 108.46 7.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.675 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.456 HG21 ' HA2' ' A' ' 139' ' ' GLY . 24.4 t -109.5 142.97 20.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.901 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -135.04 135.84 41.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.356 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 14.5 tpt -152.56 147.82 26.64 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -162.39 161.16 27.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 127' ' ' LYS . 11.8 m120 -106.75 129.68 24.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 165.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 40' ' ' THR . 59.7 Cg_endo -70.46 41.42 0.36 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.913 2.409 . . . . 0.0 114.199 -173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 39' ' ' PRO . 14.8 t 158.22 -10.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.792 0.837 . . . . 0.0 111.064 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.2 t -132.63 19.34 4.27 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-O 121.071 0.462 . . . . 0.0 111.179 -170.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.547 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . 164.21 48.61 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.15 -31.3 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.647 ' O ' ' HA2' ' A' ' 63' ' ' GLY . 4.0 ptm180 -159.15 137.97 11.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 119.679 1.127 . . . . 0.0 112.374 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 36' ' ' MET . 11.0 tt -133.48 95.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 162.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.742 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 38.4 ttm-85 -95.89 107.71 20.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.927 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 136' ' ' LEU . 61.8 tp -104.54 103.69 13.41 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 18.1 p -114.58 106.14 13.9 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.843 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.647 ' HB2' HD11 ' A' ' 32' ' ' ILE . 61.7 mtt -105.19 167.23 9.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.219 0.533 . . . . 0.0 111.097 -175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 57' ' ' GLU . 62.0 tttp -126.94 86.81 2.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.254 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -95.35 82.02 3.66 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.843 0.83 . . . . 0.0 109.414 174.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.31 68.79 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.841 0.829 . . . . 0.0 109.273 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.1 -99.9 0.22 Allowed Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.776 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -145.38 21.25 1.53 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.442 0.639 . . . . 0.0 109.395 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.9 pp -133.87 151.42 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.808 -168.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.03 89.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 168.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HB2' HD13 ' A' ' 55' ' ' ILE . 13.1 tp10 -75.38 -57.54 3.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 110.04 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -125.01 160.44 28.98 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.263 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -156.83 119.24 3.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.605 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 45.9 mmtm -112.75 138.13 50.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -129.06 100.25 5.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.184 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ARG . 38.8 tt0 -90.77 99.81 12.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 44' ' ' ARG . . . -126.28 115.51 2.31 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.77 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -127.39 126.63 42.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . 169.78 -130.76 2.1 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.634 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -96.45 162.53 13.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.612 0.244 . . . . 0.0 110.466 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -57.8 -37.86 74.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.635 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 69' ' ' SER . 2.7 pp -73.72 -35.38 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.64 ' N ' HD12 ' A' ' 68' ' ' ILE . 24.8 p -79.13 -33.58 44.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.328 0.585 . . . . 0.0 110.131 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 90.4 mtp -74.26 -15.68 60.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.405 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.23 -51.56 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.003 177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 p -59.23 -44.88 92.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.4 -62.33 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.532 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.9 m -55.74 -42.77 75.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.358 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 15.8 tpt -68.97 -51.27 41.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.302 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.596 ' HB3' HD22 ' A' ' 136' ' ' LEU . 92.4 mtp -72.29 -37.93 68.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.241 -175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.58 ' HA ' HD11 ' A' ' 136' ' ' LEU . 90.9 m -62.73 -29.26 70.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.707 0.289 . . . . 0.0 111.264 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -86.03 -37.61 18.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.804 0.335 . . . . 0.0 110.327 -176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.94 89.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.103 0.478 . . . . 0.0 110.064 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.66 -22.02 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.462 0.648 . . . . 0.0 109.4 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' THR . 81.4 tttt -64.63 -21.74 66.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.629 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.62 40.04 2.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.942 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 80' ' ' ILE . 98.4 mttt -133.95 -172.79 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -116.03 -168.96 1.51 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.646 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -80.69 -45.69 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.471 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.14 -39.92 91.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.168 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -62.74 -36.03 81.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.842 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.07 -39.34 60.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.461 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 45.3 mt -61.05 -42.44 98.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.198 0.523 . . . . 0.0 109.667 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 t -63.96 -36.1 82.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.319 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.433 ' HA ' HG22 ' A' ' 94' ' ' ILE . 27.9 ttt -68.25 -28.31 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 0.0 110.843 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 31.0 t -86.22 -35.06 20.26 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.87 -49.84 73.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.821 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 97' ' ' ASP . 13.3 tt -72.87 -22.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 98' ' ' MET . 48.6 t80 -59.23 -45.08 92.09 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.54 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.6 p -85.95 -28.45 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.082 0.468 . . . . 0.0 111.379 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 33.6 t70 -71.1 -19.45 62.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.58 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 95' ' ' PHE . 24.2 ptm -48.92 -31.6 7.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.6 mmt -60.0 -44.15 94.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.386 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.943 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -110.22 -4.25 15.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.23 -31.33 78.7 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 46.5 tptt 73.23 -69.03 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.243 0.617 . . . . 0.0 111.726 170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -121.14 120.95 36.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -167.07 166.7 15.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -132.96 119.44 20.12 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.044 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -49.76 96.19 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 124.022 0.826 . . . . 0.0 110.19 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.3 m 61.32 23.79 13.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.257 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm 75.28 -15.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.212 0.605 . . . . 0.0 111.04 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -142.65 105.29 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 110' ' ' LEU . 1.3 mp -89.81 36.04 0.85 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.587 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.88 -27.06 73.62 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.691 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.85 -48.0 14.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 0.0 111.391 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 16.4 tt -63.62 -31.32 52.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.365 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 8.0 mm-40 -66.08 -28.15 68.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.651 0.263 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -31.0 71.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 110.593 175.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.19 -15.16 24.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.822 0.344 . . . . 0.0 110.5 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.593 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 4.2 tp-100 -49.02 -43.85 40.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.653 -173.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.9 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -78.74 -33.83 36.61 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.553 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 HD13 ' A' ' 68' ' ' ILE . 29.0 m -87.55 -17.79 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 26.6 t -50.71 -18.89 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -165.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -169.34 27.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.439 1.018 . . . . 0.0 111.15 -167.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -93.46 138.42 23.0 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.96 -34.91 6.74 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.191 2.594 . . . . 0.0 113.303 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.05 5.96 20.58 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 84.2 mtt180 -121.72 -9.03 8.92 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.423 -0.798 . . . . 0.0 110.374 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' HD2' ' A' ' 127' ' ' LYS . 15.5 tt -77.42 -29.35 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.567 -167.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.584 ' HD2' HG23 ' A' ' 126' ' ' ILE . 14.0 mptt -74.74 -22.88 58.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.033 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 67.7 m -85.89 -22.54 27.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.158 0.504 . . . . 0.0 110.017 174.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -72.73 -47.73 44.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.533 174.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.6 p -65.42 -30.74 71.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.062 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 6.5 tt -49.8 -53.65 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.362 173.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.8 m -71.52 -51.01 25.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -67.59 -41.61 83.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.948 0.404 . . . . 0.0 111.643 -173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.713 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 71.8 mmtt -73.5 -17.61 61.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.35 -44.64 11.91 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.174 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 76' ' ' MET . 3.0 tp -84.19 -63.27 1.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.02 -172.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.41 -30.89 60.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.054 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HB3' ' O ' ' A' ' 134' ' ' LYS . 49.3 tttm -85.17 -4.32 59.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.355 0.598 . . . . 0.0 109.621 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -73.6 -50.57 11.28 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.452 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 141' ' ' ALA . 9.8 m -76.0 -57.04 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.796 -0.202 . . . . 0.0 110.501 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . . . 169.59 152.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.704 0.802 . . . . 0.0 109.054 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -96.19 127.93 42.65 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.152 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 92' ' ' SER . 35.5 tt0 67.5 -76.13 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.501 0.501 . . . . 0.0 111.608 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.38 95.21 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.41 -73.38 1.01 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.776 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.26 77.16 1.19 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.923 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.477 ' C ' HD22 ' A' ' 147' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 110.834 -0.062 . . . . 0.0 110.834 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.67 0.272 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -75.76 110.24 10.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 110.933 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -94.81 126.41 40.11 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -152.59 117.14 5.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.069 0.461 . . . . 0.0 111.272 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.59 13.65 2.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.045 174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -115.53 -29.16 6.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.583 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.614 HD11 ' HA3' ' A' ' 118' ' ' GLY . 94.0 mt -86.1 -37.75 18.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.62 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -51.03 -46.99 61.76 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.466 0.479 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.89 -24.92 52.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 14' ' ' VAL . 3.1 tm? -78.32 -58.69 3.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.445 -174.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -76.57 -21.77 55.18 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.812 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.1 ttp180 -69.15 -35.74 76.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -69.12 -41.04 77.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.667 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 10' ' ' LEU . 94.7 t -69.05 -48.59 68.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.375 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.583 HD12 ' HB2' ' A' ' 67' ' ' SER . 13.9 tt -66.29 -29.29 46.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.965 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -61.94 -49.02 77.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 110.051 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.55 -34.77 65.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.808 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -74.27 -19.31 60.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -77.23 -32.8 56.05 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -31.65 62.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.762 175.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -129.76 84.62 60.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.267 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -90.69 140.33 2.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.946 2.431 . . . . 0.0 111.886 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 16.4 ttm180 -145.44 17.2 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.412 0.625 . . . . 0.0 110.654 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 14.9 m120 -84.08 83.79 7.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.56 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 23.1 tptm -165.64 24.81 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.017 0.437 . . . . 0.0 111.181 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.45 136.1 6.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 113.874 -175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.26 104.35 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.701 ' O ' ' HB ' ' A' ' 48' ' ' THR . 60.9 tp -105.71 95.93 6.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.985 0.422 . . . . 0.0 111.825 -173.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -84.18 91.27 7.66 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' CG ' ' HG2' ' A' ' 50' ' ' LYS . 13.4 t70 -127.58 -69.7 0.73 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.583 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -127.04 -51.13 1.43 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.059 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 49' ' ' MET . 71.4 mt -106.84 129.42 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.044 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.835 HG12 HG22 ' A' ' 48' ' ' THR . 3.1 m -142.2 82.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.508 0.67 . . . . 0.0 110.928 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 135' ' ' ALA . 49.1 t -98.81 134.69 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.272 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -128.34 147.01 50.6 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -153.1 151.2 29.91 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -152.04 145.32 24.7 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 111.898 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 41' ' ' CYS . 47.0 t-20 -124.23 111.77 28.36 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 169.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -21.56 -64.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 1 C-N-CA 125.688 4.259 . . . . 0.0 115.679 -169.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.1 m -126.6 23.65 6.76 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.551 0.691 . . . . 0.0 110.904 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' HB3' ' CG ' ' A' ' 38' ' ' ASN . 38.3 t -129.43 -36.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.687 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' HB3' ' A' ' 38' ' ' ASN . . . -140.88 62.16 0.54 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -34.82 -53.3 0.55 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.399 1.08 . . . . 0.0 113.666 -171.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -156.7 141.75 17.19 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.357 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 tt -141.44 105.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.448 0.642 . . . . 0.0 110.053 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 18.8 mmt180 -93.34 110.89 22.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.787 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD21 ' HE3' ' A' ' 49' ' ' MET . 52.2 tp -104.57 94.94 5.58 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.835 HG22 HG12 ' A' ' 33' ' ' VAL . 10.9 p -115.66 111.2 20.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -174.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.601 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 65.5 mtt -109.34 161.34 15.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.913 0.387 . . . . 0.0 111.452 -173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HE3' ' HB2' ' A' ' 52' ' ' ASP . 8.7 tmtm? -126.06 100.46 6.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 pp -100.35 108.16 20.12 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.614 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.817 ' HB2' ' HE3' ' A' ' 50' ' ' LYS . 35.6 t70 -100.06 65.77 1.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.764 0.792 . . . . 0.0 109.263 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.36 -101.45 0.27 Allowed Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.838 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 7.7 m-20 -142.63 28.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.711 -0.745 . . . . 0.0 109.811 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 1.9 pp -132.5 151.71 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 121.206 0.527 . . . . 0.0 110.193 -170.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -86.56 96.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.958 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -91.48 -69.98 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -112.46 159.02 19.17 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.21 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -157.58 132.76 8.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.636 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -123.96 120.36 32.27 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.724 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -115.96 81.13 1.55 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.415 0.626 . . . . 0.0 111.436 -176.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.95 117.31 24.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.548 176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.39 161.06 29.97 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.259 -1.448 . . . . 0.0 113.586 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.03 164.39 27.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.55 -130.46 3.33 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.255 -171.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 34.0 m -81.25 159.35 24.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.903 0.382 . . . . 0.0 110.797 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.583 ' HB2' HD12 ' A' ' 15' ' ' ILE . 5.7 p -61.82 -32.94 73.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.975 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -90.57 -24.49 5.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.694 -176.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.493 ' N ' HD13 ' A' ' 68' ' ' ILE . 31.2 p -76.68 -40.15 49.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.072 0.463 . . . . 0.0 110.913 -174.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.5 ptp -72.03 -17.22 62.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.304 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.54 -46.72 9.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.119 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' MET . 13.7 p -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.59 -51.94 43.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.26 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -70.57 -27.24 63.97 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 27.5 ttt -79.04 -49.18 13.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.083 0.468 . . . . 0.0 110.288 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 112' ' ' ASP . 90.2 mmm -63.65 -39.84 95.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.192 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.445 HG23 ' HE2' ' A' ' 49' ' ' MET . 31.5 m -75.12 -21.21 59.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.44 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.88 -41.26 78.59 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.23 -26.9 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.298 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.461 ' CD1' HG21 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -72.38 -31.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.667 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.95 -24.58 67.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.579 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -85.68 19.7 23.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.814 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 1.6 mptm? -133.69 -179.25 5.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 109.984 -176.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 5.6 p-10 -116.36 -171.37 1.99 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.34 -40.48 19.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.491 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -64.23 -40.97 97.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.408 0.623 . . . . 0.0 109.688 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.561 ' O ' ' HG3' ' A' ' 91' ' ' MET . 23.2 m -74.86 -32.02 61.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.001 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' HA ' ' CE ' ' A' ' 91' ' ' MET . . . -61.28 -48.65 80.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.91 0.386 . . . . 0.0 110.847 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 141' ' ' ALA . 72.2 mt -59.14 -39.75 83.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.355 0.598 . . . . 0.0 109.577 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.2 m -70.51 -19.89 62.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.232 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.678 ' HA ' HG12 ' A' ' 94' ' ' ILE . 67.1 mtm -79.32 -19.38 50.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.81 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 23.6 t -85.46 -32.62 22.18 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -58.62 -43.13 89.56 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.245 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.678 HG12 ' HA ' ' A' ' 91' ' ' MET . 40.5 pt -82.87 -23.94 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.105 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 37.7 t80 -58.11 -46.97 84.65 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.131 0.491 . . . . 0.0 110.172 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 p -79.85 -27.85 40.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 94' ' ' ILE . 22.0 t70 -66.1 -31.22 71.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.7 ttt -54.33 -21.83 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.0 ttm -82.34 -24.52 34.52 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -134.4 -42.49 0.78 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.79 -37.42 7.37 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.571 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 tptp 71.52 25.37 3.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.304 0.642 . . . . 0.0 111.114 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.75 137.56 51.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.082 0.468 . . . . 0.0 110.753 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' HD12 ' A' ' 94' ' ' ILE . 2.2 m-85 -117.02 -145.99 0.39 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -127.18 75.08 1.55 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 70.35 -4.34 1.61 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.774 169.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 109' ' ' ASP . 13.4 p -70.79 -55.5 8.43 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 104' ' ' TYR . 1.7 mp 71.32 -36.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 123.578 0.549 . . . . 0.0 111.564 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 107' ' ' SER . 4.6 p-10 -127.15 152.85 46.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 113' ' ' ILE . 2.4 mp -150.84 74.21 1.15 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.4 0.619 . . . . 0.0 109.644 -172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -57.35 -19.74 34.13 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.683 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 1.2 p-10 -65.27 -48.57 72.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.57 0.348 . . . . 0.0 111.506 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 110' ' ' LEU . 10.6 tt -71.87 -19.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.0 110.453 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.464 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 70.2 mm-40 -57.51 -31.03 65.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.594 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.96 -35.22 59.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.148 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.75 -39.22 18.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 114' ' ' GLU . 12.0 pt20 -62.1 -19.88 63.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -171.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -75.67 -51.19 7.35 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.596 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.852 HG23 ' HB2' ' A' ' 129' ' ' ALA . 23.2 m -78.51 -17.04 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 75.3 m -43.52 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -147.34 6.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.365 0.984 . . . . 0.0 112.584 -163.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.788 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 36.3 m-85 -81.38 142.5 50.52 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.96 -37.16 12.01 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.218 2.612 . . . . 0.0 113.384 -175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.93 -1.27 15.52 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 95.5 mtt180 -114.34 -3.29 13.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 121.261 -0.899 . . . . 0.0 110.095 -174.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 120' ' ' SER . 11.9 tt -70.58 -31.0 44.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.727 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HA ' ' OG1' ' A' ' 130' ' ' THR . 97.2 mttt -81.88 -22.08 37.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 55.9 m -69.54 -34.84 74.82 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.852 ' HB2' HG23 ' A' ' 119' ' ' VAL . . . -78.77 -46.53 18.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.275 -178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 127' ' ' LYS . 22.8 p -62.6 -33.96 76.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.711 -177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 128' ' ' CYS . 4.3 pp -67.68 -41.61 83.4 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.281 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 131' ' ' LEU . 17.3 m -71.73 -48.29 48.04 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.616 0.722 . . . . 0.0 110.481 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.3 t90 -63.34 -55.35 25.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.801 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.842 ' HA ' ' HB3' ' A' ' 137' ' ' GLU . 68.7 mmtt -72.6 -19.34 61.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.477 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -61.3 -45.26 95.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 110.063 173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 76' ' ' MET . 6.5 mp -86.52 -34.16 20.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.223 0.535 . . . . 0.0 109.957 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 8.3 tp10 -63.96 -20.84 66.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.681 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -109.67 -41.56 4.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.941 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.14 -50.91 60.77 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.203 -0.522 . . . . 0.0 114.138 -172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' CD1' ' A' ' 80' ' ' ILE . 15.5 m -125.27 -8.05 6.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.897 0.38 . . . . 0.0 111.753 -172.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -128.15 162.63 26.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.028 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 2.4 ttpm? 179.68 54.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.69 0.619 . . . . 0.0 109.88 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.47 ' H ' ' CB ' ' A' ' 92' ' ' SER . 36.8 mt-10 60.51 -99.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.004 174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -171.15 -66.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -159.98 106.37 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.581 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.18 96.35 0.11 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.87 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 120.638 0.256 . . . . 0.0 110.37 -179.736 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_